<html xmlns:ecco="http://owl.cs.manchester.ac.uk/diff">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>ecco</title>
      <meta charset="utf-8">
      <link rel="stylesheet" href="css/style.css">
      <link rel="stylesheet" href="css/reveal.css"><script type="text/javascript" src="js/jquery-1.4.4.js"></script><script type="text/javascript" src="js/jquery-ui-1.8.12.custom.min.js"></script><script type="text/javascript" src="js/script.js"></script><script type="text/javascript" src="js/jquery.checkboxtree.js"></script><script type="text/javascript" src="js/jquery.reveal.js"></script><script type="text/javascript" src="js/jscript.js"></script></head>
   <body>
      <h1><br></h1>
      				[<a href="index.jsp">Back Home</a>]
      				
      <form action="getXml" method="post" class="inl">
         						[<a id="top3" target="_blank" href="EccoChangeSet_labels.xml">Source XML</a>]
         					
      </form><br><br><h2 style="display:inline;">Change Summary</h2>&nbsp;
      				[<a id="top1" href="javascript:;" onClick="showAll();$('#tree1').checkboxTree('expandAll');$('#tree2').checkboxTree('expandAll')">Show All</a> | 
      				<a id="top2" href="javascript:;" onClick="hideAll();$('#tree1').checkboxTree('collapseAll');$('#tree2').checkboxTree('collapseAll');">Hide All</a>] 
      				[<a id="genViewPerml" href="#" onclick="setPermalink();">Generate View Permalink</a>]
      				
      <div id="view-plink-modal" class="reveal-modal">
         <h3>view-permalink</h3><textarea id="view-plink" rows="3" cols="60" readonly="true" style="resize: none;"></textarea><br>
         					[<a href="javascript:;" onclick="select_all('view-plink');">Select all</a>]
         					<a class="close-reveal-modal">x</a></div><br><br><form action="output" method="post" name="GenSymTrigger"><input type="hidden" name="uuid" value="51931469-aed8-4ff1-8152-fc80e01877a1-lbl"><input type="button" name="gensyms" onClick="parent.location='index_labels.html'" value="Use Labels"> <input type="button" name="gensyms" onClick="parent.location='index_names.html'" value="Use Term Names"> <input type="button" name="gensyms" onClick="parent.location='index_gensyms.html'" value="Use GenSyms"></form>
      <table width="70%" style="table-layout:fixed;">
         <tr>
            <th class="topright"><input type="checkbox" name="removals" onClick="toggleGroup('removals')">  
               <h3 style="display:inline;">Removals (543)</h3>
            </th>
            <th class="topleft"><input type="checkbox" name="additions" onClick="toggleGroup('additions')">  
               <h3 style="display:inline;">Additions (2378)</h3>
            </th>
         </tr>
         <tr>
            <td class="topright">
               <ul id="tree1">
                  <li>  <input type="checkbox" name="effRemsTrigger" onClick="toggleChanges('effRems','effRemsTrigger')">  
                     <h4 style="display:inline;">Effectual (447)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 1, not in Ontology 2, and are not entailed by Ontology 2');"><ul>
                        <li>  Weakenings (0)</li>
                        <li>  <input type="checkbox" name="effRems" onClick="toggleDiv('wkequiv','wkequivrt');">  <b>Modified Definitions (3)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Equivalence axioms that have been extended; if split into subsumptions then one was strengthened and the other weakened');"><ul style="display:none">
                              <li id="wkequivtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('wkequiv');">  <a href="#wkequiv">With Shared Terms (3)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With Retired Terms (0)
                              </li>
                           </ul>
                        </li>
                        <li id="retdesctrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effRems" onClick="toggleDiv('retdesc');">  <a href="#retdesc">Retired Descriptions (1)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms describing retired terms, i.e., terms that no longer exist in Ontology 2');"></li>
                        <li>  <input type="checkbox" name="effRems" onClick="toggleDiv('rem','remrt');">  <b>Pure Removals (443)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms with no co-relation with axioms in Ontology 2; typically related to hierachy changes');"><ul style="display:none">
                              <li id="remtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('rem');">  <a href="#rem">With Shared Terms (443)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With Retired Terms (0)
                              </li>
                           </ul>
                        </li><br></ul>
                  </li><br><li>  <input type="checkbox" name="ineffRemsTrigger" onClick="toggleChanges('ineffRems','ineffRemsTrigger')">  
                     <h4 style="display:inline;">Ineffectual (96)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 1, not in Ontology 2, but are entailed by Ontology 2, i.e., that have been removed but are still entailed');"><ul>
                        <li>  <input type="checkbox" name="ineffRems" onClick="toggleDiv('ravred','rst','rpsnovred');">  <b>Prospective Redundancy (100)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 1 for which there are more constraining related axioms in Ontology 2');"><ul style="display:none">
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Reshuffle (0)
                              </li>
                              <li>  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rst','rpsnovred');">  <b>Retired Prospective Redundancy (100)</b><b id="t1"></b>  
                                 <ul style="display:none">
                                    <li id="rsttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rst');">  <a href="#rst">Novel (74)</a></li>
                                    <li id="rpsnovredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffRems" onClick="toggleDiv('rpsnovred');">  <a href="#rpsnovred">Pseudo Novel (26)</a></li>
                                 </ul>
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Rewritten (0)
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Redundant (0)
                        </li>
                     </ul>
                  </li>
               </ul>
            </td>
            <td class="topleft" style="vertical-align:top">
               <ul id="tree2">
                  <li>  <input type="checkbox" name="effAddsTrigger" onClick="toggleChanges('effAdds','effAddsTrigger')">  
                     <h4 style="display:inline;">Effectual (2333)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 2, not in Ontology 1, and are not entailed by Ontology 1');"><ul>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('st','stnt');">  <b>Strengthenings (1)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are more constraining than existing axioms in Ontology 1');"><ul style="display:none">
                              <li id="sttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('st');">  <a href="#st">With Shared Terms (1)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With New Terms (0)
                              </li>
                           </ul>
                        </li>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequiv','stequivnt');">  <b>Modified Definitions (40)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Equivalence axioms that have been extended; if split into subsumptions then one was strengthened and the other weakened');"><ul style="display:none">
                              <li id="stequivtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('stequiv');">  <a href="#aed">With Shared Terms (40)</a></li>
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;With New Terms (0)
                              </li>
                           </ul>
                        </li>
                        <li id="newdesctrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('newdesc');">  <a href="#newdesc">New Descriptions (1791)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms describing newly created terms, i.e., terms that did not exist in Ontology 1');"></li>
                        <li>  <input type="checkbox" name="effAdds" onClick="toggleDiv('add','addnt');">  <b>Pure Additions (501)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms with no co-relation with axioms in Ontology 1; typically related to hierachy changes');"><ul style="display:none">
                              <li id="addtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('add');">  <a href="#add">With Shared Terms (459)</a></li>
                              <li id="addnttrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="effAdds" onClick="toggleDiv('addnt');">  <a href="#addnt">With New Terms (42)</a></li>
                           </ul>
                        </li>
                     </ul>
                  </li><br><li>  <input type="checkbox" name="ineffAddsTrigger" onClick="toggleChanges('ineffAdds','ineffAddsTrigger')">  
                     <h4 style="display:inline;">Ineffectual (45)</h4>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms that are in Ontology 2, not in Ontology 1, but are entailed by Ontology 1, i.e., that have been added but were already entailed');"><ul>
                        <li>  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aavred','apseudopred','aweak');">  <b>Retrospective Redundancy (42)</b>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 2 for which there are more constraining related axioms in Ontology 1');"><ul style="display:none">
                              <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Reshuffle (0)
                              </li>
                              <li>  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aweak','apseudopred');">  <b>New Retrospective Redundancy (42)</b>  
                                 <ul style="display:none">
                                    <li id="aweaktrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('aweak');">  <a href="#aweak">Novel (42)</a></li>
                                    <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Pseudo Novel (0)
                                    </li>
                                 </ul>
                              </li>
                           </ul>
                        </li>
                        <li><img src="images/blank.png" alt="">&nbsp;&nbsp;Rewritten (0)
                        </li>
                        <li id="aredtrig"><img src="images/blank.png" alt="">  <input type="checkbox" name="ineffAdds" onClick="toggleDiv('ared')">  <a href="#ared">Redundant (3)</a>  <img src="images/info_bubble.png" alt="" align="right" width="14" height="14" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Axioms in Ontology 2 that are entailed by at least one shared axiom between Ontology 1 and 2');"></li>
                     </ul>
                  </li>
               </ul>
            </td>
         </tr>
         <tr>
            <td class="topright">[<a href="javascript:void(0);" id="tree1-expandAll">Expand All</a> | <a href="javascript:void(0);" id="tree1-collapseAll">Collapse All</a>]
            </td>
            <td class="topleft">[<a href="javascript:void(0);" id="tree2-expandAll">Expand All</a> | <a href="javascript:void(0);" id="tree2-collapseAll">Collapse All</a>]
            </td>
         </tr>
      </table>
      <table width="100%" style="table-layout:fixed;">
         <colgroup>
            <col>
            <col width="47.5%">
            <col width="47.5%">
         </colgroup>
         <tbody id="st" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Strengthenings with Shared Terms (1)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Weaker Axiom in Ontology 1</th>
               <th class="addition">Strengthened Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1</td>
               <td>Coagulation Factor X<span class="subclass"> SubClassOf </span>Coagulation Factor. 
               </td>
               <td>Coagulation Factor X<span class="subclass"> EquivalentTo </span>Coagulation Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>F10 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Coagulation Factor)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Intrinsic Prothrombin Activation Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Homeostasis)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Proteolytic Processing).<br></td>
            </tr>
         </tbody>
         <tbody id="newdesc" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">New Descriptions (1791)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">New Description Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>60</td>
               <td colspan="2">.Alpha.-D-Glucopyranose<span class="subclass"> SubClassOf </span>Carbohydrate. <br><i>New Terms: .Alpha.-D-Glucopyranose</i></td>
            </tr>
            <tr class="addition">
               <td>227</td>
               <td colspan="2">.Beta.-D-Fructopyranose<span class="subclass"> SubClassOf </span>Carbohydrate. <br><i>New Terms: .Beta.-D-Fructopyranose</i></td>
            </tr>
            <tr class="addition">
               <td>228</td>
               <td colspan="2">.Beta.-D-Xylopyranose<span class="subclass"> SubClassOf </span>Carbohydrate. <br><i>New Terms: .Beta.-D-Xylopyranose</i></td>
            </tr>
            <tr class="addition">
               <td>1636</td>
               <td colspan="2">1,1,2,2-Tetrafluoroethane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: 1,1,2,2-Tetrafluoroethane</i></td>
            </tr>
            <tr class="addition">
               <td>1784</td>
               <td colspan="2">1,3-Dimethylol-5,5-Dimethyl-Hydantoin<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: 1,3-Dimethylol-5,5-Dimethyl-Hydantoin</i></td>
            </tr>
            <tr class="addition">
               <td>1174</td>
               <td colspan="2">1-Methyl-2-Pyrrolidinone<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: 1-Methyl-2-Pyrrolidinone</i></td>
            </tr>
            <tr class="addition">
               <td>1792</td>
               <td colspan="2">1-O-Tolylbiguanide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: 1-O-Tolylbiguanide</i></td>
            </tr>
            <tr class="addition">
               <td>1183</td>
               <td colspan="2">2-(Diethylamino)Ethyl Methacrylate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: 2-(Diethylamino)Ethyl Methacrylate</i></td>
            </tr>
            <tr class="addition">
               <td>1785</td>
               <td colspan="2">2-Amino-5-Nitrothiazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: 2-Amino-5-Nitrothiazole</i></td>
            </tr>
            <tr class="addition">
               <td>1786</td>
               <td colspan="2">3,6-Diamino-10-methylacridinium Chloride<span class="subclass"> SubClassOf </span>Dye. <br><i>New Terms: 3,6-Diamino-10-methylacridinium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>1787</td>
               <td colspan="2">3,6-Diamino-10-methylacridinium Chloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: 3,6-Diamino-10-methylacridinium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>1788</td>
               <td colspan="2">4-Iodo-3-Nitrobenzamide<span class="subclass"> SubClassOf </span>Poly (ADP-Ribose) Polymerase Inhibitor. <br><i>New Terms: 4-Iodo-3-Nitrobenzamide</i></td>
            </tr>
            <tr class="addition">
               <td>1789</td>
               <td colspan="2">50% Oxygen/50% Nitrous Oxide Premix<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: 50% Oxygen/50% Nitrous Oxide Premix</i></td>
            </tr>
            <tr class="addition">
               <td>1790</td>
               <td colspan="2">99mTc-DTPA-Mannosyl-Dextran<span class="subclass"> SubClassOf </span>Radioconjugate. <br><i>New Terms: 99mTc-DTPA-Mannosyl-Dextran</i></td>
            </tr>
            <tr class="addition">
               <td>2</td>
               <td colspan="2">Abdominal Fluid<span class="subclass"> SubClassOf </span>Biospecimen. <br><i>New Terms: Abdominal Fluid</i></td>
            </tr>
            <tr class="addition">
               <td>3</td>
               <td colspan="2">Abdominal Wall<span class="subclass"> SubClassOf </span>Body Part. <br><i>New Terms: Abdominal Wall</i></td>
            </tr>
            <tr class="addition">
               <td>4</td>
               <td colspan="2">Abecarnil<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Abecarnil</i></td>
            </tr>
            <tr class="addition">
               <td>5</td>
               <td colspan="2">Abiraterone<span class="subclass"> SubClassOf </span>Anti-Androgen. <br><i>New Terms: Abiraterone</i></td>
            </tr>
            <tr class="addition">
               <td>6</td>
               <td colspan="2">Acebrochol<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Acebrochol</i></td>
            </tr>
            <tr class="addition">
               <td>7</td>
               <td colspan="2">Acecarbromal<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Acecarbromal</i></td>
            </tr>
            <tr class="addition">
               <td>8</td>
               <td colspan="2">Acedapsone<span class="subclass"> SubClassOf </span>Sulfone Anti-Infective Agent. <br><i>New Terms: Acedapsone</i></td>
            </tr>
            <tr class="addition">
               <td>9</td>
               <td colspan="2">Acediasulfone<span class="subclass"> SubClassOf </span>Sulfone Anti-Infective Agent. <br><i>New Terms: Acediasulfone</i></td>
            </tr>
            <tr class="addition">
               <td>10</td>
               <td colspan="2">Acefluranol<span class="subclass"> SubClassOf </span>Antiestrogen. <br><i>New Terms: Acefluranol</i></td>
            </tr>
            <tr class="addition">
               <td>11</td>
               <td colspan="2">Aceglutamide<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Aceglutamide</i></td>
            </tr>
            <tr class="addition">
               <td>13</td>
               <td colspan="2">Acepromazine Maleate<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Acepromazine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>12</td>
               <td colspan="2">Acepromazine<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Acepromazine</i></td>
            </tr>
            <tr class="addition">
               <td>15</td>
               <td colspan="2">Acesulfame Potassium<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Acesulfame Potassium</i></td>
            </tr>
            <tr class="addition">
               <td>14</td>
               <td colspan="2">Acesulfame<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Acesulfame</i></td>
            </tr>
            <tr class="addition">
               <td>16</td>
               <td colspan="2">Acetanilide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Acetanilide</i></td>
            </tr>
            <tr class="addition">
               <td>17</td>
               <td colspan="2">Acetomeroctol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Acetomeroctol</i></td>
            </tr>
            <tr class="addition">
               <td>18</td>
               <td colspan="2">Acetone Sodium Bisulfite<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Acetone Sodium Bisulfite</i></td>
            </tr>
            <tr class="addition">
               <td>19</td>
               <td colspan="2">Acetophenone<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Acetophenone</i></td>
            </tr>
            <tr class="addition">
               <td>21</td>
               <td colspan="2">Acetosulfone Sodium<span class="subclass"> SubClassOf </span>Sulfone Anti-Infective Agent. <br><i>New Terms: Acetosulfone Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>20</td>
               <td colspan="2">Acetosulfone<span class="subclass"> SubClassOf </span>Sulfone Anti-Infective Agent. <br><i>New Terms: Acetosulfone</i></td>
            </tr>
            <tr class="addition">
               <td>22</td>
               <td colspan="2">Acetylcholine<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Acetylcholine</i></td>
            </tr>
            <tr class="addition">
               <td>23</td>
               <td colspan="2">Acetyltryptophan<span class="subclass"> SubClassOf </span>Amino Acid. <br><i>New Terms: Acetyltryptophan</i></td>
            </tr>
            <tr class="addition">
               <td>24</td>
               <td colspan="2">Acevaltrate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Acevaltrate</i></td>
            </tr>
            <tr class="addition">
               <td>25</td>
               <td colspan="2">Aconiazide<span class="subclass"> SubClassOf </span>Antitubercular Agent. <br><i>New Terms: Aconiazide</i></td>
            </tr>
            <tr class="addition">
               <td>26</td>
               <td colspan="2">Acridorex<span class="subclass"> SubClassOf </span>Anorexiant. <br><i>New Terms: Acridorex</i></td>
            </tr>
            <tr class="addition">
               <td>27</td>
               <td colspan="2">Acrocinonide<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Acrocinonide</i></td>
            </tr>
            <tr class="addition">
               <td>28</td>
               <td colspan="2">Ad-sig-hMUC-1/ecdCD40L Vaccine<span class="subclass"> SubClassOf </span>Adenovirus Vaccine. <br><i>New Terms: Ad-sig-hMUC-1/ecdCD40L Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>29</td>
               <td colspan="2">Adaprolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Adaprolol</i></td>
            </tr>
            <tr class="addition">
               <td>30</td>
               <td colspan="2">Adekalant<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Adekalant</i></td>
            </tr>
            <tr class="addition">
               <td>32</td>
               <td colspan="2">Adinazolam Mesylate<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Adinazolam Mesylate</i></td>
            </tr>
            <tr class="addition">
               <td>31</td>
               <td colspan="2">Adinazolam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Adinazolam</i></td>
            </tr>
            <tr class="addition">
               <td>33</td>
               <td colspan="2">Adiphenine<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Adiphenine</i></td>
            </tr>
            <tr class="addition">
               <td>34</td>
               <td colspan="2">Adipic Acid<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Adipic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>35</td>
               <td colspan="2">Adipiplon<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Adipiplon</i></td>
            </tr>
            <tr class="addition">
               <td>36</td>
               <td colspan="2">Aerosol Sargramostim<span class="subclass"> SubClassOf </span>Recombinant Granulocyte-Macrophage Colony-Stimulating Factor. <br><i>New Terms: Aerosol Sargramostim</i></td>
            </tr>
            <tr class="addition">
               <td>37</td>
               <td colspan="2">Aglepristone<span class="subclass"> SubClassOf </span>Progesterone Antagonist. <br><i>New Terms: Aglepristone</i></td>
            </tr>
            <tr class="addition">
               <td>38</td>
               <td colspan="2">Ajellomyces capsulatus<span class="subclass"> SubClassOf </span>Ascomycota. <br><i>New Terms: Ajellomyces capsulatus, Ascomycota</i></td>
            </tr>
            <tr class="addition">
               <td>39</td>
               <td colspan="2">Aklomide<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Aklomide</i></td>
            </tr>
            <tr class="addition">
               <td>40</td>
               <td colspan="2">Alamifovir<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Alamifovir</i></td>
            </tr>
            <tr class="addition">
               <td>41</td>
               <td colspan="2">Albiglutide<span class="subclass"> SubClassOf </span>Anti-diabetic Agent. <br><i>New Terms: Albiglutide</i></td>
            </tr>
            <tr class="addition">
               <td>42</td>
               <td colspan="2">Alcloxa<span class="subclass"> SubClassOf </span>Astringent. <br><i>New Terms: Alcloxa</i></td>
            </tr>
            <tr class="addition">
               <td>43</td>
               <td colspan="2">Aldioxa<span class="subclass"> SubClassOf </span>Astringent. <br><i>New Terms: Aldioxa</i></td>
            </tr>
            <tr class="addition">
               <td>44</td>
               <td colspan="2">Alentemol<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Alentemol</i></td>
            </tr>
            <tr class="addition">
               <td>45</td>
               <td colspan="2">Alestramustine<span class="subclass"> SubClassOf </span>Nitrogen Mustard Compound. <br><i>New Terms: Alestramustine</i></td>
            </tr>
            <tr class="addition">
               <td>46</td>
               <td colspan="2">Aletamine<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Aletamine</i></td>
            </tr>
            <tr class="addition">
               <td>47</td>
               <td colspan="2">Aletamine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Aletamine</i></td>
            </tr>
            <tr class="addition">
               <td>48</td>
               <td colspan="2">Alifedrine<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Alifedrine</i></td>
            </tr>
            <tr class="addition">
               <td>49</td>
               <td colspan="2">Alitame Anhydrous<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Alitame Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>50</td>
               <td colspan="2">Alletorphine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Alletorphine</i></td>
            </tr>
            <tr class="addition">
               <td>51</td>
               <td colspan="2">Allobarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Allobarbital</i></td>
            </tr>
            <tr class="addition">
               <td>52</td>
               <td colspan="2">Allogeneic Human Adult Bone Marrow-Derived Progenitor Cells<span class="subclass"> SubClassOf </span>Biological Agent. <br><i>New Terms: Allogeneic Human Adult Bone Marrow-Derived Progenitor Cells</i></td>
            </tr>
            <tr class="addition">
               <td>53</td>
               <td colspan="2">Almokalant<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Almokalant</i></td>
            </tr>
            <tr class="addition">
               <td>54</td>
               <td colspan="2">Alniditan<span class="subclass"> SubClassOf </span>Serotonin Agonist. <br><i>New Terms: Alniditan</i></td>
            </tr>
            <tr class="addition">
               <td>55</td>
               <td colspan="2">Alogliptin<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Alogliptin</i></td>
            </tr>
            <tr class="addition">
               <td>56</td>
               <td colspan="2">Aloin<span class="subclass"> SubClassOf </span>Laxative. <br><i>New Terms: Aloin</i></td>
            </tr>
            <tr class="addition">
               <td>57</td>
               <td colspan="2">Alonacic<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Alonacic</i></td>
            </tr>
            <tr class="addition">
               <td>58</td>
               <td colspan="2">Aloxistatin<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Aloxistatin</i></td>
            </tr>
            <tr class="addition">
               <td>59</td>
               <td colspan="2">Alpha-Cypermethrin<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Alpha-Cypermethrin</i></td>
            </tr>
            <tr class="addition">
               <td>61</td>
               <td colspan="2">Alpha-Terpineol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Alpha-Terpineol</i></td>
            </tr>
            <tr class="addition">
               <td>62</td>
               <td colspan="2">Altanserin<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Altanserin</i></td>
            </tr>
            <tr class="addition">
               <td>63</td>
               <td colspan="2">Alteconazole<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Alteconazole</i></td>
            </tr>
            <tr class="addition">
               <td>64</td>
               <td colspan="2">Altinicline<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Altinicline</i></td>
            </tr>
            <tr class="addition">
               <td>65</td>
               <td colspan="2">Aluminum Chloride<span class="subclass"> SubClassOf </span>Astringent. <br><i>New Terms: Aluminum Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>66</td>
               <td colspan="2">Aluminum Monostearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Aluminum Monostearate</i></td>
            </tr>
            <tr class="addition">
               <td>67</td>
               <td colspan="2">Aluminum Oxide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Aluminum Oxide</i></td>
            </tr>
            <tr class="addition">
               <td>68</td>
               <td colspan="2">Aluminum Subacetate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Aluminum Subacetate</i></td>
            </tr>
            <tr class="addition">
               <td>70</td>
               <td colspan="2">Alvameline Maleate<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Alvameline Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>69</td>
               <td colspan="2">Alvameline<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Alvameline</i></td>
            </tr>
            <tr class="addition">
               <td>71</td>
               <td colspan="2">Alverine<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Alverine</i></td>
            </tr>
            <tr class="addition">
               <td>72</td>
               <td colspan="2">Alvespimycin Hydrochloride<span class="subclass"> SubClassOf </span>Heat Shock Protein Inhibitor. <br><i>New Terms: Alvespimycin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>73</td>
               <td colspan="2">Alvimopan Anhydrous<span class="subclass"> SubClassOf </span>Opiate Antagonist. <br><i>New Terms: Alvimopan Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>74</td>
               <td colspan="2">Ambroxol Hydrochloride<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Ambroxol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>75</td>
               <td colspan="2">Ambuphylline<span class="subclass"> SubClassOf </span>Bronchodilator. <br><i>New Terms: Ambuphylline</i></td>
            </tr>
            <tr class="addition">
               <td>76</td>
               <td colspan="2">Amdoxovir<span class="subclass"> SubClassOf </span>Reverse Transcriptase Inhibitor. <br><i>New Terms: Amdoxovir</i></td>
            </tr>
            <tr class="addition">
               <td>77</td>
               <td colspan="2">Amibegron<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Amibegron</i></td>
            </tr>
            <tr class="addition">
               <td>79</td>
               <td colspan="2">Aminacrine Hydrochloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Aminacrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>78</td>
               <td colspan="2">Aminacrine<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Aminacrine</i></td>
            </tr>
            <tr class="addition">
               <td>80</td>
               <td colspan="2">Aminomethylpropanol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Aminomethylpropanol</i></td>
            </tr>
            <tr class="addition">
               <td>81</td>
               <td colspan="2">Aminometradine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Aminometradine</i></td>
            </tr>
            <tr class="addition">
               <td>83</td>
               <td colspan="2">Aminopromazine Fumarate<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Aminopromazine Fumarate</i></td>
            </tr>
            <tr class="addition">
               <td>82</td>
               <td colspan="2">Aminopromazine<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Aminopromazine</i></td>
            </tr>
            <tr class="addition">
               <td>84</td>
               <td colspan="2">Aminopyrine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Aminopyrine</i></td>
            </tr>
            <tr class="addition">
               <td>85</td>
               <td colspan="2">Aminosalicylate Calcium<span class="subclass"> SubClassOf </span>Antitubercular Agent. <br><i>New Terms: Aminosalicylate Calcium</i></td>
            </tr>
            <tr class="addition">
               <td>87</td>
               <td colspan="2">Amiprilose Hydrochloride<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Amiprilose Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>86</td>
               <td colspan="2">Amiprilose<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Amiprilose</i></td>
            </tr>
            <tr class="addition">
               <td>88</td>
               <td colspan="2">Amisometradine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Amisometradine</i></td>
            </tr>
            <tr class="addition">
               <td>89</td>
               <td colspan="2">Ammonia<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ammonia</i></td>
            </tr>
            <tr class="addition">
               <td>90</td>
               <td colspan="2">Ammonium Acetate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ammonium Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>91</td>
               <td colspan="2">Ammonium Bromide<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Ammonium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>92</td>
               <td colspan="2">Ammonium Lauryl Sulfate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ammonium Lauryl Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>93</td>
               <td colspan="2">Ammonium Phosphate<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Ammonium Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>94</td>
               <td colspan="2">Ammonium Salicylate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Ammonium Salicylate</i></td>
            </tr>
            <tr class="addition">
               <td>95</td>
               <td colspan="2">Ammonium Sulfate<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Ammonium Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>97</td>
               <td colspan="2">Amobarbital Sodium<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Amobarbital Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>96</td>
               <td colspan="2">Amobarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Amobarbital</i></td>
            </tr>
            <tr class="addition">
               <td>98</td>
               <td colspan="2">Amogastrin<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br><i>New Terms: Amogastrin</i></td>
            </tr>
            <tr class="addition">
               <td>99</td>
               <td colspan="2">Amotosalen<span class="subclass"> SubClassOf </span>DNA Intercalating Agent. <br><i>New Terms: Amotosalen</i></td>
            </tr>
            <tr class="addition">
               <td>100</td>
               <td colspan="2">Amperozide Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Amperozide Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>101</td>
               <td colspan="2">Amphenidone<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Amphenidone</i></td>
            </tr>
            <tr class="addition">
               <td>102</td>
               <td colspan="2">Amphetamine Hydrochloride<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Amphetamine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>103</td>
               <td colspan="2">Amprolium<span class="subclass"> SubClassOf </span>Antiparasitic Agent. <br><i>New Terms: Amprolium</i></td>
            </tr>
            <tr class="addition">
               <td>104</td>
               <td colspan="2">Ampullary Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Ampullary Gland</i></td>
            </tr>
            <tr class="addition">
               <td>105</td>
               <td colspan="2">Ampyzine Sulfate<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Ampyzine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>106</td>
               <td colspan="2">Amyl Acetate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Amyl Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>108</td>
               <td colspan="2">Anaritide Acetate<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Anaritide Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>107</td>
               <td colspan="2">Anaritide<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Anaritide</i></td>
            </tr>
            <tr class="addition">
               <td>109</td>
               <td colspan="2">Anazocine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Anazocine</i></td>
            </tr>
            <tr class="addition">
               <td>110</td>
               <td colspan="2">Anethole<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Anethole</i></td>
            </tr>
            <tr class="addition">
               <td>111</td>
               <td colspan="2">Angiotensin Amide<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Angiotensin Amide</i></td>
            </tr>
            <tr class="addition">
               <td>112</td>
               <td colspan="2">Animalia<span class="subclass"> SubClassOf </span>Other Organism Groupings. <br><i>New Terms: Animalia</i></td>
            </tr>
            <tr class="addition">
               <td>113</td>
               <td colspan="2">Anipamil<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Anipamil</i></td>
            </tr>
            <tr class="addition">
               <td>114</td>
               <td colspan="2">Anisperimus<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Anisperimus</i></td>
            </tr>
            <tr class="addition">
               <td>115</td>
               <td colspan="2">Antazoline Hydrochloride<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Antazoline Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>116</td>
               <td colspan="2">Anti-CD200 Monoclonal Antibody ALXN6000<span class="subclass"> SubClassOf </span>Monoclonal Antibody. <br><i>New Terms: Anti-CD200 Monoclonal Antibody ALXN6000</i></td>
            </tr>
            <tr class="addition">
               <td>117</td>
               <td colspan="2">Anti-CD30 Monoclonal Antibody MDX-1401<span class="subclass"> SubClassOf </span>Monoclonal Antibody. <br><i>New Terms: Anti-CD30 Monoclonal Antibody MDX-1401</i></td>
            </tr>
            <tr class="addition">
               <td>118</td>
               <td colspan="2">Anti-CEA IgCD28TCR-Transduced Autologous T Cells<span class="subclass"> SubClassOf </span>Biological Agent. <br><i>New Terms: Anti-CEA IgCD28TCR-Transduced Autologous T Cells</i></td>
            </tr>
            <tr class="addition">
               <td>119</td>
               <td colspan="2">Anti-EpCAM/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT110<span class="subclass"> SubClassOf </span>Bispecific Antibody. <br><i>New Terms: Anti-EpCAM/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT110</i></td>
            </tr>
            <tr class="addition">
               <td>120</td>
               <td colspan="2">Antimony Potassium Tartrate<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Antimony Potassium Tartrate</i></td>
            </tr>
            <tr class="addition">
               <td>121</td>
               <td colspan="2">Antipyrine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Antipyrine</i></td>
            </tr>
            <tr class="addition">
               <td>122</td>
               <td colspan="2">Apafant<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Apafant</i></td>
            </tr>
            <tr class="addition">
               <td>123</td>
               <td colspan="2">Apaflurane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Apaflurane</i></td>
            </tr>
            <tr class="addition">
               <td>125</td>
               <td colspan="2">Aplaviroc Hydrochloride<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Aplaviroc Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>124</td>
               <td colspan="2">Aplaviroc<span class="subclass"> SubClassOf </span>Anti-HIV Agent. <br><i>New Terms: Aplaviroc</i></td>
            </tr>
            <tr class="addition">
               <td>127</td>
               <td colspan="2">Aplindore Fumarate<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Aplindore Fumarate</i></td>
            </tr>
            <tr class="addition">
               <td>126</td>
               <td colspan="2">Aplindore<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Aplindore</i></td>
            </tr>
            <tr class="addition">
               <td>128</td>
               <td colspan="2">Application Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Application Site</i></td>
            </tr>
            <tr class="addition">
               <td>129</td>
               <td colspan="2">Apratastat<span class="subclass"> SubClassOf </span>Matrix Metalloproteinase Inhibitor. <br><i>New Terms: Apratastat</i></td>
            </tr>
            <tr class="addition">
               <td>130</td>
               <td colspan="2">Apricoxib<span class="subclass"> SubClassOf </span>Cyclooxygenase Inhibitor. <br><i>New Terms: Apricoxib</i></td>
            </tr>
            <tr class="addition">
               <td>131</td>
               <td colspan="2">Aprikalim<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Aprikalim</i></td>
            </tr>
            <tr class="addition">
               <td>133</td>
               <td colspan="2">Aprindine Hydrochloride<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Aprindine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>132</td>
               <td colspan="2">Aprindine<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Aprindine</i></td>
            </tr>
            <tr class="addition">
               <td>134</td>
               <td colspan="2">Aprobarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Aprobarbital</i></td>
            </tr>
            <tr class="addition">
               <td>135</td>
               <td colspan="2">Aprosulate Sodium<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Aprosulate Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>136</td>
               <td colspan="2">Arbitrary Fluorescence Units<span class="subclass"> SubClassOf </span>Fluorescence Units. <br><i>New Terms: Arbitrary Fluorescence Units</i></td>
            </tr>
            <tr class="addition">
               <td>137</td>
               <td colspan="2">Arecoline<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Arecoline</i></td>
            </tr>
            <tr class="addition">
               <td>138</td>
               <td colspan="2">Argimesna<span class="subclass"> SubClassOf </span>Uroprotective Agent. <br><i>New Terms: Argimesna</i></td>
            </tr>
            <tr class="addition">
               <td>139</td>
               <td colspan="2">Arginine Glutamate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Arginine Glutamate</i></td>
            </tr>
            <tr class="addition">
               <td>140</td>
               <td colspan="2">Arildone<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Arildone</i></td>
            </tr>
            <tr class="addition">
               <td>141</td>
               <td colspan="2">Arsthinol<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Arsthinol</i></td>
            </tr>
            <tr class="addition">
               <td>142</td>
               <td colspan="2">Artemisinin<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Artemisinin</i></td>
            </tr>
            <tr class="addition">
               <td>143</td>
               <td colspan="2">Arthropoda<span class="subclass"> SubClassOf </span>Invertebrate. <br><i>New Terms: Arthropoda</i></td>
            </tr>
            <tr class="addition">
               <td>144</td>
               <td colspan="2">Ascomycota<span class="subclass"> SubClassOf </span>Fungus. <br><i>New Terms: Ascomycota</i></td>
            </tr>
            <tr class="addition">
               <td>145</td>
               <td colspan="2">Ashwagandha Root Powder Extract<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Ashwagandha Root Powder Extract</i></td>
            </tr>
            <tr class="addition">
               <td>146</td>
               <td colspan="2">Aspartame<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Aspartame</i></td>
            </tr>
            <tr class="addition">
               <td>147</td>
               <td colspan="2">Aspergillus<span class="subclass"> SubClassOf </span>Ascomycota. <br><i>New Terms: Ascomycota, Aspergillus</i></td>
            </tr>
            <tr class="addition">
               <td>148</td>
               <td colspan="2">Aspergillus flavus<span class="subclass"> SubClassOf </span>Aspergillus. <br><i>New Terms: Aspergillus flavus, Aspergillus</i></td>
            </tr>
            <tr class="addition">
               <td>149</td>
               <td colspan="2">Aspergillus fumigatus<span class="subclass"> SubClassOf </span>Aspergillus. <br><i>New Terms: Aspergillus fumigatus, Aspergillus</i></td>
            </tr>
            <tr class="addition">
               <td>150</td>
               <td colspan="2">Aspergillus niger<span class="subclass"> SubClassOf </span>Aspergillus. <br><i>New Terms: Aspergillus niger, Aspergillus</i></td>
            </tr>
            <tr class="addition">
               <td>151</td>
               <td colspan="2">Aspirin Aluminum<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Aspirin Aluminum</i></td>
            </tr>
            <tr class="addition">
               <td>152</td>
               <td colspan="2">Ataprost<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Ataprost</i></td>
            </tr>
            <tr class="addition">
               <td>153</td>
               <td colspan="2">Atilmotin<span class="subclass"> SubClassOf </span>Miscellaneous Hormone Agent. <br><i>New Terms: Atilmotin</i></td>
            </tr>
            <tr class="addition">
               <td>154</td>
               <td colspan="2">Atiprimod Dihydrochloride<span class="subclass"> SubClassOf </span>Signal Transduction Inhibitor. <br><i>New Terms: Atiprimod Dihydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>155</td>
               <td colspan="2">Atiprimod Dimaleate<span class="subclass"> SubClassOf </span>Signal Transduction Inhibitor. <br><i>New Terms: Atiprimod Dimaleate</i></td>
            </tr>
            <tr class="addition">
               <td>156</td>
               <td colspan="2">Atiprosin<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Antagonist. <br><i>New Terms: Atiprosin</i></td>
            </tr>
            <tr class="addition">
               <td>157</td>
               <td colspan="2">Atolide<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Atolide</i></td>
            </tr>
            <tr class="addition">
               <td>158</td>
               <td colspan="2">Auricular Vein<span class="subclass"> SubClassOf </span>Vein. <br><i>New Terms: Auricular Vein</i></td>
            </tr>
            <tr class="addition">
               <td>159</td>
               <td colspan="2">Avridine<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: Avridine</i></td>
            </tr>
            <tr class="addition">
               <td>160</td>
               <td colspan="2">Azacosterol Hydrochloride<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Azacosterol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>161</td>
               <td colspan="2">Azacosterol Hydrochloride<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Azacosterol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>163</td>
               <td colspan="2">Azacyclonol Hydrochloride<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Azacyclonol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>162</td>
               <td colspan="2">Azacyclonol<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Azacyclonol</i></td>
            </tr>
            <tr class="addition">
               <td>164</td>
               <td colspan="2">Azaribine<span class="subclass"> SubClassOf </span>Pyrimidine Antagonist. <br><i>New Terms: Azaribine</i></td>
            </tr>
            <tr class="addition">
               <td>165</td>
               <td colspan="2">Azasetron Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Azasetron Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>166</td>
               <td colspan="2">Azastene<span class="subclass"> SubClassOf </span>Oral Contraceptive. <br><i>New Terms: Azastene</i></td>
            </tr>
            <tr class="addition">
               <td>167</td>
               <td colspan="2">Azatadine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Azatadine</i></td>
            </tr>
            <tr class="addition">
               <td>168</td>
               <td colspan="2">Azetepa<span class="subclass"> SubClassOf </span>Ethylenimine Compound. <br><i>New Terms: Azetepa</i></td>
            </tr>
            <tr class="addition">
               <td>169</td>
               <td colspan="2">Azidocillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Azidocillin</i></td>
            </tr>
            <tr class="addition">
               <td>170</td>
               <td colspan="2">Azimilide Dihydrochloride<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Azimilide Dihydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>171</td>
               <td colspan="2">Azolimine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Azolimine</i></td>
            </tr>
            <tr class="addition">
               <td>172</td>
               <td colspan="2">Azosemide<span class="subclass"> SubClassOf </span>Loop Diuretic. <br><i>New Terms: Azosemide</i></td>
            </tr>
            <tr class="addition">
               <td>173</td>
               <td colspan="2">B7-DC Crosslinking Antibody rHIgM12B7<span class="subclass"> SubClassOf </span>Monoclonal Antibody. <br><i>New Terms: B7-DC Crosslinking Antibody rHIgM12B7</i></td>
            </tr>
            <tr class="addition">
               <td>174</td>
               <td colspan="2">Bacillus Calmette-Guerin Antigen<span class="subclass"> SubClassOf </span>Antigen. <br><i>New Terms: Bacillus Calmette-Guerin Antigen</i></td>
            </tr>
            <tr class="addition">
               <td>175</td>
               <td colspan="2">Bacillus Calmette-Guerin Live Antigen, A<span class="subclass"> SubClassOf </span>Bacillus Calmette-Guerin Antigen. <br><i>New Terms: Bacillus Calmette-Guerin Antigen, Bacillus Calmette-Guerin Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>176</td>
               <td colspan="2">Bacillus Calmette-Guerin Live Antigen, B<span class="subclass"> SubClassOf </span>Bacillus Calmette-Guerin Antigen. <br><i>New Terms: Bacillus Calmette-Guerin Antigen, Bacillus Calmette-Guerin Live Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>177</td>
               <td colspan="2">Balaglitazone<span class="subclass"> SubClassOf </span>Anti-diabetic Agent. <br><i>New Terms: Balaglitazone</i></td>
            </tr>
            <tr class="addition">
               <td>178</td>
               <td colspan="2">Balamapimod<span class="subclass"> SubClassOf </span>Mitogen-Activated Protein Kinase Inhibitor. <br><i>New Terms: Balamapimod</i></td>
            </tr>
            <tr class="addition">
               <td>180</td>
               <td colspan="2">Bamifylline Hydrochloride<span class="subclass"> SubClassOf </span>Bronchodilator. <br><i>New Terms: Bamifylline Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>179</td>
               <td colspan="2">Bamifylline<span class="subclass"> SubClassOf </span>Bronchodilator. <br><i>New Terms: Bamifylline</i></td>
            </tr>
            <tr class="addition">
               <td>181</td>
               <td colspan="2">Barbexaclone<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Barbexaclone</i></td>
            </tr>
            <tr class="addition">
               <td>183</td>
               <td colspan="2">Barbital Sodium<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Barbital Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>182</td>
               <td colspan="2">Barbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Barbital</i></td>
            </tr>
            <tr class="addition">
               <td>184</td>
               <td colspan="2">Basidiomycota<span class="subclass"> SubClassOf </span>Fungus. <br><i>New Terms: Basidiomycota</i></td>
            </tr>
            <tr class="addition">
               <td>186</td>
               <td colspan="2">Batelapine Maleate<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Batelapine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>185</td>
               <td colspan="2">Batelapine<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Batelapine</i></td>
            </tr>
            <tr class="addition">
               <td>187</td>
               <td colspan="2">Becanthone Hydrochloride<span class="subclass"> SubClassOf </span>Antiparasitic Agent. <br><i>New Terms: Becanthone Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>188</td>
               <td colspan="2">Becocalcidiol<span class="subclass"> SubClassOf </span>Vitamin D Analog. <br><i>New Terms: Becocalcidiol</i></td>
            </tr>
            <tr class="addition">
               <td>189</td>
               <td colspan="2">Bederocin<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Bederocin</i></td>
            </tr>
            <tr class="addition">
               <td>190</td>
               <td colspan="2">Bedoradrine Sulfate<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Bedoradrine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>191</td>
               <td colspan="2">Befetupitant<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Befetupitant</i></td>
            </tr>
            <tr class="addition">
               <td>192</td>
               <td colspan="2">Befloxatone<span class="subclass"> SubClassOf </span>Monoamine Oxidase Inhibitor. <br><i>New Terms: Befloxatone</i></td>
            </tr>
            <tr class="addition">
               <td>193</td>
               <td colspan="2">Beloxamide<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Beloxamide</i></td>
            </tr>
            <tr class="addition">
               <td>194</td>
               <td colspan="2">Beloxepin<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Beloxepin</i></td>
            </tr>
            <tr class="addition">
               <td>195</td>
               <td colspan="2">Bemegride<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Bemegride</i></td>
            </tr>
            <tr class="addition">
               <td>196</td>
               <td colspan="2">Bemitradine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Bemitradine</i></td>
            </tr>
            <tr class="addition">
               <td>197</td>
               <td colspan="2">Benactyzine Hydrochloride<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Benactyzine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>198</td>
               <td colspan="2">Benapryzine Hydrochloride<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Benapryzine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>199</td>
               <td colspan="2">Bencisteine<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Bencisteine</i></td>
            </tr>
            <tr class="addition">
               <td>200</td>
               <td colspan="2">Bencisteine<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Bencisteine</i></td>
            </tr>
            <tr class="addition">
               <td>201</td>
               <td colspan="2">Benfurodil Hemisuccinate<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Benfurodil Hemisuccinate</i></td>
            </tr>
            <tr class="addition">
               <td>202</td>
               <td colspan="2">Benmoxin<span class="subclass"> SubClassOf </span>Monoamine Oxidase Inhibitor. <br><i>New Terms: Benmoxin</i></td>
            </tr>
            <tr class="addition">
               <td>203</td>
               <td colspan="2">Benolizime<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Benolizime</i></td>
            </tr>
            <tr class="addition">
               <td>204</td>
               <td colspan="2">Benoxaprofen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Benoxaprofen</i></td>
            </tr>
            <tr class="addition">
               <td>205</td>
               <td colspan="2">Benproperine<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Benproperine</i></td>
            </tr>
            <tr class="addition">
               <td>206</td>
               <td colspan="2">Bentiamine<span class="subclass"> SubClassOf </span>Vitamin, Other. <br><i>New Terms: Bentiamine</i></td>
            </tr>
            <tr class="addition">
               <td>207</td>
               <td colspan="2">Bentipimine<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Bentipimine</i></td>
            </tr>
            <tr class="addition">
               <td>208</td>
               <td colspan="2">Benzestrol<span class="subclass"> SubClassOf </span>Therapeutic Estrogen. <br><i>New Terms: Benzestrol</i></td>
            </tr>
            <tr class="addition">
               <td>209</td>
               <td colspan="2">Benzethidine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Benzethidine</i></td>
            </tr>
            <tr class="addition">
               <td>210</td>
               <td colspan="2">Benzethonium Chloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Benzethonium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>211</td>
               <td colspan="2">Benzetimide Hydrochloride<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Benzetimide Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>212</td>
               <td colspan="2">Benzobarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Benzobarbital</i></td>
            </tr>
            <tr class="addition">
               <td>213</td>
               <td colspan="2">Benzoclidine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Benzoclidine</i></td>
            </tr>
            <tr class="addition">
               <td>214</td>
               <td colspan="2">Benzoin<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Benzoin</i></td>
            </tr>
            <tr class="addition">
               <td>215</td>
               <td colspan="2">Benzopyrronium Bromide<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Benzopyrronium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>216</td>
               <td colspan="2">Benzoquinonium Chloride<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Benzoquinonium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>217</td>
               <td colspan="2">Benzotript<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Benzotript</i></td>
            </tr>
            <tr class="addition">
               <td>218</td>
               <td colspan="2">Benzoxiquine<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Benzoxiquine</i></td>
            </tr>
            <tr class="addition">
               <td>219</td>
               <td colspan="2">Benzpyrinium Bromide<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Benzpyrinium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>220</td>
               <td colspan="2">Benzquinamide Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Benzquinamide Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>221</td>
               <td colspan="2">Benzyl Alcohol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Benzyl Alcohol</i></td>
            </tr>
            <tr class="addition">
               <td>222</td>
               <td colspan="2">Benzyl Chloride<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Benzyl Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>223</td>
               <td colspan="2">Bepafant<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Bepafant</i></td>
            </tr>
            <tr class="addition">
               <td>224</td>
               <td colspan="2">Bepotastine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Bepotastine</i></td>
            </tr>
            <tr class="addition">
               <td>225</td>
               <td colspan="2">Beraprost<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Beraprost</i></td>
            </tr>
            <tr class="addition">
               <td>226</td>
               <td colspan="2">Bervastatin<span class="subclass"> SubClassOf </span>HMG-CoA Reductase Inhibitor. <br><i>New Terms: Bervastatin</i></td>
            </tr>
            <tr class="addition">
               <td>229</td>
               <td colspan="2">Beta-sitosterol<span class="subclass"> SubClassOf </span>Retired Concept. <br><i>New Terms: Beta-sitosterol</i></td>
            </tr>
            <tr class="addition">
               <td>230</td>
               <td colspan="2">Betacetylmethadol<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Betacetylmethadol</i></td>
            </tr>
            <tr class="addition">
               <td>231</td>
               <td colspan="2">Betamethadol<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Betamethadol</i></td>
            </tr>
            <tr class="addition">
               <td>232</td>
               <td colspan="2">Betamethasone Dihydrogen Phosphate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Betamethasone Dihydrogen Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>234</td>
               <td colspan="2">Bevirimat Dimeglumine<span class="subclass"> SubClassOf </span>Anti-HIV Agent. <br><i>New Terms: Bevirimat Dimeglumine</i></td>
            </tr>
            <tr class="addition">
               <td>233</td>
               <td colspan="2">Bevirimat<span class="subclass"> SubClassOf </span>Anti-HIV Agent. <br><i>New Terms: Bevirimat</i></td>
            </tr>
            <tr class="addition">
               <td>235</td>
               <td colspan="2">Bialamicol Hydrochloride<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Bialamicol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>236</td>
               <td colspan="2">Bifluranol<span class="subclass"> SubClassOf </span>Anti-Androgen. <br><i>New Terms: Bifluranol</i></td>
            </tr>
            <tr class="addition">
               <td>237</td>
               <td colspan="2">Biopsy Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Biopsy Site</i></td>
            </tr>
            <tr class="addition">
               <td>238</td>
               <td colspan="2">Biriperone<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Biriperone</i></td>
            </tr>
            <tr class="addition">
               <td>239</td>
               <td colspan="2">Bisantrene Hydrochloride<span class="subclass"> SubClassOf </span>Anthraquinone Compound. <br><i>New Terms: Bisantrene Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>240</td>
               <td colspan="2">Bisfenazone<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Bisfenazone</i></td>
            </tr>
            <tr class="addition">
               <td>241</td>
               <td colspan="2">Bismuth Citrate<span class="subclass"> SubClassOf </span>Antidiarrheal Agent. <br><i>New Terms: Bismuth Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>242</td>
               <td colspan="2">Bismuth Subcarbonate<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Bismuth Subcarbonate</i></td>
            </tr>
            <tr class="addition">
               <td>243</td>
               <td colspan="2">Bismuth Subgallate<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Bismuth Subgallate</i></td>
            </tr>
            <tr class="addition">
               <td>244</td>
               <td colspan="2">Bismuth Subnitrate<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Bismuth Subnitrate</i></td>
            </tr>
            <tr class="addition">
               <td>245</td>
               <td colspan="2">Bithionol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Bithionol</i></td>
            </tr>
            <tr class="addition">
               <td>246</td>
               <td colspan="2">Bithionoloxide<span class="subclass"> SubClassOf </span>Antihelminthic Agent. <br><i>New Terms: Bithionoloxide</i></td>
            </tr>
            <tr class="addition">
               <td>247</td>
               <td colspan="2">Black South<br><span class="keyword"> or </span>Central American<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Black South or Central American</i></td>
            </tr>
            <tr class="addition">
               <td>252</td>
               <td colspan="2">Bone Marrow Smear<span class="subclass"> SubClassOf </span>Hematology Test. <br><i>New Terms: Bone Marrow Smear</i></td>
            </tr>
            <tr class="addition">
               <td>248</td>
               <td colspan="2">Bone Marrow, Femur<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Femur</i></td>
            </tr>
            <tr class="addition">
               <td>249</td>
               <td colspan="2">Bone Marrow, Humerus<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Humerus</i></td>
            </tr>
            <tr class="addition">
               <td>250</td>
               <td colspan="2">Bone Marrow, Rib<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Rib</i></td>
            </tr>
            <tr class="addition">
               <td>251</td>
               <td colspan="2">Bone Marrow, Scapula<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Scapula</i></td>
            </tr>
            <tr class="addition">
               <td>253</td>
               <td colspan="2">Bone Marrow, Sternum<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Sternum</i></td>
            </tr>
            <tr class="addition">
               <td>254</td>
               <td colspan="2">Bone Marrow, Tibia<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Tibia</i></td>
            </tr>
            <tr class="addition">
               <td>255</td>
               <td colspan="2">Bone Marrow, Vertebral<span class="subclass"> SubClassOf </span>Bone Marrow. <br><i>New Terms: Bone Marrow, Vertebral</i></td>
            </tr>
            <tr class="addition">
               <td>256</td>
               <td colspan="2">Bordetella Pertussis Antigen, A<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella Pertussis Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>257</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, A<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Filamentous Hemagglutinin Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>258</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, B<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Filamentous Hemagglutinin Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>259</td>
               <td colspan="2">Bordetella pertussis Filamentous Hemagglutinin Antigen, C<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Filamentous Hemagglutinin Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>260</td>
               <td colspan="2">Bordetella pertussis Fimbriae 2/3 Antigen, A<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Fimbriae 2/3 Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>261</td>
               <td colspan="2">Bordetella pertussis Pertactin Antigen, A<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Pertactin Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>262</td>
               <td colspan="2">Bordetella pertussis Pertactin Antigen, B<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Pertactin Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>263</td>
               <td colspan="2">Bordetella pertussis Toxoid Antigen, A<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Toxoid Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>264</td>
               <td colspan="2">Bordetella pertussis Toxoid Antigen, B<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Toxoid Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>265</td>
               <td colspan="2">Bordetella pertussis Toxoid Antigen, C<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br><i>New Terms: Bordetella pertussis Toxoid Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>267</td>
               <td colspan="2">Brasofensine Maleate<span class="subclass"> SubClassOf </span>Antiparkinsonian Agent. <br><i>New Terms: Brasofensine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>266</td>
               <td colspan="2">Brasofensine<span class="subclass"> SubClassOf </span>Antiparkinsonian Agent. <br><i>New Terms: Brasofensine</i></td>
            </tr>
            <tr class="addition">
               <td>268</td>
               <td colspan="2">Brecanavir<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Brecanavir</i></td>
            </tr>
            <tr class="addition">
               <td>269</td>
               <td colspan="2">Bremelanotide<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Bremelanotide</i></td>
            </tr>
            <tr class="addition">
               <td>270</td>
               <td colspan="2">Bretylium<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Antagonist. <br><i>New Terms: Bretylium</i></td>
            </tr>
            <tr class="addition">
               <td>271</td>
               <td colspan="2">Brindoxime<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Brindoxime</i></td>
            </tr>
            <tr class="addition">
               <td>272</td>
               <td colspan="2">Brocresine<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Brocresine</i></td>
            </tr>
            <tr class="addition">
               <td>273</td>
               <td colspan="2">Bromisovalum<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Bromisovalum</i></td>
            </tr>
            <tr class="addition">
               <td>274</td>
               <td colspan="2">Bromperidol<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Bromperidol</i></td>
            </tr>
            <tr class="addition">
               <td>275</td>
               <td colspan="2">Bronopol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Bronopol</i></td>
            </tr>
            <tr class="addition">
               <td>276</td>
               <td colspan="2">Broparestrol<span class="subclass"> SubClassOf </span>Therapeutic Estrogen. <br><i>New Terms: Broparestrol</i></td>
            </tr>
            <tr class="addition">
               <td>277</td>
               <td colspan="2">Broperamole<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Broperamole</i></td>
            </tr>
            <tr class="addition">
               <td>278</td>
               <td colspan="2">Bucainide<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Bucainide</i></td>
            </tr>
            <tr class="addition">
               <td>279</td>
               <td colspan="2">Bufeniode<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Bufeniode</i></td>
            </tr>
            <tr class="addition">
               <td>280</td>
               <td colspan="2">Bufogenin<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Bufogenin</i></td>
            </tr>
            <tr class="addition">
               <td>281</td>
               <td colspan="2">Bunamiodyl Sodium<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Bunamiodyl Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>282</td>
               <td colspan="2">Bunazosin Hydrochloride<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Antagonist. <br><i>New Terms: Bunazosin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>283</td>
               <td colspan="2">Buquinolate<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Buquinolate</i></td>
            </tr>
            <tr class="addition">
               <td>284</td>
               <td colspan="2">Butacaine Sulfate<span class="subclass"> SubClassOf </span>Anesthetic Agent. <br><i>New Terms: Butacaine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>285</td>
               <td colspan="2">Butalamine<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Butalamine</i></td>
            </tr>
            <tr class="addition">
               <td>286</td>
               <td colspan="2">Butaperazine Maleate<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Butaperazine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>287</td>
               <td colspan="2">Butinoline<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Butinoline</i></td>
            </tr>
            <tr class="addition">
               <td>288</td>
               <td colspan="2">Butixirate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Butixirate</i></td>
            </tr>
            <tr class="addition">
               <td>289</td>
               <td colspan="2">Butocrolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Butocrolol</i></td>
            </tr>
            <tr class="addition">
               <td>290</td>
               <td colspan="2">Butoctamide<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Butoctamide</i></td>
            </tr>
            <tr class="addition">
               <td>291</td>
               <td colspan="2">Butofilolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Butofilolol</i></td>
            </tr>
            <tr class="addition">
               <td>292</td>
               <td colspan="2">Butopiprine<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Butopiprine</i></td>
            </tr>
            <tr class="addition">
               <td>293</td>
               <td colspan="2">Butopyrammonium Iodide<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Butopyrammonium Iodide</i></td>
            </tr>
            <tr class="addition">
               <td>294</td>
               <td colspan="2">Butopyronoxyl<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Butopyronoxyl</i></td>
            </tr>
            <tr class="addition">
               <td>295</td>
               <td colspan="2">Butoxylate<span class="subclass"> SubClassOf </span>Antidiarrheal Agent. <br><i>New Terms: Butoxylate</i></td>
            </tr>
            <tr class="addition">
               <td>296</td>
               <td colspan="2">Butyl Alcohol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Butyl Alcohol</i></td>
            </tr>
            <tr class="addition">
               <td>297</td>
               <td colspan="2">Butyl Stearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Butyl Stearate</i></td>
            </tr>
            <tr class="addition">
               <td>298</td>
               <td colspan="2">Butylated Hydroxyanisole II<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Butylated Hydroxyanisole II</i></td>
            </tr>
            <tr class="addition">
               <td>299</td>
               <td colspan="2">Butylene Glycol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Butylene Glycol</i></td>
            </tr>
            <tr class="addition">
               <td>300</td>
               <td colspan="2">Butylparaben<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Butylparaben</i></td>
            </tr>
            <tr class="addition">
               <td>301</td>
               <td colspan="2">Buzepide Metiodide<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Buzepide Metiodide</i></td>
            </tr>
            <tr class="addition">
               <td>302</td>
               <td colspan="2">CDH2 Gene<span class="subclass"> SubClassOf </span>Cell Adhesion Molecule Gene. <br><i>New Terms: CDH2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>303</td>
               <td colspan="2">CDH2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Cell Adhesion. <br><i>New Terms: CDH2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>304</td>
               <td colspan="2">CDH2 wt Allele<span class="subclass"> SubClassOf </span>CDH2 Gene. <br><i>New Terms: CDH2 Gene, CDH2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>305</td>
               <td colspan="2">CDH2 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: CDH2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>306</td>
               <td colspan="2">CDISC CDASH Terminology<span class="subclass"> SubClassOf </span>Clinical Data Interchange Standards Consortium Terminology. <br><i>New Terms: CDISC CDASH Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>307</td>
               <td colspan="2">CDISC SEND Biospecimens Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Biospecimens Terminology, CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>308</td>
               <td colspan="2">CDISC SEND Laboratory Animal Species Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology, CDISC SEND Laboratory Animal Species Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>309</td>
               <td colspan="2">CDISC SEND Laboratory Animal Strain Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology, CDISC SEND Laboratory Animal Strain Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>310</td>
               <td colspan="2">CDISC SEND Pre-clinical Units of Measure Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology, CDISC SEND Pre-clinical Units of Measure Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>311</td>
               <td colspan="2">CDISC SEND Terminology<span class="subclass"> SubClassOf </span>Clinical Data Interchange Standards Consortium Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>312</td>
               <td colspan="2">CF-1 Mouse<span class="subclass"> SubClassOf </span>Inbred Mouse Strains. <br><i>New Terms: CF-1 Mouse</i></td>
            </tr>
            <tr class="addition">
               <td>313</td>
               <td colspan="2">CHFR Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Cell Cycle Checkpoint. <br><i>New Terms: CHFR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>314</td>
               <td colspan="2">CHFR Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Ubiquitination. <br><i>New Terms: CHFR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>315</td>
               <td colspan="2">CHFR Gene<span class="subclass"> SubClassOf </span>Ubiquitin Ligase Gene. <br><i>New Terms: CHFR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>316</td>
               <td colspan="2">CHFR wt Allele<span class="subclass"> SubClassOf </span>CHFR Gene. <br><i>New Terms: CHFR wt Allele, CHFR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>317</td>
               <td colspan="2">CHFR wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: CHFR wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>318</td>
               <td colspan="2">CHRNA3 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Lung Carcinoma. <br><i>New Terms: CHRNA3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>319</td>
               <td colspan="2">CHRNA3 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transport Reaction. <br><i>New Terms: CHRNA3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>320</td>
               <td colspan="2">CHRNA3 Gene<span class="subclass"> SubClassOf </span>Ion Channel Protein Gene. <br><i>New Terms: CHRNA3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>321</td>
               <td colspan="2">CHRNA3 wt Allele<span class="subclass"> SubClassOf </span>CHRNA3 Gene. <br><i>New Terms: CHRNA3 Gene, CHRNA3 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>322</td>
               <td colspan="2">CHRNA3 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: CHRNA3 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>323</td>
               <td colspan="2">CHRNA3 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>15q24. <br><i>New Terms: CHRNA3 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>324</td>
               <td colspan="2">CHRNA5 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Lung Carcinoma. <br><i>New Terms: CHRNA5 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>325</td>
               <td colspan="2">CHRNA5 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transport Reaction. <br><i>New Terms: CHRNA5 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>326</td>
               <td colspan="2">CHRNA5 Gene<span class="subclass"> SubClassOf </span>Ion Channel Protein Gene. <br><i>New Terms: CHRNA5 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>327</td>
               <td colspan="2">CHRNA5 wt Allele<span class="subclass"> SubClassOf </span>CHRNA5 Gene. <br><i>New Terms: CHRNA5 wt Allele, CHRNA5 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>328</td>
               <td colspan="2">CHRNA5 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: CHRNA5 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>329</td>
               <td colspan="2">CHRNA5 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>15q24. <br><i>New Terms: CHRNA5 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>330</td>
               <td colspan="2">CHRNB4 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Lung Carcinoma. <br><i>New Terms: CHRNB4 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>331</td>
               <td colspan="2">CHRNB4 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transport Reaction. <br><i>New Terms: CHRNB4 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>332</td>
               <td colspan="2">CHRNB4 Gene<span class="subclass"> SubClassOf </span>Ion Channel Protein Gene. <br><i>New Terms: CHRNB4 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>333</td>
               <td colspan="2">CHRNB4 wt Allele<span class="subclass"> SubClassOf </span>CHRNB4 Gene. <br><i>New Terms: CHRNB4 Gene, CHRNB4 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>334</td>
               <td colspan="2">CHRNB4 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: CHRNB4 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>335</td>
               <td colspan="2">CHRNB4 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>15q24. <br><i>New Terms: CHRNB4 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>336</td>
               <td colspan="2">Calcifediol Anhydrous<span class="subclass"> SubClassOf </span>Vitamin D Analog. <br><i>New Terms: Calcifediol Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>337</td>
               <td colspan="2">Calcitonin, Human<span class="subclass"> SubClassOf </span>Thyroid Agent. <br><i>New Terms: Calcitonin, Human</i></td>
            </tr>
            <tr class="addition">
               <td>338</td>
               <td colspan="2">Calcium Ascorbate<span class="subclass"> SubClassOf </span>Vitamin, Other. <br><i>New Terms: Calcium Ascorbate</i></td>
            </tr>
            <tr class="addition">
               <td>339</td>
               <td colspan="2">Calcium Bromide<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Calcium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>340</td>
               <td colspan="2">Calcium Cyclamate<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Calcium Cyclamate</i></td>
            </tr>
            <tr class="addition">
               <td>341</td>
               <td colspan="2">Calcium Hydroxide<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Calcium Hydroxide</i></td>
            </tr>
            <tr class="addition">
               <td>342</td>
               <td colspan="2">Calcium Hypophosphite<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Calcium Hypophosphite</i></td>
            </tr>
            <tr class="addition">
               <td>343</td>
               <td colspan="2">Calcium Lactate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Calcium Lactate</i></td>
            </tr>
            <tr class="addition">
               <td>344</td>
               <td colspan="2">Calcium Lactobionate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Calcium Lactobionate</i></td>
            </tr>
            <tr class="addition">
               <td>345</td>
               <td colspan="2">Calcium Lactophosphate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Calcium Lactophosphate</i></td>
            </tr>
            <tr class="addition">
               <td>346</td>
               <td colspan="2">Calcium Levulinate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Calcium Levulinate</i></td>
            </tr>
            <tr class="addition">
               <td>347</td>
               <td colspan="2">Calcium Mandelate<span class="subclass"> SubClassOf </span>Urinary Anti-Infective Agent. <br><i>New Terms: Calcium Mandelate</i></td>
            </tr>
            <tr class="addition">
               <td>348</td>
               <td colspan="2">Calcium Phosphate, Dibasic<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Calcium Phosphate, Dibasic</i></td>
            </tr>
            <tr class="addition">
               <td>349</td>
               <td colspan="2">Calcium Salicylate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Calcium Salicylate</i></td>
            </tr>
            <tr class="addition">
               <td>350</td>
               <td colspan="2">Calcium Stearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Calcium Stearate</i></td>
            </tr>
            <tr class="addition">
               <td>351</td>
               <td colspan="2">Caldaret<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Caldaret</i></td>
            </tr>
            <tr class="addition">
               <td>352</td>
               <td colspan="2">Calomel<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Calomel</i></td>
            </tr>
            <tr class="addition">
               <td>353</td>
               <td colspan="2">Camiverine<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Camiverine</i></td>
            </tr>
            <tr class="addition">
               <td>354</td>
               <td colspan="2">Canadian Cardiovascular Society Grading Scale Class I<span class="subclass"> SubClassOf </span>Canadian Cardiovascular Society Grading Scale Class. <br><i>New Terms: Canadian Cardiovascular Society Grading Scale Class I</i></td>
            </tr>
            <tr class="addition">
               <td>355</td>
               <td colspan="2">Canadian Cardiovascular Society Grading Scale Class II<span class="subclass"> SubClassOf </span>Canadian Cardiovascular Society Grading Scale Class. <br><i>New Terms: Canadian Cardiovascular Society Grading Scale Class II</i></td>
            </tr>
            <tr class="addition">
               <td>356</td>
               <td colspan="2">Canadian Cardiovascular Society Grading Scale Class III<span class="subclass"> SubClassOf </span>Canadian Cardiovascular Society Grading Scale Class. <br><i>New Terms: Canadian Cardiovascular Society Grading Scale Class III</i></td>
            </tr>
            <tr class="addition">
               <td>357</td>
               <td colspan="2">Canadian Cardiovascular Society Grading Scale Class IV<span class="subclass"> SubClassOf </span>Canadian Cardiovascular Society Grading Scale Class. <br><i>New Terms: Canadian Cardiovascular Society Grading Scale Class IV</i></td>
            </tr>
            <tr class="addition">
               <td>358</td>
               <td colspan="2">Candida<span class="subclass"> SubClassOf </span>Ascomycota. <br><i>New Terms: Ascomycota, Candida</i></td>
            </tr>
            <tr class="addition">
               <td>359</td>
               <td colspan="2">Candida albicans<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Candida, Candida albicans</i></td>
            </tr>
            <tr class="addition">
               <td>360</td>
               <td colspan="2">Candida glabrata<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Candida glabrata, Candida</i></td>
            </tr>
            <tr class="addition">
               <td>361</td>
               <td colspan="2">Candida parapsilosis<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Candida, Candida parapsilosis</i></td>
            </tr>
            <tr class="addition">
               <td>362</td>
               <td colspan="2">Candida tropicalis<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Candida, Candida tropicalis</i></td>
            </tr>
            <tr class="addition">
               <td>363</td>
               <td colspan="2">Candocuronium Iodide<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Candocuronium Iodide</i></td>
            </tr>
            <tr class="addition">
               <td>364</td>
               <td colspan="2">Candoxatrilat<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Candoxatrilat</i></td>
            </tr>
            <tr class="addition">
               <td>365</td>
               <td colspan="2">Canertinib<span class="subclass"> SubClassOf </span>Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. <br><i>New Terms: Canertinib</i></td>
            </tr>
            <tr class="addition">
               <td>366</td>
               <td colspan="2">Cangrelor<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Cangrelor</i></td>
            </tr>
            <tr class="addition">
               <td>367</td>
               <td colspan="2">Cangrelor Tetrasodium<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Cangrelor Tetrasodium</i></td>
            </tr>
            <tr class="addition">
               <td>368</td>
               <td colspan="2">Capeserod<span class="subclass"> SubClassOf </span>Serotonin Agonist. <br><i>New Terms: Capeserod</i></td>
            </tr>
            <tr class="addition">
               <td>369</td>
               <td colspan="2">Captan<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Captan</i></td>
            </tr>
            <tr class="addition">
               <td>370</td>
               <td colspan="2">Captodiame Hydrochloride<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Captodiame Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>371</td>
               <td colspan="2">Carabersat<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Carabersat</i></td>
            </tr>
            <tr class="addition">
               <td>372</td>
               <td colspan="2">Caramiphen Edisylate<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Caramiphen Edisylate</i></td>
            </tr>
            <tr class="addition">
               <td>373</td>
               <td colspan="2">Caramiphen Hydrochloride<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Caramiphen Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>374</td>
               <td colspan="2">Carazolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Carazolol</i></td>
            </tr>
            <tr class="addition">
               <td>375</td>
               <td colspan="2">Carbamide Peroxide<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Carbamide Peroxide</i></td>
            </tr>
            <tr class="addition">
               <td>376</td>
               <td colspan="2">Carbaril<span class="subclass"> SubClassOf </span>Antiparasitic Agent. <br><i>New Terms: Carbaril</i></td>
            </tr>
            <tr class="addition">
               <td>377</td>
               <td colspan="2">Carbarsone<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Carbarsone</i></td>
            </tr>
            <tr class="addition">
               <td>378</td>
               <td colspan="2">Carbazochrome Salicylate<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Carbazochrome Salicylate</i></td>
            </tr>
            <tr class="addition">
               <td>380</td>
               <td colspan="2">Carbetapentane Citrate<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Carbetapentane Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>379</td>
               <td colspan="2">Carbetapentane<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Carbetapentane</i></td>
            </tr>
            <tr class="addition">
               <td>381</td>
               <td colspan="2">Carbon Black<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Carbon Black</i></td>
            </tr>
            <tr class="addition">
               <td>382</td>
               <td colspan="2">Carbon Monoxide<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Carbon Monoxide</i></td>
            </tr>
            <tr class="addition">
               <td>383</td>
               <td colspan="2">Carbromal<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Carbromal</i></td>
            </tr>
            <tr class="addition">
               <td>384</td>
               <td colspan="2">Carbubarb<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Carbubarb</i></td>
            </tr>
            <tr class="addition">
               <td>385</td>
               <td colspan="2">Carburazepam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Carburazepam</i></td>
            </tr>
            <tr class="addition">
               <td>386</td>
               <td colspan="2">Carebastine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Carebastine</i></td>
            </tr>
            <tr class="addition">
               <td>387</td>
               <td colspan="2">Carfentanil Citrate<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Carfentanil Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>388</td>
               <td colspan="2">Carglumic Acid<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Carglumic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>389</td>
               <td colspan="2">Caribbean Indian<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Caribbean Indian</i></td>
            </tr>
            <tr class="addition">
               <td>390</td>
               <td colspan="2">Carnidazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Carnidazole</i></td>
            </tr>
            <tr class="addition">
               <td>391</td>
               <td colspan="2">Carocainide<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Carocainide</i></td>
            </tr>
            <tr class="addition">
               <td>392</td>
               <td colspan="2">Carprazidil<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Carprazidil</i></td>
            </tr>
            <tr class="addition">
               <td>393</td>
               <td colspan="2">Carpronium Chloride<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Carpronium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>394</td>
               <td colspan="2">Carsalam<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Carsalam</i></td>
            </tr>
            <tr class="addition">
               <td>395</td>
               <td colspan="2">Cartasteine<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Cartasteine</i></td>
            </tr>
            <tr class="addition">
               <td>396</td>
               <td colspan="2">Casokefamide<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Casokefamide</i></td>
            </tr>
            <tr class="addition">
               <td>397</td>
               <td colspan="2">Catramilast<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Catramilast</i></td>
            </tr>
            <tr class="addition">
               <td>398</td>
               <td colspan="2">Cebaracetam<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Cebaracetam</i></td>
            </tr>
            <tr class="addition">
               <td>399</td>
               <td colspan="2">Cedefingol<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: Cedefingol</i></td>
            </tr>
            <tr class="addition">
               <td>400</td>
               <td colspan="2">Cefprozil Anhydrous, E-Isomer<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cefprozil Anhydrous, E-Isomer</i></td>
            </tr>
            <tr class="addition">
               <td>401</td>
               <td colspan="2">Cefprozil, E-Isomer<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cefprozil, E-Isomer</i></td>
            </tr>
            <tr class="addition">
               <td>402</td>
               <td colspan="2">Cefrotil<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cefrotil</i></td>
            </tr>
            <tr class="addition">
               <td>403</td>
               <td colspan="2">Ceftiofur Sodium<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Ceftiofur Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>404</td>
               <td colspan="2">Center for Epidemiologic Studies Depression Scale<span class="subclass"> SubClassOf </span>Symptom Specific Assessment Tool. <br><i>New Terms: Center for Epidemiologic Studies Depression Scale</i></td>
            </tr>
            <tr class="addition">
               <td>405</td>
               <td colspan="2">Cephacetrile Sodium<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cephacetrile Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>406</td>
               <td colspan="2">Cephaloglycin Anhydrous<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cephaloglycin Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>407</td>
               <td colspan="2">Cephaloridine<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cephaloridine</i></td>
            </tr>
            <tr class="addition">
               <td>408</td>
               <td colspan="2">Cephapirin Benzathine<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br><i>New Terms: Cephapirin Benzathine</i></td>
            </tr>
            <tr class="addition">
               <td>409</td>
               <td colspan="2">Cetalkonium Chloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Cetalkonium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>410</td>
               <td colspan="2">Cetilistat<span class="subclass"> SubClassOf </span>Gastrointestinal Lipase Inhibitor. <br><i>New Terms: Cetilistat</i></td>
            </tr>
            <tr class="addition">
               <td>411</td>
               <td colspan="2">Cetohexazine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Cetohexazine</i></td>
            </tr>
            <tr class="addition">
               <td>412</td>
               <td colspan="2">Cetyl Palmitate<span class="subclass"> SubClassOf </span>Fatty Acid. <br><i>New Terms: Cetyl Palmitate</i></td>
            </tr>
            <tr class="addition">
               <td>413</td>
               <td colspan="2">Cetylpyridinium Chloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Cetylpyridinium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>414</td>
               <td colspan="2">Cevipabulin<span class="subclass"> SubClassOf </span>Tubulin Binding Agent. <br><i>New Terms: Cevipabulin</i></td>
            </tr>
            <tr class="addition">
               <td>415</td>
               <td colspan="2">Charcoal, Activated<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Charcoal, Activated</i></td>
            </tr>
            <tr class="addition">
               <td>416</td>
               <td colspan="2">Chinese Hamster<span class="subclass"> SubClassOf </span>Hamster. <br><i>New Terms: Chinese Hamster</i></td>
            </tr>
            <tr class="addition">
               <td>417</td>
               <td colspan="2">Chinese Syrian Gold Hamster<span class="subclass"> SubClassOf </span>Hamster. <br><i>New Terms: Chinese Syrian Gold Hamster</i></td>
            </tr>
            <tr class="addition">
               <td>418</td>
               <td colspan="2">Chinese Syrian Hamster<span class="subclass"> SubClassOf </span>Hamster. <br><i>New Terms: Chinese Syrian Hamster</i></td>
            </tr>
            <tr class="addition">
               <td>419</td>
               <td colspan="2">Chiniofon<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Chiniofon</i></td>
            </tr>
            <tr class="addition">
               <td>420</td>
               <td colspan="2">Chloral<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Chloral</i></td>
            </tr>
            <tr class="addition">
               <td>421</td>
               <td colspan="2">Chloramine-T<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chloramine-T</i></td>
            </tr>
            <tr class="addition">
               <td>422</td>
               <td colspan="2">Chlorbenzoxamine Hydrochloride<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Chlorbenzoxamine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>423</td>
               <td colspan="2">Chlorbetamide<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Chlorbetamide</i></td>
            </tr>
            <tr class="addition">
               <td>424</td>
               <td colspan="2">Chlorcyclizine Hydrochloride<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Chlorcyclizine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>425</td>
               <td colspan="2">Chlordimorine<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Chlordimorine</i></td>
            </tr>
            <tr class="addition">
               <td>426</td>
               <td colspan="2">Chlordimorine<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Chlordimorine</i></td>
            </tr>
            <tr class="addition">
               <td>427</td>
               <td colspan="2">Chlorindanol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chlorindanol</i></td>
            </tr>
            <tr class="addition">
               <td>428</td>
               <td colspan="2">Chlorisondamine Chloride<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Chlorisondamine Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>429</td>
               <td colspan="2">Chlormerodrin, Hg-197<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br><i>New Terms: Chlormerodrin, Hg-197</i></td>
            </tr>
            <tr class="addition">
               <td>430</td>
               <td colspan="2">Chlormidazole<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Chlormidazole</i></td>
            </tr>
            <tr class="addition">
               <td>431</td>
               <td colspan="2">Chloroazodin<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chloroazodin</i></td>
            </tr>
            <tr class="addition">
               <td>432</td>
               <td colspan="2">Chlorocresol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chlorocresol</i></td>
            </tr>
            <tr class="addition">
               <td>433</td>
               <td colspan="2">Chlorophenothane<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Chlorophenothane</i></td>
            </tr>
            <tr class="addition">
               <td>434</td>
               <td colspan="2">Chloroquine Sulfate<span class="subclass"> SubClassOf </span>Antimalarial Agent. <br><i>New Terms: Chloroquine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>435</td>
               <td colspan="2">Chloroquine Sulfate<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Chloroquine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>436</td>
               <td colspan="2">Chloroserpidine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Chloroserpidine</i></td>
            </tr>
            <tr class="addition">
               <td>437</td>
               <td colspan="2">Chlorothen Citrate<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Chlorothen Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>438</td>
               <td colspan="2">Chlorothymol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chlorothymol</i></td>
            </tr>
            <tr class="addition">
               <td>439</td>
               <td colspan="2">Chloroxylenol<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Chloroxylenol</i></td>
            </tr>
            <tr class="addition">
               <td>440</td>
               <td colspan="2">Chlorphenesin<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chlorphenesin</i></td>
            </tr>
            <tr class="addition">
               <td>441</td>
               <td colspan="2">Chlorpheniramine Polistirex<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Chlorpheniramine Polistirex</i></td>
            </tr>
            <tr class="addition">
               <td>442</td>
               <td colspan="2">Chlorphenoctium Amsonate<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chlorphenoctium Amsonate</i></td>
            </tr>
            <tr class="addition">
               <td>443</td>
               <td colspan="2">Chlorphenoxamine Hydrochloride<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Chlorphenoxamine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>444</td>
               <td colspan="2">Chlorproethazine Hydrochloride<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Chlorproethazine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>445</td>
               <td colspan="2">Chlorproguanil Hydrochloride<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Chlorproguanil Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>446</td>
               <td colspan="2">Chlorquinaldol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Chlorquinaldol</i></td>
            </tr>
            <tr class="addition">
               <td>447</td>
               <td colspan="2">Chlortetracycline Bisulfate<span class="subclass"> SubClassOf </span>Tetracycline Antibiotic. <br><i>New Terms: Chlortetracycline Bisulfate</i></td>
            </tr>
            <tr class="addition">
               <td>448</td>
               <td colspan="2">Chlorthenoxazine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Chlorthenoxazine</i></td>
            </tr>
            <tr class="addition">
               <td>449</td>
               <td colspan="2">Choline Bitartrate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Choline Bitartrate</i></td>
            </tr>
            <tr class="addition">
               <td>450</td>
               <td colspan="2">Choline Chloride<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Choline Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>451</td>
               <td colspan="2">Choline Salicylate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Choline Salicylate</i></td>
            </tr>
            <tr class="addition">
               <td>452</td>
               <td colspan="2">Chromocarb<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Chromocarb</i></td>
            </tr>
            <tr class="addition">
               <td>453</td>
               <td colspan="2">Chymotrypsin<span class="subclass"> SubClassOf </span>Biological Agent. <br><i>New Terms: Chymotrypsin</i></td>
            </tr>
            <tr class="addition">
               <td>454</td>
               <td colspan="2">Cianergoline<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Cianergoline</i></td>
            </tr>
            <tr class="addition">
               <td>455</td>
               <td colspan="2">Ciapilome<span class="subclass"> SubClassOf </span>Uricosuric Agent. <br><i>New Terms: Ciapilome</i></td>
            </tr>
            <tr class="addition">
               <td>456</td>
               <td colspan="2">Ciclafrine Hydrochloride<span class="subclass"> SubClassOf </span>Adrenergic Agent. <br><i>New Terms: Ciclafrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>457</td>
               <td colspan="2">Cicletanine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Cicletanine</i></td>
            </tr>
            <tr class="addition">
               <td>458</td>
               <td colspan="2">Ciclosidomine<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Ciclosidomine</i></td>
            </tr>
            <tr class="addition">
               <td>459</td>
               <td colspan="2">Ciclotizolam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Ciclotizolam</i></td>
            </tr>
            <tr class="addition">
               <td>460</td>
               <td colspan="2">Cicloxilic Acid<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Cicloxilic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>461</td>
               <td colspan="2">Cicortonide<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Cicortonide</i></td>
            </tr>
            <tr class="addition">
               <td>462</td>
               <td colspan="2">Cidofovir Anhydrous<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Cidofovir Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>463</td>
               <td colspan="2">Cifostodine<span class="subclass"> SubClassOf </span>Pyrimidine Antagonist. <br><i>New Terms: Cifostodine</i></td>
            </tr>
            <tr class="addition">
               <td>464</td>
               <td colspan="2">Ciheptolane<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Ciheptolane</i></td>
            </tr>
            <tr class="addition">
               <td>465</td>
               <td colspan="2">Ciheptolane<span class="subclass"> SubClassOf </span>Antihypertensive Agent. <br><i>New Terms: Ciheptolane</i></td>
            </tr>
            <tr class="addition">
               <td>466</td>
               <td colspan="2">Cilansetron Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Cilansetron Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>467</td>
               <td colspan="2">Cilobamine Mesylate<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Cilobamine Mesylate</i></td>
            </tr>
            <tr class="addition">
               <td>468</td>
               <td colspan="2">Ciltoprazine<span class="subclass"> SubClassOf </span>Muscle Relaxant. <br><i>New Terms: Ciltoprazine</i></td>
            </tr>
            <tr class="addition">
               <td>469</td>
               <td colspan="2">Cimemoxin<span class="subclass"> SubClassOf </span>Monoamine Oxidase Inhibitor. <br><i>New Terms: Cimemoxin</i></td>
            </tr>
            <tr class="addition">
               <td>470</td>
               <td colspan="2">Cimepanol<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Cimepanol</i></td>
            </tr>
            <tr class="addition">
               <td>471</td>
               <td colspan="2">Cimicoxib<span class="subclass"> SubClassOf </span>Cyclooxygenase Inhibitor. <br><i>New Terms: Cimicoxib</i></td>
            </tr>
            <tr class="addition">
               <td>472</td>
               <td colspan="2">Cinamolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Cinamolol</i></td>
            </tr>
            <tr class="addition">
               <td>473</td>
               <td colspan="2">Cinaproxen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Cinaproxen</i></td>
            </tr>
            <tr class="addition">
               <td>474</td>
               <td colspan="2">Cinfenine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Cinfenine</i></td>
            </tr>
            <tr class="addition">
               <td>475</td>
               <td colspan="2">Cinitapride<span class="subclass"> SubClassOf </span>Serotonin Agonist. <br><i>New Terms: Cinitapride</i></td>
            </tr>
            <tr class="addition">
               <td>476</td>
               <td colspan="2">Cinitapride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Cinitapride</i></td>
            </tr>
            <tr class="addition">
               <td>477</td>
               <td colspan="2">Cinnamaldehyde<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Cinnamaldehyde</i></td>
            </tr>
            <tr class="addition">
               <td>478</td>
               <td colspan="2">Cinnamaverine<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Cinnamaverine</i></td>
            </tr>
            <tr class="addition">
               <td>479</td>
               <td colspan="2">Cinnofuradione<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Cinnofuradione</i></td>
            </tr>
            <tr class="addition">
               <td>480</td>
               <td colspan="2">Cinolazepam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Cinolazepam</i></td>
            </tr>
            <tr class="addition">
               <td>481</td>
               <td colspan="2">Cinoxate<span class="subclass"> SubClassOf </span>Sunscreen. <br><i>New Terms: Cinoxate</i></td>
            </tr>
            <tr class="addition">
               <td>482</td>
               <td colspan="2">Cinpropazide<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Cinpropazide</i></td>
            </tr>
            <tr class="addition">
               <td>484</td>
               <td colspan="2">Cipralisant Maleate<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Cipralisant Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>483</td>
               <td colspan="2">Cipralisant<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Cipralisant</i></td>
            </tr>
            <tr class="addition">
               <td>485</td>
               <td colspan="2">Ciprazafone<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Ciprazafone</i></td>
            </tr>
            <tr class="addition">
               <td>486</td>
               <td colspan="2">Cipropride<span class="subclass"> SubClassOf </span>Antiemetic Agent. <br><i>New Terms: Cipropride</i></td>
            </tr>
            <tr class="addition">
               <td>487</td>
               <td colspan="2">Ciramadol<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Ciramadol</i></td>
            </tr>
            <tr class="addition">
               <td>488</td>
               <td colspan="2">Cirazoline<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Agonist. <br><i>New Terms: Cirazoline</i></td>
            </tr>
            <tr class="addition">
               <td>489</td>
               <td colspan="2">Circumanal Gland<span class="subclass"> SubClassOf </span>Apocrine Sweat Gland. <br><i>New Terms: Circumanal Gland</i></td>
            </tr>
            <tr class="addition">
               <td>490</td>
               <td colspan="2">Cisatracurium<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Cisatracurium</i></td>
            </tr>
            <tr class="addition">
               <td>491</td>
               <td colspan="2">Cistinexine<span class="subclass"> SubClassOf </span>Expectorant. <br><i>New Terms: Cistinexine</i></td>
            </tr>
            <tr class="addition">
               <td>492</td>
               <td colspan="2">Cistinexine<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Cistinexine</i></td>
            </tr>
            <tr class="addition">
               <td>493</td>
               <td colspan="2">Citatepine<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Citatepine</i></td>
            </tr>
            <tr class="addition">
               <td>494</td>
               <td colspan="2">Citiolone<span class="subclass"> SubClassOf </span>Expectorant. <br><i>New Terms: Citiolone</i></td>
            </tr>
            <tr class="addition">
               <td>495</td>
               <td colspan="2">Citiolone<span class="subclass"> SubClassOf </span>Hepatoprotective Agent. <br><i>New Terms: Citiolone</i></td>
            </tr>
            <tr class="addition">
               <td>496</td>
               <td colspan="2">Cizolirtine<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Cizolirtine</i></td>
            </tr>
            <tr class="addition">
               <td>497</td>
               <td colspan="2">Clamikalant<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Clamikalant</i></td>
            </tr>
            <tr class="addition">
               <td>499</td>
               <td colspan="2">Clamoxyquin Hydrochloride<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Clamoxyquin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>498</td>
               <td colspan="2">Clamoxyquin<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Clamoxyquin</i></td>
            </tr>
            <tr class="addition">
               <td>500</td>
               <td colspan="2">Clanfenur<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: Clanfenur</i></td>
            </tr>
            <tr class="addition">
               <td>501</td>
               <td colspan="2">Clanobutin<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Clanobutin</i></td>
            </tr>
            <tr class="addition">
               <td>502</td>
               <td colspan="2">Clantifen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clantifen</i></td>
            </tr>
            <tr class="addition">
               <td>503</td>
               <td colspan="2">Clavispora lusitaniae<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Clavispora lusitaniae, Candida</i></td>
            </tr>
            <tr class="addition">
               <td>504</td>
               <td colspan="2">Clazolimine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Clazolimine</i></td>
            </tr>
            <tr class="addition">
               <td>505</td>
               <td colspan="2">Clefamide<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Clefamide</i></td>
            </tr>
            <tr class="addition">
               <td>506</td>
               <td colspan="2">Clenpirin<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Clenpirin</i></td>
            </tr>
            <tr class="addition">
               <td>507</td>
               <td colspan="2">Clibucaine<span class="subclass"> SubClassOf </span>Anesthetic Agent. <br><i>New Terms: Clibucaine</i></td>
            </tr>
            <tr class="addition">
               <td>508</td>
               <td colspan="2">Clidanac<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clidanac</i></td>
            </tr>
            <tr class="addition">
               <td>509</td>
               <td colspan="2">Climazolam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Climazolam</i></td>
            </tr>
            <tr class="addition">
               <td>510</td>
               <td colspan="2">Climbazole<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Climbazole</i></td>
            </tr>
            <tr class="addition">
               <td>511</td>
               <td colspan="2">Climiqualine<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Climiqualine</i></td>
            </tr>
            <tr class="addition">
               <td>512</td>
               <td colspan="2">Clinical Test Result<span class="subclass"> SubClassOf </span>Finding. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>513</td>
               <td colspan="2">Clinofibrate<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Clinofibrate</i></td>
            </tr>
            <tr class="addition">
               <td>514</td>
               <td colspan="2">Clinolamide<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Clinolamide</i></td>
            </tr>
            <tr class="addition">
               <td>515</td>
               <td colspan="2">Cliprofen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Cliprofen</i></td>
            </tr>
            <tr class="addition">
               <td>516</td>
               <td colspan="2">Cliropamine<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Cliropamine</i></td>
            </tr>
            <tr class="addition">
               <td>517</td>
               <td colspan="2">Clitoral Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Clitoral Gland</i></td>
            </tr>
            <tr class="addition">
               <td>518</td>
               <td colspan="2">Clobenoside<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clobenoside</i></td>
            </tr>
            <tr class="addition">
               <td>519</td>
               <td colspan="2">Clobenzepam<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Clobenzepam</i></td>
            </tr>
            <tr class="addition">
               <td>520</td>
               <td colspan="2">Clobenzorex<span class="subclass"> SubClassOf </span>Anorexiant. <br><i>New Terms: Clobenzorex</i></td>
            </tr>
            <tr class="addition">
               <td>522</td>
               <td colspan="2">Clobetasone Butyrate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Clobetasone Butyrate</i></td>
            </tr>
            <tr class="addition">
               <td>521</td>
               <td colspan="2">Clobetasone<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Clobetasone</i></td>
            </tr>
            <tr class="addition">
               <td>523</td>
               <td colspan="2">Clobutinol<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Clobutinol</i></td>
            </tr>
            <tr class="addition">
               <td>524</td>
               <td colspan="2">Clobuzarit<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clobuzarit</i></td>
            </tr>
            <tr class="addition">
               <td>525</td>
               <td colspan="2">Clocapramine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Clocapramine</i></td>
            </tr>
            <tr class="addition">
               <td>526</td>
               <td colspan="2">Clociguanil<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Clociguanil</i></td>
            </tr>
            <tr class="addition">
               <td>527</td>
               <td colspan="2">Clocinizine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Clocinizine</i></td>
            </tr>
            <tr class="addition">
               <td>528</td>
               <td colspan="2">Clocortolone Acetate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Clocortolone Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>529</td>
               <td colspan="2">Clocoumarol<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Clocoumarol</i></td>
            </tr>
            <tr class="addition">
               <td>530</td>
               <td colspan="2">Clodacaine<span class="subclass"> SubClassOf </span>Anesthetic Agent. <br><i>New Terms: Clodacaine</i></td>
            </tr>
            <tr class="addition">
               <td>532</td>
               <td colspan="2">Clodazon Hydrochloride<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Clodazon Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>531</td>
               <td colspan="2">Clodazon<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Clodazon</i></td>
            </tr>
            <tr class="addition">
               <td>533</td>
               <td colspan="2">Clodoxopone<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Clodoxopone</i></td>
            </tr>
            <tr class="addition">
               <td>534</td>
               <td colspan="2">Clofenamide<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Clofenamide</i></td>
            </tr>
            <tr class="addition">
               <td>535</td>
               <td colspan="2">Clofenciclan<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Clofenciclan</i></td>
            </tr>
            <tr class="addition">
               <td>537</td>
               <td colspan="2">Clofenetamine Hydrochloride<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Clofenetamine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>536</td>
               <td colspan="2">Clofenetamine<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Clofenetamine</i></td>
            </tr>
            <tr class="addition">
               <td>538</td>
               <td colspan="2">Clofenoxyde<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Clofenoxyde</i></td>
            </tr>
            <tr class="addition">
               <td>539</td>
               <td colspan="2">Clofeverine<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Clofeverine</i></td>
            </tr>
            <tr class="addition">
               <td>540</td>
               <td colspan="2">Clofexamide<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clofexamide</i></td>
            </tr>
            <tr class="addition">
               <td>541</td>
               <td colspan="2">Clofezone<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clofezone</i></td>
            </tr>
            <tr class="addition">
               <td>542</td>
               <td colspan="2">Clofibride<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Clofibride</i></td>
            </tr>
            <tr class="addition">
               <td>543</td>
               <td colspan="2">Clofoctol<span class="subclass"> SubClassOf </span>Anti-Infective Agent. <br><i>New Terms: Clofoctol</i></td>
            </tr>
            <tr class="addition">
               <td>544</td>
               <td colspan="2">Clofurac<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clofurac</i></td>
            </tr>
            <tr class="addition">
               <td>545</td>
               <td colspan="2">Clometacin<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Clometacin</i></td>
            </tr>
            <tr class="addition">
               <td>546</td>
               <td colspan="2">Clomoxir<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Clomoxir</i></td>
            </tr>
            <tr class="addition">
               <td>547</td>
               <td colspan="2">Clonazoline<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Agonist. <br><i>New Terms: Clonazoline</i></td>
            </tr>
            <tr class="addition">
               <td>548</td>
               <td colspan="2">Clonitazene<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Clonitazene</i></td>
            </tr>
            <tr class="addition">
               <td>549</td>
               <td colspan="2">Cloperastine<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Cloperastine</i></td>
            </tr>
            <tr class="addition">
               <td>550</td>
               <td colspan="2">Clopidol<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Clopidol</i></td>
            </tr>
            <tr class="addition">
               <td>551</td>
               <td colspan="2">Clopimozide<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Clopimozide</i></td>
            </tr>
            <tr class="addition">
               <td>552</td>
               <td colspan="2">Cloprostenol Sodium<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Cloprostenol Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>553</td>
               <td colspan="2">Cloprothiazole<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Cloprothiazole</i></td>
            </tr>
            <tr class="addition">
               <td>554</td>
               <td colspan="2">Clorazepate Monopotassium<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Clorazepate Monopotassium</i></td>
            </tr>
            <tr class="addition">
               <td>555</td>
               <td colspan="2">Clorgiline<span class="subclass"> SubClassOf </span>Monoamine Oxidase Inhibitor. <br><i>New Terms: Clorgiline</i></td>
            </tr>
            <tr class="addition">
               <td>556</td>
               <td colspan="2">Cloricromen<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Cloricromen</i></td>
            </tr>
            <tr class="addition">
               <td>557</td>
               <td colspan="2">Clorindanic Acid<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Clorindanic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>558</td>
               <td colspan="2">Clormecaine<span class="subclass"> SubClassOf </span>Anesthetic Agent. <br><i>New Terms: Clormecaine</i></td>
            </tr>
            <tr class="addition">
               <td>559</td>
               <td colspan="2">Cloroqualone<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Cloroqualone</i></td>
            </tr>
            <tr class="addition">
               <td>560</td>
               <td colspan="2">Clorotepine<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Clorotepine</i></td>
            </tr>
            <tr class="addition">
               <td>561</td>
               <td colspan="2">Clostebol<span class="subclass"> SubClassOf </span>Anabolic Steroid. <br><i>New Terms: Clostebol</i></td>
            </tr>
            <tr class="addition">
               <td>562</td>
               <td colspan="2">Clostridium tetani Toxoid Antigen, A<span class="subclass"> SubClassOf </span>Clostridium Tetani Antigen. <br><i>New Terms: Clostridium tetani Toxoid Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>563</td>
               <td colspan="2">Clostridium tetani Toxoid Antigen, B<span class="subclass"> SubClassOf </span>Clostridium Tetani Antigen. <br><i>New Terms: Clostridium tetani Toxoid Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>564</td>
               <td colspan="2">Clostridium tetani Toxoid Antigen, C<span class="subclass"> SubClassOf </span>Clostridium Tetani Antigen. <br><i>New Terms: Clostridium tetani Toxoid Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>565</td>
               <td colspan="2">Clotioxone<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Clotioxone</i></td>
            </tr>
            <tr class="addition">
               <td>566</td>
               <td colspan="2">Clovoxamine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Clovoxamine</i></td>
            </tr>
            <tr class="addition">
               <td>567</td>
               <td colspan="2">Cloxacepride<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Cloxacepride</i></td>
            </tr>
            <tr class="addition">
               <td>568</td>
               <td colspan="2">Cloxacillin Benzathine<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Cloxacillin Benzathine</i></td>
            </tr>
            <tr class="addition">
               <td>569</td>
               <td colspan="2">Cloximate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Cloximate</i></td>
            </tr>
            <tr class="addition">
               <td>570</td>
               <td colspan="2">Cloxypendyl<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Cloxypendyl</i></td>
            </tr>
            <tr class="addition">
               <td>571</td>
               <td colspan="2">Coagulating Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Coagulating Gland</i></td>
            </tr>
            <tr class="addition">
               <td>572</td>
               <td colspan="2">Cobalt Chloride<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Cobalt Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>573</td>
               <td colspan="2">Cobiprostone<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Cobiprostone</i></td>
            </tr>
            <tr class="addition">
               <td>574</td>
               <td colspan="2">Codeine Polistirex<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Codeine Polistirex</i></td>
            </tr>
            <tr class="addition">
               <td>575</td>
               <td colspan="2">Colesevelam<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Colesevelam</i></td>
            </tr>
            <tr class="addition">
               <td>576</td>
               <td colspan="2">Colfenamate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Colfenamate</i></td>
            </tr>
            <tr class="addition">
               <td>577</td>
               <td colspan="2">Coluracetam<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Coluracetam</i></td>
            </tr>
            <tr class="addition">
               <td>578</td>
               <td colspan="2">Cortisuzol<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Cortisuzol</i></td>
            </tr>
            <tr class="addition">
               <td>579</td>
               <td colspan="2">Corynebacterium diphtheriae Toxoid Antigen, A<span class="subclass"> SubClassOf </span>Corynebacterium Diphtheriae Antigen. <br><i>New Terms: Corynebacterium diphtheriae Toxoid Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>580</td>
               <td colspan="2">Corynebacterium diphtheriae Toxoid Antigen, B<span class="subclass"> SubClassOf </span>Corynebacterium Diphtheriae Antigen. <br><i>New Terms: Corynebacterium diphtheriae Toxoid Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>581</td>
               <td colspan="2">Corynebacterium diphtheriae Toxoid Antigen, C<span class="subclass"> SubClassOf </span>Corynebacterium Diphtheriae Antigen. <br><i>New Terms: Corynebacterium diphtheriae Toxoid Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>582</td>
               <td colspan="2">Cotriptyline<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Cotriptyline</i></td>
            </tr>
            <tr class="addition">
               <td>583</td>
               <td colspan="2">Cotton Rat<span class="subclass"> SubClassOf </span>Rat. <br><i>New Terms: Cotton Rat</i></td>
            </tr>
            <tr class="addition">
               <td>584</td>
               <td colspan="2">Coumaphos<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Coumaphos</i></td>
            </tr>
            <tr class="addition">
               <td>585</td>
               <td colspan="2">Coumetarol<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Coumetarol</i></td>
            </tr>
            <tr class="addition">
               <td>586</td>
               <td colspan="2">Cranial Cavity<span class="subclass"> SubClassOf </span>Body Cavity. <br><i>New Terms: Cranial Cavity</i></td>
            </tr>
            <tr class="addition">
               <td>587</td>
               <td colspan="2">Creatinolfosfate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Creatinolfosfate</i></td>
            </tr>
            <tr class="addition">
               <td>588</td>
               <td colspan="2">Cresotamide<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Cresotamide</i></td>
            </tr>
            <tr class="addition">
               <td>589</td>
               <td colspan="2">Cridanimod<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Cridanimod</i></td>
            </tr>
            <tr class="addition">
               <td>590</td>
               <td colspan="2">Croconazole<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Croconazole</i></td>
            </tr>
            <tr class="addition">
               <td>591</td>
               <td colspan="2">Cromoglicate Lisetil<span class="subclass"> SubClassOf </span>Mast Cell Stabilizer. <br><i>New Terms: Cromoglicate Lisetil</i></td>
            </tr>
            <tr class="addition">
               <td>592</td>
               <td colspan="2">Crying<span class="subclass"> SubClassOf </span>Action. <br><i>New Terms: Crying</i></td>
            </tr>
            <tr class="addition">
               <td>593</td>
               <td colspan="2">Cryptococcus<span class="subclass"> SubClassOf </span>Basidiomycota. <br><i>New Terms: Basidiomycota, Cryptococcus</i></td>
            </tr>
            <tr class="addition">
               <td>594</td>
               <td colspan="2">Cryptosporidium<span class="subclass"> SubClassOf </span>Protista. <br><i>New Terms: Cryptosporidium, Protista</i></td>
            </tr>
            <tr class="addition">
               <td>595</td>
               <td colspan="2">Cyanamide<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Cyanamide</i></td>
            </tr>
            <tr class="addition">
               <td>596</td>
               <td colspan="2">Cyclamic Acid<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Cyclamic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>597</td>
               <td colspan="2">Cyclandelate<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Cyclandelate</i></td>
            </tr>
            <tr class="addition">
               <td>598</td>
               <td colspan="2">Cyclarbamate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Cyclarbamate</i></td>
            </tr>
            <tr class="addition">
               <td>599</td>
               <td colspan="2">Cyclexanone<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Cyclexanone</i></td>
            </tr>
            <tr class="addition">
               <td>600</td>
               <td colspan="2">Cyclizine Hydrochloride<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Cyclizine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>601</td>
               <td colspan="2">Cyclobendazole<span class="subclass"> SubClassOf </span>Antihelminthic Agent. <br><i>New Terms: Cyclobendazole</i></td>
            </tr>
            <tr class="addition">
               <td>602</td>
               <td colspan="2">Cyclofenil<span class="subclass"> SubClassOf </span>Antiestrogen. <br><i>New Terms: Cyclofenil</i></td>
            </tr>
            <tr class="addition">
               <td>603</td>
               <td colspan="2">Cyclopregnol<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Cyclopregnol</i></td>
            </tr>
            <tr class="addition">
               <td>604</td>
               <td colspan="2">Cyhalothrin<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Cyhalothrin</i></td>
            </tr>
            <tr class="addition">
               <td>605</td>
               <td colspan="2">Cynomolgus Maritius Monkey<span class="subclass"> SubClassOf </span>Macaque. <br><i>New Terms: Cynomolgus Maritius Monkey</i></td>
            </tr>
            <tr class="addition">
               <td>606</td>
               <td colspan="2">Cypermethrin<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Cypermethrin</i></td>
            </tr>
            <tr class="addition">
               <td>607</td>
               <td colspan="2">Cyprazepam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Cyprazepam</i></td>
            </tr>
            <tr class="addition">
               <td>608</td>
               <td colspan="2">Cyprodenate<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Cyprodenate</i></td>
            </tr>
            <tr class="addition">
               <td>609</td>
               <td colspan="2">Cyromazine<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Cyromazine</i></td>
            </tr>
            <tr class="addition">
               <td>610</td>
               <td colspan="2">Cysteine Hydrochloride Anhydrous<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Cysteine Hydrochloride Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>611</td>
               <td colspan="2">Cythioate<span class="subclass"> SubClassOf </span>Antiparasitic Agent. <br><i>New Terms: Cythioate</i></td>
            </tr>
            <tr class="addition">
               <td>616</td>
               <td colspan="2">D&amp;C Red No. 9<span class="subclass"> SubClassOf </span>Dye. <br><i>New Terms: D&amp;C Red No. 9</i></td>
            </tr>
            <tr class="addition">
               <td>612</td>
               <td colspan="2">D-Arginine<span class="subclass"> SubClassOf </span>Amino Acid. <br><i>New Terms: D-Arginine</i></td>
            </tr>
            <tr class="addition">
               <td>613</td>
               <td colspan="2">D-Camphorsulfonic Acid<span class="subclass"> SubClassOf </span>Sunscreen. <br><i>New Terms: D-Camphorsulfonic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>614</td>
               <td colspan="2">DL-Arginine<span class="subclass"> SubClassOf </span>Amino Acid. <br><i>New Terms: DL-Arginine</i></td>
            </tr>
            <tr class="addition">
               <td>761</td>
               <td colspan="2">DL-Methylephedrine Hydrochloride<span class="subclass"> SubClassOf </span>Adrenergic Agent. <br><i>New Terms: DL-Methylephedrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>615</td>
               <td colspan="2">DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015<span class="subclass"> SubClassOf </span>Monoclonal Antibody. <br><i>New Terms: DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015</i></td>
            </tr>
            <tr class="addition">
               <td>617</td>
               <td colspan="2">Dapagliflozin<span class="subclass"> SubClassOf </span>Anti-diabetic Agent. <br><i>New Terms: Dapagliflozin</i></td>
            </tr>
            <tr class="addition">
               <td>618</td>
               <td colspan="2">Darenzepine<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Darenzepine</i></td>
            </tr>
            <tr class="addition">
               <td>619</td>
               <td colspan="2">Darifenacin Hydrobromide<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Darifenacin Hydrobromide</i></td>
            </tr>
            <tr class="addition">
               <td>620</td>
               <td colspan="2">Darunavir Ethanolate<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Darunavir Ethanolate</i></td>
            </tr>
            <tr class="addition">
               <td>621</td>
               <td colspan="2">Dasantafil<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Dasantafil</i></td>
            </tr>
            <tr class="addition">
               <td>622</td>
               <td colspan="2">Datelliptium Chloride<span class="subclass"> SubClassOf </span>DNA Intercalating Agent. <br><i>New Terms: Datelliptium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>623</td>
               <td colspan="2">Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>624</td>
               <td colspan="2">Dazidamine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Dazidamine</i></td>
            </tr>
            <tr class="addition">
               <td>625</td>
               <td colspan="2">Deanol Aceglumate<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Deanol Aceglumate</i></td>
            </tr>
            <tr class="addition">
               <td>626</td>
               <td colspan="2">Deanol Acetamidobenzoate<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Deanol Acetamidobenzoate</i></td>
            </tr>
            <tr class="addition">
               <td>627</td>
               <td colspan="2">Deboxamet<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Deboxamet</i></td>
            </tr>
            <tr class="addition">
               <td>628</td>
               <td colspan="2">Debrisoquin Sulfate<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Antagonist. <br><i>New Terms: Debrisoquin Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>629</td>
               <td colspan="2">Debropol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Debropol</i></td>
            </tr>
            <tr class="addition">
               <td>630</td>
               <td colspan="2">Decamethonium<span class="subclass"> SubClassOf </span>Muscle Relaxant. <br><i>New Terms: Decamethonium</i></td>
            </tr>
            <tr class="addition">
               <td>631</td>
               <td colspan="2">Declenperone<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Declenperone</i></td>
            </tr>
            <tr class="addition">
               <td>632</td>
               <td colspan="2">Decloxizine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Decloxizine</i></td>
            </tr>
            <tr class="addition">
               <td>633</td>
               <td colspan="2">Decoquinate<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Decoquinate</i></td>
            </tr>
            <tr class="addition">
               <td>635</td>
               <td colspan="2">Deditonium Bromide<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Deditonium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>634</td>
               <td colspan="2">Deditonium<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Deditonium</i></td>
            </tr>
            <tr class="addition">
               <td>636</td>
               <td colspan="2">Deferitrin<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Deferitrin</i></td>
            </tr>
            <tr class="addition">
               <td>637</td>
               <td colspan="2">Dehydrocholate Sodium<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Dehydrocholate Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>638</td>
               <td colspan="2">Dehydrocholic Acid<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Dehydrocholic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>639</td>
               <td colspan="2">Delfantrine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Delfantrine</i></td>
            </tr>
            <tr class="addition">
               <td>640</td>
               <td colspan="2">Delmetacin<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Delmetacin</i></td>
            </tr>
            <tr class="addition">
               <td>641</td>
               <td colspan="2">Delmopinol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Delmopinol</i></td>
            </tr>
            <tr class="addition">
               <td>642</td>
               <td colspan="2">Delucemine<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Delucemine</i></td>
            </tr>
            <tr class="addition">
               <td>643</td>
               <td colspan="2">Dembrexine<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Dembrexine</i></td>
            </tr>
            <tr class="addition">
               <td>644</td>
               <td colspan="2">Demelverine<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Demelverine</i></td>
            </tr>
            <tr class="addition">
               <td>645</td>
               <td colspan="2">Demexiptiline<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Demexiptiline</i></td>
            </tr>
            <tr class="addition">
               <td>646</td>
               <td colspan="2">Democonazole<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Democonazole</i></td>
            </tr>
            <tr class="addition">
               <td>647</td>
               <td colspan="2">Denagliptin<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Denagliptin</i></td>
            </tr>
            <tr class="addition">
               <td>648</td>
               <td colspan="2">Denatonium Benzoate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Denatonium Benzoate</i></td>
            </tr>
            <tr class="addition">
               <td>649</td>
               <td colspan="2">Denaverine<span class="subclass"> SubClassOf </span>Anticholinergic Agent. <br><i>New Terms: Denaverine</i></td>
            </tr>
            <tr class="addition">
               <td>650</td>
               <td colspan="2">Denibulin<span class="subclass"> SubClassOf </span>Tubulin Binding Agent. <br><i>New Terms: Denibulin</i></td>
            </tr>
            <tr class="addition">
               <td>651</td>
               <td colspan="2">Denipride<span class="subclass"> SubClassOf </span>Antiemetic Agent. <br><i>New Terms: Denipride</i></td>
            </tr>
            <tr class="addition">
               <td>652</td>
               <td colspan="2">Denopamine<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Denopamine</i></td>
            </tr>
            <tr class="addition">
               <td>653</td>
               <td colspan="2">Denotivir<span class="subclass"> SubClassOf </span>Anti-Infective Agent. <br><i>New Terms: Denotivir</i></td>
            </tr>
            <tr class="addition">
               <td>654</td>
               <td colspan="2">Denotivir<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Denotivir</i></td>
            </tr>
            <tr class="addition">
               <td>655</td>
               <td colspan="2">Denpidazone<span class="subclass"> SubClassOf </span>Muscle Relaxant. <br><i>New Terms: Denpidazone</i></td>
            </tr>
            <tr class="addition">
               <td>656</td>
               <td colspan="2">Denufosol<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Denufosol</i></td>
            </tr>
            <tr class="addition">
               <td>657</td>
               <td colspan="2">Denzimol<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Denzimol</i></td>
            </tr>
            <tr class="addition">
               <td>658</td>
               <td colspan="2">Depramine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Depramine</i></td>
            </tr>
            <tr class="addition">
               <td>659</td>
               <td colspan="2">Deprodone<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Deprodone</i></td>
            </tr>
            <tr class="addition">
               <td>660</td>
               <td colspan="2">Dequalinium Chloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Dequalinium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>661</td>
               <td colspan="2">Deriglidole<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Antagonist. <br><i>New Terms: Deriglidole</i></td>
            </tr>
            <tr class="addition">
               <td>662</td>
               <td colspan="2">Dersalazine<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Dersalazine</i></td>
            </tr>
            <tr class="addition">
               <td>663</td>
               <td colspan="2">Desmeninol<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Desmeninol</i></td>
            </tr>
            <tr class="addition">
               <td>664</td>
               <td colspan="2">Desmethylmoramide<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Desmethylmoramide</i></td>
            </tr>
            <tr class="addition">
               <td>665</td>
               <td colspan="2">Detanosal<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Detanosal</i></td>
            </tr>
            <tr class="addition">
               <td>666</td>
               <td colspan="2">Detiviciclovir<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Detiviciclovir</i></td>
            </tr>
            <tr class="addition">
               <td>667</td>
               <td colspan="2">Devapamil<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Devapamil</i></td>
            </tr>
            <tr class="addition">
               <td>668</td>
               <td colspan="2">Dexamethasone Acefurate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Acefurate</i></td>
            </tr>
            <tr class="addition">
               <td>669</td>
               <td colspan="2">Dexamethasone Acetate Anhydrous<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Acetate Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>670</td>
               <td colspan="2">Dexamethasone Acetate Monohydrate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Acetate Monohydrate</i></td>
            </tr>
            <tr class="addition">
               <td>671</td>
               <td colspan="2">Dexamethasone Beloxil<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Beloxil</i></td>
            </tr>
            <tr class="addition">
               <td>672</td>
               <td colspan="2">Dexamethasone Cipecilate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Cipecilate</i></td>
            </tr>
            <tr class="addition">
               <td>673</td>
               <td colspan="2">Dexamethasone Dipropionate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Dipropionate</i></td>
            </tr>
            <tr class="addition">
               <td>674</td>
               <td colspan="2">Dexamethasone Isonicotinate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Isonicotinate</i></td>
            </tr>
            <tr class="addition">
               <td>675</td>
               <td colspan="2">Dexamethasone Phosphate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>676</td>
               <td colspan="2">Dexamethasone Pivalate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dexamethasone Pivalate</i></td>
            </tr>
            <tr class="addition">
               <td>677</td>
               <td colspan="2">Dexamisole<span class="subclass"> SubClassOf </span>Antihelminthic Agent. <br><i>New Terms: Dexamisole</i></td>
            </tr>
            <tr class="addition">
               <td>678</td>
               <td colspan="2">Dexecadotril<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Dexecadotril</i></td>
            </tr>
            <tr class="addition">
               <td>679</td>
               <td colspan="2">Dexefaroxan<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Dexefaroxan</i></td>
            </tr>
            <tr class="addition">
               <td>680</td>
               <td colspan="2">Dexelvucitabine<span class="subclass"> SubClassOf </span>Reverse Transcriptase Inhibitor. <br><i>New Terms: Dexelvucitabine</i></td>
            </tr>
            <tr class="addition">
               <td>681</td>
               <td colspan="2">Dexetimide<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Dexetimide</i></td>
            </tr>
            <tr class="addition">
               <td>682</td>
               <td colspan="2">Dexetozoline<span class="subclass"> SubClassOf </span>Antihypertensive Agent. <br><i>New Terms: Dexetozoline</i></td>
            </tr>
            <tr class="addition">
               <td>683</td>
               <td colspan="2">Deximafen<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Deximafen</i></td>
            </tr>
            <tr class="addition">
               <td>684</td>
               <td colspan="2">Dexindoprofen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Dexindoprofen</i></td>
            </tr>
            <tr class="addition">
               <td>685</td>
               <td colspan="2">Dexlofexidine<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Agonist. <br><i>New Terms: Dexlofexidine</i></td>
            </tr>
            <tr class="addition">
               <td>686</td>
               <td colspan="2">Dexnafenodone<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Dexnafenodone</i></td>
            </tr>
            <tr class="addition">
               <td>687</td>
               <td colspan="2">Dexoxadrol Hydrochloride<span class="subclass"> SubClassOf </span>Anesthetic Agent. <br><i>New Terms: Dexoxadrol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>689</td>
               <td colspan="2">Dexpropranolol Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Dexpropranolol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>688</td>
               <td colspan="2">Dexpropranolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Dexpropranolol</i></td>
            </tr>
            <tr class="addition">
               <td>690</td>
               <td colspan="2">Dexproxibutene<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Dexproxibutene</i></td>
            </tr>
            <tr class="addition">
               <td>691</td>
               <td colspan="2">Dextilidine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Dextilidine</i></td>
            </tr>
            <tr class="addition">
               <td>692</td>
               <td colspan="2">Dextiopronin<span class="subclass"> SubClassOf </span>Uroprotective Agent. <br><i>New Terms: Dextiopronin</i></td>
            </tr>
            <tr class="addition">
               <td>693</td>
               <td colspan="2">Dextofisopam<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Dextofisopam</i></td>
            </tr>
            <tr class="addition">
               <td>694</td>
               <td colspan="2">Dextroamphetamine Phosphate<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Dextroamphetamine Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>695</td>
               <td colspan="2">Dextrofemine<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Dextrofemine</i></td>
            </tr>
            <tr class="addition">
               <td>696</td>
               <td colspan="2">Dextromoramide Tartrate<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Dextromoramide Tartrate</i></td>
            </tr>
            <tr class="addition">
               <td>697</td>
               <td colspan="2">Diacetamate<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Diacetamate</i></td>
            </tr>
            <tr class="addition">
               <td>698</td>
               <td colspan="2">Diamfenetide<span class="subclass"> SubClassOf </span>Antiparasitic Agent. <br><i>New Terms: Diamfenetide</i></td>
            </tr>
            <tr class="addition">
               <td>699</td>
               <td colspan="2">Diampromide<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Diampromide</i></td>
            </tr>
            <tr class="addition">
               <td>700</td>
               <td colspan="2">Diarbarone<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Diarbarone</i></td>
            </tr>
            <tr class="addition">
               <td>701</td>
               <td colspan="2">Diathymosulfone<span class="subclass"> SubClassOf </span>Sulfone Anti-Infective Agent. <br><i>New Terms: Diathymosulfone</i></td>
            </tr>
            <tr class="addition">
               <td>702</td>
               <td colspan="2">Dibemethine<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Dibemethine</i></td>
            </tr>
            <tr class="addition">
               <td>703</td>
               <td colspan="2">Dibuprol<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Dibuprol</i></td>
            </tr>
            <tr class="addition">
               <td>704</td>
               <td colspan="2">Dibupyrone<span class="subclass"> SubClassOf </span>Analgesic<br><span class="keyword"> and </span>Antipyretic. <br><i>New Terms: Dibupyrone</i></td>
            </tr>
            <tr class="addition">
               <td>705</td>
               <td colspan="2">Dibusadol<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Dibusadol</i></td>
            </tr>
            <tr class="addition">
               <td>706</td>
               <td colspan="2">Dibutyl Phthalate<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Dibutyl Phthalate</i></td>
            </tr>
            <tr class="addition">
               <td>707</td>
               <td colspan="2">Dibutyl Sebacate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Dibutyl Sebacate</i></td>
            </tr>
            <tr class="addition">
               <td>708</td>
               <td colspan="2">Dicarbine<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Dicarbine</i></td>
            </tr>
            <tr class="addition">
               <td>709</td>
               <td colspan="2">Dicarbine<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Dicarbine</i></td>
            </tr>
            <tr class="addition">
               <td>710</td>
               <td colspan="2">Dicarfen<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Dicarfen</i></td>
            </tr>
            <tr class="addition">
               <td>711</td>
               <td colspan="2">Dichlorisone<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Dichlorisone</i></td>
            </tr>
            <tr class="addition">
               <td>712</td>
               <td colspan="2">Dichlormezanone<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Dichlormezanone</i></td>
            </tr>
            <tr class="addition">
               <td>713</td>
               <td colspan="2">Dichlorobenzyl Alcohol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Dichlorobenzyl Alcohol</i></td>
            </tr>
            <tr class="addition">
               <td>714</td>
               <td colspan="2">Dichlorodifluoromethane<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Dichlorodifluoromethane</i></td>
            </tr>
            <tr class="addition">
               <td>715</td>
               <td colspan="2">Dichlorofluoromethane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Dichlorofluoromethane</i></td>
            </tr>
            <tr class="addition">
               <td>716</td>
               <td colspan="2">Dichlorotetrafluoroethane<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Dichlorotetrafluoroethane</i></td>
            </tr>
            <tr class="addition">
               <td>717</td>
               <td colspan="2">Dichloroxylenol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Dichloroxylenol</i></td>
            </tr>
            <tr class="addition">
               <td>718</td>
               <td colspan="2">Dichlorvos<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Dichlorvos</i></td>
            </tr>
            <tr class="addition">
               <td>719</td>
               <td colspan="2">Diclazuril<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Diclazuril</i></td>
            </tr>
            <tr class="addition">
               <td>720</td>
               <td colspan="2">Diclofenac Epolamine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Diclofenac Epolamine</i></td>
            </tr>
            <tr class="addition">
               <td>721</td>
               <td colspan="2">Diclofensine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Diclofensine</i></td>
            </tr>
            <tr class="addition">
               <td>722</td>
               <td colspan="2">Diclofurime<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Diclofurime</i></td>
            </tr>
            <tr class="addition">
               <td>723</td>
               <td colspan="2">Diclonixin<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Diclonixin</i></td>
            </tr>
            <tr class="addition">
               <td>724</td>
               <td colspan="2">Dicloralurea<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Dicloralurea</i></td>
            </tr>
            <tr class="addition">
               <td>725</td>
               <td colspan="2">Didrovaltrate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Didrovaltrate</i></td>
            </tr>
            <tr class="addition">
               <td>726</td>
               <td colspan="2">Diethadione<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Diethadione</i></td>
            </tr>
            <tr class="addition">
               <td>727</td>
               <td colspan="2">Diethanolamine<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Diethanolamine</i></td>
            </tr>
            <tr class="addition">
               <td>728</td>
               <td colspan="2">Diethyl Phthalate<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Diethyl Phthalate</i></td>
            </tr>
            <tr class="addition">
               <td>729</td>
               <td colspan="2">Diethyl Sebacate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Diethyl Sebacate</i></td>
            </tr>
            <tr class="addition">
               <td>730</td>
               <td colspan="2">Diethylthiambutene<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Diethylthiambutene</i></td>
            </tr>
            <tr class="addition">
               <td>731</td>
               <td colspan="2">Dietifen<span class="subclass"> SubClassOf </span>Antifungal Agent. <br><i>New Terms: Dietifen</i></td>
            </tr>
            <tr class="addition">
               <td>732</td>
               <td colspan="2">Difebarbamate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Difebarbamate</i></td>
            </tr>
            <tr class="addition">
               <td>733</td>
               <td colspan="2">Difemetorex<span class="subclass"> SubClassOf </span>Anorexiant. <br><i>New Terms: Difemetorex</i></td>
            </tr>
            <tr class="addition">
               <td>734</td>
               <td colspan="2">Difenamizole<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Difenamizole</i></td>
            </tr>
            <tr class="addition">
               <td>736</td>
               <td colspan="2">Difencloxazine Hydrochloride<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Difencloxazine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>735</td>
               <td colspan="2">Difencloxazine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Difencloxazine</i></td>
            </tr>
            <tr class="addition">
               <td>737</td>
               <td colspan="2">Difenoximide Hydrochloride<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Difenoximide Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>738</td>
               <td colspan="2">Difetarsone<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Difetarsone</i></td>
            </tr>
            <tr class="addition">
               <td>739</td>
               <td colspan="2">Difeterol<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Difeterol</i></td>
            </tr>
            <tr class="addition">
               <td>740</td>
               <td colspan="2">Difolatan<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Difolatan</i></td>
            </tr>
            <tr class="addition">
               <td>741</td>
               <td colspan="2">Digalloyl Trioleate<span class="subclass"> SubClassOf </span>Sunscreen. <br><i>New Terms: Digalloyl Trioleate</i></td>
            </tr>
            <tr class="addition">
               <td>742</td>
               <td colspan="2">Dihydroxyacetone<span class="subclass"> SubClassOf </span>Carbohydrate. <br><i>New Terms: Dihydroxyacetone</i></td>
            </tr>
            <tr class="addition">
               <td>743</td>
               <td colspan="2">Dihydroxyaluminum Sodium Carbonate<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Dihydroxyaluminum Sodium Carbonate</i></td>
            </tr>
            <tr class="addition">
               <td>744</td>
               <td colspan="2">Diisopropyl Adipate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Diisopropyl Adipate</i></td>
            </tr>
            <tr class="addition">
               <td>745</td>
               <td colspan="2">Dimepheptanol<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Dimepheptanol</i></td>
            </tr>
            <tr class="addition">
               <td>746</td>
               <td colspan="2">Dimethindene Maleate<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Dimethindene Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>747</td>
               <td colspan="2">Dimethoxanate Hydrochloride<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Dimethoxanate Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>748</td>
               <td colspan="2">Dimethyl Phthalate<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Dimethyl Phthalate</i></td>
            </tr>
            <tr class="addition">
               <td>749</td>
               <td colspan="2">Dimetridazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Dimetridazole</i></td>
            </tr>
            <tr class="addition">
               <td>750</td>
               <td colspan="2">Dioxyline Phosphate<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Dioxyline Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>751</td>
               <td colspan="2">Diphemanil<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Diphemanil</i></td>
            </tr>
            <tr class="addition">
               <td>752</td>
               <td colspan="2">Diphenidol Pamoate<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Diphenidol Pamoate</i></td>
            </tr>
            <tr class="addition">
               <td>753</td>
               <td colspan="2">Dipipanone Hydrochloride<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Dipipanone Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>754</td>
               <td colspan="2">Diprotrizoate Sodium<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Diprotrizoate Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>755</td>
               <td colspan="2">Diprotrizoic Acid<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Diprotrizoic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>756</td>
               <td colspan="2">Dirlotapide<span class="subclass"> SubClassOf </span>Anorexiant. <br><i>New Terms: Dirlotapide</i></td>
            </tr>
            <tr class="addition">
               <td>757</td>
               <td colspan="2">Disogluside<span class="subclass"> SubClassOf </span>Antilipidemic Agent. <br><i>New Terms: Disogluside</i></td>
            </tr>
            <tr class="addition">
               <td>758</td>
               <td colspan="2">Disufenton Sodium<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Disufenton Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>759</td>
               <td colspan="2">Ditercalinium Chloride<span class="subclass"> SubClassOf </span>DNA Intercalating Agent. <br><i>New Terms: Ditercalinium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>760</td>
               <td colspan="2">Ditiocade Sodium<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Ditiocade Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>762</td>
               <td colspan="2">Docebenone<span class="subclass"> SubClassOf </span>Lipooxygenase Inhibitor. <br><i>New Terms: Docebenone</i></td>
            </tr>
            <tr class="addition">
               <td>764</td>
               <td colspan="2">Docusate Potassium<span class="subclass"> SubClassOf </span>Stool Softener. <br><i>New Terms: Docusate Potassium</i></td>
            </tr>
            <tr class="addition">
               <td>763</td>
               <td colspan="2">Docusate<span class="subclass"> SubClassOf </span>Stool Softener. <br><i>New Terms: Docusate</i></td>
            </tr>
            <tr class="addition">
               <td>765</td>
               <td colspan="2">Domazoline Fumarate<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Domazoline Fumarate</i></td>
            </tr>
            <tr class="addition">
               <td>766</td>
               <td colspan="2">Domestic Short Hair Cat<span class="subclass"> SubClassOf </span>Felidae. <br><i>New Terms: Domestic Short Hair Cat</i></td>
            </tr>
            <tr class="addition">
               <td>767</td>
               <td colspan="2">Donetidine<span class="subclass"> SubClassOf </span>Histamine-2 Receptor Antagonist. <br><i>New Terms: Donetidine</i></td>
            </tr>
            <tr class="addition">
               <td>768</td>
               <td colspan="2">Donor Cellular Infusion<span class="subclass"> SubClassOf </span>Infusion Procedure. <br><i>New Terms: Donor Cellular Infusion</i></td>
            </tr>
            <tr class="addition">
               <td>769</td>
               <td colspan="2">Dopexamine Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Dopexamine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>770</td>
               <td colspan="2">Doramapimod<span class="subclass"> SubClassOf </span>Mitogen-Activated Protein Kinase Inhibitor. <br><i>New Terms: Doramapimod</i></td>
            </tr>
            <tr class="addition">
               <td>771</td>
               <td colspan="2">Doreptide<span class="subclass"> SubClassOf </span>Antiparkinsonian Agent. <br><i>New Terms: Doreptide</i></td>
            </tr>
            <tr class="addition">
               <td>772</td>
               <td colspan="2">Doretinel<span class="subclass"> SubClassOf </span>Vitamin, Other. <br><i>New Terms: Doretinel</i></td>
            </tr>
            <tr class="addition">
               <td>773</td>
               <td colspan="2">Dorsolateral Prostate Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Dorsolateral Prostate Gland</i></td>
            </tr>
            <tr class="addition">
               <td>774</td>
               <td colspan="2">Dotarizine<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Dotarizine</i></td>
            </tr>
            <tr class="addition">
               <td>775</td>
               <td colspan="2">Dotarizine<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Dotarizine</i></td>
            </tr>
            <tr class="addition">
               <td>776</td>
               <td colspan="2">Dothiepin Hydrochloride<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Dothiepin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>777</td>
               <td colspan="2">Doxycycline Anhydrous<span class="subclass"> SubClassOf </span>Tetracycline Antibiotic. <br><i>New Terms: Doxycycline Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>778</td>
               <td colspan="2">Drometrizole<span class="subclass"> SubClassOf </span>Sunscreen. <br><i>New Terms: Drometrizole</i></td>
            </tr>
            <tr class="addition">
               <td>779</td>
               <td colspan="2">Dunkin Hartley Guinea Pig<span class="subclass"> SubClassOf </span>Guinea Pig. <br><i>New Terms: Dunkin Hartley Guinea Pig</i></td>
            </tr>
            <tr class="addition">
               <td>780</td>
               <td colspan="2">Duroc Pig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Duroc Pig</i></td>
            </tr>
            <tr class="addition">
               <td>781</td>
               <td colspan="2">Dutacatib<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Dutacatib</i></td>
            </tr>
            <tr class="addition">
               <td>782</td>
               <td colspan="2">E3 Ubiquitin-Protein Ligase CHFR<span class="subclass"> EquivalentTo </span>E3 Ubiquitin Ligase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>CHFR Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>E3 Ubiquitin Ligase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Has_Structural_Domain_Or_Motif<span class="some"> some </span>Ring Finger Domain)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Cycle Checkpoint)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Ubiquitination). <br><i>New Terms: E3 Ubiquitin-Protein Ligase CHFR, CHFR Gene</i></td>
            </tr>
            <tr class="addition">
               <td>783</td>
               <td colspan="2">Eastern European<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Eastern European</i></td>
            </tr>
            <tr class="addition">
               <td>784</td>
               <td colspan="2">Ebastine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Ebastine</i></td>
            </tr>
            <tr class="addition">
               <td>785</td>
               <td colspan="2">Ebiratide<span class="subclass"> SubClassOf </span>Pituitary Agent. <br><i>New Terms: Ebiratide</i></td>
            </tr>
            <tr class="addition">
               <td>786</td>
               <td colspan="2">Ebrotidine<span class="subclass"> SubClassOf </span>Histamine-2 Receptor Antagonist. <br><i>New Terms: Ebrotidine</i></td>
            </tr>
            <tr class="addition">
               <td>787</td>
               <td colspan="2">Ecomustine<span class="subclass"> SubClassOf </span>Nitrosourea Compound. <br><i>New Terms: Ecomustine</i></td>
            </tr>
            <tr class="addition">
               <td>788</td>
               <td colspan="2">Ecopladib<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Ecopladib</i></td>
            </tr>
            <tr class="addition">
               <td>789</td>
               <td colspan="2">Ecraprost<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Ecraprost</i></td>
            </tr>
            <tr class="addition">
               <td>790</td>
               <td colspan="2">Ectylurea<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Ectylurea</i></td>
            </tr>
            <tr class="addition">
               <td>791</td>
               <td colspan="2">Edetate Sodium<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Edetate Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>792</td>
               <td colspan="2">Edetate Tripotassium<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Edetate Tripotassium</i></td>
            </tr>
            <tr class="addition">
               <td>793</td>
               <td colspan="2">Edetate Trisodium<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Edetate Trisodium</i></td>
            </tr>
            <tr class="addition">
               <td>794</td>
               <td colspan="2">Edetol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Edetol</i></td>
            </tr>
            <tr class="addition">
               <td>796</td>
               <td colspan="2">Edonentan Anhydrous<span class="subclass"> SubClassOf </span>Cardiovascular Agent. <br><i>New Terms: Edonentan Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>795</td>
               <td colspan="2">Edonentan<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Edonentan</i></td>
            </tr>
            <tr class="addition">
               <td>797</td>
               <td colspan="2">Efipladib<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Efipladib</i></td>
            </tr>
            <tr class="addition">
               <td>798</td>
               <td colspan="2">Efonidipine Hydrochloride<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Efonidipine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>799</td>
               <td colspan="2">Eglumetad<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Eglumetad</i></td>
            </tr>
            <tr class="addition">
               <td>800</td>
               <td colspan="2">Elanzepine<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Elanzepine</i></td>
            </tr>
            <tr class="addition">
               <td>801</td>
               <td colspan="2">Elgodipine<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Elgodipine</i></td>
            </tr>
            <tr class="addition">
               <td>802</td>
               <td colspan="2">Eltenac<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Eltenac</i></td>
            </tr>
            <tr class="addition">
               <td>803</td>
               <td colspan="2">Elvitegravir<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Elvitegravir</i></td>
            </tr>
            <tr class="addition">
               <td>804</td>
               <td colspan="2">Emricasan<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Emricasan</i></td>
            </tr>
            <tr class="addition">
               <td>805</td>
               <td colspan="2">Emylcamate<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Emylcamate</i></td>
            </tr>
            <tr class="addition">
               <td>807</td>
               <td colspan="2">Endralazine Mesylate<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Endralazine Mesylate</i></td>
            </tr>
            <tr class="addition">
               <td>806</td>
               <td colspan="2">Endralazine<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Endralazine</i></td>
            </tr>
            <tr class="addition">
               <td>808</td>
               <td colspan="2">Entecavir Anhydrous<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Entecavir Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>809</td>
               <td colspan="2">Enzastaurin<span class="subclass"> SubClassOf </span>Protein Kinase C Inhibitor. <br><i>New Terms: Enzastaurin</i></td>
            </tr>
            <tr class="addition">
               <td>810</td>
               <td colspan="2">Epervudine<span class="subclass"> SubClassOf </span>Pyrimidine Antagonist. <br><i>New Terms: Epervudine</i></td>
            </tr>
            <tr class="addition">
               <td>811</td>
               <td colspan="2">Epipropidine<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: Epipropidine</i></td>
            </tr>
            <tr class="addition">
               <td>812</td>
               <td colspan="2">Epithiazide<span class="subclass"> SubClassOf </span>Thiazide Diuretic. <br><i>New Terms: Epithiazide</i></td>
            </tr>
            <tr class="addition">
               <td>813</td>
               <td colspan="2">Epothilone KOS-1584<span class="subclass"> SubClassOf </span>Tubulin Binding Agent. <br><i>New Terms: Epothilone KOS-1584</i></td>
            </tr>
            <tr class="addition">
               <td>815</td>
               <td colspan="2">ErbB Kinase Inhibitor AZD8931<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: ErbB Kinase Inhibitor AZD8931</i></td>
            </tr>
            <tr class="addition">
               <td>814</td>
               <td colspan="2">ErbB-2 Inhibitor ARRY-380<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: ErbB-2 Inhibitor ARRY-380</i></td>
            </tr>
            <tr class="addition">
               <td>816</td>
               <td colspan="2">Ergonovine Maleate<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Ergonovine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>817</td>
               <td colspan="2">Eribaxaban<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Eribaxaban</i></td>
            </tr>
            <tr class="addition">
               <td>818</td>
               <td colspan="2">Erythromycin Ethylcarbonate<span class="subclass"> SubClassOf </span>Macrolide Antibiotic. <br><i>New Terms: Erythromycin Ethylcarbonate</i></td>
            </tr>
            <tr class="addition">
               <td>819</td>
               <td colspan="2">Escherichia<span class="subclass"> SubClassOf </span>Proteobacteria. <br><i>New Terms: Escherichia</i></td>
            </tr>
            <tr class="addition">
               <td>821</td>
               <td colspan="2">Esmirtazapine Maleate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Esmirtazapine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>820</td>
               <td colspan="2">Esmirtazapine<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Esmirtazapine</i></td>
            </tr>
            <tr class="addition">
               <td>822</td>
               <td colspan="2">Estradiol Enanthate<span class="subclass"> SubClassOf </span>Therapeutic Estrogen. <br><i>New Terms: Estradiol Enanthate</i></td>
            </tr>
            <tr class="addition">
               <td>823</td>
               <td colspan="2">Etafedrine<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Etafedrine</i></td>
            </tr>
            <tr class="addition">
               <td>824</td>
               <td colspan="2">Eterobarb<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Eterobarb</i></td>
            </tr>
            <tr class="addition">
               <td>825</td>
               <td colspan="2">Ethamivan<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Ethamivan</i></td>
            </tr>
            <tr class="addition">
               <td>826</td>
               <td colspan="2">Ethisterone<span class="subclass"> SubClassOf </span>Progestin. <br><i>New Terms: Ethisterone</i></td>
            </tr>
            <tr class="addition">
               <td>828</td>
               <td colspan="2">Ethoheptazine Citrate<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Ethoheptazine Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>827</td>
               <td colspan="2">Ethoheptazine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Ethoheptazine</i></td>
            </tr>
            <tr class="addition">
               <td>829</td>
               <td colspan="2">Ethohexadiol<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Ethohexadiol</i></td>
            </tr>
            <tr class="addition">
               <td>830</td>
               <td colspan="2">Ethopabate<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Ethopabate</i></td>
            </tr>
            <tr class="addition">
               <td>831</td>
               <td colspan="2">Ethyl Acetate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethyl Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>832</td>
               <td colspan="2">Ethyl Docosahexaenoate<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Ethyl Docosahexaenoate</i></td>
            </tr>
            <tr class="addition">
               <td>833</td>
               <td colspan="2">Ethyl Maltol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethyl Maltol</i></td>
            </tr>
            <tr class="addition">
               <td>834</td>
               <td colspan="2">Ethyl Oleate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethyl Oleate</i></td>
            </tr>
            <tr class="addition">
               <td>835</td>
               <td colspan="2">Ethyl Vanillin<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethyl Vanillin</i></td>
            </tr>
            <tr class="addition">
               <td>838</td>
               <td colspan="2">Ethylene Glycol Monoethyl Ether<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethylene Glycol Monoethyl Ether</i></td>
            </tr>
            <tr class="addition">
               <td>837</td>
               <td colspan="2">Ethylene Glycol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethylene Glycol</i></td>
            </tr>
            <tr class="addition">
               <td>836</td>
               <td colspan="2">Ethylene<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Ethylene</i></td>
            </tr>
            <tr class="addition">
               <td>839</td>
               <td colspan="2">Ethylmorphine Hydrochloride<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Ethylmorphine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>840</td>
               <td colspan="2">Ethylnorepinephrine Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Ethylnorepinephrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>841</td>
               <td colspan="2">Ethylparaben<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ethylparaben</i></td>
            </tr>
            <tr class="addition">
               <td>842</td>
               <td colspan="2">Etidocaine Hydrochloride<span class="subclass"> SubClassOf </span>Anesthetic Agent. <br><i>New Terms: Etidocaine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>843</td>
               <td colspan="2">Etiracetam<span class="subclass"> SubClassOf </span>Anticonvulsant Agent. <br><i>New Terms: Etiracetam</i></td>
            </tr>
            <tr class="addition">
               <td>844</td>
               <td colspan="2">Eucalyptol<span class="subclass"> SubClassOf </span>Mucolytic Agent. <br><i>New Terms: Eucalyptol</i></td>
            </tr>
            <tr class="addition">
               <td>845</td>
               <td colspan="2">Exteriorization Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Exteriorization Site</i></td>
            </tr>
            <tr class="addition">
               <td>846</td>
               <td colspan="2">FGF Receptor Antagonist FP-1039<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: FGF Receptor Antagonist FP-1039</i></td>
            </tr>
            <tr class="addition">
               <td>847</td>
               <td colspan="2">Fadolmidine Hydrochloride<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Agonist. <br><i>New Terms: Fadolmidine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>849</td>
               <td colspan="2">Famotine Hydrochloride<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Famotine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>848</td>
               <td colspan="2">Famotine<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Famotine</i></td>
            </tr>
            <tr class="addition">
               <td>850</td>
               <td colspan="2">Fampridine<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Fampridine</i></td>
            </tr>
            <tr class="addition">
               <td>851</td>
               <td colspan="2">Fear<span class="subclass"> SubClassOf </span>Emotion. <br><i>New Terms: Fear</i></td>
            </tr>
            <tr class="addition">
               <td>852</td>
               <td colspan="2">Feelings<span class="subclass"> SubClassOf </span>Mental Process. <br><i>New Terms: Feelings</i></td>
            </tr>
            <tr class="addition">
               <td>853</td>
               <td colspan="2">Fenabutene<span class="subclass"> SubClassOf </span>Hormone Antagonist. <br><i>New Terms: Fenabutene</i></td>
            </tr>
            <tr class="addition">
               <td>854</td>
               <td colspan="2">Fenaftic Acid<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Fenaftic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>855</td>
               <td colspan="2">Fenoctimine<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Fenoctimine</i></td>
            </tr>
            <tr class="addition">
               <td>856</td>
               <td colspan="2">Fenoctimine Sulfate<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Fenoctimine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>857</td>
               <td colspan="2">Fenpipramide Hydrochloride<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Fenpipramide Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>858</td>
               <td colspan="2">Fenprostalene<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Fenprostalene</i></td>
            </tr>
            <tr class="addition">
               <td>859</td>
               <td colspan="2">Fenthion<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Fenthion</i></td>
            </tr>
            <tr class="addition">
               <td>860</td>
               <td colspan="2">Ferret<span class="subclass"> SubClassOf </span>Mustelidae. <br><i>New Terms: Ferret, Mustelidae</i></td>
            </tr>
            <tr class="addition">
               <td>861</td>
               <td colspan="2">Ferric Chloride<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Ferric Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>862</td>
               <td colspan="2">Ferric Hypophosphite<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ferric Hypophosphite</i></td>
            </tr>
            <tr class="addition">
               <td>863</td>
               <td colspan="2">Ferric Sulfate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Ferric Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>864</td>
               <td colspan="2">Ferrocholinate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Ferrocholinate</i></td>
            </tr>
            <tr class="addition">
               <td>865</td>
               <td colspan="2">Ferrous Sulfate Anhydrous<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Ferrous Sulfate Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>866</td>
               <td colspan="2">Firategrast<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Firategrast</i></td>
            </tr>
            <tr class="addition">
               <td>867</td>
               <td colspan="2">Flindokalner<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Flindokalner</i></td>
            </tr>
            <tr class="addition">
               <td>868</td>
               <td colspan="2">Flumethasone 21-Acetate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Flumethasone 21-Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>869</td>
               <td colspan="2">Flunixin Meglumine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Flunixin Meglumine</i></td>
            </tr>
            <tr class="addition">
               <td>870</td>
               <td colspan="2">Flunoprost<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Flunoprost</i></td>
            </tr>
            <tr class="addition">
               <td>871</td>
               <td colspan="2">Fluprednidene<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Fluprednidene</i></td>
            </tr>
            <tr class="addition">
               <td>872</td>
               <td colspan="2">Fluprostenol<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Fluprostenol</i></td>
            </tr>
            <tr class="addition">
               <td>873</td>
               <td colspan="2">Flurogestone Acetate<span class="subclass"> SubClassOf </span>Progestin. <br><i>New Terms: Flurogestone Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>874</td>
               <td colspan="2">Flurothyl<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Flurothyl</i></td>
            </tr>
            <tr class="addition">
               <td>875</td>
               <td colspan="2">Fluticasone Furoate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Fluticasone Furoate</i></td>
            </tr>
            <tr class="addition">
               <td>876</td>
               <td colspan="2">Follicle Stimulating Hormone Beta Polypeptide<span class="subclass"> SubClassOf </span>Pituitary Agent. <br><i>New Terms: Follicle Stimulating Hormone Beta Polypeptide</i></td>
            </tr>
            <tr class="addition">
               <td>877</td>
               <td colspan="2">Foot/Footpad<span class="subclass"> SubClassOf </span>Tissue Sample. <br><i>New Terms: Foot/Footpad</i></td>
            </tr>
            <tr class="addition">
               <td>878</td>
               <td colspan="2">Forestomach<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Forestomach</i></td>
            </tr>
            <tr class="addition">
               <td>879</td>
               <td colspan="2">Fosfonet Sodium<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Fosfonet Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>880</td>
               <td colspan="2">Fospropofol<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Fospropofol</i></td>
            </tr>
            <tr class="addition">
               <td>881</td>
               <td colspan="2">Frakefamide<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Frakefamide</i></td>
            </tr>
            <tr class="addition">
               <td>882</td>
               <td colspan="2">Friendly<span class="subclass"> SubClassOf </span>General Qualifier. <br><i>New Terms: Friendly</i></td>
            </tr>
            <tr class="addition">
               <td>883</td>
               <td colspan="2">Furbucillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Furbucillin</i></td>
            </tr>
            <tr class="addition">
               <td>884</td>
               <td colspan="2">Fusarium<span class="subclass"> SubClassOf </span>Ascomycota. <br><i>New Terms: Fusarium, Ascomycota</i></td>
            </tr>
            <tr class="addition">
               <td>885</td>
               <td colspan="2">Gabexate<span class="subclass"> SubClassOf </span>Serine Proteinase Inhibitor. <br><i>New Terms: Gabexate</i></td>
            </tr>
            <tr class="addition">
               <td>886</td>
               <td colspan="2">Gacyclidine<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Gacyclidine</i></td>
            </tr>
            <tr class="addition">
               <td>887</td>
               <td colspan="2">Gadobenate Dimeglumine<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Gadobenate Dimeglumine</i></td>
            </tr>
            <tr class="addition">
               <td>888</td>
               <td colspan="2">Gadopenamide<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Gadopenamide</i></td>
            </tr>
            <tr class="addition">
               <td>889</td>
               <td colspan="2">Gadoxetate Disodium<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Gadoxetate Disodium</i></td>
            </tr>
            <tr class="addition">
               <td>890</td>
               <td colspan="2">Gadoxetic Acid<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Gadoxetic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>891</td>
               <td colspan="2">Galamustine<span class="subclass"> SubClassOf </span>Nitrosourea Compound. <br><i>New Terms: Galamustine</i></td>
            </tr>
            <tr class="addition">
               <td>892</td>
               <td colspan="2">Gallium Cation<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Gallium Cation</i></td>
            </tr>
            <tr class="addition">
               <td>893</td>
               <td colspan="2">Ganirelix<span class="subclass"> SubClassOf </span>Gonadotropin Releasing Hormone Antagonist. <br><i>New Terms: Ganirelix</i></td>
            </tr>
            <tr class="addition">
               <td>894</td>
               <td colspan="2">Gastric Content<span class="subclass"> SubClassOf </span>Biospecimen. <br><i>New Terms: Gastric Content</i></td>
            </tr>
            <tr class="addition">
               <td>895</td>
               <td colspan="2">Gentisic Acid<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Gentisic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>896</td>
               <td colspan="2">Gerbil<span class="subclass"> SubClassOf </span>Rodent. <br><i>New Terms: Gerbil</i></td>
            </tr>
            <tr class="addition">
               <td>897</td>
               <td colspan="2">Giardia<span class="subclass"> SubClassOf </span>Protozoa. <br><i>New Terms: Protozoa, Giardia</i></td>
            </tr>
            <tr class="addition">
               <td>898</td>
               <td colspan="2">Gizzard<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Gizzard</i></td>
            </tr>
            <tr class="addition">
               <td>899</td>
               <td colspan="2">Gland of the Third Eyelid<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Gland of the Third Eyelid</i></td>
            </tr>
            <tr class="addition">
               <td>900</td>
               <td colspan="2">Glandular Stomach<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Glandular Stomach</i></td>
            </tr>
            <tr class="addition">
               <td>901</td>
               <td colspan="2">Glidazamide<span class="subclass"> SubClassOf </span>Anti-diabetic Agent. <br><i>New Terms: Glidazamide</i></td>
            </tr>
            <tr class="addition">
               <td>902</td>
               <td colspan="2">Gluceptate Sodium<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Gluceptate Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>903</td>
               <td colspan="2">Glucosamine Sulfate/Chondroitin Sulfate Tablet<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Glucosamine Sulfate/Chondroitin Sulfate Tablet</i></td>
            </tr>
            <tr class="addition">
               <td>904</td>
               <td colspan="2">Glyceryl Distearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Glyceryl Distearate</i></td>
            </tr>
            <tr class="addition">
               <td>905</td>
               <td colspan="2">Glyceryl Oleate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Glyceryl Oleate</i></td>
            </tr>
            <tr class="addition">
               <td>906</td>
               <td colspan="2">Glyceryl Palmitate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Glyceryl Palmitate</i></td>
            </tr>
            <tr class="addition">
               <td>907</td>
               <td colspan="2">Glycobiarsol<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Glycobiarsol</i></td>
            </tr>
            <tr class="addition">
               <td>908</td>
               <td colspan="2">Glycocholic Acid<span class="subclass"> SubClassOf </span>Steroid Compound. <br><i>New Terms: Glycocholic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>909</td>
               <td colspan="2">Glycosylated Recombinant Human Interleukin-7<span class="subclass"> SubClassOf </span>Recombinant Interleukin. <br><i>New Terms: Glycosylated Recombinant Human Interleukin-7</i></td>
            </tr>
            <tr class="addition">
               <td>910</td>
               <td colspan="2">Glycyrrhizin, Ammoniated<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Glycyrrhizin, Ammoniated</i></td>
            </tr>
            <tr class="addition">
               <td>911</td>
               <td colspan="2">Golotimod<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Golotimod</i></td>
            </tr>
            <tr class="addition">
               <td>912</td>
               <td colspan="2">Gottingen Pig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Gottingen Pig</i></td>
            </tr>
            <tr class="addition">
               <td>913</td>
               <td colspan="2">Gravid Uterus<span class="subclass"> SubClassOf </span>Reproductive System Finding. <br><i>New Terms: Gravid Uterus</i></td>
            </tr>
            <tr class="addition">
               <td>914</td>
               <td colspan="2">Guaiacol<span class="subclass"> SubClassOf </span>Expectorant. <br><i>New Terms: Guaiacol</i></td>
            </tr>
            <tr class="addition">
               <td>915</td>
               <td colspan="2">Guaiacol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Guaiacol</i></td>
            </tr>
            <tr class="addition">
               <td>916</td>
               <td colspan="2">Guanidine<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Guanidine</i></td>
            </tr>
            <tr class="addition">
               <td>917</td>
               <td colspan="2">Guanoxabenz<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Agonist. <br><i>New Terms: Guanoxabenz</i></td>
            </tr>
            <tr class="addition">
               <td>918</td>
               <td colspan="2">HDAC Inhibitor JNJ-26481585<span class="subclass"> SubClassOf </span>((Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Histone Deacetylase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cell Cycle Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cell Differentiation Induction)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Chromatin Structure Alteration)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Gene Expression Alteration))<br><span class="keyword"> or </span>((Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Free Radical Formation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Apoptosis)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Mitochondrial Damage)). <br><i>New Terms: HDAC Inhibitor JNJ-26481585</i></td>
            </tr>
            <tr class="addition">
               <td>919</td>
               <td colspan="2">HDAC Inhibitor JNJ-26481585<span class="subclass"> SubClassOf </span>Histone Deacetylase Inhibitor. <br><i>New Terms: HDAC Inhibitor JNJ-26481585</i></td>
            </tr>
            <tr class="addition">
               <td>920</td>
               <td colspan="2">HDM2 Inhibitor JNJ-26854165<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: HDM2 Inhibitor JNJ-26854165</i></td>
            </tr>
            <tr class="addition">
               <td>921</td>
               <td colspan="2">HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 Multipeptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>923</td>
               <td colspan="2">HLA-A*0201-Restricted VEGFR1 Peptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*0201-Restricted VEGFR1 Peptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>922</td>
               <td colspan="2">HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*0201-Restricted VEGFR1-VEGFR2 Multipeptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>924</td>
               <td colspan="2">HLA-A*2402-Restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 Multipeptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*2402-Restricted KOC1-TTK-CO16-DEPDC1-MPHOSPH1 Multipeptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>925</td>
               <td colspan="2">HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*2402-Restricted URLC10-KOC1-VEGFR1-VEGFR2 Multipeptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>926</td>
               <td colspan="2">HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*2402-Restricted URLC10-TTK-KOC1 Multipeptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>927</td>
               <td colspan="2">HLA-A*2402-Restricted VEGFR1 Peptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*2402-Restricted VEGFR1 Peptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>928</td>
               <td colspan="2">HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 Multipeptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>929</td>
               <td colspan="2">HPV DNA Plasmids Therapeutic Vaccine VGX-3100<span class="subclass"> SubClassOf </span>DNA Vaccine. <br><i>New Terms: HPV DNA Plasmids Therapeutic Vaccine VGX-3100</i></td>
            </tr>
            <tr class="addition">
               <td>930</td>
               <td colspan="2">Haemophilus influenzae<span class="subclass"> Type </span>B Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Haemophilus Influenzae<span class="subclass"> Type </span>B Antigen. <br><i>New Terms: Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>931</td>
               <td colspan="2">Haemophilus influenzae<span class="subclass"> Type </span>B Polysaccharide Conjugate Antigen, B<span class="subclass"> SubClassOf </span>Haemophilus Influenzae<span class="subclass"> Type </span>B Antigen. <br><i>New Terms: Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>932</td>
               <td colspan="2">Haemophilus influenzae<span class="subclass"> Type </span>B Polysaccharide Conjugate Antigen, C<span class="subclass"> SubClassOf </span>Haemophilus Influenzae<span class="subclass"> Type </span>B Antigen. <br><i>New Terms: Haemophilus influenzae Type B Polysaccharide Conjugate Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>933</td>
               <td colspan="2">Haloperidol Lactate<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Haloperidol Lactate</i></td>
            </tr>
            <tr class="addition">
               <td>934</td>
               <td colspan="2">Hampshire Pig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Hampshire Pig</i></td>
            </tr>
            <tr class="addition">
               <td>935</td>
               <td colspan="2">Hanford Pig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Hanford Pig</i></td>
            </tr>
            <tr class="addition">
               <td>936</td>
               <td colspan="2">Harderian Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Harderian Gland</i></td>
            </tr>
            <tr class="addition">
               <td>937</td>
               <td colspan="2">Hartley Albino Hairless Guinea Pig<span class="subclass"> SubClassOf </span>Guinea Pig. <br><i>New Terms: Hartley Albino Hairless Guinea Pig</i></td>
            </tr>
            <tr class="addition">
               <td>938</td>
               <td colspan="2">Hartley Guinea Pig<span class="subclass"> SubClassOf </span>Guinea Pig. <br><i>New Terms: Hartley Guinea Pig</i></td>
            </tr>
            <tr class="addition">
               <td>939</td>
               <td colspan="2">Hepatic Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Hepatic Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>940</td>
               <td colspan="2">Hepatitis B Virus Surface Protein Antigen, A<span class="subclass"> SubClassOf </span>Hepatitis B Surface Antigen. <br><i>New Terms: Hepatitis B Virus Surface Protein Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>941</td>
               <td colspan="2">Hepatitis B Virus Surface Protein Antigen, B<span class="subclass"> SubClassOf </span>Hepatitis B Surface Antigen. <br><i>New Terms: Hepatitis B Virus Surface Protein Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>942</td>
               <td colspan="2">Heptabarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Heptabarbital</i></td>
            </tr>
            <tr class="addition">
               <td>943</td>
               <td colspan="2">Hexadecylamine<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Hexadecylamine</i></td>
            </tr>
            <tr class="addition">
               <td>944</td>
               <td colspan="2">Hexamethonium Chloride<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Hexamethonium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>945</td>
               <td colspan="2">Hexane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Hexane</i></td>
            </tr>
            <tr class="addition">
               <td>946</td>
               <td colspan="2">Hexetidine<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Hexetidine</i></td>
            </tr>
            <tr class="addition">
               <td>947</td>
               <td colspan="2">Hexobarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Hexobarbital</i></td>
            </tr>
            <tr class="addition">
               <td>948</td>
               <td colspan="2">Hexocyclium<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Hexocyclium</i></td>
            </tr>
            <tr class="addition">
               <td>949</td>
               <td colspan="2">Hexylene Glycol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Hexylene Glycol</i></td>
            </tr>
            <tr class="addition">
               <td>950</td>
               <td colspan="2">Hind Limb<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Hind Limb</i></td>
            </tr>
            <tr class="addition">
               <td>951</td>
               <td colspan="2">Histoplasmosis<span class="subclass"> SubClassOf </span>Fungal Infection. <br><i>New Terms: Histoplasmosis</i></td>
            </tr>
            <tr class="addition">
               <td>952</td>
               <td colspan="2">Histrelin Acetate<span class="subclass"> SubClassOf </span>Gonadotropin-Releasing Hormone Analogue. <br><i>New Terms: Histrelin Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>953</td>
               <td colspan="2">Hoof Wall<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Hoof Wall</i></td>
            </tr>
            <tr class="addition">
               <td>954</td>
               <td colspan="2">Hope<span class="subclass"> SubClassOf </span>Emotion. <br><i>New Terms: Hope</i></td>
            </tr>
            <tr class="addition">
               <td>955</td>
               <td colspan="2">Hsp90 Inhibitor STA-9090<span class="subclass"> SubClassOf </span>Heat Shock Protein Inhibitor. <br><i>New Terms: Hsp90 Inhibitor STA-9090</i></td>
            </tr>
            <tr class="addition">
               <td>956</td>
               <td colspan="2">Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307<span class="subclass"> SubClassOf </span>Monoclonal Antibody. <br><i>New Terms: Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307</i></td>
            </tr>
            <tr class="addition">
               <td>957</td>
               <td colspan="2">Human Papillomavirus<span class="subclass"> Type </span>11 Capsid Protein Antigen, A<span class="subclass"> SubClassOf </span>Human Papillomavirus Antigen. <br><i>New Terms: Human Papillomavirus Type 11 Capsid Protein Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>958</td>
               <td colspan="2">Human Papillomavirus<span class="subclass"> Type </span>16 Capsid Protein Antigen, A<span class="subclass"> SubClassOf </span>Human Papillomavirus Antigen. <br><i>New Terms: Human Papillomavirus Type 16 Capsid Protein Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>959</td>
               <td colspan="2">Human Papillomavirus<span class="subclass"> Type </span>18 Capsid Protein Antigen, A<span class="subclass"> SubClassOf </span>Human Papillomavirus Antigen. <br><i>New Terms: Human Papillomavirus Type 18 Capsid Protein Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>960</td>
               <td colspan="2">Human Papillomavirus<span class="subclass"> Type </span>6 Capsid Protein Antigen, A<span class="subclass"> SubClassOf </span>Human Papillomavirus Antigen. <br><i>New Terms: Human Papillomavirus Type 6 Capsid Protein Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>961</td>
               <td colspan="2">Hydrochloric Acid<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Hydrochloric Acid</i></td>
            </tr>
            <tr class="addition">
               <td>962</td>
               <td colspan="2">Hydrocodone Polistirex<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Hydrocodone Polistirex</i></td>
            </tr>
            <tr class="addition">
               <td>963</td>
               <td colspan="2">Hydrogen Cyanide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Hydrogen Cyanide</i></td>
            </tr>
            <tr class="addition">
               <td>964</td>
               <td colspan="2">Hydroxocobalamin Acetate<span class="subclass"> SubClassOf </span>Vitamin, Other. <br><i>New Terms: Hydroxocobalamin Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>965</td>
               <td colspan="2">Hydroxymethanesulfinic Acid<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Hydroxymethanesulfinic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>966</td>
               <td colspan="2">IDH1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Carbohydrate Metabolism. <br><i>New Terms: IDH1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>967</td>
               <td colspan="2">IDH1 Gene<span class="subclass"> SubClassOf </span>Oxidoreductase Gene. <br><i>New Terms: IDH1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>968</td>
               <td colspan="2">IDH1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Glioblastoma. <br><i>New Terms: IDH1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>969</td>
               <td colspan="2">IDH1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: IDH1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>970</td>
               <td colspan="2">IDH1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>Citrate Cycle (TCA Cycle) Pathway. <br><i>New Terms: IDH1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>971</td>
               <td colspan="2">IDH1 wt Allele<span class="subclass"> SubClassOf </span>IDH1 Gene. <br><i>New Terms: IDH1 Gene, IDH1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>972</td>
               <td colspan="2">IMT-1012 Immunotherapeutic Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: IMT-1012 Immunotherapeutic Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>973</td>
               <td colspan="2">ING2 Gene<span class="subclass"> SubClassOf </span>Apoptosis Regulation Gene. <br><i>New Terms: ING2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>974</td>
               <td colspan="2">ING2 Gene<span class="subclass"> SubClassOf </span>Gene_Associated_With_Disease<span class="some"> some </span>Colon Carcinoma. <br><i>New Terms: ING2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>975</td>
               <td colspan="2">ING2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Histone Deacetylation. <br><i>New Terms: ING2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>976</td>
               <td colspan="2">ING2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Induction of Apoptosis. <br><i>New Terms: ING2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>977</td>
               <td colspan="2">ING2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Protein Acetylation. <br><i>New Terms: ING2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>978</td>
               <td colspan="2">ING2 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation. <br><i>New Terms: ING2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>979</td>
               <td colspan="2">ING2 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: ING2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>980</td>
               <td colspan="2">ING2 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>4q35.1. <br><i>New Terms: ING2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>981</td>
               <td colspan="2">ING2 wt Allele<span class="subclass"> SubClassOf </span>ING2 Gene. <br><i>New Terms: ING2 Gene, ING2 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>982</td>
               <td colspan="2">ITGA2B Gene<span class="subclass"> SubClassOf </span>Cell Adhesion Molecule Gene. <br><i>New Terms: ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>983</td>
               <td colspan="2">ITGA2B Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Cell Adhesion. <br><i>New Terms: ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>984</td>
               <td colspan="2">ITGA2B Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Platelet Aggregation. <br><i>New Terms: ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>985</td>
               <td colspan="2">ITGA2B Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Protein-Protein Interaction. <br><i>New Terms: ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>986</td>
               <td colspan="2">ITGA2B Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Receptor Signaling. <br><i>New Terms: ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>987</td>
               <td colspan="2">ITGA2B Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Wound Repair. <br><i>New Terms: ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>988</td>
               <td colspan="2">ITGA2B wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: ITGA2B wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>989</td>
               <td colspan="2">ITGA2B wt Allele<span class="subclass"> SubClassOf </span>ITGA2B Gene. <br><i>New Terms: ITGA2B wt Allele, ITGA2B Gene</i></td>
            </tr>
            <tr class="addition">
               <td>990</td>
               <td colspan="2">Ileocecocolic Lymph Node<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Ileocecocolic Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>991</td>
               <td colspan="2">Imidocarb Hydrochloride<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Imidocarb Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>992</td>
               <td colspan="2">Implantation Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Implantation Site</i></td>
            </tr>
            <tr class="addition">
               <td>993</td>
               <td colspan="2">Inamrinone Lactate<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Inamrinone Lactate</i></td>
            </tr>
            <tr class="addition">
               <td>994</td>
               <td colspan="2">Incision Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Incision Site</i></td>
            </tr>
            <tr class="addition">
               <td>995</td>
               <td colspan="2">Indium In-111 Oxyquinoline<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. <br><i>New Terms: Indium In-111 Oxyquinoline</i></td>
            </tr>
            <tr class="addition">
               <td>996</td>
               <td colspan="2">Indopine Hydrochloride<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Indopine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>997</td>
               <td colspan="2">Influenza A Virus H1N1 Hemagglutinin Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Hemagglutinin Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>998</td>
               <td colspan="2">Influenza A Virus H1N1 Hemagglutinin Antigen, B<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Hemagglutinin Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>999</td>
               <td colspan="2">Influenza A Virus H1N1 Hemagglutinin Antigen, C<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Hemagglutinin Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>1000</td>
               <td colspan="2">Influenza A Virus H1N1 Hemagglutinin Antigen, D<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Hemagglutinin Antigen, D</i></td>
            </tr>
            <tr class="addition">
               <td>1001</td>
               <td colspan="2">Influenza A Virus H1N1 Hemagglutinin Antigen, E<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Hemagglutinin Antigen, E</i></td>
            </tr>
            <tr class="addition">
               <td>1002</td>
               <td colspan="2">Influenza A Virus H1N1 Live Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1003</td>
               <td colspan="2">Influenza A Virus H1N1 Neuraminidase Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Neuraminidase Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1004</td>
               <td colspan="2">Influenza A Virus H1N1 Neuraminidase Antigen, B<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Neuraminidase Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1005</td>
               <td colspan="2">Influenza A Virus H1N1 Neuraminidase Antigen, C<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Neuraminidase Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>1006</td>
               <td colspan="2">Influenza A Virus H1N1 Neuraminidase Antigen, D<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Neuraminidase Antigen, D</i></td>
            </tr>
            <tr class="addition">
               <td>1007</td>
               <td colspan="2">Influenza A Virus H1N1 Neuraminidase Antigen, E<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H1N1 Neuraminidase Antigen, E</i></td>
            </tr>
            <tr class="addition">
               <td>1008</td>
               <td colspan="2">Influenza A Virus H3N2 Hemagglutinin Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Hemagglutinin Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1009</td>
               <td colspan="2">Influenza A Virus H3N2 Hemagglutinin Antigen, B<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Hemagglutinin Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1010</td>
               <td colspan="2">Influenza A Virus H3N2 Hemagglutinin Antigen, C<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Hemagglutinin Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>1011</td>
               <td colspan="2">Influenza A Virus H3N2 Hemagglutinin Antigen, D<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Hemagglutinin Antigen, D</i></td>
            </tr>
            <tr class="addition">
               <td>1012</td>
               <td colspan="2">Influenza A Virus H3N2 Hemagglutinin Antigen, E<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Hemagglutinin Antigen, E</i></td>
            </tr>
            <tr class="addition">
               <td>1013</td>
               <td colspan="2">Influenza A Virus H3N2 Live Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1014</td>
               <td colspan="2">Influenza A Virus H3N2 Neuraminidase Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Neuraminidase Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1015</td>
               <td colspan="2">Influenza A Virus H3N2 Neuraminidase Antigen, B<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Neuraminidase Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1016</td>
               <td colspan="2">Influenza A Virus H3N2 Neuraminidase Antigen, C<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Neuraminidase Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>1017</td>
               <td colspan="2">Influenza A Virus H3N2 Neuraminidase Antigen, D<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Neuraminidase Antigen, D</i></td>
            </tr>
            <tr class="addition">
               <td>1018</td>
               <td colspan="2">Influenza A Virus H3N2 Neuraminidase Antigen, E<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H3N2 Neuraminidase Antigen, E</i></td>
            </tr>
            <tr class="addition">
               <td>1019</td>
               <td colspan="2">Influenza A Virus H5N1 Hemagglutinin Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H5N1 Hemagglutinin Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1020</td>
               <td colspan="2">Influenza A Virus H5N1 Neuraminidase Antigen, A<span class="subclass"> SubClassOf </span>Influenza A Virus Antigen. <br><i>New Terms: Influenza A Virus H5N1 Neuraminidase Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1021</td>
               <td colspan="2">Influenza B Virus Hemagglutinin Antigen, A<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Hemagglutinin Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1022</td>
               <td colspan="2">Influenza B Virus Hemagglutinin Antigen, B<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Hemagglutinin Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1023</td>
               <td colspan="2">Influenza B Virus Hemagglutinin Antigen, C<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Hemagglutinin Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>1024</td>
               <td colspan="2">Influenza B Virus Hemagglutinin Antigen, D<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Hemagglutinin Antigen, D</i></td>
            </tr>
            <tr class="addition">
               <td>1025</td>
               <td colspan="2">Influenza B Virus Hemagglutinin Antigen, E<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Hemagglutinin Antigen, E</i></td>
            </tr>
            <tr class="addition">
               <td>1026</td>
               <td colspan="2">Influenza B Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1027</td>
               <td colspan="2">Influenza B Virus Neuraminidase Antigen, A<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Neuraminidase Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1028</td>
               <td colspan="2">Influenza B Virus Neuraminidase Antigen, B<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Neuraminidase Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1029</td>
               <td colspan="2">Influenza B Virus Neuraminidase Antigen, C<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Neuraminidase Antigen, C</i></td>
            </tr>
            <tr class="addition">
               <td>1030</td>
               <td colspan="2">Influenza B Virus Neuraminidase Antigen, D<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Neuraminidase Antigen, D</i></td>
            </tr>
            <tr class="addition">
               <td>1031</td>
               <td colspan="2">Influenza B Virus Neuraminidase Antigen, E<span class="subclass"> SubClassOf </span>Influenza B Virus Antigen. <br><i>New Terms: Influenza B Virus Neuraminidase Antigen, E</i></td>
            </tr>
            <tr class="addition">
               <td>1032</td>
               <td colspan="2">Infusion Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Infusion Site</i></td>
            </tr>
            <tr class="addition">
               <td>1033</td>
               <td colspan="2">Inhibitor of Growth Protein 2<span class="subclass"> EquivalentTo </span>Apoptosis Regulator<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ING2 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Apoptosis Promoter)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Colon Carcinoma)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Histone Deacetylation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Induction of Apoptosis)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein Acetylation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcriptional Regulation). <br><i>New Terms: ING2 Gene, Inhibitor of Growth Protein 2</i></td>
            </tr>
            <tr class="addition">
               <td>1034</td>
               <td colspan="2">Injection Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Injection Site</i></td>
            </tr>
            <tr class="addition">
               <td>1035</td>
               <td colspan="2">Injury Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Injury Site</i></td>
            </tr>
            <tr class="addition">
               <td>1036</td>
               <td colspan="2">Integrin Alpha-IIb<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA2B Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair). <br><i>New Terms: ITGA2B Gene, Integrin Alpha-IIb</i></td>
            </tr>
            <tr class="addition">
               <td>1037</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1038</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1039</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Platelet Aggregation. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1040</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1041</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1042</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1043</td>
               <td colspan="2">Integrin Alpha-IIb/Beta-3<span class="subclass"> SubClassOf </span>Protein<br><span class="keyword"> or </span>Riboprotein Complex. <br><i>New Terms: Integrin Alpha-IIb/Beta-3</i></td>
            </tr>
            <tr class="addition">
               <td>1044</td>
               <td colspan="2">Intercostal Lymph Node<span class="subclass"> SubClassOf </span>Thoracic Lymph Node. <br><i>New Terms: Intercostal Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1045</td>
               <td colspan="2">Iodine I 123 Anti-CEA Recombinant Diabody T84.66<span class="subclass"> SubClassOf </span>Radioimmunoconjugate. <br><i>New Terms: Iodine I 123 Anti-CEA Recombinant Diabody T84.66</i></td>
            </tr>
            <tr class="addition">
               <td>1046</td>
               <td colspan="2">Iodoantipyrine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Iodoantipyrine</i></td>
            </tr>
            <tr class="addition">
               <td>1047</td>
               <td colspan="2">Iodofiltic Acid I 123<span class="subclass"> SubClassOf </span>Image Enhancement Agent. <br><i>New Terms: Iodofiltic Acid I 123</i></td>
            </tr>
            <tr class="addition">
               <td>1048</td>
               <td colspan="2">Iodoform<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Iodoform</i></td>
            </tr>
            <tr class="addition">
               <td>1049</td>
               <td colspan="2">Ioseric Acid<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Ioseric Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1050</td>
               <td colspan="2">Ipenoxazone<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Ipenoxazone</i></td>
            </tr>
            <tr class="addition">
               <td>1051</td>
               <td colspan="2">Ipodic Acid<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Ipodic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1052</td>
               <td colspan="2">Ipronidazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Ipronidazole</i></td>
            </tr>
            <tr class="addition">
               <td>1053</td>
               <td colspan="2">Iralukast<span class="subclass"> SubClassOf </span>Anti-asthmatic Agent. <br><i>New Terms: Iralukast</i></td>
            </tr>
            <tr class="addition">
               <td>1054</td>
               <td colspan="2">Irindalone<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Irindalone</i></td>
            </tr>
            <tr class="addition">
               <td>1055</td>
               <td colspan="2">Iron Dextran<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Iron Dextran</i></td>
            </tr>
            <tr class="addition">
               <td>1056</td>
               <td colspan="2">Irritation<span class="subclass"> SubClassOf </span>Emotion. <br><i>New Terms: Irritation</i></td>
            </tr>
            <tr class="addition">
               <td>1057</td>
               <td colspan="2">Isbogrel<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Isbogrel</i></td>
            </tr>
            <tr class="addition">
               <td>1058</td>
               <td colspan="2">Isocitrate Dehydrogenase [NADP] Cytoplasmic<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>IDH1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Citrate Cycle (TCA Cycle) Pathway)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Glioblastoma)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Carbohydrate Metabolism). <br><i>New Terms: IDH1 Gene, Isocitrate Dehydrogenase [NADP] Cytoplasmic</i></td>
            </tr>
            <tr class="addition">
               <td>1060</td>
               <td colspan="2">Isoflupredone Acetate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Isoflupredone Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>1059</td>
               <td colspan="2">Isoflupredone<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Isoflupredone</i></td>
            </tr>
            <tr class="addition">
               <td>1061</td>
               <td colspan="2">Isopropyl Myristate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Isopropyl Myristate</i></td>
            </tr>
            <tr class="addition">
               <td>1062</td>
               <td colspan="2">Isopropyl Palmitate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Isopropyl Palmitate</i></td>
            </tr>
            <tr class="addition">
               <td>1063</td>
               <td colspan="2">Isovaleramide<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Isovaleramide</i></td>
            </tr>
            <tr class="addition">
               <td>1064</td>
               <td colspan="2">Ispinesib Mesylate<span class="subclass"> SubClassOf </span>Mitotic Kinesin Modulator. <br><i>New Terms: Ispinesib Mesylate</i></td>
            </tr>
            <tr class="addition">
               <td>1065</td>
               <td colspan="2">Issatchenkia orientalis<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Candida, Issatchenkia orientalis</i></td>
            </tr>
            <tr class="addition">
               <td>1066</td>
               <td colspan="2">Joy<span class="subclass"> SubClassOf </span>Emotion. <br><i>New Terms: Joy</i></td>
            </tr>
            <tr class="addition">
               <td>1067</td>
               <td colspan="2">Ketotrexate<span class="subclass"> SubClassOf </span>Folate Antagonist. <br><i>New Terms: Ketotrexate</i></td>
            </tr>
            <tr class="addition">
               <td>1068</td>
               <td colspan="2">Killip Class I<span class="subclass"> SubClassOf </span>Killip Class. <br><i>New Terms: Killip Class I</i></td>
            </tr>
            <tr class="addition">
               <td>1069</td>
               <td colspan="2">Killip Class II<span class="subclass"> SubClassOf </span>Killip Class. <br><i>New Terms: Killip Class II</i></td>
            </tr>
            <tr class="addition">
               <td>1070</td>
               <td colspan="2">Killip Class III<span class="subclass"> SubClassOf </span>Killip Class. <br><i>New Terms: Killip Class III</i></td>
            </tr>
            <tr class="addition">
               <td>1071</td>
               <td colspan="2">Killip Class IV<span class="subclass"> SubClassOf </span>Killip Class. <br><i>New Terms: Killip Class IV</i></td>
            </tr>
            <tr class="addition">
               <td>1072</td>
               <td colspan="2">LVG Hamster<span class="subclass"> SubClassOf </span>Hamster. <br><i>New Terms: LVG Hamster</i></td>
            </tr>
            <tr class="addition">
               <td>1073</td>
               <td colspan="2">Lactic Acid<span class="subclass"> SubClassOf </span>Reagent. <br><i>New Terms: Lactic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1074</td>
               <td colspan="2">Lactitol Monohydrate<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Lactitol Monohydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1075</td>
               <td colspan="2">Lactose Monohydrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Lactose Monohydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1076</td>
               <td colspan="2">Ladostigil<span class="subclass"> SubClassOf </span>Acetylcholinesterase Inhibitor. <br><i>New Terms: Ladostigil</i></td>
            </tr>
            <tr class="addition">
               <td>1077</td>
               <td colspan="2">Ladostigil<span class="subclass"> SubClassOf </span>Monoamine Oxidase Inhibitor. <br><i>New Terms: Ladostigil</i></td>
            </tr>
            <tr class="addition">
               <td>1078</td>
               <td colspan="2">Landrace Pig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Landrace Pig</i></td>
            </tr>
            <tr class="addition">
               <td>1079</td>
               <td colspan="2">Lanicemine<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Lanicemine</i></td>
            </tr>
            <tr class="addition">
               <td>1081</td>
               <td colspan="2">Laquinimod Sodium<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Laquinimod Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1080</td>
               <td colspan="2">Laquinimod<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Laquinimod</i></td>
            </tr>
            <tr class="addition">
               <td>1082</td>
               <td colspan="2">Lauric Diethanolamide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Lauric Diethanolamide</i></td>
            </tr>
            <tr class="addition">
               <td>1083</td>
               <td colspan="2">Leghorn Chicken<span class="subclass"> SubClassOf </span>Chicken. <br><i>New Terms: Leghorn Chicken</i></td>
            </tr>
            <tr class="addition">
               <td>1084</td>
               <td colspan="2">Lenperone Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Lenperone Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1085</td>
               <td colspan="2">Lenperone Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Lenperone Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1086</td>
               <td colspan="2">Levamisole Phosphate<span class="subclass"> SubClassOf </span>Antihelminthic Agent. <br><i>New Terms: Levamisole Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>1087</td>
               <td colspan="2">Levamisole Phosphate<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Levamisole Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>1088</td>
               <td colspan="2">Levamlodipine Malate<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Levamlodipine Malate</i></td>
            </tr>
            <tr class="addition">
               <td>1089</td>
               <td colspan="2">Levomepromazine Hydrochloride<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Levomepromazine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1090</td>
               <td colspan="2">Levonorgestrel Acetate<span class="subclass"> SubClassOf </span>Progestin. <br><i>New Terms: Levonorgestrel Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>1091</td>
               <td colspan="2">Levotofisopam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Levotofisopam</i></td>
            </tr>
            <tr class="addition">
               <td>1092</td>
               <td colspan="2">Like<span class="subclass"> SubClassOf </span>Emotion. <br><i>New Terms: Like</i></td>
            </tr>
            <tr class="addition">
               <td>1093</td>
               <td colspan="2">Linaclotide Acetate<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Linaclotide Acetate</i></td>
            </tr>
            <tr class="addition">
               <td>1094</td>
               <td colspan="2">Linarotene<span class="subclass"> SubClassOf </span>Vitamin, Other. <br><i>New Terms: Linarotene</i></td>
            </tr>
            <tr class="addition">
               <td>1095</td>
               <td colspan="2">Lisdexamfetamine Dimesylate<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Lisdexamfetamine Dimesylate</i></td>
            </tr>
            <tr class="addition">
               <td>1096</td>
               <td colspan="2">Lithium Hydroxide Anhydrous<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Lithium Hydroxide Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1097</td>
               <td colspan="2">Lithium Hydroxide Monohydrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Lithium Hydroxide Monohydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1098</td>
               <td colspan="2">Liver/Gallbladder<span class="subclass"> SubClassOf </span>Tissue Sample. <br><i>New Terms: Liver/Gallbladder</i></td>
            </tr>
            <tr class="addition">
               <td>1099</td>
               <td colspan="2">Lovastatin Acid<span class="subclass"> SubClassOf </span>HMG-CoA Reductase Inhibitor. <br><i>New Terms: Lovastatin Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1100</td>
               <td colspan="2">Loxapine Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Loxapine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1101</td>
               <td colspan="2">Loxapine Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Loxapine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1102</td>
               <td colspan="2">Lubazodone<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Lubazodone</i></td>
            </tr>
            <tr class="addition">
               <td>1103</td>
               <td colspan="2">Lufenuron<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Lufenuron</i></td>
            </tr>
            <tr class="addition">
               <td>1106</td>
               <td colspan="2">Lurasidone Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Lurasidone Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1107</td>
               <td colspan="2">Lurasidone Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Lurasidone Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1104</td>
               <td colspan="2">Lurasidone<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Lurasidone</i></td>
            </tr>
            <tr class="addition">
               <td>1105</td>
               <td colspan="2">Lurasidone<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Lurasidone</i></td>
            </tr>
            <tr class="addition">
               <td>1108</td>
               <td colspan="2">Lusupultide<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Lusupultide</i></td>
            </tr>
            <tr class="addition">
               <td>1109</td>
               <td colspan="2">Lymecycline<span class="subclass"> SubClassOf </span>Tetracycline Antibiotic. <br><i>New Terms: Lymecycline</i></td>
            </tr>
            <tr class="addition">
               <td>1110</td>
               <td colspan="2">MEK Inhibitor GSK1120212<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: MEK Inhibitor GSK1120212</i></td>
            </tr>
            <tr class="addition">
               <td>1111</td>
               <td colspan="2">MKC-1106-MT<span class="subclass"> SubClassOf </span>Biological Agent. <br><i>New Terms: MKC-1106-MT</i></td>
            </tr>
            <tr class="addition">
               <td>1112</td>
               <td colspan="2">Magnesium Chloride Anhydrous<span class="subclass"> SubClassOf </span>Electrolyte Replacement Agent. <br><i>New Terms: Magnesium Chloride Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1113</td>
               <td colspan="2">Magnesium Salicylate, Anhydrous<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Magnesium Salicylate, Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1114</td>
               <td colspan="2">Magnesium Sulfate Heptahydrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Magnesium Sulfate Heptahydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1115</td>
               <td colspan="2">Maleylsulfathiazole<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Maleylsulfathiazole</i></td>
            </tr>
            <tr class="addition">
               <td>1116</td>
               <td colspan="2">Maltitol<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Maltitol</i></td>
            </tr>
            <tr class="addition">
               <td>1117</td>
               <td colspan="2">Maltol<span class="subclass"> SubClassOf </span>Phytochemical. <br><i>New Terms: Maltol</i></td>
            </tr>
            <tr class="addition">
               <td>1118</td>
               <td colspan="2">Manganese Chloride Anhydrous<span class="subclass"> SubClassOf </span>Electrolyte Replacement Agent. <br><i>New Terms: Manganese Chloride Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1119</td>
               <td colspan="2">Manganese Sulfate Anhydrous<span class="subclass"> SubClassOf </span>Electrolyte Replacement Agent. <br><i>New Terms: Manganese Sulfate Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1120</td>
               <td colspan="2">Marmoset<span class="subclass"> SubClassOf </span>Monkey. <br><i>New Terms: Marmoset</i></td>
            </tr>
            <tr class="addition">
               <td>1121</td>
               <td colspan="2">Maropitant Citrate<span class="subclass"> SubClassOf </span>Antiemetic Agent. <br><i>New Terms: Maropitant Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>1122</td>
               <td colspan="2">Mavacoxib<span class="subclass"> SubClassOf </span>Cyclooxygenase Inhibitor. <br><i>New Terms: Mavacoxib</i></td>
            </tr>
            <tr class="addition">
               <td>1123</td>
               <td colspan="2">Measles Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Measles Virus Antigen. <br><i>New Terms: Measles Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1124</td>
               <td colspan="2">Meclizine Hydrochloride Anhydrous<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Meclizine Hydrochloride Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1125</td>
               <td colspan="2">Mediterranean<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Mediterranean</i></td>
            </tr>
            <tr class="addition">
               <td>1126</td>
               <td colspan="2">Medronate Disodium<span class="subclass"> SubClassOf </span>Biphosphonate. <br><i>New Terms: Medronate Disodium</i></td>
            </tr>
            <tr class="addition">
               <td>1127</td>
               <td colspan="2">Mefeclorazine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Mefeclorazine</i></td>
            </tr>
            <tr class="addition">
               <td>1128</td>
               <td colspan="2">Mefenorex Hydrochldride<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Mefenorex Hydrochldride</i></td>
            </tr>
            <tr class="addition">
               <td>1129</td>
               <td colspan="2">Mephenesin<span class="subclass"> SubClassOf </span>Muscle Relaxant. <br><i>New Terms: Mephenesin</i></td>
            </tr>
            <tr class="addition">
               <td>1130</td>
               <td colspan="2">Mephobarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Mephobarbital</i></td>
            </tr>
            <tr class="addition">
               <td>1131</td>
               <td colspan="2">Meprochol<span class="subclass"> SubClassOf </span>Fungicide. <br><i>New Terms: Meprochol</i></td>
            </tr>
            <tr class="addition">
               <td>1132</td>
               <td colspan="2">Mersalyl Sodium<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Mersalyl Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1133</td>
               <td colspan="2">Mesenteric Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Mesenteric Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1134</td>
               <td colspan="2">Methenamine Mandelate<span class="subclass"> SubClassOf </span>Urinary Anti-Infective Agent. <br><i>New Terms: Methenamine Mandelate</i></td>
            </tr>
            <tr class="addition">
               <td>1135</td>
               <td colspan="2">Methisazone<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Methisazone</i></td>
            </tr>
            <tr class="addition">
               <td>1137</td>
               <td colspan="2">Methoxyamine Hydrochloride<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: Methoxyamine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1136</td>
               <td colspan="2">Methoxyamine<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: Methoxyamine</i></td>
            </tr>
            <tr class="addition">
               <td>1138</td>
               <td colspan="2">Methyl Aminolevulinate Hydrochloride<span class="subclass"> SubClassOf </span>Photosensitizing Agent. <br><i>New Terms: Methyl Aminolevulinate Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1139</td>
               <td colspan="2">Methyl Chloride<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Methyl Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>1140</td>
               <td colspan="2">Methyl Ethyl Ketone<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Methyl Ethyl Ketone</i></td>
            </tr>
            <tr class="addition">
               <td>1141</td>
               <td colspan="2">Methyl Stearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Methyl Stearate</i></td>
            </tr>
            <tr class="addition">
               <td>1143</td>
               <td colspan="2">Methylparaben Sodium<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Methylparaben Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1142</td>
               <td colspan="2">Methylparaben<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Methylparaben</i></td>
            </tr>
            <tr class="addition">
               <td>1144</td>
               <td colspan="2">Methylprednisolone Suleptanate<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Methylprednisolone Suleptanate</i></td>
            </tr>
            <tr class="addition">
               <td>1145</td>
               <td colspan="2">Metipranolol Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Metipranolol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1147</td>
               <td colspan="2">Metoserpate Hydrochloride<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Metoserpate Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1146</td>
               <td colspan="2">Metoserpate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Metoserpate</i></td>
            </tr>
            <tr class="addition">
               <td>1148</td>
               <td colspan="2">Metrizoic Acid<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Metrizoic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1149</td>
               <td colspan="2">Microchip Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Microchip Site</i></td>
            </tr>
            <tr class="addition">
               <td>1150</td>
               <td colspan="2">Micrococcus<span class="subclass"> SubClassOf </span>Actinobacteria. <br><i>New Terms: Micrococcus</i></td>
            </tr>
            <tr class="addition">
               <td>1151</td>
               <td colspan="2">Micropig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Micropig</i></td>
            </tr>
            <tr class="addition">
               <td>1152</td>
               <td colspan="2">Middle Eastern<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Middle Eastern</i></td>
            </tr>
            <tr class="addition">
               <td>1154</td>
               <td colspan="2">Migalastat Hydrochloride<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Migalastat Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1153</td>
               <td colspan="2">Migalastat<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Migalastat</i></td>
            </tr>
            <tr class="addition">
               <td>1155</td>
               <td colspan="2">Milk Protein-Based Energy Drink<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Milk Protein-Based Energy Drink</i></td>
            </tr>
            <tr class="addition">
               <td>1156</td>
               <td colspan="2">Milk Serum<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Milk Serum</i></td>
            </tr>
            <tr class="addition">
               <td>1158</td>
               <td colspan="2">Milnacipran Hydrochloride<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Milnacipran Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1157</td>
               <td colspan="2">Milnacipran<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Milnacipran</i></td>
            </tr>
            <tr class="addition">
               <td>1160</td>
               <td colspan="2">Milveterol Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Milveterol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1159</td>
               <td colspan="2">Milveterol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Milveterol</i></td>
            </tr>
            <tr class="addition">
               <td>1161</td>
               <td colspan="2">Minipig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Minipig</i></td>
            </tr>
            <tr class="addition">
               <td>1162</td>
               <td colspan="2">Molgramostim<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: Molgramostim</i></td>
            </tr>
            <tr class="addition">
               <td>1163</td>
               <td colspan="2">Mongolian Gerbil<span class="subclass"> SubClassOf </span>Gerbil. <br><i>New Terms: Gerbil, Mongolian Gerbil</i></td>
            </tr>
            <tr class="addition">
               <td>1164</td>
               <td colspan="2">Monoxerutin<span class="subclass"> SubClassOf </span>Flavonoid. <br><i>New Terms: Monoxerutin</i></td>
            </tr>
            <tr class="addition">
               <td>1165</td>
               <td colspan="2">Montirelin<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Montirelin</i></td>
            </tr>
            <tr class="addition">
               <td>1166</td>
               <td colspan="2">Mozavaptan<span class="subclass"> SubClassOf </span>Recombinant Vasopressin. <br><i>New Terms: Mozavaptan</i></td>
            </tr>
            <tr class="addition">
               <td>1167</td>
               <td colspan="2">Mozenavir<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Mozenavir</i></td>
            </tr>
            <tr class="addition">
               <td>1168</td>
               <td colspan="2">Multitargeted Kinase Inhibitor JNJ-26483327<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: Multitargeted Kinase Inhibitor JNJ-26483327</i></td>
            </tr>
            <tr class="addition">
               <td>1169</td>
               <td colspan="2">Mumps Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Mumps Virus Antigen. <br><i>New Terms: Mumps Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1170</td>
               <td colspan="2">Murine TYRP2 Plasmid DNA Vaccine<span class="subclass"> SubClassOf </span>DNA Vaccine. <br><i>New Terms: Murine TYRP2 Plasmid DNA Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>1171</td>
               <td colspan="2">Mustelidae<span class="subclass"> SubClassOf </span>Mammal. <br><i>New Terms: Mustelidae</i></td>
            </tr>
            <tr class="addition">
               <td>1184</td>
               <td colspan="2">N,N,4-Trimethylbenzenamine<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: N,N,4-Trimethylbenzenamine</i></td>
            </tr>
            <tr class="addition">
               <td>1731</td>
               <td colspan="2">N-(4-Chloro-3-((3-Methyl-2-Butenyl)Oxy)Phenyl)-2-Methyl-3-Furancarbothioamide<span class="subclass"> SubClassOf </span>Anti-HIV Agent. <br><i>New Terms: N-(4-Chloro-3-((3-Methyl-2-Butenyl)Oxy)Phenyl)-2-Methyl-3-Furancarbothioamide</i></td>
            </tr>
            <tr class="addition">
               <td>1172</td>
               <td colspan="2">N-Acetyl-.Alpha.-D-Glucosamine<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: N-Acetyl-.Alpha.-D-Glucosamine</i></td>
            </tr>
            <tr class="addition">
               <td>1173</td>
               <td colspan="2">N-Lauroylsarcosine<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: N-Lauroylsarcosine</i></td>
            </tr>
            <tr class="addition">
               <td>1175</td>
               <td colspan="2">NACHT, LRR<br><span class="keyword"> and </span>PYD Domains-Containing Protein 3<span class="subclass"> EquivalentTo </span>Apoptosis Regulator<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NLRP3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Apoptosis Promoter)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Induction of Apoptosis)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Inflammatory Response). <br><i>New Terms: NACHT, LRR and PYD Domains-Containing Protein 3, NLRP3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1176</td>
               <td colspan="2">NAE Inhibitor MLN4924<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: NAE Inhibitor MLN4924</i></td>
            </tr>
            <tr class="addition">
               <td>1177</td>
               <td colspan="2">NLRP3 Gene<span class="subclass"> SubClassOf </span>Apoptosis Regulation Gene. <br><i>New Terms: NLRP3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1178</td>
               <td colspan="2">NLRP3 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Induction of Apoptosis. <br><i>New Terms: NLRP3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1179</td>
               <td colspan="2">NLRP3 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Inflammatory Response. <br><i>New Terms: NLRP3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1180</td>
               <td colspan="2">NLRP3 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: NLRP3 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1181</td>
               <td colspan="2">NLRP3 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>1q44. <br><i>New Terms: NLRP3 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1182</td>
               <td colspan="2">NLRP3 wt Allele<span class="subclass"> SubClassOf </span>NLRP3 Gene. <br><i>New Terms: NLRP3 wt Allele, NLRP3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1185</td>
               <td colspan="2">Nafagrel<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Nafagrel</i></td>
            </tr>
            <tr class="addition">
               <td>1186</td>
               <td colspan="2">Nafcaproic Acid<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Nafcaproic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1187</td>
               <td colspan="2">Nafiverine<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Nafiverine</i></td>
            </tr>
            <tr class="addition">
               <td>1188</td>
               <td colspan="2">Nalorphine Hydrochloride<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Nalorphine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1189</td>
               <td colspan="2">Naminidil<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Naminidil</i></td>
            </tr>
            <tr class="addition">
               <td>1190</td>
               <td colspan="2">Nanofin<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Nanofin</i></td>
            </tr>
            <tr class="addition">
               <td>1191</td>
               <td colspan="2">Nanterinone<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Nanterinone</i></td>
            </tr>
            <tr class="addition">
               <td>1192</td>
               <td colspan="2">Naphthonone<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Naphthonone</i></td>
            </tr>
            <tr class="addition">
               <td>1193</td>
               <td colspan="2">Napirimus<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Napirimus</i></td>
            </tr>
            <tr class="addition">
               <td>1194</td>
               <td colspan="2">Nardeterol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Nardeterol</i></td>
            </tr>
            <tr class="addition">
               <td>1195</td>
               <td colspan="2">Nasal-Associated Lymphoid Tissue<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Nasal-Associated Lymphoid Tissue</i></td>
            </tr>
            <tr class="addition">
               <td>1196</td>
               <td colspan="2">Natalizumab<span class="subclass"> SubClassOf </span>Monoclonal Antibody. <br><i>New Terms: Natalizumab</i></td>
            </tr>
            <tr class="addition">
               <td>1197</td>
               <td colspan="2">Neisseria meningitidis Group A Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group A Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1198</td>
               <td colspan="2">Neisseria meningitidis Group A Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group A Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1199</td>
               <td colspan="2">Neisseria meningitidis Group C Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group C Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1200</td>
               <td colspan="2">Neisseria meningitidis Group C Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group C Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1201</td>
               <td colspan="2">Neisseria meningitidis Group W-135 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group W-135 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1202</td>
               <td colspan="2">Neisseria meningitidis Group W-135 Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group W-135 Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1203</td>
               <td colspan="2">Neisseria meningitidis Group Y Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group Y Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1204</td>
               <td colspan="2">Neisseria meningitidis Group Y Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Neisseria meningitidis Antigen. <br><i>New Terms: Neisseria meningitidis Group Y Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1205</td>
               <td colspan="2">Neostigmine Bromide<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Neostigmine Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>1206</td>
               <td colspan="2">Neostigmine Methylsulfate<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Neostigmine Methylsulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1207</td>
               <td colspan="2">Nepinalone<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Nepinalone</i></td>
            </tr>
            <tr class="addition">
               <td>1208</td>
               <td colspan="2">Nequinate<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Nequinate</i></td>
            </tr>
            <tr class="addition">
               <td>1209</td>
               <td colspan="2">Neramexane<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Neramexane</i></td>
            </tr>
            <tr class="addition">
               <td>1210</td>
               <td colspan="2">Neraminol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Neraminol</i></td>
            </tr>
            <tr class="addition">
               <td>1211</td>
               <td colspan="2">Nesbuvir<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Nesbuvir</i></td>
            </tr>
            <tr class="addition">
               <td>1212</td>
               <td colspan="2">Neuronal Acetylcholine Receptor Subunit Alpha-3<span class="subclass"> EquivalentTo </span>Ion Channel Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>CHRNA3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Ion Channel Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Lung Carcinoma)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transport Process). <br><i>New Terms: Neuronal Acetylcholine Receptor Subunit Alpha-3, CHRNA3 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1213</td>
               <td colspan="2">Neuronal Acetylcholine Receptor Subunit Alpha-5<span class="subclass"> EquivalentTo </span>Ion Channel Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>CHRNA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Ion Channel Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Lung Carcinoma)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transport Process). <br><i>New Terms: CHRNA5 Gene, Neuronal Acetylcholine Receptor Subunit Alpha-5</i></td>
            </tr>
            <tr class="addition">
               <td>1214</td>
               <td colspan="2">Neuronal Acetylcholine Receptor Subunit Beta-4<span class="subclass"> EquivalentTo </span>Ion Channel Protein<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>CHRNB4 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Ion Channel Protein)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Malfunction_Associated_With_Disease<span class="some"> some </span>Lung Carcinoma)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transport Process). <br><i>New Terms: CHRNB4 Gene, Neuronal Acetylcholine Receptor Subunit Beta-4</i></td>
            </tr>
            <tr class="addition">
               <td>1215</td>
               <td colspan="2">New Zealand Black Rabbit<span class="subclass"> SubClassOf </span>Rabbit. <br><i>New Terms: New Zealand Black Rabbit</i></td>
            </tr>
            <tr class="addition">
               <td>1216</td>
               <td colspan="2">New Zealand Hybrid Rabbit<span class="subclass"> SubClassOf </span>Rabbit. <br><i>New Terms: New Zealand Hybrid Rabbit</i></td>
            </tr>
            <tr class="addition">
               <td>1217</td>
               <td colspan="2">New Zealand Red Rabbit<span class="subclass"> SubClassOf </span>Rabbit. <br><i>New Terms: New Zealand Red Rabbit</i></td>
            </tr>
            <tr class="addition">
               <td>1218</td>
               <td colspan="2">New Zealand White Rabbit<span class="subclass"> SubClassOf </span>Rabbit. <br><i>New Terms: New Zealand White Rabbit</i></td>
            </tr>
            <tr class="addition">
               <td>1219</td>
               <td colspan="2">Niaprazine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Niaprazine</i></td>
            </tr>
            <tr class="addition">
               <td>1220</td>
               <td colspan="2">Nicainoprol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Nicainoprol</i></td>
            </tr>
            <tr class="addition">
               <td>1221</td>
               <td colspan="2">Nicametate<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Nicametate</i></td>
            </tr>
            <tr class="addition">
               <td>1222</td>
               <td colspan="2">Nicaraven<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Nicaraven</i></td>
            </tr>
            <tr class="addition">
               <td>1223</td>
               <td colspan="2">Nicogrelate<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Nicogrelate</i></td>
            </tr>
            <tr class="addition">
               <td>1224</td>
               <td colspan="2">Nicoracetam<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Nicoracetam</i></td>
            </tr>
            <tr class="addition">
               <td>1225</td>
               <td colspan="2">Nicotinyl Alcohol Tartrate<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Nicotinyl Alcohol Tartrate</i></td>
            </tr>
            <tr class="addition">
               <td>1226</td>
               <td colspan="2">Nicoxamat<span class="subclass"> SubClassOf </span>Uricosuric Agent. <br><i>New Terms: Nicoxamat</i></td>
            </tr>
            <tr class="addition">
               <td>1227</td>
               <td colspan="2">Nictindole<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Nictindole</i></td>
            </tr>
            <tr class="addition">
               <td>1228</td>
               <td colspan="2">Nictitating Membrane<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Nictitating Membrane</i></td>
            </tr>
            <tr class="addition">
               <td>1229</td>
               <td colspan="2">Nifenalol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Nifenalol</i></td>
            </tr>
            <tr class="addition">
               <td>1230</td>
               <td colspan="2">Nifenazone<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Nifenazone</i></td>
            </tr>
            <tr class="addition">
               <td>1231</td>
               <td colspan="2">Niflumic Acid<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Niflumic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1232</td>
               <td colspan="2">Nifluridide<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Nifluridide</i></td>
            </tr>
            <tr class="addition">
               <td>1233</td>
               <td colspan="2">Nifuraldezone<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Nifuraldezone</i></td>
            </tr>
            <tr class="addition">
               <td>1234</td>
               <td colspan="2">Nifuroquine<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Nifuroquine</i></td>
            </tr>
            <tr class="addition">
               <td>1235</td>
               <td colspan="2">Nifuroxime<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Nifuroxime</i></td>
            </tr>
            <tr class="addition">
               <td>1236</td>
               <td colspan="2">Nikethamide<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Nikethamide</i></td>
            </tr>
            <tr class="addition">
               <td>1237</td>
               <td colspan="2">Nileprost<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Nileprost</i></td>
            </tr>
            <tr class="addition">
               <td>1238</td>
               <td colspan="2">Nilprazole<span class="subclass"> SubClassOf </span>Proton Pump Inhibitor. <br><i>New Terms: Nilprazole</i></td>
            </tr>
            <tr class="addition">
               <td>1239</td>
               <td colspan="2">Niludipine<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Niludipine</i></td>
            </tr>
            <tr class="addition">
               <td>1240</td>
               <td colspan="2">Nimetazepam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Nimetazepam</i></td>
            </tr>
            <tr class="addition">
               <td>1241</td>
               <td colspan="2">Nimidane<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Nimidane</i></td>
            </tr>
            <tr class="addition">
               <td>1242</td>
               <td colspan="2">Nimorazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Nimorazole</i></td>
            </tr>
            <tr class="addition">
               <td>1243</td>
               <td colspan="2">Nipradilol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Nipradilol</i></td>
            </tr>
            <tr class="addition">
               <td>1244</td>
               <td colspan="2">Niprofazone<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Niprofazone</i></td>
            </tr>
            <tr class="addition">
               <td>1245</td>
               <td colspan="2">Nitarsone<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Nitarsone</i></td>
            </tr>
            <tr class="addition">
               <td>1246</td>
               <td colspan="2">Nitrocefin<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br><i>New Terms: Nitrocefin</i></td>
            </tr>
            <tr class="addition">
               <td>1247</td>
               <td colspan="2">Nitrocycline<span class="subclass"> SubClassOf </span>Tetracycline Antibiotic. <br><i>New Terms: Nitrocycline</i></td>
            </tr>
            <tr class="addition">
               <td>1248</td>
               <td colspan="2">Nitrofurantoin Monohydrate<span class="subclass"> SubClassOf </span>Urinary Anti-Infective Agent. <br><i>New Terms: Nitrofurantoin Monohydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1249</td>
               <td colspan="2">Nitroprusside<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br><i>New Terms: Nitroprusside</i></td>
            </tr>
            <tr class="addition">
               <td>1250</td>
               <td colspan="2">Nitroprusside<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Nitroprusside</i></td>
            </tr>
            <tr class="addition">
               <td>1251</td>
               <td colspan="2">Nixylic Acid<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Nixylic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1252</td>
               <td colspan="2">Nizofenone<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Nizofenone</i></td>
            </tr>
            <tr class="addition">
               <td>1253</td>
               <td colspan="2">Nonglandular Stomach<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Nonglandular Stomach</i></td>
            </tr>
            <tr class="addition">
               <td>1254</td>
               <td colspan="2">Norbudrine<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Norbudrine</i></td>
            </tr>
            <tr class="addition">
               <td>1255</td>
               <td colspan="2">Norclostebol<span class="subclass"> SubClassOf </span>Anabolic Steroid. <br><i>New Terms: Norclostebol</i></td>
            </tr>
            <tr class="addition">
               <td>1256</td>
               <td colspan="2">Norfloxacin Succinil<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Norfloxacin Succinil</i></td>
            </tr>
            <tr class="addition">
               <td>1257</td>
               <td colspan="2">Norflurane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Norflurane</i></td>
            </tr>
            <tr class="addition">
               <td>1258</td>
               <td colspan="2">Norgestomet<span class="subclass"> SubClassOf </span>Progestin. <br><i>New Terms: Norgestomet</i></td>
            </tr>
            <tr class="addition">
               <td>1259</td>
               <td colspan="2">Normethadone<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Normethadone</i></td>
            </tr>
            <tr class="addition">
               <td>1260</td>
               <td colspan="2">Nortetrazepam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Nortetrazepam</i></td>
            </tr>
            <tr class="addition">
               <td>1261</td>
               <td colspan="2">North American<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: North American</i></td>
            </tr>
            <tr class="addition">
               <td>1262</td>
               <td colspan="2">North Coast of Africa<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: North Coast of Africa</i></td>
            </tr>
            <tr class="addition">
               <td>1263</td>
               <td colspan="2">Northern European<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Northern European</i></td>
            </tr>
            <tr class="addition">
               <td>1264</td>
               <td colspan="2">Ocaperidone<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Ocaperidone</i></td>
            </tr>
            <tr class="addition">
               <td>1265</td>
               <td colspan="2">Ocfentanil Hydrochloride<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Ocfentanil Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1266</td>
               <td colspan="2">Octisalate<span class="subclass"> SubClassOf </span>Sunscreen. <br><i>New Terms: Octisalate</i></td>
            </tr>
            <tr class="addition">
               <td>1267</td>
               <td colspan="2">Octyldodecanol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Octyldodecanol</i></td>
            </tr>
            <tr class="addition">
               <td>1268</td>
               <td colspan="2">Olanzapine Pamoate<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Olanzapine Pamoate</i></td>
            </tr>
            <tr class="addition">
               <td>1269</td>
               <td colspan="2">Oleyl Alcohol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Oleyl Alcohol</i></td>
            </tr>
            <tr class="addition">
               <td>1270</td>
               <td colspan="2">Oral JAK Inhibitor INCB18424<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: Oral JAK Inhibitor INCB18424</i></td>
            </tr>
            <tr class="addition">
               <td>1271</td>
               <td colspan="2">Oral Milataxel<span class="subclass"> SubClassOf </span>Taxane-Pocket Binding Agent. <br><i>New Terms: Oral Milataxel</i></td>
            </tr>
            <tr class="addition">
               <td>1272</td>
               <td colspan="2">Oral Mucosa<span class="subclass"> SubClassOf </span>Mucosa. <br><i>New Terms: Oral Mucosa</i></td>
            </tr>
            <tr class="addition">
               <td>1273</td>
               <td colspan="2">Oral Zoledronic Acid<span class="subclass"> SubClassOf </span>Biphosphonate. <br><i>New Terms: Oral Zoledronic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1274</td>
               <td colspan="2">Orange B<span class="subclass"> SubClassOf </span>Dye. <br><i>New Terms: Orange B</i></td>
            </tr>
            <tr class="addition">
               <td>1275</td>
               <td colspan="2">Orestrate<span class="subclass"> SubClassOf </span>Therapeutic Estrogen. <br><i>New Terms: Orestrate</i></td>
            </tr>
            <tr class="addition">
               <td>1276</td>
               <td colspan="2">Orientation<span class="subclass"> SubClassOf </span>Mental Process. <br><i>New Terms: Orientation</i></td>
            </tr>
            <tr class="addition">
               <td>1277</td>
               <td colspan="2">Ormetoprim<span class="subclass"> SubClassOf </span>Dihydrofolate Reductase Inhibitor. <br><i>New Terms: Ormetoprim</i></td>
            </tr>
            <tr class="addition">
               <td>1278</td>
               <td colspan="2">Orphenadrine Hydrochloride<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Orphenadrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1279</td>
               <td colspan="2">Osalmid<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br><i>New Terms: Osalmid</i></td>
            </tr>
            <tr class="addition">
               <td>1280</td>
               <td colspan="2">Ospemifene<span class="subclass"> SubClassOf </span>Selective Estrogen Receptor Modulator. <br><i>New Terms: Ospemifene</i></td>
            </tr>
            <tr class="addition">
               <td>1281</td>
               <td colspan="2">Oteracil<span class="subclass"> SubClassOf </span>Pyrimidine Antagonist. <br><i>New Terms: Oteracil</i></td>
            </tr>
            <tr class="addition">
               <td>1282</td>
               <td colspan="2">Oviduct<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Oviduct</i></td>
            </tr>
            <tr class="addition">
               <td>1283</td>
               <td colspan="2">Oxetorone Fumarate<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Oxetorone Fumarate</i></td>
            </tr>
            <tr class="addition">
               <td>1284</td>
               <td colspan="2">Oxetorone Fumarate<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Oxetorone Fumarate</i></td>
            </tr>
            <tr class="addition">
               <td>1285</td>
               <td colspan="2">Oxolinic Acid<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Oxolinic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1286</td>
               <td colspan="2">Oxpheneridine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Oxpheneridine</i></td>
            </tr>
            <tr class="addition">
               <td>1287</td>
               <td colspan="2">Oxyfedrine Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Oxyfedrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1288</td>
               <td colspan="2">Oxyfedrine Hydrochloride<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Oxyfedrine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1289</td>
               <td colspan="2">Oxyphenonium<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Oxyphenonium</i></td>
            </tr>
            <tr class="addition">
               <td>1290</td>
               <td colspan="2">Palmitamine Oxide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Palmitamine Oxide</i></td>
            </tr>
            <tr class="addition">
               <td>1291</td>
               <td colspan="2">Pancreatic Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Pancreatic Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1292</td>
               <td colspan="2">Paraaortic Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Paraaortic Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1293</td>
               <td colspan="2">Paw<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Paw</i></td>
            </tr>
            <tr class="addition">
               <td>1294</td>
               <td colspan="2">Pegademase Bovine<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Pegademase Bovine</i></td>
            </tr>
            <tr class="addition">
               <td>1296</td>
               <td colspan="2">Pelanserin Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Pelanserin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1295</td>
               <td colspan="2">Pelanserin<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Pelanserin</i></td>
            </tr>
            <tr class="addition">
               <td>1297</td>
               <td colspan="2">Pelitrexol<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Pelitrexol</i></td>
            </tr>
            <tr class="addition">
               <td>1298</td>
               <td colspan="2">Pentadecalactone<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Pentadecalactone</i></td>
            </tr>
            <tr class="addition">
               <td>1299</td>
               <td colspan="2">Pentafluranol<span class="subclass"> SubClassOf </span>Non-Steroidal Estrogen. <br><i>New Terms: Pentafluranol</i></td>
            </tr>
            <tr class="addition">
               <td>1300</td>
               <td colspan="2">Pentasodium Triphosphate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Pentasodium Triphosphate</i></td>
            </tr>
            <tr class="addition">
               <td>1301</td>
               <td colspan="2">Pentazocine Lactate<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Pentazocine Lactate</i></td>
            </tr>
            <tr class="addition">
               <td>1302</td>
               <td colspan="2">Pentetate Zinc Trisodium<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Pentetate Zinc Trisodium</i></td>
            </tr>
            <tr class="addition">
               <td>1303</td>
               <td colspan="2">Pentolinium<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Pentolinium</i></td>
            </tr>
            <tr class="addition">
               <td>1304</td>
               <td colspan="2">Perflubutane<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Perflubutane</i></td>
            </tr>
            <tr class="addition">
               <td>1305</td>
               <td colspan="2">Perianal Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Perianal Gland</i></td>
            </tr>
            <tr class="addition">
               <td>1306</td>
               <td colspan="2">Perineal Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Perineal Gland</i></td>
            </tr>
            <tr class="addition">
               <td>1307</td>
               <td colspan="2">Peritoneal Fluid<span class="subclass"> SubClassOf </span>Biospecimen. <br><i>New Terms: Peritoneal Fluid</i></td>
            </tr>
            <tr class="addition">
               <td>1308</td>
               <td colspan="2">Peritoneal Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Peritoneal Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1309</td>
               <td colspan="2">Pexacerfont<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Pexacerfont</i></td>
            </tr>
            <tr class="addition">
               <td>1310</td>
               <td colspan="2">Phenbutazone Sodium Glycerate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Phenbutazone Sodium Glycerate</i></td>
            </tr>
            <tr class="addition">
               <td>1311</td>
               <td colspan="2">Phenethyl Alcohol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Phenethyl Alcohol</i></td>
            </tr>
            <tr class="addition">
               <td>1312</td>
               <td colspan="2">Phenobarbital Sodium<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Phenobarbital Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1313</td>
               <td colspan="2">Phenolsulfonphthalein<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br><i>New Terms: Phenolsulfonphthalein</i></td>
            </tr>
            <tr class="addition">
               <td>1314</td>
               <td colspan="2">Phenoxyethanol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Phenoxyethanol</i></td>
            </tr>
            <tr class="addition">
               <td>1315</td>
               <td colspan="2">Phenylacetic Acid<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Phenylacetic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1316</td>
               <td colspan="2">Phosmet<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Phosmet</i></td>
            </tr>
            <tr class="addition">
               <td>1317</td>
               <td colspan="2">Phthalylsulfamethizole<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Phthalylsulfamethizole</i></td>
            </tr>
            <tr class="addition">
               <td>1318</td>
               <td colspan="2">Picenadol Hydrochloride<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Picenadol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1319</td>
               <td colspan="2">Pichia guilliermondii<span class="subclass"> SubClassOf </span>Candida. <br><i>New Terms: Pichia guilliermondii, Candida</i></td>
            </tr>
            <tr class="addition">
               <td>1320</td>
               <td colspan="2">Picobenzide<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Picobenzide</i></td>
            </tr>
            <tr class="addition">
               <td>1321</td>
               <td colspan="2">Picolamine<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Picolamine</i></td>
            </tr>
            <tr class="addition">
               <td>1322</td>
               <td colspan="2">Piconol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Piconol</i></td>
            </tr>
            <tr class="addition">
               <td>1323</td>
               <td colspan="2">Picoperine<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Picoperine</i></td>
            </tr>
            <tr class="addition">
               <td>1325</td>
               <td colspan="2">Picumeterol Fumarate<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Picumeterol Fumarate</i></td>
            </tr>
            <tr class="addition">
               <td>1324</td>
               <td colspan="2">Picumeterol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Picumeterol</i></td>
            </tr>
            <tr class="addition">
               <td>1326</td>
               <td colspan="2">Pidobenzone<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Pidobenzone</i></td>
            </tr>
            <tr class="addition">
               <td>1327</td>
               <td colspan="2">Pidotimod<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: Pidotimod</i></td>
            </tr>
            <tr class="addition">
               <td>1328</td>
               <td colspan="2">Pifarnine<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Pifarnine</i></td>
            </tr>
            <tr class="addition">
               <td>1329</td>
               <td colspan="2">Pifexole<span class="subclass"> SubClassOf </span>Muscle Relaxant. <br><i>New Terms: Pifexole</i></td>
            </tr>
            <tr class="addition">
               <td>1330</td>
               <td colspan="2">Pimagedine Hydrochloride<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Pimagedine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1331</td>
               <td colspan="2">Pimavanserin<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Pimavanserin</i></td>
            </tr>
            <tr class="addition">
               <td>1332</td>
               <td colspan="2">Pimeclone<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Pimeclone</i></td>
            </tr>
            <tr class="addition">
               <td>1333</td>
               <td colspan="2">Pimelautide<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Pimelautide</i></td>
            </tr>
            <tr class="addition">
               <td>1334</td>
               <td colspan="2">Pimilprost<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Pimilprost</i></td>
            </tr>
            <tr class="addition">
               <td>1335</td>
               <td colspan="2">Pinafide<span class="subclass"> SubClassOf </span>DNA Intercalating Agent. <br><i>New Terms: Pinafide</i></td>
            </tr>
            <tr class="addition">
               <td>1336</td>
               <td colspan="2">Pinoxepin Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Pinoxepin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1337</td>
               <td colspan="2">Pipecuronium<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Pipecuronium</i></td>
            </tr>
            <tr class="addition">
               <td>1338</td>
               <td colspan="2">Piperazine Phosphate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Piperazine Phosphate</i></td>
            </tr>
            <tr class="addition">
               <td>1339</td>
               <td colspan="2">Piragliatin<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Piragliatin</i></td>
            </tr>
            <tr class="addition">
               <td>1341</td>
               <td colspan="2">Pirazmonam Sodium<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br><i>New Terms: Pirazmonam Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1340</td>
               <td colspan="2">Pirazmonam<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br><i>New Terms: Pirazmonam</i></td>
            </tr>
            <tr class="addition">
               <td>1342</td>
               <td colspan="2">Pirbuterol Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Pirbuterol Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1343</td>
               <td colspan="2">Piridicillin Sodium<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Piridicillin Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1344</td>
               <td colspan="2">Piridoxilate<span class="subclass"> SubClassOf </span>Cardiovascular Agent. <br><i>New Terms: Piridoxilate</i></td>
            </tr>
            <tr class="addition">
               <td>1345</td>
               <td colspan="2">Piroxicillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Piroxicillin</i></td>
            </tr>
            <tr class="addition">
               <td>1346</td>
               <td colspan="2">Plantar Nerve<span class="subclass"> SubClassOf </span>Peripheral Nerve. <br><i>New Terms: Plantar Nerve</i></td>
            </tr>
            <tr class="addition">
               <td>1347</td>
               <td colspan="2">Pleural Fluid<span class="subclass"> SubClassOf </span>Biospecimen. <br><i>New Terms: Pleural Fluid</i></td>
            </tr>
            <tr class="addition">
               <td>1348</td>
               <td colspan="2">Polyethylene Glycol-Based Laxative<span class="subclass"> SubClassOf </span>Laxative. <br><i>New Terms: Polyethylene Glycol-Based Laxative</i></td>
            </tr>
            <tr class="addition">
               <td>1349</td>
               <td colspan="2">Polyvalent Antigen-KLH Conjugate Vaccine<span class="subclass"> SubClassOf </span>Antineoplastic Vaccine. <br><i>New Terms: Polyvalent Antigen-KLH Conjugate Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>1350</td>
               <td colspan="2">Poor<span class="subclass"> SubClassOf </span>General Qualifier. <br><i>New Terms: Poor</i></td>
            </tr>
            <tr class="addition">
               <td>1351</td>
               <td colspan="2">Portal Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Portal Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1352</td>
               <td colspan="2">Potassium Bisulfite<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Potassium Bisulfite</i></td>
            </tr>
            <tr class="addition">
               <td>1353</td>
               <td colspan="2">Potassium Bromide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Potassium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>1354</td>
               <td colspan="2">Potassium Lactate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Potassium Lactate</i></td>
            </tr>
            <tr class="addition">
               <td>1355</td>
               <td colspan="2">Potassium Permanganate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Potassium Permanganate</i></td>
            </tr>
            <tr class="addition">
               <td>1356</td>
               <td colspan="2">Potassium Sorbate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Potassium Sorbate</i></td>
            </tr>
            <tr class="addition">
               <td>1357</td>
               <td colspan="2">Povidone<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Povidone</i></td>
            </tr>
            <tr class="addition">
               <td>1358</td>
               <td colspan="2">Practolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Practolol</i></td>
            </tr>
            <tr class="addition">
               <td>1359</td>
               <td colspan="2">Pralidoxime<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Pralidoxime</i></td>
            </tr>
            <tr class="addition">
               <td>1360</td>
               <td colspan="2">Pralnacasan<span class="subclass"> SubClassOf </span>Matrix Metalloproteinase Inhibitor. <br><i>New Terms: Pralnacasan</i></td>
            </tr>
            <tr class="addition">
               <td>1361</td>
               <td colspan="2">Prasterone Sodium Sulfate<span class="subclass"> SubClassOf </span>Therapeutic Androgen. <br><i>New Terms: Prasterone Sodium Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1362</td>
               <td colspan="2">Preladenant<span class="subclass"> SubClassOf </span>Antiparkinsonian Agent. <br><i>New Terms: Preladenant</i></td>
            </tr>
            <tr class="addition">
               <td>1363</td>
               <td colspan="2">Prescapular Lymph Node<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Prescapular Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1364</td>
               <td colspan="2">Prethcamide<span class="subclass"> SubClassOf </span>CNS Stimulant. <br><i>New Terms: Prethcamide</i></td>
            </tr>
            <tr class="addition">
               <td>1365</td>
               <td colspan="2">Primidolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Primidolol</i></td>
            </tr>
            <tr class="addition">
               <td>1366</td>
               <td colspan="2">Prinaberel<span class="subclass"> SubClassOf </span>Selective Estrogen Receptor Modulator. <br><i>New Terms: Prinaberel</i></td>
            </tr>
            <tr class="addition">
               <td>1367</td>
               <td colspan="2">Prizidilol Hydrochloride Anhydrous<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Prizidilol Hydrochloride Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1368</td>
               <td colspan="2">Probarbital Sodium<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Probarbital Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1369</td>
               <td colspan="2">Proctocolitis<span class="subclass"> SubClassOf </span>Non-Neoplastic Gastrointestinal Disorder. <br><i>New Terms: Proctocolitis</i></td>
            </tr>
            <tr class="addition">
               <td>1370</td>
               <td colspan="2">Proflavine<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Proflavine</i></td>
            </tr>
            <tr class="addition">
               <td>1371</td>
               <td colspan="2">Proflavine Sulfate<span class="subclass"> SubClassOf </span>DNA Intercalating Agent. <br><i>New Terms: Proflavine Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1372</td>
               <td colspan="2">Proligestone<span class="subclass"> SubClassOf </span>Progestin. <br><i>New Terms: Proligestone</i></td>
            </tr>
            <tr class="addition">
               <td>1373</td>
               <td colspan="2">Promestriene<span class="subclass"> SubClassOf </span>Therapeutic Estrogen. <br><i>New Terms: Promestriene</i></td>
            </tr>
            <tr class="addition">
               <td>1374</td>
               <td colspan="2">Propane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Propane</i></td>
            </tr>
            <tr class="addition">
               <td>1375</td>
               <td colspan="2">Propantheline<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Propantheline</i></td>
            </tr>
            <tr class="addition">
               <td>1376</td>
               <td colspan="2">Propetamphos<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Propetamphos</i></td>
            </tr>
            <tr class="addition">
               <td>1377</td>
               <td colspan="2">Propoxate<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Propoxate</i></td>
            </tr>
            <tr class="addition">
               <td>1378</td>
               <td colspan="2">Propyl Docetrizoate<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Propyl Docetrizoate</i></td>
            </tr>
            <tr class="addition">
               <td>1379</td>
               <td colspan="2">Propyl Gallate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Propyl Gallate</i></td>
            </tr>
            <tr class="addition">
               <td>1380</td>
               <td colspan="2">Propylene Carbonate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Propylene Carbonate</i></td>
            </tr>
            <tr class="addition">
               <td>1381</td>
               <td colspan="2">Propylene Glycol Diacetate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Propylene Glycol Diacetate</i></td>
            </tr>
            <tr class="addition">
               <td>1382</td>
               <td colspan="2">Propylene Glycol Monolaurate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Propylene Glycol Monolaurate</i></td>
            </tr>
            <tr class="addition">
               <td>1383</td>
               <td colspan="2">Propylparaben<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Propylparaben</i></td>
            </tr>
            <tr class="addition">
               <td>1384</td>
               <td colspan="2">Prostalene<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Prostalene</i></td>
            </tr>
            <tr class="addition">
               <td>1385</td>
               <td colspan="2">Prostate Health Cocktail Dietary Supplement<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Prostate Health Cocktail Dietary Supplement</i></td>
            </tr>
            <tr class="addition">
               <td>1386</td>
               <td colspan="2">Prostate/Seminal Vesicles<span class="subclass"> SubClassOf </span>Tissue Sample. <br><i>New Terms: Prostate/Seminal Vesicles</i></td>
            </tr>
            <tr class="addition">
               <td>1387</td>
               <td colspan="2">Protheobromine<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Protheobromine</i></td>
            </tr>
            <tr class="addition">
               <td>1388</td>
               <td colspan="2">Protista<span class="subclass"> SubClassOf </span>Organism. <br><i>New Terms: Protista</i></td>
            </tr>
            <tr class="addition">
               <td>1389</td>
               <td colspan="2">Protoporphyrin Disodium<span class="subclass"> SubClassOf </span>Hepatoprotective Agent. <br><i>New Terms: Protoporphyrin Disodium</i></td>
            </tr>
            <tr class="addition">
               <td>1390</td>
               <td colspan="2">Protozoa<span class="subclass"> SubClassOf </span>Invertebrate. <br><i>New Terms: Protozoa</i></td>
            </tr>
            <tr class="addition">
               <td>1391</td>
               <td colspan="2">Pyrilamine<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Pyrilamine</i></td>
            </tr>
            <tr class="addition">
               <td>1392</td>
               <td colspan="2">Pyrophenindane<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Pyrophenindane</i></td>
            </tr>
            <tr class="addition">
               <td>1393</td>
               <td colspan="2">Pyroxamine Maleate<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Pyroxamine Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>1394</td>
               <td colspan="2">Pyrvinium<span class="subclass"> SubClassOf </span>Antiparasitic Agent. <br><i>New Terms: Pyrvinium</i></td>
            </tr>
            <tr class="addition">
               <td>1395</td>
               <td colspan="2">Quinestradol<span class="subclass"> SubClassOf </span>Therapeutic Estrogen. <br><i>New Terms: Quinestradol</i></td>
            </tr>
            <tr class="addition">
               <td>1396</td>
               <td colspan="2">Quinezamide<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Quinezamide</i></td>
            </tr>
            <tr class="addition">
               <td>1397</td>
               <td colspan="2">Racefemine<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Racefemine</i></td>
            </tr>
            <tr class="addition">
               <td>1398</td>
               <td colspan="2">Racemoramide<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Racemoramide</i></td>
            </tr>
            <tr class="addition">
               <td>1399</td>
               <td colspan="2">Racepinephrine<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Racepinephrine</i></td>
            </tr>
            <tr class="addition">
               <td>1400</td>
               <td colspan="2">Radafaxine Hydrochloride<span class="subclass"> SubClassOf </span>Antidepressant Agent. <br><i>New Terms: Radafaxine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1401</td>
               <td colspan="2">Ramatroban<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Ramatroban</i></td>
            </tr>
            <tr class="addition">
               <td>1402</td>
               <td colspan="2">Ramixotidine<span class="subclass"> SubClassOf </span>Histamine-2 Receptor Antagonist. <br><i>New Terms: Ramixotidine</i></td>
            </tr>
            <tr class="addition">
               <td>1403</td>
               <td colspan="2">Ramnodigin<span class="subclass"> SubClassOf </span>Cardiovascular Agent. <br><i>New Terms: Ramnodigin</i></td>
            </tr>
            <tr class="addition">
               <td>1404</td>
               <td colspan="2">Ranelic Acid<span class="subclass"> SubClassOf </span>Bone Resorption Inhibitor. <br><i>New Terms: Ranelic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1405</td>
               <td colspan="2">Ranelic Acid<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Ranelic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1406</td>
               <td colspan="2">Rating<span class="subclass"> SubClassOf </span>Action. <br><i>New Terms: Rating</i></td>
            </tr>
            <tr class="addition">
               <td>1407</td>
               <td colspan="2">Razinodil<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Razinodil</i></td>
            </tr>
            <tr class="addition">
               <td>1408</td>
               <td colspan="2">Rebimastat<span class="subclass"> SubClassOf </span>Matrix Metalloproteinase Inhibitor. <br><i>New Terms: Rebimastat</i></td>
            </tr>
            <tr class="addition">
               <td>1409</td>
               <td colspan="2">Recumbent Position<span class="subclass"> SubClassOf </span>Body Position. <br><i>New Terms: Recumbent Position</i></td>
            </tr>
            <tr class="addition">
               <td>1410</td>
               <td colspan="2">Relative Fluorescence Units<span class="subclass"> SubClassOf </span>Fluorescence Units. <br><i>New Terms: Relative Fluorescence Units</i></td>
            </tr>
            <tr class="addition">
               <td>1411</td>
               <td colspan="2">Relocation<span class="subclass"> SubClassOf </span>Action. <br><i>New Terms: Relocation</i></td>
            </tr>
            <tr class="addition">
               <td>1412</td>
               <td colspan="2">Relomycin<span class="subclass"> SubClassOf </span>Macrolide Antibiotic. <br><i>New Terms: Relomycin</i></td>
            </tr>
            <tr class="addition">
               <td>1413</td>
               <td colspan="2">Renal Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Renal Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1414</td>
               <td colspan="2">Renal Tumor RNA/CD40L-Transfected Dendritic Cell Vaccine<span class="subclass"> SubClassOf </span>Dendritic Cell Vaccine. <br><i>New Terms: Renal Tumor RNA/CD40L-Transfected Dendritic Cell Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>1415</td>
               <td colspan="2">Resorcinol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Resorcinol</i></td>
            </tr>
            <tr class="addition">
               <td>1416</td>
               <td colspan="2">Retinoid Analogue NRX 195183<span class="subclass"> SubClassOf </span>Retinoic Acid Agent. <br><i>New Terms: Retinoid Analogue NRX 195183</i></td>
            </tr>
            <tr class="addition">
               <td>1417</td>
               <td colspan="2">Retosiban<span class="subclass"> SubClassOf </span>Hormone Antagonist. <br><i>New Terms: Retosiban</i></td>
            </tr>
            <tr class="addition">
               <td>1418</td>
               <td colspan="2">Retropharyngeal Lymph Node<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Lymph Node. <br><i>New Terms: Retropharyngeal Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1419</td>
               <td colspan="2">Retrosacral Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node by Anatomic Site. <br><i>New Terms: Retrosacral Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1420</td>
               <td colspan="2">Revaprazan<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Revaprazan</i></td>
            </tr>
            <tr class="addition">
               <td>1421</td>
               <td colspan="2">Revizinone<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Revizinone</i></td>
            </tr>
            <tr class="addition">
               <td>1422</td>
               <td colspan="2">Revospirone<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Revospirone</i></td>
            </tr>
            <tr class="addition">
               <td>1423</td>
               <td colspan="2">Rhinovirus<span class="subclass"> SubClassOf </span>Picornavirus. <br><i>New Terms: Rhinovirus</i></td>
            </tr>
            <tr class="addition">
               <td>1424</td>
               <td colspan="2">Rhizopus<span class="subclass"> SubClassOf </span>Zygomycota. <br><i>New Terms: Zygomycota, Rhizopus</i></td>
            </tr>
            <tr class="addition">
               <td>1425</td>
               <td colspan="2">Ricasetron<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Ricasetron</i></td>
            </tr>
            <tr class="addition">
               <td>1426</td>
               <td colspan="2">Ridazolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Ridazolol</i></td>
            </tr>
            <tr class="addition">
               <td>1427</td>
               <td colspan="2">Rilapine<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Rilapine</i></td>
            </tr>
            <tr class="addition">
               <td>1428</td>
               <td colspan="2">Rilapladib<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Rilapladib</i></td>
            </tr>
            <tr class="addition">
               <td>1429</td>
               <td colspan="2">Rilmazafone<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Rilmazafone</i></td>
            </tr>
            <tr class="addition">
               <td>1430</td>
               <td colspan="2">Rilpivirine<span class="subclass"> SubClassOf </span>Reverse Transcriptase Inhibitor. <br><i>New Terms: Rilpivirine</i></td>
            </tr>
            <tr class="addition">
               <td>1431</td>
               <td colspan="2">Rimazolium Metilsulfate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Rimazolium Metilsulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1432</td>
               <td colspan="2">Riodipine<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Riodipine</i></td>
            </tr>
            <tr class="addition">
               <td>1433</td>
               <td colspan="2">Rivaroxaban<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Rivaroxaban</i></td>
            </tr>
            <tr class="addition">
               <td>1435</td>
               <td colspan="2">Robenidine Hydrochloride<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Robenidine Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1434</td>
               <td colspan="2">Robenidine<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Robenidine</i></td>
            </tr>
            <tr class="addition">
               <td>1436</td>
               <td colspan="2">Rofleponide<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Rofleponide</i></td>
            </tr>
            <tr class="addition">
               <td>1437</td>
               <td colspan="2">Roflumilast<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Roflumilast</i></td>
            </tr>
            <tr class="addition">
               <td>1438</td>
               <td colspan="2">Ronnel<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Ronnel</i></td>
            </tr>
            <tr class="addition">
               <td>1439</td>
               <td colspan="2">Ropidoxuridine<span class="subclass"> SubClassOf </span>Pyrimidine Antagonist. <br><i>New Terms: Ropidoxuridine</i></td>
            </tr>
            <tr class="addition">
               <td>1440</td>
               <td colspan="2">Rosabulin<span class="subclass"> SubClassOf </span>Tubulin Binding Agent. <br><i>New Terms: Rosabulin</i></td>
            </tr>
            <tr class="addition">
               <td>1441</td>
               <td colspan="2">Ross Chicken<span class="subclass"> SubClassOf </span>Chicken. <br><i>New Terms: Ross Chicken</i></td>
            </tr>
            <tr class="addition">
               <td>1444</td>
               <td colspan="2">Rotavirus G1 P(8) Live Antigen, A<span class="subclass"> SubClassOf </span>Rotavirus Antigen. <br><i>New Terms: Rotavirus G1 P(8) Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1443</td>
               <td colspan="2">Rotavirus G1 P7(5) Live Antigen, A<span class="subclass"> SubClassOf </span>Rotavirus Antigen. <br><i>New Terms: Rotavirus G1 P7(5) Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1445</td>
               <td colspan="2">Rotavirus G2 P7(5) Live Antigen, A<span class="subclass"> SubClassOf </span>Rotavirus Antigen. <br><i>New Terms: Rotavirus G2 P7(5) Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1446</td>
               <td colspan="2">Rotavirus G3 P7(5) Live Antigen, A<span class="subclass"> SubClassOf </span>Rotavirus Antigen. <br><i>New Terms: Rotavirus G3 P7(5) Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1447</td>
               <td colspan="2">Rotavirus G4 P7(5) Live Antigen, A<span class="subclass"> SubClassOf </span>Rotavirus Antigen. <br><i>New Terms: Rotavirus G4 P7(5) Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1448</td>
               <td colspan="2">Rotavirus G6 P1a(8) Live Antigen, A<span class="subclass"> SubClassOf </span>Rotavirus Antigen. <br><i>New Terms: Rotavirus G6 P1a(8) Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1442</td>
               <td colspan="2">Rotavirus<span class="subclass"> SubClassOf </span>Double Stranded RNA Virus. <br><i>New Terms: Rotavirus</i></td>
            </tr>
            <tr class="addition">
               <td>1449</td>
               <td colspan="2">Rotigotine<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Rotigotine</i></td>
            </tr>
            <tr class="addition">
               <td>1450</td>
               <td colspan="2">Rotoxamine Tartrate<span class="subclass"> SubClassOf </span>Histamine-1 Receptor Antagonist. <br><i>New Terms: Rotoxamine Tartrate</i></td>
            </tr>
            <tr class="addition">
               <td>1451</td>
               <td colspan="2">Rotraxate<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Rotraxate</i></td>
            </tr>
            <tr class="addition">
               <td>1452</td>
               <td colspan="2">Roxarsone<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Roxarsone</i></td>
            </tr>
            <tr class="addition">
               <td>1453</td>
               <td colspan="2">Roxoperone<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Roxoperone</i></td>
            </tr>
            <tr class="addition">
               <td>1455</td>
               <td colspan="2">Rubella Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Rubella Virus Antigen. <br><i>New Terms: Rubella Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1454</td>
               <td colspan="2">Rubella Virus<span class="subclass"> SubClassOf </span>Togaviridae. <br><i>New Terms: Rubella Virus, Togaviridae</i></td>
            </tr>
            <tr class="addition">
               <td>1456</td>
               <td colspan="2">SLC5A1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transport Process. <br><i>New Terms: SLC5A1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1457</td>
               <td colspan="2">SLC5A1 Gene<span class="subclass"> SubClassOf </span>Transport Protein Gene. <br><i>New Terms: SLC5A1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1458</td>
               <td colspan="2">SLC5A1 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br><i>New Terms: SLC5A1 wt Allele</i></td>
            </tr>
            <tr class="addition">
               <td>1459</td>
               <td colspan="2">SLC5A1 wt Allele<span class="subclass"> SubClassOf </span>SLC5A1 Gene. <br><i>New Terms: SLC5A1 wt Allele, SLC5A1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1462</td>
               <td colspan="2">Saccharin Sodium Anhydrous<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Saccharin Sodium Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1461</td>
               <td colspan="2">Saccharin Sodium<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Saccharin Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1460</td>
               <td colspan="2">Saccharin<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Saccharin</i></td>
            </tr>
            <tr class="addition">
               <td>1463</td>
               <td colspan="2">Sacral Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node. <br><i>New Terms: Sacral Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1464</td>
               <td colspan="2">Safinamide<span class="subclass"> SubClassOf </span>Monoamine Oxidase Inhibitor. <br><i>New Terms: Safinamide</i></td>
            </tr>
            <tr class="addition">
               <td>1465</td>
               <td colspan="2">Salinomycin<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Salinomycin</i></td>
            </tr>
            <tr class="addition">
               <td>1466</td>
               <td colspan="2">Salmefamol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Salmefamol</i></td>
            </tr>
            <tr class="addition">
               <td>1467</td>
               <td colspan="2">Salmonella Typhi Antigen, B<span class="subclass"> SubClassOf </span>Salmonella typhi Antigen. <br><i>New Terms: Salmonella Typhi Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1469</td>
               <td colspan="2">Salmonella typhi Ty2 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Salmonella typhi Antigen. <br><i>New Terms: Salmonella typhi Ty2 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1468</td>
               <td colspan="2">Salmonella typhi Ty21a Live Antigen, A<span class="subclass"> SubClassOf </span>Salmonella typhi Antigen. <br><i>New Terms: Salmonella typhi Ty21a Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1471</td>
               <td colspan="2">Sapropterin Dihydrochloride<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Sapropterin Dihydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1470</td>
               <td colspan="2">Sapropterin<span class="subclass"> SubClassOf </span>Antioxidant. <br><i>New Terms: Sapropterin</i></td>
            </tr>
            <tr class="addition">
               <td>1474</td>
               <td colspan="2">Sarizotan Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Sarizotan Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1472</td>
               <td colspan="2">Sarizotan<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Sarizotan</i></td>
            </tr>
            <tr class="addition">
               <td>1473</td>
               <td colspan="2">Sarizotan<span class="subclass"> SubClassOf </span>Serotonin Agonist. <br><i>New Terms: Sarizotan</i></td>
            </tr>
            <tr class="addition">
               <td>1475</td>
               <td colspan="2">Seganserin<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Seganserin</i></td>
            </tr>
            <tr class="addition">
               <td>1476</td>
               <td colspan="2">Selprazine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Selprazine</i></td>
            </tr>
            <tr class="addition">
               <td>1477</td>
               <td colspan="2">Semorphone<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Semorphone</i></td>
            </tr>
            <tr class="addition">
               <td>1478</td>
               <td colspan="2">Senicapoc<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Senicapoc</i></td>
            </tr>
            <tr class="addition">
               <td>1479</td>
               <td colspan="2">Sergliflozin<span class="subclass"> SubClassOf </span>Anti-diabetic Agent. <br><i>New Terms: Sergliflozin</i></td>
            </tr>
            <tr class="addition">
               <td>1480</td>
               <td colspan="2">Sermetacin<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Sermetacin</i></td>
            </tr>
            <tr class="addition">
               <td>1481</td>
               <td colspan="2">Setipafant<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Setipafant</i></td>
            </tr>
            <tr class="addition">
               <td>1482</td>
               <td colspan="2">Sevelamer Carbonate<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Sevelamer Carbonate</i></td>
            </tr>
            <tr class="addition">
               <td>1483</td>
               <td colspan="2">Sevopramide<span class="subclass"> SubClassOf </span>Muscle Relaxant. <br><i>New Terms: Sevopramide</i></td>
            </tr>
            <tr class="addition">
               <td>1485</td>
               <td colspan="2">Sibenadet Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Sibenadet Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1486</td>
               <td colspan="2">Sibenadet Hydrochloride<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Sibenadet Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1484</td>
               <td colspan="2">Sibenadet<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Sibenadet</i></td>
            </tr>
            <tr class="addition">
               <td>1487</td>
               <td colspan="2">Silver Nitrate<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Silver Nitrate</i></td>
            </tr>
            <tr class="addition">
               <td>1489</td>
               <td colspan="2">Sitafloxacin Anhydrous<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Sitafloxacin Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1488</td>
               <td colspan="2">Sitafloxacin<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Sitafloxacin</i></td>
            </tr>
            <tr class="addition">
               <td>1490</td>
               <td colspan="2">Sivelestat Sodium<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Sivelestat Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1491</td>
               <td colspan="2">Skinfold Thickness Analysis<span class="subclass"> SubClassOf </span>Diagnostic Procedure. <br><i>New Terms: Skinfold Thickness Analysis</i></td>
            </tr>
            <tr class="addition">
               <td>1492</td>
               <td colspan="2">Smoothened Antagonist BMS-833923<span class="subclass"> SubClassOf </span>Signal Transduction Inhibitor. <br><i>New Terms: Smoothened Antagonist BMS-833923</i></td>
            </tr>
            <tr class="addition">
               <td>1493</td>
               <td colspan="2">Sodium Aminobenzoate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Aminobenzoate</i></td>
            </tr>
            <tr class="addition">
               <td>1494</td>
               <td colspan="2">Sodium Bisulfate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Bisulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1495</td>
               <td colspan="2">Sodium Bisulfide<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Bisulfide</i></td>
            </tr>
            <tr class="addition">
               <td>1497</td>
               <td colspan="2">Sodium Borate Decahydrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Borate Decahydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1496</td>
               <td colspan="2">Sodium Borate<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Sodium Borate</i></td>
            </tr>
            <tr class="addition">
               <td>1498</td>
               <td colspan="2">Sodium Chlorate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Chlorate</i></td>
            </tr>
            <tr class="addition">
               <td>1499</td>
               <td colspan="2">Sodium Dithionite<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Dithionite</i></td>
            </tr>
            <tr class="addition">
               <td>1500</td>
               <td colspan="2">Sodium Feredetate<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Sodium Feredetate</i></td>
            </tr>
            <tr class="addition">
               <td>1501</td>
               <td colspan="2">Sodium Ferric Gluconate Complex<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Sodium Ferric Gluconate Complex</i></td>
            </tr>
            <tr class="addition">
               <td>1502</td>
               <td colspan="2">Sodium Formaldehyde Sulfoxylate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Formaldehyde Sulfoxylate</i></td>
            </tr>
            <tr class="addition">
               <td>1507</td>
               <td colspan="2">Sodium Glycididazole<span class="subclass"> SubClassOf </span>Radiosensitizing Agent. <br><i>New Terms: Sodium Glycididazole</i></td>
            </tr>
            <tr class="addition">
               <td>1508</td>
               <td colspan="2">Sodium Lauryl Sulfate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Lauryl Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1509</td>
               <td colspan="2">Sodium Metabisulfite<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Metabisulfite</i></td>
            </tr>
            <tr class="addition">
               <td>1510</td>
               <td colspan="2">Sodium Phosphate, Tribasic Dodecahydrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Phosphate, Tribasic Dodecahydrate</i></td>
            </tr>
            <tr class="addition">
               <td>1511</td>
               <td colspan="2">Sodium Pyrophosphate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Pyrophosphate</i></td>
            </tr>
            <tr class="addition">
               <td>1512</td>
               <td colspan="2">Sodium Stearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Stearate</i></td>
            </tr>
            <tr class="addition">
               <td>1513</td>
               <td colspan="2">Sodium Tartrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Tartrate</i></td>
            </tr>
            <tr class="addition">
               <td>1514</td>
               <td colspan="2">Sodium Thioglycolate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Thioglycolate</i></td>
            </tr>
            <tr class="addition">
               <td>1515</td>
               <td colspan="2">Sodium Trimetaphosphate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Sodium Trimetaphosphate</i></td>
            </tr>
            <tr class="addition">
               <td>1503</td>
               <td colspan="2">Sodium/Glucose Cotransporter 1<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>SLC5A1 Gene. <br><i>New Terms: Sodium/Glucose Cotransporter 1, SLC5A1 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>1504</td>
               <td colspan="2">Sodium/Glucose Cotransporter 1<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Transport Protein. <br><i>New Terms: Sodium/Glucose Cotransporter 1</i></td>
            </tr>
            <tr class="addition">
               <td>1505</td>
               <td colspan="2">Sodium/Glucose Cotransporter 1<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transport Process. <br><i>New Terms: Sodium/Glucose Cotransporter 1</i></td>
            </tr>
            <tr class="addition">
               <td>1506</td>
               <td colspan="2">Sodium/Glucose Cotransporter 1<span class="subclass"> SubClassOf </span>Transport Protein. <br><i>New Terms: Sodium/Glucose Cotransporter 1</i></td>
            </tr>
            <tr class="addition">
               <td>1516</td>
               <td colspan="2">Sotirimod<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: Sotirimod</i></td>
            </tr>
            <tr class="addition">
               <td>1517</td>
               <td colspan="2">South<br><span class="keyword"> or </span>Central American Indian<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: South or Central American Indian</i></td>
            </tr>
            <tr class="addition">
               <td>1518</td>
               <td colspan="2">Span<span class="subclass"> SubClassOf </span>Distance. <br><i>New Terms: Span</i></td>
            </tr>
            <tr class="addition">
               <td>1519</td>
               <td colspan="2">Squalane<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Squalane</i></td>
            </tr>
            <tr class="addition">
               <td>1520</td>
               <td colspan="2">Squalene<span class="subclass"> SubClassOf </span>Terpene Compound. <br><i>New Terms: Squalene</i></td>
            </tr>
            <tr class="addition">
               <td>1521</td>
               <td colspan="2">Squirrel Monkey<span class="subclass"> SubClassOf </span>Monkey. <br><i>New Terms: Squirrel Monkey</i></td>
            </tr>
            <tr class="addition">
               <td>1522</td>
               <td colspan="2">Stannous Chloride Anhydrous<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Stannous Chloride Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1523</td>
               <td colspan="2">Stannous Fluoride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Stannous Fluoride</i></td>
            </tr>
            <tr class="addition">
               <td>1524</td>
               <td colspan="2">Stannous Tartrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Stannous Tartrate</i></td>
            </tr>
            <tr class="addition">
               <td>1525</td>
               <td colspan="2">Stearalkonium Chloride<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Stearalkonium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>1526</td>
               <td colspan="2">Stearyl Alcohol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Stearyl Alcohol</i></td>
            </tr>
            <tr class="addition">
               <td>1527</td>
               <td colspan="2">Strawberry-Blackberry-Black Raspberry-Blueberry Mixture<span class="subclass"> SubClassOf </span>Dietary Supplement. <br><i>New Terms: Strawberry-Blackberry-Black Raspberry-Blueberry Mixture</i></td>
            </tr>
            <tr class="addition">
               <td>1540</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>1 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 1 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1528</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>10A Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 10A Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1529</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>11A Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 11A Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1530</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>12F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 12F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1531</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>14 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 14 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1532</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>14 Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 14 Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1533</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>15B Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 15B Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1534</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>17F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 17F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1535</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>18C Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 18C Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1536</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>18C Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 18C Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1537</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>19A Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 19A Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1538</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>19F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 19F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1539</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>19F Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 19F Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1545</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>2 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 2 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1541</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>20 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 20 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1542</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>22F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 22F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1543</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>23F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 23F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1544</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>23F Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 23F Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1547</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>3 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 3 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1546</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>33F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 33F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1548</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>4 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 4 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1549</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>4 Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 4 Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1550</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>5 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 5 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1551</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>6B Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 6B Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1552</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>6B Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 6B Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1553</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>7F Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 7F Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1554</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>8 Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 8 Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1555</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>9N Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 9N Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1556</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>9V Polysaccharide Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 9V Polysaccharide Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1557</td>
               <td colspan="2">Streptococcus pneumoniae<span class="subclass"> Type </span>9V Polysaccharide Conjugate Antigen, A<span class="subclass"> SubClassOf </span>Streptococcus pneumoniae Antigen. <br><i>New Terms: Streptococcus pneumoniae Type 9V Polysaccharide Conjugate Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1558</td>
               <td colspan="2">Sublumbar Lymph Node<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Sublumbar Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1559</td>
               <td colspan="2">Submandibular Lymph Node<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Lymph Node. <br><i>New Terms: Submandibular Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1560</td>
               <td colspan="2">Sugammadex Sodium<span class="subclass"> SubClassOf </span>Pharmacologic Substance. <br><i>New Terms: Sugammadex Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1561</td>
               <td colspan="2">Sulfacecole<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Sulfacecole</i></td>
            </tr>
            <tr class="addition">
               <td>1562</td>
               <td colspan="2">Sulfachlorpyridazine<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfachlorpyridazine</i></td>
            </tr>
            <tr class="addition">
               <td>1564</td>
               <td colspan="2">Sulfadimethoxine Sodium<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfadimethoxine Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1563</td>
               <td colspan="2">Sulfadimethoxine<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfadimethoxine</i></td>
            </tr>
            <tr class="addition">
               <td>1565</td>
               <td colspan="2">Sulfaguanidine<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfaguanidine</i></td>
            </tr>
            <tr class="addition">
               <td>1566</td>
               <td colspan="2">Sulfan Blue<span class="subclass"> SubClassOf </span>Dye. <br><i>New Terms: Sulfan Blue</i></td>
            </tr>
            <tr class="addition">
               <td>1567</td>
               <td colspan="2">Sulfanitran<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfanitran</i></td>
            </tr>
            <tr class="addition">
               <td>1568</td>
               <td colspan="2">Sulfaquinoxaline<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfaquinoxaline</i></td>
            </tr>
            <tr class="addition">
               <td>1569</td>
               <td colspan="2">Sulfasomizole<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfasomizole</i></td>
            </tr>
            <tr class="addition">
               <td>1570</td>
               <td colspan="2">Sulfasuccinamide<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfasuccinamide</i></td>
            </tr>
            <tr class="addition">
               <td>1571</td>
               <td colspan="2">Sulfathiourea<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfathiourea</i></td>
            </tr>
            <tr class="addition">
               <td>1572</td>
               <td colspan="2">Sulfatolamide<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfatolamide</i></td>
            </tr>
            <tr class="addition">
               <td>1573</td>
               <td colspan="2">Sulfatrozole<span class="subclass"> SubClassOf </span>Sulfonamide Anti-infective Agent. <br><i>New Terms: Sulfatrozole</i></td>
            </tr>
            <tr class="addition">
               <td>1574</td>
               <td colspan="2">Sulfonterol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Sulfonterol</i></td>
            </tr>
            <tr class="addition">
               <td>1575</td>
               <td colspan="2">Suloxifen<span class="subclass"> SubClassOf </span>Bronchodilator. <br><i>New Terms: Suloxifen</i></td>
            </tr>
            <tr class="addition">
               <td>1576</td>
               <td colspan="2">Sulukast<span class="subclass"> SubClassOf </span>Bronchodilator. <br><i>New Terms: Sulukast</i></td>
            </tr>
            <tr class="addition">
               <td>1577</td>
               <td colspan="2">Sumanirole<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br><i>New Terms: Sumanirole</i></td>
            </tr>
            <tr class="addition">
               <td>1578</td>
               <td colspan="2">Suprapharyngeal Lymph Node<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Suprapharyngeal Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1579</td>
               <td colspan="2">Sural Nerve<span class="subclass"> SubClassOf </span>Peripheral Nerve. <br><i>New Terms: Sural Nerve</i></td>
            </tr>
            <tr class="addition">
               <td>1580</td>
               <td colspan="2">Suxemerid Sulfate<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Suxemerid Sulfate</i></td>
            </tr>
            <tr class="addition">
               <td>1581</td>
               <td colspan="2">Symetine<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Symetine</i></td>
            </tr>
            <tr class="addition">
               <td>1582</td>
               <td colspan="2">Syrian Hamster<span class="subclass"> SubClassOf </span>Hamster. <br><i>New Terms: Syrian Hamster</i></td>
            </tr>
            <tr class="addition">
               <td>1583</td>
               <td colspan="2">T-Butylhydroquinone<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: T-Butylhydroquinone</i></td>
            </tr>
            <tr class="addition">
               <td>1584</td>
               <td colspan="2">TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes<span class="subclass"> SubClassOf </span>Biological Agent. <br><i>New Terms: TGF-b-Resistant LMP-Specific Cytotoxic T-Lymphocytes</i></td>
            </tr>
            <tr class="addition">
               <td>1585</td>
               <td colspan="2">TLR Agonist CADI-05<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: TLR Agonist CADI-05</i></td>
            </tr>
            <tr class="addition">
               <td>1586</td>
               <td colspan="2">Tabilautide<span class="subclass"> SubClassOf </span>Biological Response Modifier. <br><i>New Terms: Tabilautide</i></td>
            </tr>
            <tr class="addition">
               <td>1587</td>
               <td colspan="2">Tabimorelin<span class="subclass"> SubClassOf </span>Growth Hormone-Releasing Hormone Analogue. <br><i>New Terms: Tabimorelin</i></td>
            </tr>
            <tr class="addition">
               <td>1588</td>
               <td colspan="2">Tacapenem<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br><i>New Terms: Tacapenem</i></td>
            </tr>
            <tr class="addition">
               <td>1589</td>
               <td colspan="2">Tacedinaline<span class="subclass"> SubClassOf </span>Histone Deacetylase Inhibitor. <br><i>New Terms: Tacedinaline</i></td>
            </tr>
            <tr class="addition">
               <td>1590</td>
               <td colspan="2">Tail<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Tail</i></td>
            </tr>
            <tr class="addition">
               <td>1591</td>
               <td colspan="2">Talibegron Hydrochloride<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Talibegron Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1592</td>
               <td colspan="2">Talmetacin<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Talmetacin</i></td>
            </tr>
            <tr class="addition">
               <td>1593</td>
               <td colspan="2">Talmetoprim<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Talmetoprim</i></td>
            </tr>
            <tr class="addition">
               <td>1594</td>
               <td colspan="2">Talnetant<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Talnetant</i></td>
            </tr>
            <tr class="addition">
               <td>1595</td>
               <td colspan="2">Talosalate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Talosalate</i></td>
            </tr>
            <tr class="addition">
               <td>1596</td>
               <td colspan="2">Taltirelin<span class="subclass"> SubClassOf </span>Therapeutic Hormone. <br><i>New Terms: Taltirelin</i></td>
            </tr>
            <tr class="addition">
               <td>1597</td>
               <td colspan="2">Tameridone<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Tameridone</i></td>
            </tr>
            <tr class="addition">
               <td>1598</td>
               <td colspan="2">Tamitinol<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Tamitinol</i></td>
            </tr>
            <tr class="addition">
               <td>1599</td>
               <td colspan="2">Tamolarizine<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Tamolarizine</i></td>
            </tr>
            <tr class="addition">
               <td>1600</td>
               <td colspan="2">Taniplon<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Taniplon</i></td>
            </tr>
            <tr class="addition">
               <td>1601</td>
               <td colspan="2">Taprostene<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Taprostene</i></td>
            </tr>
            <tr class="addition">
               <td>1602</td>
               <td colspan="2">Tarazepide<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Tarazepide</i></td>
            </tr>
            <tr class="addition">
               <td>1604</td>
               <td colspan="2">Taribavirin Hydrochloride<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Taribavirin Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1603</td>
               <td colspan="2">Taribavirin<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Taribavirin</i></td>
            </tr>
            <tr class="addition">
               <td>1605</td>
               <td colspan="2">Tasidotin<span class="subclass"> SubClassOf </span>Tubulin Binding Agent. <br><i>New Terms: Tasidotin</i></td>
            </tr>
            <tr class="addition">
               <td>1606</td>
               <td colspan="2">Tattoo Site<span class="subclass"> SubClassOf </span>Anatomic Site. <br><i>New Terms: Tattoo Site</i></td>
            </tr>
            <tr class="addition">
               <td>1607</td>
               <td colspan="2">Tazanolast<span class="subclass"> SubClassOf </span>Mast Cell Stabilizer. <br><i>New Terms: Tazanolast</i></td>
            </tr>
            <tr class="addition">
               <td>1608</td>
               <td colspan="2">Tazeprofen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tazeprofen</i></td>
            </tr>
            <tr class="addition">
               <td>1609</td>
               <td colspan="2">Taziprinone<span class="subclass"> SubClassOf </span>Antitussive Agent. <br><i>New Terms: Taziprinone</i></td>
            </tr>
            <tr class="addition">
               <td>1610</td>
               <td colspan="2">Tazofelone<span class="subclass"> SubClassOf </span>Immunosuppressant. <br><i>New Terms: Tazofelone</i></td>
            </tr>
            <tr class="addition">
               <td>1611</td>
               <td colspan="2">Teat<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Teat</i></td>
            </tr>
            <tr class="addition">
               <td>1612</td>
               <td colspan="2">Tebanicline<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Tebanicline</i></td>
            </tr>
            <tr class="addition">
               <td>1613</td>
               <td colspan="2">Tebipenem Pivoxil<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br><i>New Terms: Tebipenem Pivoxil</i></td>
            </tr>
            <tr class="addition">
               <td>1614</td>
               <td colspan="2">Tecadenoson<span class="subclass"> SubClassOf </span>Antiarrhythmic Agent. <br><i>New Terms: Tecadenoson</i></td>
            </tr>
            <tr class="addition">
               <td>1616</td>
               <td colspan="2">Tecalcet Hydrochloride<span class="subclass"> SubClassOf </span>Hormone Antagonist. <br><i>New Terms: Tecalcet Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1615</td>
               <td colspan="2">Tecalcet<span class="subclass"> SubClassOf </span>Hormone Antagonist. <br><i>New Terms: Tecalcet</i></td>
            </tr>
            <tr class="addition">
               <td>1617</td>
               <td colspan="2">Teclothiazide<span class="subclass"> SubClassOf </span>Thiazide Diuretic. <br><i>New Terms: Teclothiazide</i></td>
            </tr>
            <tr class="addition">
               <td>1618</td>
               <td colspan="2">Teflutixol<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Teflutixol</i></td>
            </tr>
            <tr class="addition">
               <td>1619</td>
               <td colspan="2">Tegaserod Maleate<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Tegaserod Maleate</i></td>
            </tr>
            <tr class="addition">
               <td>1620</td>
               <td colspan="2">Telinavir<span class="subclass"> SubClassOf </span>Protease Inhibitor. <br><i>New Terms: Telinavir</i></td>
            </tr>
            <tr class="addition">
               <td>1621</td>
               <td colspan="2">Temocillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Temocillin</i></td>
            </tr>
            <tr class="addition">
               <td>1622</td>
               <td colspan="2">Temodox<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Temodox</i></td>
            </tr>
            <tr class="addition">
               <td>1623</td>
               <td colspan="2">Tenilapine<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Tenilapine</i></td>
            </tr>
            <tr class="addition">
               <td>1624</td>
               <td colspan="2">Tenilsetam<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Tenilsetam</i></td>
            </tr>
            <tr class="addition">
               <td>1625</td>
               <td colspan="2">Tenosal<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Tenosal</i></td>
            </tr>
            <tr class="addition">
               <td>1626</td>
               <td colspan="2">Tenosiprol<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tenosiprol</i></td>
            </tr>
            <tr class="addition">
               <td>1627</td>
               <td colspan="2">Tepirindole<span class="subclass"> SubClassOf </span>Dopamine Antagonist. <br><i>New Terms: Tepirindole</i></td>
            </tr>
            <tr class="addition">
               <td>1628</td>
               <td colspan="2">Tepoxalin<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tepoxalin</i></td>
            </tr>
            <tr class="addition">
               <td>1629</td>
               <td colspan="2">Terflavoxate<span class="subclass"> SubClassOf </span>Antispasmotic Agent. <br><i>New Terms: Terflavoxate</i></td>
            </tr>
            <tr class="addition">
               <td>1630</td>
               <td colspan="2">Teriflunomide<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br><i>New Terms: Teriflunomide</i></td>
            </tr>
            <tr class="addition">
               <td>1631</td>
               <td colspan="2">Terlipressin<span class="subclass"> SubClassOf </span>Recombinant Vasopressin. <br><i>New Terms: Terlipressin</i></td>
            </tr>
            <tr class="addition">
               <td>1632</td>
               <td colspan="2">Ternidazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Ternidazole</i></td>
            </tr>
            <tr class="addition">
               <td>1633</td>
               <td colspan="2">Terofenamate<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Terofenamate</i></td>
            </tr>
            <tr class="addition">
               <td>1634</td>
               <td colspan="2">Tesamorelin<span class="subclass"> SubClassOf </span>Gonadotropin-Releasing Hormone Analogue. <br><i>New Terms: Tesamorelin</i></td>
            </tr>
            <tr class="addition">
               <td>1635</td>
               <td colspan="2">Testis/Epididymis<span class="subclass"> SubClassOf </span>Tissue Sample. <br><i>New Terms: Testis/Epididymis</i></td>
            </tr>
            <tr class="addition">
               <td>1637</td>
               <td colspan="2">Tetroxoprim<span class="subclass"> SubClassOf </span>Dihydrofolate Reductase Inhibitor. <br><i>New Terms: Tetroxoprim</i></td>
            </tr>
            <tr class="addition">
               <td>1638</td>
               <td colspan="2">Texacromil<span class="subclass"> SubClassOf </span>Mast Cell Stabilizer. <br><i>New Terms: Texacromil</i></td>
            </tr>
            <tr class="addition">
               <td>1639</td>
               <td colspan="2">Tezampanel<span class="subclass"> SubClassOf </span>Analgesic Agent. <br><i>New Terms: Tezampanel</i></td>
            </tr>
            <tr class="addition">
               <td>1640</td>
               <td colspan="2">Thialbarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Thialbarbital</i></td>
            </tr>
            <tr class="addition">
               <td>1641</td>
               <td colspan="2">Thiocarbanidin<span class="subclass"> SubClassOf </span>Antitubercular Agent. <br><i>New Terms: Thiocarbanidin</i></td>
            </tr>
            <tr class="addition">
               <td>1642</td>
               <td colspan="2">Thioglycerol<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Thioglycerol</i></td>
            </tr>
            <tr class="addition">
               <td>1643</td>
               <td colspan="2">Thioglycolic Acid<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Thioglycolic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1644</td>
               <td colspan="2">Thiophanate<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Thiophanate</i></td>
            </tr>
            <tr class="addition">
               <td>1646</td>
               <td colspan="2">Thiphencillin Potassium<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Thiphencillin Potassium</i></td>
            </tr>
            <tr class="addition">
               <td>1645</td>
               <td colspan="2">Thiphencillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Thiphencillin</i></td>
            </tr>
            <tr class="addition">
               <td>1647</td>
               <td colspan="2">Thymol<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Thymol</i></td>
            </tr>
            <tr class="addition">
               <td>1648</td>
               <td colspan="2">Thymotrinan<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: Thymotrinan</i></td>
            </tr>
            <tr class="addition">
               <td>1649</td>
               <td colspan="2">Thyroid/Parathyroid<span class="subclass"> SubClassOf </span>Tissue Sample. <br><i>New Terms: Thyroid/Parathyroid</i></td>
            </tr>
            <tr class="addition">
               <td>1650</td>
               <td colspan="2">Tiametonium Iodide<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Tiametonium Iodide</i></td>
            </tr>
            <tr class="addition">
               <td>1651</td>
               <td colspan="2">Tianafac<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tianafac</i></td>
            </tr>
            <tr class="addition">
               <td>1652</td>
               <td colspan="2">Tiazuril<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Tiazuril</i></td>
            </tr>
            <tr class="addition">
               <td>1653</td>
               <td colspan="2">Ticagrelor<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Ticagrelor</i></td>
            </tr>
            <tr class="addition">
               <td>1654</td>
               <td colspan="2">Tidiacic<span class="subclass"> SubClassOf </span>Hepatoprotective Agent. <br><i>New Terms: Tidiacic</i></td>
            </tr>
            <tr class="addition">
               <td>1655</td>
               <td colspan="2">Tienocarbine<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Tienocarbine</i></td>
            </tr>
            <tr class="addition">
               <td>1656</td>
               <td colspan="2">Tilisolol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Tilisolol</i></td>
            </tr>
            <tr class="addition">
               <td>1657</td>
               <td colspan="2">Tilmacoxib<span class="subclass"> SubClassOf </span>Cyclooxygenase Inhibitor. <br><i>New Terms: Tilmacoxib</i></td>
            </tr>
            <tr class="addition">
               <td>1658</td>
               <td colspan="2">Tilnoprofen Arbamel<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tilnoprofen Arbamel</i></td>
            </tr>
            <tr class="addition">
               <td>1659</td>
               <td colspan="2">Timelotem<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Timelotem</i></td>
            </tr>
            <tr class="addition">
               <td>1660</td>
               <td colspan="2">Timiperone<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Timiperone</i></td>
            </tr>
            <tr class="addition">
               <td>1661</td>
               <td colspan="2">Timirdine<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Timirdine</i></td>
            </tr>
            <tr class="addition">
               <td>1662</td>
               <td colspan="2">Tinoridine<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tinoridine</i></td>
            </tr>
            <tr class="addition">
               <td>1663</td>
               <td colspan="2">Tioctilate<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Tioctilate</i></td>
            </tr>
            <tr class="addition">
               <td>1664</td>
               <td colspan="2">Tiomesterone<span class="subclass"> SubClassOf </span>Therapeutic Androgen. <br><i>New Terms: Tiomesterone</i></td>
            </tr>
            <tr class="addition">
               <td>1665</td>
               <td colspan="2">Tiopropamine<span class="subclass"> SubClassOf </span>Anti-ulcer Agent. <br><i>New Terms: Tiopropamine</i></td>
            </tr>
            <tr class="addition">
               <td>1666</td>
               <td colspan="2">Tioxacin<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Tioxacin</i></td>
            </tr>
            <tr class="addition">
               <td>1667</td>
               <td colspan="2">Tioxaprofen<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tioxaprofen</i></td>
            </tr>
            <tr class="addition">
               <td>1668</td>
               <td colspan="2">Tioxolone<span class="subclass"> SubClassOf </span>Astringent. <br><i>New Terms: Tioxolone</i></td>
            </tr>
            <tr class="addition">
               <td>1669</td>
               <td colspan="2">Tipepidine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Tipepidine</i></td>
            </tr>
            <tr class="addition">
               <td>1670</td>
               <td colspan="2">Tipetropium Bromide<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Tipetropium Bromide</i></td>
            </tr>
            <tr class="addition">
               <td>1671</td>
               <td colspan="2">Tipindole<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br><i>New Terms: Tipindole</i></td>
            </tr>
            <tr class="addition">
               <td>1672</td>
               <td colspan="2">Tiplasinin<span class="subclass"> SubClassOf </span>Thrombolytic Agent. <br><i>New Terms: Tiplasinin</i></td>
            </tr>
            <tr class="addition">
               <td>1673</td>
               <td colspan="2">Tiprinast Meglumine<span class="subclass"> SubClassOf </span>Mast Cell Stabilizer. <br><i>New Terms: Tiprinast Meglumine</i></td>
            </tr>
            <tr class="addition">
               <td>1674</td>
               <td colspan="2">Tipropidil Hydrochloride<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Tipropidil Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1675</td>
               <td colspan="2">Tiprotimod<span class="subclass"> SubClassOf </span>Immunostimulant. <br><i>New Terms: Tiprotimod</i></td>
            </tr>
            <tr class="addition">
               <td>1676</td>
               <td colspan="2">Tirofiban<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Tirofiban</i></td>
            </tr>
            <tr class="addition">
               <td>1677</td>
               <td colspan="2">Tiviciclovir<span class="subclass"> SubClassOf </span>Antiviral Agent. <br><i>New Terms: Tiviciclovir</i></td>
            </tr>
            <tr class="addition">
               <td>1678</td>
               <td colspan="2">Tivirapine<span class="subclass"> SubClassOf </span>Reverse Transcriptase Inhibitor. <br><i>New Terms: Tivirapine</i></td>
            </tr>
            <tr class="addition">
               <td>1679</td>
               <td colspan="2">Tixadil<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Tixadil</i></td>
            </tr>
            <tr class="addition">
               <td>1680</td>
               <td colspan="2">Tobicillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br><i>New Terms: Tobicillin</i></td>
            </tr>
            <tr class="addition">
               <td>1681</td>
               <td colspan="2">Tobuterol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Agonist. <br><i>New Terms: Tobuterol</i></td>
            </tr>
            <tr class="addition">
               <td>1682</td>
               <td colspan="2">Todralazine<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Todralazine</i></td>
            </tr>
            <tr class="addition">
               <td>1683</td>
               <td colspan="2">Tofimilast<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Tofimilast</i></td>
            </tr>
            <tr class="addition">
               <td>1684</td>
               <td colspan="2">Tofisoline<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Tofisoline</i></td>
            </tr>
            <tr class="addition">
               <td>1685</td>
               <td colspan="2">Togaviridae<span class="subclass"> SubClassOf </span>Positive Sense ssRNA Virus. <br><i>New Terms: Togaviridae</i></td>
            </tr>
            <tr class="addition">
               <td>1686</td>
               <td colspan="2">Tolbutamide Sodium<span class="subclass"> SubClassOf </span>Anti-diabetic Agent. <br><i>New Terms: Tolbutamide Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1687</td>
               <td colspan="2">Toliodium Chloride<span class="subclass"> SubClassOf </span>Topical Anti-Infective Agent. <br><i>New Terms: Toliodium Chloride</i></td>
            </tr>
            <tr class="addition">
               <td>1688</td>
               <td colspan="2">Tolpiprazole<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Tolpiprazole</i></td>
            </tr>
            <tr class="addition">
               <td>1689</td>
               <td colspan="2">Toluene<span class="subclass"> SubClassOf </span>Aromatic Hydrocarbon. <br><i>New Terms: Toluene</i></td>
            </tr>
            <tr class="addition">
               <td>1690</td>
               <td colspan="2">Toluene<span class="subclass"> SubClassOf </span>Reagent. <br><i>New Terms: Toluene</i></td>
            </tr>
            <tr class="addition">
               <td>1691</td>
               <td colspan="2">Tolufazepam<span class="subclass"> SubClassOf </span>Benzodiazepine. <br><i>New Terms: Tolufazepam</i></td>
            </tr>
            <tr class="addition">
               <td>1692</td>
               <td colspan="2">Tolvaptan<span class="subclass"> SubClassOf </span>Vasopressin Antagonist. <br><i>New Terms: Tolvaptan</i></td>
            </tr>
            <tr class="addition">
               <td>1693</td>
               <td colspan="2">Tomopenem<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br><i>New Terms: Tomopenem</i></td>
            </tr>
            <tr class="addition">
               <td>1694</td>
               <td colspan="2">Toprilidine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Toprilidine</i></td>
            </tr>
            <tr class="addition">
               <td>1695</td>
               <td colspan="2">Tosagestin<span class="subclass"> SubClassOf </span>Progestin. <br><i>New Terms: Tosagestin</i></td>
            </tr>
            <tr class="addition">
               <td>1696</td>
               <td colspan="2">Tosulur<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Tosulur</i></td>
            </tr>
            <tr class="addition">
               <td>1697</td>
               <td colspan="2">Totrombopag Choline<span class="subclass"> SubClassOf </span>Chemoprotective Agent. <br><i>New Terms: Totrombopag Choline</i></td>
            </tr>
            <tr class="addition">
               <td>1698</td>
               <td colspan="2">Tracheobronchial Lymph Node<span class="subclass"> SubClassOf </span>Lymph Node by Anatomic Site. <br><i>New Terms: Tracheobronchial Lymph Node</i></td>
            </tr>
            <tr class="addition">
               <td>1699</td>
               <td colspan="2">Tramiprosate<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br><i>New Terms: Tramiprosate</i></td>
            </tr>
            <tr class="addition">
               <td>1700</td>
               <td colspan="2">Triamcinolone Furetonide<span class="subclass"> SubClassOf </span>Therapeutic Glucocorticoid. <br><i>New Terms: Triamcinolone Furetonide</i></td>
            </tr>
            <tr class="addition">
               <td>1701</td>
               <td colspan="2">Tribendilol<span class="subclass"> SubClassOf </span>Beta-Adrenergic Antagonist. <br><i>New Terms: Tribendilol</i></td>
            </tr>
            <tr class="addition">
               <td>1702</td>
               <td colspan="2">Tribuzone<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Tribuzone</i></td>
            </tr>
            <tr class="addition">
               <td>1703</td>
               <td colspan="2">Trichloromonofluoromethane<span class="subclass"> SubClassOf </span>Industrial Product. <br><i>New Terms: Trichloromonofluoromethane</i></td>
            </tr>
            <tr class="addition">
               <td>1704</td>
               <td colspan="2">Triclodazol<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Triclodazol</i></td>
            </tr>
            <tr class="addition">
               <td>1705</td>
               <td colspan="2">Triclofylline<span class="subclass"> SubClassOf </span>Bronchodilator. <br><i>New Terms: Triclofylline</i></td>
            </tr>
            <tr class="addition">
               <td>1706</td>
               <td colspan="2">Tridihexethyl<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Tridihexethyl</i></td>
            </tr>
            <tr class="addition">
               <td>1707</td>
               <td colspan="2">Triethyl Citrate<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Triethyl Citrate</i></td>
            </tr>
            <tr class="addition">
               <td>1708</td>
               <td colspan="2">Trifenagrel<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Trifenagrel</i></td>
            </tr>
            <tr class="addition">
               <td>1709</td>
               <td colspan="2">Trifezolac<span class="subclass"> SubClassOf </span>Nonsteroidal Antiinflammatory Drug. <br><i>New Terms: Trifezolac</i></td>
            </tr>
            <tr class="addition">
               <td>1710</td>
               <td colspan="2">Triflocin<span class="subclass"> SubClassOf </span>Diuretic. <br><i>New Terms: Triflocin</i></td>
            </tr>
            <tr class="addition">
               <td>1711</td>
               <td colspan="2">Trifluomeprazine<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Trifluomeprazine</i></td>
            </tr>
            <tr class="addition">
               <td>1712</td>
               <td colspan="2">Trifluperidol<span class="subclass"> SubClassOf </span>Antipsychotic Agent. <br><i>New Terms: Trifluperidol</i></td>
            </tr>
            <tr class="addition">
               <td>1713</td>
               <td colspan="2">Triflusal<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Triflusal</i></td>
            </tr>
            <tr class="addition">
               <td>1714</td>
               <td colspan="2">Trifosmin<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br><i>New Terms: Trifosmin</i></td>
            </tr>
            <tr class="addition">
               <td>1715</td>
               <td colspan="2">Trimeperidine<span class="subclass"> SubClassOf </span>Opioid Receptor Agonist. <br><i>New Terms: Trimeperidine</i></td>
            </tr>
            <tr class="addition">
               <td>1716</td>
               <td colspan="2">Trimetazidine<span class="subclass"> SubClassOf </span>Cardiovascular Agent. <br><i>New Terms: Trimetazidine</i></td>
            </tr>
            <tr class="addition">
               <td>1717</td>
               <td colspan="2">Trimethaphan<span class="subclass"> SubClassOf </span>Nicotinic Antagonist. <br><i>New Terms: Trimethaphan</i></td>
            </tr>
            <tr class="addition">
               <td>1718</td>
               <td colspan="2">Trimethoprim Hydrochloride<span class="subclass"> SubClassOf </span>Dihydrofolate Reductase Inhibitor. <br><i>New Terms: Trimethoprim Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1719</td>
               <td colspan="2">Trimetozine<span class="subclass"> SubClassOf </span>Anxiolytic. <br><i>New Terms: Trimetozine</i></td>
            </tr>
            <tr class="addition">
               <td>1720</td>
               <td colspan="2">Trimexiline<span class="subclass"> SubClassOf </span>Nitrogen Compound. <br><i>New Terms: Trimexiline</i></td>
            </tr>
            <tr class="addition">
               <td>1721</td>
               <td colspan="2">Triolein<span class="subclass"> SubClassOf </span>Lipid. <br><i>New Terms: Triolein</i></td>
            </tr>
            <tr class="addition">
               <td>1722</td>
               <td colspan="2">Tristearin<span class="subclass"> SubClassOf </span>Lipid. <br><i>New Terms: Tristearin</i></td>
            </tr>
            <tr class="addition">
               <td>1723</td>
               <td colspan="2">Tropantiol<span class="subclass"> SubClassOf </span>Chelating Agent. <br><i>New Terms: Tropantiol</i></td>
            </tr>
            <tr class="addition">
               <td>1724</td>
               <td colspan="2">Troquidazole<span class="subclass"> SubClassOf </span>Antiprotozoal Agent. <br><i>New Terms: Troquidazole</i></td>
            </tr>
            <tr class="addition">
               <td>1725</td>
               <td colspan="2">Trospium<span class="subclass"> SubClassOf </span>Antimuscarinic Agent. <br><i>New Terms: Trospium</i></td>
            </tr>
            <tr class="addition">
               <td>1726</td>
               <td colspan="2">Trovirdine<span class="subclass"> SubClassOf </span>Reverse Transcriptase Inhibitor. <br><i>New Terms: Trovirdine</i></td>
            </tr>
            <tr class="addition">
               <td>1727</td>
               <td colspan="2">Tubulin Inhibitor CYT997<span class="subclass"> SubClassOf </span>Tubulin Binding Agent. <br><i>New Terms: Tubulin Inhibitor CYT997</i></td>
            </tr>
            <tr class="addition">
               <td>1728</td>
               <td colspan="2">Tyropanic Acid<span class="subclass"> SubClassOf </span>Contrast Agent. <br><i>New Terms: Tyropanic Acid</i></td>
            </tr>
            <tr class="addition">
               <td>1729</td>
               <td colspan="2">Tyroserleutide<span class="subclass"> SubClassOf </span>Antineoplastic Agent. <br><i>New Terms: Tyroserleutide</i></td>
            </tr>
            <tr class="addition">
               <td>1730</td>
               <td colspan="2">Tyrosine Kinase Inhibitor MGCD265<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: Tyrosine Kinase Inhibitor MGCD265</i></td>
            </tr>
            <tr class="addition">
               <td>1732</td>
               <td colspan="2">Ufiprazole<span class="subclass"> SubClassOf </span>Proton Pump Inhibitor. <br><i>New Terms: Ufiprazole</i></td>
            </tr>
            <tr class="addition">
               <td>1733</td>
               <td colspan="2">Ulifloxacin<span class="subclass"> SubClassOf </span>Quinolone Compound. <br><i>New Terms: Ulifloxacin</i></td>
            </tr>
            <tr class="addition">
               <td>1734</td>
               <td colspan="2">Umbilicus<span class="subclass"> SubClassOf </span>Other Anatomic Concept. <br><i>New Terms: Umbilicus</i></td>
            </tr>
            <tr class="addition">
               <td>1735</td>
               <td colspan="2">Unit of Radiant Flux<span class="subclass"> SubClassOf </span>Unit of Illuminance. <br><i>New Terms: Unit of Radiant Flux</i></td>
            </tr>
            <tr class="addition">
               <td>1736</td>
               <td colspan="2">Unit of Radioactive Decay<span class="subclass"> SubClassOf </span>Unit of Radiation. <br><i>New Terms: Unit of Radioactive Decay</i></td>
            </tr>
            <tr class="addition">
               <td>1738</td>
               <td colspan="2">Unit per Gram<span class="subclass"> SubClassOf </span>Arbitrary Unit of Substance Rate. <br><i>New Terms: Unit per Gram</i></td>
            </tr>
            <tr class="addition">
               <td>1737</td>
               <td colspan="2">Unit per Gram<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br><i>New Terms: Unit per Gram</i></td>
            </tr>
            <tr class="addition">
               <td>1740</td>
               <td colspan="2">Unit per Milliliter<span class="subclass"> SubClassOf </span>Arbitrary Unit of Substance Rate. <br><i>New Terms: Unit per Milliliter</i></td>
            </tr>
            <tr class="addition">
               <td>1739</td>
               <td colspan="2">Unit per Milliliter<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br><i>New Terms: Unit per Milliliter</i></td>
            </tr>
            <tr class="addition">
               <td>1741</td>
               <td colspan="2">Unoprostone<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Unoprostone</i></td>
            </tr>
            <tr class="addition">
               <td>1742</td>
               <td colspan="2">Unusual<span class="subclass"> SubClassOf </span>General Qualifier. <br><i>New Terms: Unusual</i></td>
            </tr>
            <tr class="addition">
               <td>1743</td>
               <td colspan="2">Urban<span class="subclass"> SubClassOf </span>General Qualifier. <br><i>New Terms: Urban</i></td>
            </tr>
            <tr class="addition">
               <td>1744</td>
               <td colspan="2">Uterus/Ovaries<span class="subclass"> SubClassOf </span>Tissue Sample. <br><i>New Terms: Uterus/Ovaries</i></td>
            </tr>
            <tr class="addition">
               <td>1745</td>
               <td colspan="2">VEGFR1-1084 Peptide Vaccine<span class="subclass"> SubClassOf </span>Peptide Vaccine. <br><i>New Terms: VEGFR1-1084 Peptide Vaccine</i></td>
            </tr>
            <tr class="addition">
               <td>1746</td>
               <td colspan="2">Vaccinia Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Vaccinia Virus Antigen. <br><i>New Terms: Vaccinia Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1747</td>
               <td colspan="2">Vaccinia Virus Live Antigen, B<span class="subclass"> SubClassOf </span>Vaccinia Virus Antigen. <br><i>New Terms: Vaccinia Virus Live Antigen, B</i></td>
            </tr>
            <tr class="addition">
               <td>1748</td>
               <td colspan="2">Valofane<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Valofane</i></td>
            </tr>
            <tr class="addition">
               <td>1749</td>
               <td colspan="2">Vanillin<span class="subclass"> SubClassOf </span>Industrial Aid. <br><i>New Terms: Vanillin</i></td>
            </tr>
            <tr class="addition">
               <td>1751</td>
               <td colspan="2">Vapiprost Hydrochloride<span class="subclass"> SubClassOf </span>Prostaglandin Compound. <br><i>New Terms: Vapiprost Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1750</td>
               <td colspan="2">Vapiprost<span class="subclass"> SubClassOf </span>Antiplatelet Agent. <br><i>New Terms: Vapiprost</i></td>
            </tr>
            <tr class="addition">
               <td>1752</td>
               <td colspan="2">Vardenafil Dihydrochloride<span class="subclass"> SubClassOf </span>Phosphodiesterase Inhibitor. <br><i>New Terms: Vardenafil Dihydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1753</td>
               <td colspan="2">Varicella-Zoster Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Varicella-Zoster Virus Antigen. <br><i>New Terms: Varicella-Zoster Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1754</td>
               <td colspan="2">Ventral Prostate Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Ventral Prostate Gland</i></td>
            </tr>
            <tr class="addition">
               <td>1755</td>
               <td colspan="2">Vidarabine Anhydrous<span class="subclass"> SubClassOf </span>Purine Antagonist. <br><i>New Terms: Vidarabine Anhydrous</i></td>
            </tr>
            <tr class="addition">
               <td>1757</td>
               <td colspan="2">Vinbarbital Sodium<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Vinbarbital Sodium</i></td>
            </tr>
            <tr class="addition">
               <td>1756</td>
               <td colspan="2">Vinbarbital<span class="subclass"> SubClassOf </span>Barbiturate. <br><i>New Terms: Vinbarbital</i></td>
            </tr>
            <tr class="addition">
               <td>1758</td>
               <td colspan="2">Vincantril<span class="subclass"> SubClassOf </span>Vasodilating Agent. <br><i>New Terms: Vincantril</i></td>
            </tr>
            <tr class="addition">
               <td>1759</td>
               <td colspan="2">Vinconate<span class="subclass"> SubClassOf </span>Cholinergic Agonist. <br><i>New Terms: Vinconate</i></td>
            </tr>
            <tr class="addition">
               <td>1760</td>
               <td colspan="2">Vintoperol<span class="subclass"> SubClassOf </span>Calcium Channel Blocker. <br><i>New Terms: Vintoperol</i></td>
            </tr>
            <tr class="addition">
               <td>1761</td>
               <td colspan="2">Vomitus<span class="subclass"> SubClassOf </span>Biospecimen. <br><i>New Terms: Vomitus</i></td>
            </tr>
            <tr class="addition">
               <td>1762</td>
               <td colspan="2">Western European<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: Western European</i></td>
            </tr>
            <tr class="addition">
               <td>1763</td>
               <td colspan="2">White Caribbean<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: White Caribbean</i></td>
            </tr>
            <tr class="addition">
               <td>1764</td>
               <td colspan="2">White Color Worker<span class="subclass"> SubClassOf </span>Population Group. <br><i>New Terms: White Color Worker</i></td>
            </tr>
            <tr class="addition">
               <td>1765</td>
               <td colspan="2">White South<br><span class="keyword"> or </span>Central American<span class="subclass"> SubClassOf </span>Race. <br><i>New Terms: White South or Central American</i></td>
            </tr>
            <tr class="addition">
               <td>1766</td>
               <td colspan="2">Whole Animal<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Whole Animal</i></td>
            </tr>
            <tr class="addition">
               <td>1767</td>
               <td colspan="2">Workforce<span class="subclass"> SubClassOf </span>Population Group. <br><i>New Terms: Workforce</i></td>
            </tr>
            <tr class="addition">
               <td>1768</td>
               <td colspan="2">World<span class="subclass"> SubClassOf </span>Population Group. <br><i>New Terms: World</i></td>
            </tr>
            <tr class="addition">
               <td>1769</td>
               <td colspan="2">Xenon, Xe-127<span class="subclass"> SubClassOf </span>Isotope. <br><i>New Terms: Xenon, Xe-127</i></td>
            </tr>
            <tr class="addition">
               <td>1770</td>
               <td colspan="2">Ximelagatran<span class="subclass"> SubClassOf </span>Anticoagulant Agent. <br><i>New Terms: Ximelagatran</i></td>
            </tr>
            <tr class="addition">
               <td>1771</td>
               <td colspan="2">Xylitol<span class="subclass"> SubClassOf </span>Artificial Sweetener. <br><i>New Terms: Xylitol</i></td>
            </tr>
            <tr class="addition">
               <td>1772</td>
               <td colspan="2">Yellow Fever Virus Live Antigen, A<span class="subclass"> SubClassOf </span>Yellow Fever Virus Antigen. <br><i>New Terms: Yellow Fever Virus Live Antigen, A</i></td>
            </tr>
            <tr class="addition">
               <td>1773</td>
               <td colspan="2">Yohimbine<span class="subclass"> SubClassOf </span>Alpha-Adrenergic Antagonist. <br><i>New Terms: Yohimbine</i></td>
            </tr>
            <tr class="addition">
               <td>1774</td>
               <td colspan="2">Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A<span class="subclass"> SubClassOf </span>Radioimmunoconjugate. <br><i>New Terms: Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A</i></td>
            </tr>
            <tr class="addition">
               <td>1775</td>
               <td colspan="2">Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody cT84.66<span class="subclass"> SubClassOf </span>Radioimmunoconjugate. <br><i>New Terms: Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody cT84.66</i></td>
            </tr>
            <tr class="addition">
               <td>1776</td>
               <td colspan="2">Yucatan Pig<span class="subclass"> SubClassOf </span>Pig. <br><i>New Terms: Yucatan Pig</i></td>
            </tr>
            <tr class="addition">
               <td>1777</td>
               <td colspan="2">Zeranol<span class="subclass"> SubClassOf </span>Non-Steroidal Estrogen. <br><i>New Terms: Zeranol</i></td>
            </tr>
            <tr class="addition">
               <td>1778</td>
               <td colspan="2">Zinc Phosphide<span class="subclass"> SubClassOf </span>Pesticide. <br><i>New Terms: Zinc Phosphide</i></td>
            </tr>
            <tr class="addition">
               <td>1779</td>
               <td colspan="2">Zolazepam Hydrochloride<span class="subclass"> SubClassOf </span>Sedative<br><span class="keyword"> and </span>Hypnotic. <br><i>New Terms: Zolazepam Hydrochloride</i></td>
            </tr>
            <tr class="addition">
               <td>1780</td>
               <td colspan="2">Zygomatic Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Zygomatic Gland</i></td>
            </tr>
            <tr class="addition">
               <td>1781</td>
               <td colspan="2">Zygomycosis<span class="subclass"> SubClassOf </span>Fungal Infection. <br><i>New Terms: Zygomycosis</i></td>
            </tr>
            <tr class="addition">
               <td>1782</td>
               <td colspan="2">Zygomycota<span class="subclass"> SubClassOf </span>Fungus. <br><i>New Terms: Zygomycota</i></td>
            </tr>
            <tr class="addition">
               <td>1783</td>
               <td colspan="2">Zymbal Gland<span class="subclass"> SubClassOf </span>Experimental Organism Anatomical Concept. <br><i>New Terms: Zymbal Gland</i></td>
            </tr>
            <tr class="addition">
               <td>1791</td>
               <td colspan="2">c-Met Inhibitor JNJ-38877605<span class="subclass"> SubClassOf </span>Tyrosine Kinase Inhibitor. <br><i>New Terms: c-Met Inhibitor JNJ-38877605</i></td>
            </tr>
         </tbody>
         <tbody id="add" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Pure Additions with Shared Terms (459)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">Addition to Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>1793</td>
               <td colspan="2">Abnormal Hard Tissue Formation in Pulp<span class="subclass"> SubClassOf </span>Oral Cavity Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1794</td>
               <td colspan="2">Accelerated Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1795</td>
               <td colspan="2">Age Group<span class="subclass"> SubClassOf </span>Group. <br></td>
            </tr>
            <tr class="addition">
               <td>1796</td>
               <td colspan="2">Algeldrate<span class="subclass"> SubClassOf </span>Antacid Preparation. <br></td>
            </tr>
            <tr class="addition">
               <td>1797</td>
               <td colspan="2">Allele_Has_Activity<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1798</td>
               <td colspan="2">Allele_Has_Activity<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1799</td>
               <td colspan="2">Allele_Is_Cancer_Related_Type<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1800</td>
               <td colspan="2">Allele_Is_Cancer_Related_Type<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1801</td>
               <td colspan="2">Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1802</td>
               <td colspan="2">Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1803</td>
               <td colspan="2">Allylisopropylacetamide<span class="subclass"> SubClassOf </span>Enzyme Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>1804</td>
               <td colspan="2">Aminohippuric Acid<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br></td>
            </tr>
            <tr class="addition">
               <td>1805</td>
               <td colspan="2">Anatomic_Structure_Has_Location<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1806</td>
               <td colspan="2">Anatomic_Structure_Has_Location<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1807</td>
               <td colspan="2">Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1808</td>
               <td colspan="2">Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1809</td>
               <td colspan="2">Angina Pectoris Prompting Medical Attention Event<span class="subclass"> SubClassOf </span>History of Coronary Artery Disease. <br></td>
            </tr>
            <tr class="addition">
               <td>1810</td>
               <td colspan="2">Antigen Processing Cell<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>1811</td>
               <td colspan="2">Antitubercular Agent<span class="subclass"> SubClassOf </span>Antibacterial Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>1812</td>
               <td colspan="2">Arbaclofen Placarbil<span class="subclass"> SubClassOf </span>Adjuvant Analgesic. <br></td>
            </tr>
            <tr class="addition">
               <td>1813</td>
               <td colspan="2">Astaxanthin<span class="subclass"> SubClassOf </span>Canthaxanthin. <br></td>
            </tr>
            <tr class="addition">
               <td>1814</td>
               <td colspan="2">Atrial Flutter<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1815</td>
               <td colspan="2">Atrial Premature Complex<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1816</td>
               <td colspan="2">Atrioventricular Nodal Reentry Tachycardia<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1817</td>
               <td colspan="2">Atrioventricular Reentrant Tachycardia<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1818</td>
               <td colspan="2">Average Fluorescence Units<span class="subclass"> SubClassOf </span>Fluorescence Units. <br></td>
            </tr>
            <tr class="addition">
               <td>1819</td>
               <td colspan="2">Bigeminy<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1820</td>
               <td colspan="2">Biological_Process_Has_Associated_Location<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1821</td>
               <td colspan="2">Biological_Process_Has_Associated_Location<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1822</td>
               <td colspan="2">Biological_Process_Has_Initiator_Chemical_Or_Drug<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1823</td>
               <td colspan="2">Biological_Process_Has_Initiator_Chemical_Or_Drug<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1824</td>
               <td colspan="2">Biological_Process_Has_Initiator_Process<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1825</td>
               <td colspan="2">Biological_Process_Has_Initiator_Process<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1826</td>
               <td colspan="2">Biological_Process_Has_Result_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1827</td>
               <td colspan="2">Biological_Process_Has_Result_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1828</td>
               <td colspan="2">Biological_Process_Has_Result_Biological_Process<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1829</td>
               <td colspan="2">Biological_Process_Has_Result_Biological_Process<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1830</td>
               <td colspan="2">Biological_Process_Has_Result_Chemical_Or_Drug<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1831</td>
               <td colspan="2">Biological_Process_Has_Result_Chemical_Or_Drug<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1832</td>
               <td colspan="2">Biological_Process_Is_Part_Of_Process<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1833</td>
               <td colspan="2">Biological_Process_Is_Part_Of_Process<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1834</td>
               <td colspan="2">Birth Cohort<span class="subclass"> SubClassOf </span>Cohort. <br></td>
            </tr>
            <tr class="addition">
               <td>1835</td>
               <td colspan="2">Bordetella Pertussis Antigen, B<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1836</td>
               <td colspan="2">Bordetella Pertussis Antigen, C<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1837</td>
               <td colspan="2">Bordetella Pertussis Antigen, D<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1838</td>
               <td colspan="2">Bordetella Pertussis Antigen, E<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1839</td>
               <td colspan="2">Bordetella Pertussis Antigen, F<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1840</td>
               <td colspan="2">Bordetella Pertussis Antigen, G<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1841</td>
               <td colspan="2">Bordetella Pertussis Antigen, H<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1842</td>
               <td colspan="2">Bordetella Pertussis Antigen, I<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. <br></td>
            </tr>
            <tr class="addition">
               <td>1843</td>
               <td colspan="2">Brodimoprim<span class="subclass"> SubClassOf </span>Dihydrofolate Reductase Inhibitor. <br></td>
            </tr>
            <tr class="addition">
               <td>1845</td>
               <td colspan="2">CD6 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Cell-Cell Adhesion. <br></td>
            </tr>
            <tr class="addition">
               <td>1846</td>
               <td colspan="2">CD6 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>T-Cell Development. <br></td>
            </tr>
            <tr class="addition">
               <td>1848</td>
               <td colspan="2">CDISC SDTM Package 2 Terminology<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>1849</td>
               <td colspan="2">Capsule per Animal<span class="subclass"> SubClassOf </span>Capsule Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>1850</td>
               <td colspan="2">Capsule per Animal<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>1851</td>
               <td colspan="2">Cardiac Arrest<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1852</td>
               <td colspan="2">Cells per Femur<span class="subclass"> SubClassOf </span>Cell-Based Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>1853</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Abnormal_Cell<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1854</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1855</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1856</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1857</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Gene_Product<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1858</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Gene_Product<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1859</td>
               <td colspan="2">Chemical_Or_Drug_FDA_Approved_For_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1860</td>
               <td colspan="2">Chemical_Or_Drug_FDA_Approved_For_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1861</td>
               <td colspan="2">Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1862</td>
               <td colspan="2">Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1863</td>
               <td colspan="2">Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1864</td>
               <td colspan="2">Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1865</td>
               <td colspan="2">Chemical_Or_Drug_Has_Physiologic_Effect<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1866</td>
               <td colspan="2">Chemical_Or_Drug_Has_Physiologic_Effect<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1867</td>
               <td colspan="2">Chemical_Or_Drug_Has_Study_Therapeutic_Use_For<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1868</td>
               <td colspan="2">Chemical_Or_Drug_Has_Study_Therapeutic_Use_For<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1869</td>
               <td colspan="2">Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1870</td>
               <td colspan="2">Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1871</td>
               <td colspan="2">Chemical_Or_Drug_Plays_Role_In_Biological_Process<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1872</td>
               <td colspan="2">Chemical_Or_Drug_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1873</td>
               <td colspan="2">Chemotherapy_Regimen_Has_Component<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1874</td>
               <td colspan="2">Chemotherapy_Regimen_Has_Component<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1875</td>
               <td colspan="2">Chenodiol<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. <br></td>
            </tr>
            <tr class="addition">
               <td>1876</td>
               <td colspan="2">Cinacalcet<span class="subclass"> SubClassOf </span>Antithyroid Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>1847</td>
               <td colspan="2">Clinical Data Interchange Standards Consortium Proposed Terminology<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>1877</td>
               <td colspan="2">Congestive Heart Failure<span class="subclass"> SubClassOf </span>Heart Failure. <br></td>
            </tr>
            <tr class="addition">
               <td>1878</td>
               <td colspan="2">Cyanocobalamin, Co-60<span class="subclass"> SubClassOf </span>Radioconjugate. <br></td>
            </tr>
            <tr class="addition">
               <td>1879</td>
               <td colspan="2">Diagnosis Group<span class="subclass"> SubClassOf </span>Group. <br></td>
            </tr>
            <tr class="addition">
               <td>1880</td>
               <td colspan="2">Diagnostic Accuracy<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>1881</td>
               <td colspan="2">Dianisidine<span class="subclass"> SubClassOf </span>Dye. <br></td>
            </tr>
            <tr class="addition">
               <td>1884</td>
               <td colspan="2">Dihydroergotamine Mesylate<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br></td>
            </tr>
            <tr class="addition">
               <td>1885</td>
               <td colspan="2">Dihydroergotamine Mesylate<span class="subclass"> SubClassOf </span>Nonnarcotic Analgesic. <br></td>
            </tr>
            <tr class="addition">
               <td>1882</td>
               <td colspan="2">Dihydroergotamine<span class="subclass"> SubClassOf </span>Dopamine Agonist. <br></td>
            </tr>
            <tr class="addition">
               <td>1883</td>
               <td colspan="2">Dihydroergotamine<span class="subclass"> SubClassOf </span>Nonnarcotic Analgesic. <br></td>
            </tr>
            <tr class="addition">
               <td>1886</td>
               <td colspan="2">Disease_Excludes_Abnormal_Cell<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1887</td>
               <td colspan="2">Disease_Excludes_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1888</td>
               <td colspan="2">Disease_Excludes_Cytogenetic_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1889</td>
               <td colspan="2">Disease_Excludes_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1890</td>
               <td colspan="2">Disease_Excludes_Finding<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1891</td>
               <td colspan="2">Disease_Excludes_Finding<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1892</td>
               <td colspan="2">Disease_Excludes_Metastatic_Anatomic_Site<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1893</td>
               <td colspan="2">Disease_Excludes_Metastatic_Anatomic_Site<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1894</td>
               <td colspan="2">Disease_Excludes_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1895</td>
               <td colspan="2">Disease_Excludes_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1896</td>
               <td colspan="2">Disease_Excludes_Normal_Cell_Origin<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1897</td>
               <td colspan="2">Disease_Excludes_Normal_Cell_Origin<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1898</td>
               <td colspan="2">Disease_Excludes_Normal_Tissue_Origin<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1899</td>
               <td colspan="2">Disease_Excludes_Normal_Tissue_Origin<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1900</td>
               <td colspan="2">Disease_Excludes_Primary_Anatomic_Site<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1901</td>
               <td colspan="2">Disease_Excludes_Primary_Anatomic_Site<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1902</td>
               <td colspan="2">Disease_Has_Abnormal_Cell<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1903</td>
               <td colspan="2">Disease_Has_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1904</td>
               <td colspan="2">Disease_Has_Associated_Anatomic_Site<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1905</td>
               <td colspan="2">Disease_Has_Associated_Anatomic_Site<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1906</td>
               <td colspan="2">Disease_Has_Associated_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1907</td>
               <td colspan="2">Disease_Has_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1908</td>
               <td colspan="2">Disease_Has_Cytogenetic_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1909</td>
               <td colspan="2">Disease_Has_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1910</td>
               <td colspan="2">Disease_Has_Finding<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1911</td>
               <td colspan="2">Disease_Has_Finding<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1912</td>
               <td colspan="2">Disease_Has_Metastatic_Anatomic_Site<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1913</td>
               <td colspan="2">Disease_Has_Metastatic_Anatomic_Site<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1914</td>
               <td colspan="2">Disease_Has_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1915</td>
               <td colspan="2">Disease_Has_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1916</td>
               <td colspan="2">Disease_Has_Normal_Cell_Origin<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1917</td>
               <td colspan="2">Disease_Has_Normal_Cell_Origin<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1918</td>
               <td colspan="2">Disease_Has_Normal_Tissue_Origin<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1919</td>
               <td colspan="2">Disease_Has_Normal_Tissue_Origin<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1920</td>
               <td colspan="2">Disease_Has_Primary_Anatomic_Site<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1921</td>
               <td colspan="2">Disease_Has_Primary_Anatomic_Site<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1922</td>
               <td colspan="2">Disease_Is_Grade<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1923</td>
               <td colspan="2">Disease_Is_Grade<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1924</td>
               <td colspan="2">Disease_Is_Stage<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1925</td>
               <td colspan="2">Disease_Is_Stage<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1926</td>
               <td colspan="2">Disease_May_Have_Abnormal_Cell<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1927</td>
               <td colspan="2">Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1928</td>
               <td colspan="2">Disease_May_Have_Associated_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1929</td>
               <td colspan="2">Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1930</td>
               <td colspan="2">Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1931</td>
               <td colspan="2">Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1932</td>
               <td colspan="2">Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1933</td>
               <td colspan="2">Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1934</td>
               <td colspan="2">Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1935</td>
               <td colspan="2">Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1936</td>
               <td colspan="2">Disease_May_Have_Normal_Cell_Origin<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1937</td>
               <td colspan="2">Disease_May_Have_Normal_Cell_Origin<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1938</td>
               <td colspan="2">Disease_May_Have_Normal_Tissue_Origin<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1939</td>
               <td colspan="2">Disease_May_Have_Normal_Tissue_Origin<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1940</td>
               <td colspan="2">EO_Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1941</td>
               <td colspan="2">EO_Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1942</td>
               <td colspan="2">EO_Derived_By_Technique<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1943</td>
               <td colspan="2">EO_Derived_By_Technique<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1944</td>
               <td colspan="2">EO_Develops_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1945</td>
               <td colspan="2">EO_Develops_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1946</td>
               <td colspan="2">EO_Disease_Has_Associated_Cell_Type<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1947</td>
               <td colspan="2">EO_Disease_Has_Associated_Cell_Type<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1948</td>
               <td colspan="2">EO_Disease_Has_Associated_EO_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1949</td>
               <td colspan="2">EO_Disease_Has_Associated_EO_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1950</td>
               <td colspan="2">EO_Disease_Has_Property_Or_Attribute<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1951</td>
               <td colspan="2">EO_Disease_Has_Property_Or_Attribute<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1952</td>
               <td colspan="2">EO_Disease_Maps_To_Human_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1953</td>
               <td colspan="2">EO_Disease_Maps_To_Human_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1954</td>
               <td colspan="2">EO_Disease_Metastatic_To_EO_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1955</td>
               <td colspan="2">EO_Disease_Metastatic_To_EO_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1956</td>
               <td colspan="2">EO_Models_Human_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1957</td>
               <td colspan="2">EO_Models_Human_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1958</td>
               <td colspan="2">Ectopic Atrial Rhythm<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1959</td>
               <td colspan="2">Ectopic Supraventricular Rhythm<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1960</td>
               <td colspan="2">Ectopic Ventricular Rhythm<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>1962</td>
               <td colspan="2">Erythromycin Gluceptate<span class="subclass"> SubClassOf </span>Macrolide Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>1963</td>
               <td colspan="2">Eukaryota<span class="subclass"> SubClassOf </span>Other Organism Groupings. <br></td>
            </tr>
            <tr class="addition">
               <td>1964</td>
               <td colspan="2">F10 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Homeostasis. <br></td>
            </tr>
            <tr class="addition">
               <td>1965</td>
               <td colspan="2">F10 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Proteolytic Processing. <br></td>
            </tr>
            <tr class="addition">
               <td>1966</td>
               <td colspan="2">F10 wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. <br></td>
            </tr>
            <tr class="addition">
               <td>1967</td>
               <td colspan="2">F10 wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>13q34. <br></td>
            </tr>
            <tr class="addition">
               <td>1968</td>
               <td colspan="2">Faropenem Medoxomil<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>1969</td>
               <td colspan="2">Femtomole per Gram<span class="subclass"> SubClassOf </span>Molality Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>1970</td>
               <td colspan="2">Fenbenicillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>1971</td>
               <td colspan="2">Fibracillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>1972</td>
               <td colspan="2">First Ever Onset of Angina Pectoris Event<span class="subclass"> SubClassOf </span>History of Coronary Artery Disease. <br></td>
            </tr>
            <tr class="addition">
               <td>1973</td>
               <td colspan="2">First Ever Onset of Heart Failure Event<span class="subclass"> SubClassOf </span>History of Heart Failure. <br></td>
            </tr>
            <tr class="addition">
               <td>1974</td>
               <td colspan="2">Flomoxef<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>1975</td>
               <td colspan="2">Floxacrine<span class="subclass"> SubClassOf </span>Antihelminthic Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>1976</td>
               <td colspan="2">Fluorescein Sodium<span class="subclass"> SubClassOf </span>Dye. <br></td>
            </tr>
            <tr class="addition">
               <td>1977</td>
               <td colspan="2">Fuzlocillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>1979</td>
               <td colspan="2">Garenoxacin Mesylate<span class="subclass"> SubClassOf </span>Quinolone Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>1978</td>
               <td colspan="2">Garenoxacin<span class="subclass"> SubClassOf </span>Quinolone Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>1980</td>
               <td colspan="2">Gene_Associated_With_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1981</td>
               <td colspan="2">Gene_Associated_With_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1982</td>
               <td colspan="2">Gene_Found_In_Organism<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1983</td>
               <td colspan="2">Gene_Found_In_Organism<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1984</td>
               <td colspan="2">Gene_Has_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1985</td>
               <td colspan="2">Gene_Has_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1986</td>
               <td colspan="2">Gene_Has_Physical_Location<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1987</td>
               <td colspan="2">Gene_Has_Physical_Location<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1988</td>
               <td colspan="2">Gene_In_Chromosomal_Location<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1989</td>
               <td colspan="2">Gene_In_Chromosomal_Location<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1990</td>
               <td colspan="2">Gene_Is_Biomarker_Of<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1991</td>
               <td colspan="2">Gene_Is_Biomarker_Of<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1992</td>
               <td colspan="2">Gene_Is_Biomarker_Type<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1993</td>
               <td colspan="2">Gene_Is_Biomarker_Type<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1994</td>
               <td colspan="2">Gene_Is_Element_In_Pathway<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1995</td>
               <td colspan="2">Gene_Is_Element_In_Pathway<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1996</td>
               <td colspan="2">Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1997</td>
               <td colspan="2">Gene_Plays_Role_In_Process<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1998</td>
               <td colspan="2">Gene_Product_Encoded_By_Gene<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>1999</td>
               <td colspan="2">Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2000</td>
               <td colspan="2">Gene_Product_Expressed_In_Tissue<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2001</td>
               <td colspan="2">Gene_Product_Expressed_In_Tissue<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2002</td>
               <td colspan="2">Gene_Product_Has_Abnormality<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2003</td>
               <td colspan="2">Gene_Product_Has_Abnormality<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2004</td>
               <td colspan="2">Gene_Product_Has_Associated_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2005</td>
               <td colspan="2">Gene_Product_Has_Associated_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2006</td>
               <td colspan="2">Gene_Product_Has_Biochemical_Function<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2007</td>
               <td colspan="2">Gene_Product_Has_Biochemical_Function<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2008</td>
               <td colspan="2">Gene_Product_Has_Chemical_Classification<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2009</td>
               <td colspan="2">Gene_Product_Has_Chemical_Classification<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2010</td>
               <td colspan="2">Gene_Product_Has_Malfunction_Type<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2011</td>
               <td colspan="2">Gene_Product_Has_Malfunction_Type<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2012</td>
               <td colspan="2">Gene_Product_Has_Organism_Source<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2013</td>
               <td colspan="2">Gene_Product_Has_Organism_Source<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2014</td>
               <td colspan="2">Gene_Product_Has_Structural_Domain_Or_Motif<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2015</td>
               <td colspan="2">Gene_Product_Has_Structural_Domain_Or_Motif<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2016</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Of<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2017</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Of<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2018</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Type<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2019</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Type<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2020</td>
               <td colspan="2">Gene_Product_Is_Element_In_Pathway<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2021</td>
               <td colspan="2">Gene_Product_Is_Element_In_Pathway<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2022</td>
               <td colspan="2">Gene_Product_Is_Physical_Part_Of<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2023</td>
               <td colspan="2">Gene_Product_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2024</td>
               <td colspan="2">Gene_Product_Malfunction_Associated_With_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2025</td>
               <td colspan="2">Gene_Product_Malfunction_Associated_With_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2026</td>
               <td colspan="2">Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2027</td>
               <td colspan="2">Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2028</td>
               <td colspan="2">Gentamicin Sulfate<span class="subclass"> SubClassOf </span>Aminoglycoside Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>2029</td>
               <td colspan="2">Geriatric<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2030</td>
               <td colspan="2">Gram per Animal<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2031</td>
               <td colspan="2">Gram per Animal per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2032</td>
               <td colspan="2">Gram per Animal per Week<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2033</td>
               <td colspan="2">Gram per Cage<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2034</td>
               <td colspan="2">Gram per Cage per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2035</td>
               <td colspan="2">Gram per Cage per Week<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2036</td>
               <td colspan="2">Gram per Capsule<span class="subclass"> SubClassOf </span>Capsule Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2037</td>
               <td colspan="2">Gram per Gram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2038</td>
               <td colspan="2">Gram per Mole<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2039</td>
               <td colspan="2">Gram per Square Meter per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2040</td>
               <td colspan="2">Gram per Square Meter per Day<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2041</td>
               <td colspan="2">Gram per Tablet<span class="subclass"> SubClassOf </span>Tablet Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2042</td>
               <td colspan="2">Gram per Vial<span class="subclass"> SubClassOf </span>Vial Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2043</td>
               <td colspan="2">Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Serotonin 5-HT-3 Receptor. <br></td>
            </tr>
            <tr class="addition">
               <td>2044</td>
               <td colspan="2">Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br></td>
            </tr>
            <tr class="addition">
               <td>2045</td>
               <td colspan="2">Granisetron<span class="subclass"> SubClassOf </span>Serotonin Antagonist. <br></td>
            </tr>
            <tr class="addition">
               <td>2046</td>
               <td colspan="2">Gravity<span class="subclass"> SubClassOf </span>Unit of Force. <br></td>
            </tr>
            <tr class="addition">
               <td>2047</td>
               <td colspan="2">Guaiacol Carbonate<span class="subclass"> SubClassOf </span>Expectorant. <br></td>
            </tr>
            <tr class="addition">
               <td>2071</td>
               <td colspan="2">HDAC Inhibitor SNDX-275<span class="subclass"> SubClassOf </span>((Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Histone Deacetylase)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Enzyme Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cell Cycle Inhibition)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Cell Differentiation Induction)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Chromatin Structure Alteration)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Gene Expression Alteration))<br><span class="keyword"> or </span>((Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="some"> some </span>Free Radical Formation)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Apoptosis)<br><span class="keyword"> and </span>(Chemical_Or_Drug_Has_Physiologic_Effect<span class="some"> some </span>Mitochondrial Damage)). <br></td>
            </tr>
            <tr class="addition">
               <td>2048</td>
               <td colspan="2">HLA-C wt Allele<span class="subclass"> SubClassOf </span>Gene_In_Chromosomal_Location<span class="some"> some </span>6p21.3. <br></td>
            </tr>
            <tr class="addition">
               <td>2049</td>
               <td colspan="2">HLA-C wt Allele<span class="subclass"> SubClassOf </span>Gene_Is_Element_In_Pathway<span class="some"> some </span>Antigen Presentation Pathway. <br></td>
            </tr>
            <tr class="addition">
               <td>2050</td>
               <td colspan="2">Healthy Subject<span class="subclass"> SubClassOf </span>Human Study Subject. <br></td>
            </tr>
            <tr class="addition">
               <td>2051</td>
               <td colspan="2">Heart Block<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2052</td>
               <td colspan="2">Heart Failure Prompting Medical Attention Event<span class="subclass"> SubClassOf </span>History of Heart Failure. <br></td>
            </tr>
            <tr class="addition">
               <td>2053</td>
               <td colspan="2">Heart Malformation<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>2054</td>
               <td colspan="2">Hereditary<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2055</td>
               <td colspan="2">Household Income<span class="subclass"> SubClassOf </span>Income. <br></td>
            </tr>
            <tr class="addition">
               <td>2056</td>
               <td colspan="2">Human Parainfluenza Virus 1<span class="subclass"> SubClassOf </span>Parainfluenza Virus. <br></td>
            </tr>
            <tr class="addition">
               <td>2057</td>
               <td colspan="2">Immunocompromised<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2058</td>
               <td colspan="2">Infective Otitis Externa<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2059</td>
               <td colspan="2">Inherited<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2060</td>
               <td colspan="2">Iodohippurate Sodium, I-123<span class="subclass"> SubClassOf </span>Radioconjugate. <br></td>
            </tr>
            <tr class="addition">
               <td>2061</td>
               <td colspan="2">Iodohippurate Sodium, I-131<span class="subclass"> SubClassOf </span>Radioconjugate. <br></td>
            </tr>
            <tr class="addition">
               <td>2062</td>
               <td colspan="2">Isorhythmic Atrioventricular Dissociation<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2063</td>
               <td colspan="2">Junctional Rhythm<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2064</td>
               <td colspan="2">Knuckle Pads<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2065</td>
               <td colspan="2">LY573636<span class="subclass"> SubClassOf </span>Diarylsulfonylurea Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>2066</td>
               <td colspan="2">Laboratory Finding<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2067</td>
               <td colspan="2">Lactic Acid, L-<span class="subclass"> SubClassOf </span>Industrial Aid. <br></td>
            </tr>
            <tr class="addition">
               <td>2068</td>
               <td colspan="2">Lethargic<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2069</td>
               <td colspan="2">Licostinel<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>2070</td>
               <td colspan="2">Liter per Kilogram<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>1844</td>
               <td colspan="2">MDR Modulator CBT-1<span class="subclass"> SubClassOf </span>Multidrug Resistance Modulator. <br></td>
            </tr>
            <tr class="addition">
               <td>2072</td>
               <td colspan="2">Magnesium Stearate<span class="subclass"> SubClassOf </span>Industrial Aid. <br></td>
            </tr>
            <tr class="addition">
               <td>2073</td>
               <td colspan="2">Mean Arterial Pressure<span class="subclass"> SubClassOf </span>Conceptual Entity. <br></td>
            </tr>
            <tr class="addition">
               <td>1961</td>
               <td colspan="2">Measurement of Left Ventricular Ejection Fraction<span class="subclass"> SubClassOf </span>Cardiac Function Study. <br></td>
            </tr>
            <tr class="addition">
               <td>2074</td>
               <td colspan="2">Median Income<span class="subclass"> SubClassOf </span>Income. <br></td>
            </tr>
            <tr class="addition">
               <td>2075</td>
               <td colspan="2">Medical Device Difficult to Flush<span class="subclass"> SubClassOf </span>Occlusion within Medical Device. <br></td>
            </tr>
            <tr class="addition">
               <td>2076</td>
               <td colspan="2">Memantine<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>2077</td>
               <td colspan="2">Methylselenocysteine<span class="subclass"> SubClassOf </span>Amino Acid Derivative. <br></td>
            </tr>
            <tr class="addition">
               <td>2078</td>
               <td colspan="2">Microequivalent<span class="subclass"> SubClassOf </span>Unit of Equivalent Weight. <br></td>
            </tr>
            <tr class="addition">
               <td>2079</td>
               <td colspan="2">Microgram per Animal<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2080</td>
               <td colspan="2">Microgram per Gram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2081</td>
               <td colspan="2">Microgram per Gram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2082</td>
               <td colspan="2">Microgram per Kilogram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2083</td>
               <td colspan="2">Microgram per Kilogram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2084</td>
               <td colspan="2">Microgram per Milligram Protein<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2085</td>
               <td colspan="2">Microgram per Square Meter per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2086</td>
               <td colspan="2">Microgram per Square Meter per Day<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2087</td>
               <td colspan="2">Microgram per Square Meter per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2088</td>
               <td colspan="2">Microgram per Square Meter per Hour<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2089</td>
               <td colspan="2">Microgram per Square Meter per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2090</td>
               <td colspan="2">Microgram per Square Meter per Minute<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2091</td>
               <td colspan="2">Microliter per Nostril<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2092</td>
               <td colspan="2">Micromole per Milligram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2093</td>
               <td colspan="2">Microosmole<span class="subclass"> SubClassOf </span>Unit of Osmotic Pressure. <br></td>
            </tr>
            <tr class="addition">
               <td>2094</td>
               <td colspan="2">Milliequivalent per Deciliter<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2095</td>
               <td colspan="2">Milliequivalent per Milliliter<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2096</td>
               <td colspan="2">Milliequivalent per Milliliter<span class="subclass"> SubClassOf </span>Normality Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2097</td>
               <td colspan="2">Milligram per Animal<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2098</td>
               <td colspan="2">Milligram per Capsule<span class="subclass"> SubClassOf </span>Capsule Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2099</td>
               <td colspan="2">Milligram per Gram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2100</td>
               <td colspan="2">Milligram per Gram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2101</td>
               <td colspan="2">Milligram per Gram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2102</td>
               <td colspan="2">Milligram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2103</td>
               <td colspan="2">Milligram per Square Meter per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2104</td>
               <td colspan="2">Milligram per Square Meter per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2105</td>
               <td colspan="2">Milligram per Vial<span class="subclass"> SubClassOf </span>Vial Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2106</td>
               <td colspan="2">Milliliter per Animal<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2107</td>
               <td colspan="2">Milliliter per Animal per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2108</td>
               <td colspan="2">Milliliter per Animal per Week<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2109</td>
               <td colspan="2">Milliliter per Breath<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2110</td>
               <td colspan="2">Milliliter per Cage<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2111</td>
               <td colspan="2">Milliliter per Cage per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2112</td>
               <td colspan="2">Milliliter per Cage per Week<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2113</td>
               <td colspan="2">Milliliter per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2114</td>
               <td colspan="2">Milliliter per Gram<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2115</td>
               <td colspan="2">Milliliter per Gram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2116</td>
               <td colspan="2">Milliliter per Gram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2117</td>
               <td colspan="2">Milliliter per Gram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2118</td>
               <td colspan="2">Milliliter per Kilogram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2119</td>
               <td colspan="2">Milliliter per Kilogram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2120</td>
               <td colspan="2">Milliliter per Kilogram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2121</td>
               <td colspan="2">Milliliter per Square Meter<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2122</td>
               <td colspan="2">Milliliter per Square Meter<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2123</td>
               <td colspan="2">Milliliter per Square Meter per Day<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2124</td>
               <td colspan="2">Milliliter per Square Meter per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2125</td>
               <td colspan="2">Milliliter per Square Meter per Hour<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2126</td>
               <td colspan="2">Milliliter per Square Meter per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2127</td>
               <td colspan="2">Milliliter per Square Meter per Minute<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2128</td>
               <td colspan="2">Millimeter of Mercury per Second<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2129</td>
               <td colspan="2">Millipascal<span class="subclass"> SubClassOf </span>Derived Unit of International System of Units. <br></td>
            </tr>
            <tr class="addition">
               <td>2130</td>
               <td colspan="2">Millipascal<span class="subclass"> SubClassOf </span>Non-Manometric Unit of Pressure. <br></td>
            </tr>
            <tr class="addition">
               <td>2131</td>
               <td colspan="2">Mold<span class="subclass"> SubClassOf </span>Fungus. <br></td>
            </tr>
            <tr class="addition">
               <td>2132</td>
               <td colspan="2">Most Recent Angina Pectoris Event<span class="subclass"> SubClassOf </span>History of Coronary Artery Disease. <br></td>
            </tr>
            <tr class="addition">
               <td>2133</td>
               <td colspan="2">Most Recent Heart Failure Event<span class="subclass"> SubClassOf </span>History of Heart Failure. <br></td>
            </tr>
            <tr class="addition">
               <td>2134</td>
               <td colspan="2">Multifocal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2135</td>
               <td colspan="2">N-Cadherin<span class="subclass"> SubClassOf </span>Gene_Product_Has_Organism_Source<span class="some"> some </span>Human. <br></td>
            </tr>
            <tr class="addition">
               <td>2136</td>
               <td colspan="2">Nanogram per Well<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2137</td>
               <td colspan="2">Nanosecond<span class="subclass"> SubClassOf </span>Unit of Time. <br></td>
            </tr>
            <tr class="addition">
               <td>2138</td>
               <td colspan="2">Non-Sustained Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2139</td>
               <td colspan="2">Onset of Angina Pectoris Event<span class="subclass"> SubClassOf </span>History of Coronary Artery Disease. <br></td>
            </tr>
            <tr class="addition">
               <td>2140</td>
               <td colspan="2">Osteolysis<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2141</td>
               <td colspan="2">Osteopenia<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2142</td>
               <td colspan="2">Pancreatic Injury<span class="subclass"> SubClassOf </span>Gastrointestinal Injury. <br></td>
            </tr>
            <tr class="addition">
               <td>2143</td>
               <td colspan="2">Patent Foramen Ovale<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>2144</td>
               <td colspan="2">Patient Characteristics Qualifier<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2145</td>
               <td colspan="2">Patient Death<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2146</td>
               <td colspan="2">Pediatric<span class="subclass"> SubClassOf </span>General Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2147</td>
               <td colspan="2">Percentile<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>2148</td>
               <td colspan="2">Peripheral Vascular Disease<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2149</td>
               <td colspan="2">Perzinfotel<span class="subclass"> SubClassOf </span>Neuroprotective Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>2150</td>
               <td colspan="2">Phagocytic Cell<span class="subclass"> SubClassOf </span>Antigen Presenting Cell. <br></td>
            </tr>
            <tr class="addition">
               <td>2151</td>
               <td colspan="2">Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia<span class="subclass"> SubClassOf </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)). <br></td>
            </tr>
            <tr class="addition">
               <td>2152</td>
               <td colspan="2">Phlebitis<span class="subclass"> SubClassOf </span>Vein Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>2153</td>
               <td colspan="2">Photosensitive Dermatitis<span class="subclass"> SubClassOf </span>Photodermatitis. <br></td>
            </tr>
            <tr class="addition">
               <td>2154</td>
               <td colspan="2">Picosecond<span class="subclass"> SubClassOf </span>Unit of Time. <br></td>
            </tr>
            <tr class="addition">
               <td>2155</td>
               <td colspan="2">Poikilotherms<span class="subclass"> SubClassOf </span>Other Organism Groupings. <br></td>
            </tr>
            <tr class="addition">
               <td>2156</td>
               <td colspan="2">Polycystic Ovarian Disease<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2157</td>
               <td colspan="2">Poor Vascular Access<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2158</td>
               <td colspan="2">Postencephalitic Parkinsonism<span class="subclass"> SubClassOf </span>Secondary Parkinsonism. <br></td>
            </tr>
            <tr class="addition">
               <td>2159</td>
               <td colspan="2">Primary Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2160</td>
               <td colspan="2">Procedure_May_Have_Target_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2161</td>
               <td colspan="2">Procedure_May_Have_Target_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2162</td>
               <td colspan="2">Pyogenic Arthritis<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2163</td>
               <td colspan="2">Quantile<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>2164</td>
               <td colspan="2">R-R Interval<span class="subclass"> SubClassOf </span>Conceptual Entity. <br></td>
            </tr>
            <tr class="addition">
               <td>2165</td>
               <td colspan="2">Range of Motion<span class="subclass"> SubClassOf </span>Conceptual Entity. <br></td>
            </tr>
            <tr class="addition">
               <td>2166</td>
               <td colspan="2">Raynaud's Disease<span class="subclass"> SubClassOf </span>Peripheral Vascular Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>2167</td>
               <td colspan="2">Recombinant Thymosin<span class="subclass"> SubClassOf </span>Miscellaneous Hormone Agent. <br></td>
            </tr>
            <tr class="addition">
               <td>2168</td>
               <td colspan="2">Regimen_Has_Accepted_Use_For_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2169</td>
               <td colspan="2">Regimen_Has_Accepted_Use_For_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2170</td>
               <td colspan="2">Risk Estimate<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>2171</td>
               <td colspan="2">Salmonella Enterica Serovar Typhi Antigen<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2172</td>
               <td colspan="2">Salmonella Enterica Serovar Typhi Antigen, A<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2173</td>
               <td colspan="2">Se-Methyl-seleno-L-cysteine<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2174</td>
               <td colspan="2">Sedecamycin<span class="subclass"> SubClassOf </span>Macrolide Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>2175</td>
               <td colspan="2">Septic Arthritis<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2176</td>
               <td colspan="2">Serositis<span class="subclass"> SubClassOf </span>Non-Neoplastic Soft Tissue Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>2177</td>
               <td colspan="2">Sevelamer Hydrochloride<span class="subclass"> SubClassOf </span>Polyamine Compound. <br></td>
            </tr>
            <tr class="addition">
               <td>2178</td>
               <td colspan="2">Sinus Node Dysfunction<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2179</td>
               <td colspan="2">Socioeconomic Indicator<span class="subclass"> SubClassOf </span>Socioeconomic Factors. <br></td>
            </tr>
            <tr class="addition">
               <td>2180</td>
               <td colspan="2">Sodium Nitroprusside<span class="subclass"> SubClassOf </span>Diagnostic Reagent. <br></td>
            </tr>
            <tr class="addition">
               <td>2181</td>
               <td colspan="2">Sore Throat<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2182</td>
               <td colspan="2">Sprays per Nostril<span class="subclass"> SubClassOf </span>Spray Dosing Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2183</td>
               <td colspan="2">Square Micrometer<span class="subclass"> SubClassOf </span>Unit of Area. <br></td>
            </tr>
            <tr class="addition">
               <td>2184</td>
               <td colspan="2">Statistical Confidence<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>2185</td>
               <td colspan="2">Statistical Significance<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>2186</td>
               <td colspan="2">Statistically Significant<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2187</td>
               <td colspan="2">Stein-Leventhal Syndrome<span class="subclass"> SubClassOf </span>Syndrome. <br></td>
            </tr>
            <tr class="addition">
               <td>2188</td>
               <td colspan="2">Sustained Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2189</td>
               <td colspan="2">Synovitis<span class="subclass"> SubClassOf </span>Non-Neoplastic Soft Tissue Disorder. <br></td>
            </tr>
            <tr class="addition">
               <td>2190</td>
               <td colspan="2">T-Cell Differentiation Antigen CD6<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell-Cell Adhesion. <br></td>
            </tr>
            <tr class="addition">
               <td>2191</td>
               <td colspan="2">T-Cell Differentiation Antigen CD6<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>T-Cell Development. <br></td>
            </tr>
            <tr class="addition">
               <td>2192</td>
               <td colspan="2">Technique_Has_Associated_Condition<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2193</td>
               <td colspan="2">Technique_Has_Associated_Condition<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2194</td>
               <td colspan="2">Technique_Has_Purpose<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2195</td>
               <td colspan="2">Technique_Has_Purpose<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2196</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2197</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2198</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2199</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2200</td>
               <td colspan="2">Technique_Has_Target_Anatomy<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2201</td>
               <td colspan="2">Technique_Has_Target_Anatomy<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2202</td>
               <td colspan="2">Technique_Has_Target_Chemical_Or_Drug<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2203</td>
               <td colspan="2">Technique_Has_Target_Chemical_Or_Drug<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2204</td>
               <td colspan="2">Technique_Has_Target_Disease<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2205</td>
               <td colspan="2">Technique_Has_Target_Disease<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2206</td>
               <td colspan="2">Technique_Has_Target_Organism<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2207</td>
               <td colspan="2">Technique_Has_Target_Organism<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2208</td>
               <td colspan="2">Technique_Has_Target_Protein<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2209</td>
               <td colspan="2">Technique_Has_Target_Protein<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2210</td>
               <td colspan="2">Technique_Is_Used_In_Technique<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2211</td>
               <td colspan="2">Technique_Is_Used_In_Technique<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2212</td>
               <td colspan="2">Technique_Uses_Equipment<span class="subclass"> Domain </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2213</td>
               <td colspan="2">Technique_Uses_Equipment<span class="subclass"> Range </span>NCI_Kind. <br></td>
            </tr>
            <tr class="addition">
               <td>2214</td>
               <td colspan="2">Thousand per Deciliter<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2215</td>
               <td colspan="2">Thousand per Deciliter<span class="subclass"> SubClassOf </span>Unit of Mass Density. <br></td>
            </tr>
            <tr class="addition">
               <td>2216</td>
               <td colspan="2">Thrombohemorrhagic Event<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2217</td>
               <td colspan="2">Ticarcillin Disodium<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>2218</td>
               <td colspan="2">Titanium Dioxide<span class="subclass"> SubClassOf </span>Dye. <br></td>
            </tr>
            <tr class="addition">
               <td>2219</td>
               <td colspan="2">Torsades De Pointes<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2220</td>
               <td colspan="2">Tracheal Calcification<span class="subclass"> SubClassOf </span>Calcification. <br></td>
            </tr>
            <tr class="addition">
               <td>2221</td>
               <td colspan="2">Trigeminy<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2222</td>
               <td colspan="2">Type of Statistical Sample<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2223</td>
               <td colspan="2">UBD Gene<span class="subclass"> SubClassOf </span>Regulatory Gene. <br></td>
            </tr>
            <tr class="addition">
               <td>2224</td>
               <td colspan="2">Under No Medication<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2225</td>
               <td colspan="2">Under No Sedation<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
            <tr class="addition">
               <td>2226</td>
               <td colspan="2">Unit of Gravity<span class="subclass"> SubClassOf </span>Unit of Force. <br></td>
            </tr>
            <tr class="addition">
               <td>2227</td>
               <td colspan="2">Unit of Luminous Flux<span class="subclass"> SubClassOf </span>Unit of Illuminance. <br></td>
            </tr>
            <tr class="addition">
               <td>2228</td>
               <td colspan="2">Unit per Animal<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2229</td>
               <td colspan="2">Unit per Gram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2230</td>
               <td colspan="2">Unit per Gram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2231</td>
               <td colspan="2">Unit per Gram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2232</td>
               <td colspan="2">Unit per Kilogram per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2233</td>
               <td colspan="2">Unit per Kilogram per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2234</td>
               <td colspan="2">Unit per Kilogram per Minute<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2235</td>
               <td colspan="2">Unit per Milligram<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2236</td>
               <td colspan="2">Unit per Milligram of Creatinine<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2237</td>
               <td colspan="2">Unit per Milligram of Protein<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2238</td>
               <td colspan="2">Unit per Square Meter per Day<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2239</td>
               <td colspan="2">Unit per Square Meter per Hour<span class="subclass"> SubClassOf </span>Dose Calculation Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2240</td>
               <td colspan="2">Unit per Square Meter per Minute<span class="subclass"> SubClassOf </span>Arbitrary Unit of Substance Rate. <br></td>
            </tr>
            <tr class="addition">
               <td>2241</td>
               <td colspan="2">Unit per Square Meter per Minute<span class="subclass"> SubClassOf </span>Unit of Lung Diffusion Capacity. <br></td>
            </tr>
            <tr class="addition">
               <td>2242</td>
               <td colspan="2">Vancomycin Hydrochloride<span class="subclass"> SubClassOf </span>Antibiotic. <br></td>
            </tr>
            <tr class="addition">
               <td>2243</td>
               <td colspan="2">Variance<span class="subclass"> SubClassOf </span>Statistical Technique. <br></td>
            </tr>
            <tr class="addition">
               <td>2244</td>
               <td colspan="2">Ventricular Couplet<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2245</td>
               <td colspan="2">Ventricular Flutter<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2246</td>
               <td colspan="2">Ventricular Premature Complex<span class="subclass"> SubClassOf </span>Electrocardiographic Finding. <br></td>
            </tr>
            <tr class="addition">
               <td>2247</td>
               <td colspan="2">Vertical<span class="subclass"> SubClassOf </span>Spatial Qualifier. <br></td>
            </tr>
            <tr class="addition">
               <td>2248</td>
               <td colspan="2">Viable Cell per Femur<span class="subclass"> SubClassOf </span>Cell-Based Unit. <br></td>
            </tr>
            <tr class="addition">
               <td>2249</td>
               <td colspan="2">Yeast<span class="subclass"> SubClassOf </span>Fungus. <br></td>
            </tr>
            <tr class="addition">
               <td>2250</td>
               <td colspan="2">Z-Average<span class="subclass"> SubClassOf </span>Parameter. <br></td>
            </tr>
            <tr class="addition">
               <td>2251</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Retired Concept. <br></td>
            </tr>
         </tbody>
         <tbody id="addnt" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="add"></a><h4 style="display: inline-block;">Pure Additions with New Terms (42)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="addition" colspan="2">Addition to Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>2252</td>
               <td colspan="2">ADME Finding<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2253</td>
               <td colspan="2">Abnormal Patch Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2254</td>
               <td colspan="2">Bacillus Calmette-Guerin Antigen, A<span class="subclass"> SubClassOf </span>Bacillus Calmette-Guerin Antigen. <br><i>New Terms: Bacillus Calmette-Guerin Antigen</i></td>
            </tr>
            <tr class="addition">
               <td>2255</td>
               <td colspan="2">Bacillus Calmette-Guerin Antigen, B<span class="subclass"> SubClassOf </span>Bacillus Calmette-Guerin Antigen. <br><i>New Terms: Bacillus Calmette-Guerin Antigen</i></td>
            </tr>
            <tr class="addition">
               <td>2256</td>
               <td colspan="2">Buccal Mucosa<span class="subclass"> SubClassOf </span>Oral Mucosa. <br><i>New Terms: Oral Mucosa</i></td>
            </tr>
            <tr class="addition">
               <td>2259</td>
               <td colspan="2">CDISC SDTM Age Unit Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2260</td>
               <td colspan="2">CDISC SDTM Country Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2261</td>
               <td colspan="2">CDISC SDTM Frequency Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2258</td>
               <td colspan="2">CDISC SDTM Laboratory Test Terminology by Code<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2257</td>
               <td colspan="2">CDISC SDTM Laboratory Test Terminology by Name<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2262</td>
               <td colspan="2">CDISC SDTM Not Done Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2263</td>
               <td colspan="2">CDISC SDTM Pharmaceutical Dosage Form Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2264</td>
               <td colspan="2">CDISC SDTM Route of Administration Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2265</td>
               <td colspan="2">CDISC SDTM Sex of Individual Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2266</td>
               <td colspan="2">CDISC SDTM Sex of Study Group Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2267</td>
               <td colspan="2">CDISC SDTM Yes No Unknown<br><span class="keyword"> or </span>Not Applicable Response Terminology<span class="subclass"> SubClassOf </span>CDISC SEND Terminology. <br><i>New Terms: CDISC SEND Terminology</i></td>
            </tr>
            <tr class="addition">
               <td>2268</td>
               <td colspan="2">Cryptococcus neoformans<span class="subclass"> SubClassOf </span>Cryptococcus. <br><i>New Terms: Cryptococcus</i></td>
            </tr>
            <tr class="addition">
               <td>2269</td>
               <td colspan="2">Disintegration per Minute<span class="subclass"> SubClassOf </span>Unit of Radioactive Decay. <br><i>New Terms: Unit of Radioactive Decay</i></td>
            </tr>
            <tr class="addition">
               <td>2270</td>
               <td colspan="2">Donor Lymphocyte Infusion<span class="subclass"> SubClassOf </span>Donor Cellular Infusion. <br><i>New Terms: Donor Cellular Infusion</i></td>
            </tr>
            <tr class="addition">
               <td>2271</td>
               <td colspan="2">Escherichia coli<span class="subclass"> SubClassOf </span>Escherichia. <br><i>New Terms: Escherichia</i></td>
            </tr>
            <tr class="addition">
               <td>2272</td>
               <td colspan="2">False Positive<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2273</td>
               <td colspan="2">Fluorescence Units<span class="subclass"> SubClassOf </span>Unit of Radiant Flux. <br><i>New Terms: Unit of Radiant Flux</i></td>
            </tr>
            <tr class="addition">
               <td>2274</td>
               <td colspan="2">Friday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>2275</td>
               <td colspan="2">Insect<span class="subclass"> SubClassOf </span>Arthropoda. <br><i>New Terms: Arthropoda</i></td>
            </tr>
            <tr class="addition">
               <td>2289</td>
               <td colspan="2">Laboratory Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2276</td>
               <td colspan="2">Monday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>2277</td>
               <td colspan="2">Mucosa of the Lip<span class="subclass"> SubClassOf </span>Oral Mucosa. <br><i>New Terms: Oral Mucosa</i></td>
            </tr>
            <tr class="addition">
               <td>2278</td>
               <td colspan="2">N-Cadherin<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>CDH2 Gene. <br><i>New Terms: CDH2 Gene</i></td>
            </tr>
            <tr class="addition">
               <td>2279</td>
               <td colspan="2">Negative Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2280</td>
               <td colspan="2">Positive Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2281</td>
               <td colspan="2">Proctosigmoiditis<span class="subclass"> SubClassOf </span>Proctocolitis. <br><i>New Terms: Proctocolitis</i></td>
            </tr>
            <tr class="addition">
               <td>2282</td>
               <td colspan="2">Prone Position<span class="subclass"> SubClassOf </span>Recumbent Position. <br><i>New Terms: Recumbent Position</i></td>
            </tr>
            <tr class="addition">
               <td>2283</td>
               <td colspan="2">Radiologic Finding<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2284</td>
               <td colspan="2">Saccharomyces cerevisiae<span class="subclass"> SubClassOf </span>Ascomycota. <br><i>New Terms: Ascomycota</i></td>
            </tr>
            <tr class="addition">
               <td>2285</td>
               <td colspan="2">Saturday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>2286</td>
               <td colspan="2">Schirmer Test Wetting<span class="subclass"> SubClassOf </span>Clinical Test Result. <br><i>New Terms: Clinical Test Result</i></td>
            </tr>
            <tr class="addition">
               <td>2287</td>
               <td colspan="2">Sunday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>2288</td>
               <td colspan="2">Supine Position<span class="subclass"> SubClassOf </span>Recumbent Position. <br><i>New Terms: Recumbent Position</i></td>
            </tr>
            <tr class="addition">
               <td>2290</td>
               <td colspan="2">Thursday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>2291</td>
               <td colspan="2">Toxoplasma<span class="subclass"> SubClassOf </span>Protozoa. <br><i>New Terms: Protozoa</i></td>
            </tr>
            <tr class="addition">
               <td>2292</td>
               <td colspan="2">Tuesday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
            <tr class="addition">
               <td>2293</td>
               <td colspan="2">Wednesday<span class="subclass"> SubClassOf </span>Day of the Week. <br><i>New Terms: Day of the Week</i></td>
            </tr>
         </tbody>
         <tbody id="stequiv" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="aed"></a><h4 style="display: inline-block;">Modified Definitions with Shared Terms (40)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Source Definition in Ontology 1</th>
               <th class="addition">Target Definition in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td>2294</td>
               <td>ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
               </td>
               <td>ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte).<br></td>
            </tr>
            <tr class="addition">
               <td>2295</td>
               <td>Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
               </td>
               <td>Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly).<br></td>
            </tr>
            <tr class="addition">
               <td>2312</td>
               <td>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene mRNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD44 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Increased NFkappaB Pathway Activation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>PKCbeta1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated B-Lymphocyte). 
               </td>
               <td>Activated B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene mRNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD44 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Increased NFkappaB Pathway Activation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>PKCbeta1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated B-Lymphocyte).<br></td>
            </tr>
            <tr class="addition">
               <td>2296</td>
               <td>Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
               </td>
               <td>Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Opportunistic Infection)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>T-Cell Immunodeficiency))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osteoclastic Activity Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pautrier-Like Microabscess Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Bone Marrow Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy).<br></td>
            </tr>
            <tr class="addition">
               <td>2297</td>
               <td>Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
               </td>
               <td>Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;V)(p11;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MOZ-V Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation).<br></td>
            </tr>
            <tr class="addition">
               <td>2298</td>
               <td>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
               </td>
               <td>Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>2299</td>
               <td>Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
               </td>
               <td>Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(12p11p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Basophilia))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>DEK-CAN Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation).<br></td>
            </tr>
            <tr class="addition">
               <td>2300</td>
               <td>Acute Myeloid Leukemia with Multilineage Dysplasia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Large Multinucleated Erythroid Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Megaloblast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Micromegakaryocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Monolobed Megakaryocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ringed Sideroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 21)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(20)(q11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(7)(q11;q36))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;5)(q25;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Granulocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pancytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present in 50 Percent<br><span class="keyword"> or </span>More of the Cells of Two Cell Lines)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ineffective Hematopoiesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells). 
               </td>
               <td>Acute Myeloid Leukemia with Multilineage Dysplasia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>ins(3;3))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(3)(q21q26.2))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;3)(q21;q26.2))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Large Multinucleated Erythroid Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Megaloblast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Micromegakaryocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Monolobed Megakaryocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ringed Sideroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 21)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 11q ATM Gene Locus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 5q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(20)(q11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(7)(q11;q36))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;5)(q25;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Granulocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pancytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present in 50 Percent<br><span class="keyword"> or </span>More of the Cells of Two Cell Lines)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Ineffective Hematopoiesis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells).<br></td>
            </tr>
            <tr class="addition">
               <td>2301</td>
               <td>Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
               </td>
               <td>Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia).<br></td>
            </tr>
            <tr class="addition">
               <td>2302</td>
               <td>Acute Myelomonocytic Leukemia without Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil). 
               </td>
               <td>Acute Myelomonocytic Leukemia without Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil).<br></td>
            </tr>
            <tr class="addition">
               <td>2303</td>
               <td>Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
               </td>
               <td>Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>2304</td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Cell with Primitive Myoblastic Differentiation). 
               </td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;13)(q36;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FKHR Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;13)(q35;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX7-FKHR Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;2)(q35;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-NCOA1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q13;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-AFX Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Cell with Primitive Myoblastic Differentiation).<br></td>
            </tr>
            <tr class="addition">
               <td>2305</td>
               <td>Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
               </td>
               <td>Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>2306</td>
               <td>Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
               </td>
               <td>Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow).<br></td>
            </tr>
            <tr class="addition">
               <td>2307</td>
               <td>Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
               </td>
               <td>Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain).<br></td>
            </tr>
            <tr class="addition">
               <td>2308</td>
               <td>Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
               </td>
               <td>Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation).<br></td>
            </tr>
            <tr class="addition">
               <td>2309</td>
               <td>Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
               </td>
               <td>Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;4)(q44;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;13)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell))<br><span class="keyword"> or </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow).<br></td>
            </tr>
            <tr class="addition">
               <td>2310</td>
               <td>Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
               </td>
               <td>Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Mature B-Lymphocyte at the Germinal Center Stage of Differentiation))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Peripheral (Post-Thymic) T-Lymphocyte)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>2330</td>
               <td>DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
               </td>
               <td>DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Solitary Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I).<br></td>
            </tr>
            <tr class="addition">
               <td>2329</td>
               <td>DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
               </td>
               <td>DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III).<br></td>
            </tr>
            <tr class="addition">
               <td>2313</td>
               <td>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
               </td>
               <td>Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ZSG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-E1AF Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ETV1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest).<br></td>
            </tr>
            <tr class="addition">
               <td>2322</td>
               <td>Extraskeletal Myxoid Chondrosarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cribriform Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Spindle Cell Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Extraosseous Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Multinodular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myxoid Stroma Formation). 
               </td>
               <td>Extraskeletal Myxoid Chondrosarcoma<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm of Uncertain Differentiation<br><span class="keyword"> and </span>Soft Tissue Sarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;9)(q11-12;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;15)(q22;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TCF12-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;17)(q22;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>RBP56-NR4A3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q22-31;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-NR4A3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cord-Like Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cribriform Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cystic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Spindle Cell Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell with Eosinophilic Cytoplasm)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Extraosseous Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Multinodular Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myxoid Stroma Formation).<br></td>
            </tr>
            <tr class="addition">
               <td>2311</td>
               <td>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>A-myb Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL-6 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD10 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>LMO2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Germinal Center B-Lymphocyte). 
               </td>
               <td>Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>A-myb Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL-6 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD10 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>LMO2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Germinal Center B-Lymphocyte).<br></td>
            </tr>
            <tr class="addition">
               <td>2314</td>
               <td>Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
               </td>
               <td>Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Splenic Rupture)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Atypical Lymphocytes Present in Peripheral Blood)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Immunoblastic Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Polymorphic Cellular Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte).<br></td>
            </tr>
            <tr class="addition">
               <td>2315</td>
               <td>Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate). 
               </td>
               <td>Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate).<br></td>
            </tr>
            <tr class="addition">
               <td>2316</td>
               <td>Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
               </td>
               <td>Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion).<br></td>
            </tr>
            <tr class="addition">
               <td>2317</td>
               <td>Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation). 
               </td>
               <td>Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair).<br></td>
            </tr>
            <tr class="addition">
               <td>2318</td>
               <td>Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
               </td>
               <td>Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Mycosis Fungoides))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Skin Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Complete Spontaneous Regression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin).<br></td>
            </tr>
            <tr class="addition">
               <td>2319</td>
               <td>Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
               </td>
               <td>Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Deep Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lesion with Diameter Greater than 2cm))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Marked Nuclear Atypia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell).<br></td>
            </tr>
            <tr class="addition">
               <td>2320</td>
               <td>Monoblastic Sarcoma<span class="subclass"> EquivalentTo </span>Myeloid Sarcoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic Granulocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast). 
               </td>
               <td>Monoblastic Sarcoma<span class="subclass"> EquivalentTo </span>Myeloid Sarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic Granulocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast).<br></td>
            </tr>
            <tr class="addition">
               <td>2321</td>
               <td>Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
               </td>
               <td>Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Progressive Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte).<br></td>
            </tr>
            <tr class="addition">
               <td>2323</td>
               <td>Myxoid/Round Cell Liposarcoma<span class="subclass"> EquivalentTo </span>Liposarcoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Mesenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion). 
               </td>
               <td>Myxoid/Round Cell Liposarcoma<span class="subclass"> EquivalentTo </span>Liposarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-DDIT3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-DDIT3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Mesenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion).<br></td>
            </tr>
            <tr class="addition">
               <td>2324</td>
               <td>NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
               </td>
               <td>NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation).<br></td>
            </tr>
            <tr class="addition">
               <td>2325</td>
               <td>Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
               </td>
               <td>Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coarse Azurophilic Granules Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>E2A-PBX1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast).<br></td>
            </tr>
            <tr class="addition">
               <td>2326</td>
               <td>Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
               </td>
               <td>Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression).<br></td>
            </tr>
            <tr class="addition">
               <td>2327</td>
               <td>Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
               </td>
               <td>Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression).<br></td>
            </tr>
            <tr class="addition">
               <td>2328</td>
               <td>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
               </td>
               <td>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Lutzner Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte).<br></td>
            </tr>
            <tr class="addition">
               <td>2331</td>
               <td>T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
               </td>
               <td>T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>TBX1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription).<br></td>
            </tr>
            <tr class="addition">
               <td>2332</td>
               <td>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation<span class="subclass"> EquivalentTo </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lobulated Growth Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Slow Growing Mass). 
               </td>
               <td>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation<span class="subclass"> EquivalentTo </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monophasic Pattern))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lobulated Growth Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Slow Growing Mass).<br></td>
            </tr>
            <tr class="addition">
               <td>2333</td>
               <td>Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
               </td>
               <td>Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification).<br></td>
            </tr>
         </tbody>
         <tbody id="ared" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Redundant (3)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Justifications in Ontology 1</th>
               <th class="addition">Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td rowspan="1">2334</td>
               <td><i>(1)</i>&nbsp; F10 Gene<span class="subclass"> SubClassOf </span>Coagulation Factor Gene. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Coagulation Factor Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Coagulation. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">F10 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Coagulation. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2335</td>
               <td><i>(1)</i>&nbsp; HLA-C wt Allele<span class="subclass"> SubClassOf </span>HLA-C Gene. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; HLA-C Gene<span class="subclass"> SubClassOf </span>MHC Class I Gene. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; MHC Class I Gene<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">HLA-C wt Allele<span class="subclass"> SubClassOf </span>Gene_Found_In_Organism<span class="some"> some </span>Human. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2336</td>
               <td><i>(1)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cadherin<span class="subclass"> SubClassOf </span>Cell Adhesion Molecule. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; N-Cadherin<span class="subclass"> SubClassOf </span>Cadherin. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">N-Cadherin<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion. 
               </td>
            </tr>
         </tbody>
         <tbody id="aweak" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Retrospective Novel Redundant (42)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="addition">ID</th>
               <th class="normaladd">Justifications in Ontology 1</th>
               <th class="addition">Axiom in Ontology 2</th>
            </tr>
            <tr class="addition">
               <td rowspan="1">2337</td>
               <td><i>(1)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Abnormal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Abnormal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2338</td>
               <td><i>(1)</i>&nbsp; Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Achalasia<span class="subclass"> SubClassOf </span>Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Achalasia<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2339</td>
               <td><i>(1)</i>&nbsp; Eukaryota<span class="subclass"> SubClassOf </span>Organism. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br><i>(2)</i>&nbsp; Animal<span class="subclass"> SubClassOf </span>Eukaryota. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Animal<span class="subclass"> SubClassOf </span>Organism. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2340</td>
               <td><i>(1)</i>&nbsp; Bacitracin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Bacitracin<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2341</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bacitracin Zinc<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Bacitracin Zinc<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2342</td>
               <td><i>(1)</i>&nbsp; Clinical Pathology Procedure<span class="subclass"> SubClassOf </span>Laboratory Procedure. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bioassay<span class="subclass"> SubClassOf </span>Immunology Test. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Immunology Test<span class="subclass"> SubClassOf </span>Clinical Pathology Procedure. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Bioassay<span class="subclass"> SubClassOf </span>Laboratory Procedure. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2345</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clindamycin Hydrochloride<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Clindamycin Hydrochloride<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2346</td>
               <td><i>(1)</i>&nbsp; Clindamycin Phosphate<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Clindamycin Phosphate<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2344</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clindamycin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Clindamycin<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2347</td>
               <td><i>(1)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Clinical Chemistry Finding<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Clinical Chemistry Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2348</td>
               <td><i>(1)</i>&nbsp; Clofazimine<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Clofazimine<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="2">2349</td>
               <td><i>(1)</i>&nbsp; Antibacterial Agent<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cloxyquin<span class="subclass"> SubClassOf </span>Antibacterial Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="2">Cloxyquin<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
               </td>
            </tr>
            <tr class="addition">
               <td><i>(1)</i>&nbsp; Cloxyquin<span class="subclass"> SubClassOf </span>Antifungal Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Antifungal Agent<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2350</td>
               <td><i>(1)</i>&nbsp; Colistin Sulfate<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Colistin Sulfate<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2351</td>
               <td><i>(1)</i>&nbsp; Drug Level Test Result<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Drug Level Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2352</td>
               <td><i>(1)</i>&nbsp; External Ear Infection<span class="subclass"> SubClassOf </span>Otitis. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Otitis<span class="subclass"> SubClassOf </span>Ear Infection. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">External Ear Infection<span class="subclass"> SubClassOf </span>Ear Infection. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2353</td>
               <td><i>(1)</i>&nbsp; Eukaryota<span class="subclass"> SubClassOf </span>Organism. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br><i>(2)</i>&nbsp; Fungus<span class="subclass"> SubClassOf </span>Eukaryota. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Fungus<span class="subclass"> SubClassOf </span>Organism. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2354</td>
               <td><i>(1)</i>&nbsp; Internal Ear Infection<span class="subclass"> SubClassOf </span>Otitis. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Otitis<span class="subclass"> SubClassOf </span>Ear Infection. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Internal Ear Infection<span class="subclass"> SubClassOf </span>Ear Infection. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2355</td>
               <td><i>(1)</i>&nbsp; Intimal Dissection Of Blood Vessel<span class="subclass"> SubClassOf </span>Arterial Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Arterial Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Intimal Dissection Of Blood Vessel<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2356</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Ionomycin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Ionomycin<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2357</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Linezolid<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Linezolid<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2358</td>
               <td><i>(1)</i>&nbsp; Microequivalent<span class="subclass"> SubClassOf </span>Animal Dosing Unit. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Animal Dosing Unit<span class="subclass"> SubClassOf </span>Potency Unit. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Microequivalent<span class="subclass"> SubClassOf </span>Potency Unit. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2359</td>
               <td><i>(1)</i>&nbsp; Bioassay<span class="subclass"> SubClassOf </span>Immunology Test. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Mixed Lymphocyte Reaction Test<span class="subclass"> SubClassOf </span>Bioassay. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Mixed Lymphocyte Reaction Test<span class="subclass"> SubClassOf </span>Immunology Test. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2360</td>
               <td><i>(1)</i>&nbsp; Normal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Normal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2361</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Novobiocin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Novobiocin<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2362</td>
               <td><i>(1)</i>&nbsp; Otitis Media<span class="subclass"> SubClassOf </span>Otitis. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Otitis<span class="subclass"> SubClassOf </span>Ear Infection. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Otitis Media<span class="subclass"> SubClassOf </span>Ear Infection. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2363</td>
               <td><i>(1)</i>&nbsp; Pirlimycin Hydrochloride<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Pirlimycin Hydrochloride<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2364</td>
               <td><i>(1)</i>&nbsp; Plant<span class="subclass"> SubClassOf </span>Eukaryota. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Eukaryota<span class="subclass"> SubClassOf </span>Organism. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br></td>
               <td rowspan="1">Plant<span class="subclass"> SubClassOf </span>Organism. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2365</td>
               <td><i>(1)</i>&nbsp; Type of Statistical Sample<span class="subclass"> SubClassOf </span>Statistical Technique. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Population Based Sampling<span class="subclass"> SubClassOf </span>Type of Statistical Sample. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Population Based Sampling<span class="subclass"> SubClassOf </span>Statistical Technique. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2367</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Antibiotic<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Povidone-Iodine Solution<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Povidone-Iodine Solution<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2366</td>
               <td><i>(1)</i>&nbsp; Povidone-Iodine<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Antibiotic<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Povidone-Iodine<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2343</td>
               <td><i>(1)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Precise Histogenesis Unknown<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Precise Histogenesis Unknown<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2368</td>
               <td><i>(1)</i>&nbsp; Pulmonary Vascular Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Lung Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Non-Neoplastic Lung Disorder<span class="subclass"> SubClassOf </span>Lung Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Pulmonary Vascular Disorder<span class="subclass"> SubClassOf </span>Lung Disorder. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2369</td>
               <td><i>(1)</i>&nbsp; Radiation Colitis<span class="subclass"> SubClassOf </span>Radiation Enteritis. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Radiation Enteritis<span class="subclass"> SubClassOf </span>Enteritis. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Radiation Colitis<span class="subclass"> SubClassOf </span>Enteritis. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2370</td>
               <td><i>(1)</i>&nbsp; Cardiovascular System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; S3 Gallop<span class="subclass"> SubClassOf </span>Cardiovascular System Signs<br><span class="keyword"> and </span>Symptoms. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">S3 Gallop<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2371</td>
               <td><i>(1)</i>&nbsp; Addison's Disease<span class="subclass"> SubClassOf </span>Adrenal Cortical Insufficiency. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Secondary Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Addison's Disease. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Secondary Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Adrenal Cortical Insufficiency. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2372</td>
               <td><i>(1)</i>&nbsp; Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sinus Node Dysfunction. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Sinus Node Dysfunction<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2373</td>
               <td><i>(1)</i>&nbsp; Polycystic Ovarian Disease<span class="subclass"> SubClassOf </span>Ovarian Non-Neoplastic Disorder. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Stein-Leventhal Syndrome<span class="subclass"> SubClassOf </span>Polycystic Ovarian Disease. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Stein-Leventhal Syndrome<span class="subclass"> SubClassOf </span>Ovarian Non-Neoplastic Disorder. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2374</td>
               <td><i>(1)</i>&nbsp; Taurolidine<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="1">Taurolidine<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2375</td>
               <td><i>(1)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Tissue Differentiation Uncertain<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Tissue Differentiation Uncertain<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2376</td>
               <td><i>(1)</i>&nbsp; Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Toxicology Finding<span class="subclass"> SubClassOf </span>Laboratory Finding. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Toxicology Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
               </td>
            </tr>
            <tr class="addition">
               <td rowspan="2">2377</td>
               <td><i>(1)</i>&nbsp; Triclosan<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Antibiotic<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
               <td rowspan="2">Triclosan<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
               </td>
            </tr>
            <tr class="addition">
               <td><i>(1)</i>&nbsp; Antifungal Agent<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Triclosan<span class="subclass"> SubClassOf </span>Antifungal Agent. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="addition">
               <td rowspan="1">2378</td>
               <td><i>(1)</i>&nbsp; Miscellaneous Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Vancomycin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic. 
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
               <td rowspan="1">Vancomycin<span class="subclass"> SubClassOf </span>Antibiotic. 
               </td>
            </tr>
         </tbody>
         <tbody id="retdesc" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Retired Descriptions (1)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal" colspan="2">Retired Description Axiom in Ontology 1</th>
            </tr>
            <tr class="removal">
               <td>2379</td>
               <td colspan="2">Required_Intake <span class="subclass">Range: </span>string.<br><i>Retired Terms: Required_Intake</i></td>
            </tr>
         </tbody>
         <tbody id="rem" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Pure Removals with Shared Terms (443)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal" colspan="2">Removal from Ontology 1</th>
            </tr>
            <tr class="removal">
               <td>2380</td>
               <td colspan="2">ADME Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2381</td>
               <td colspan="2">Abnormal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2382</td>
               <td colspan="2">Abnormal Patch Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2383</td>
               <td colspan="2">Accelerated Idioventricular Rhythm<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2384</td>
               <td colspan="2">Achalasia<span class="subclass"> SubClassOf </span>Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms.<br></td>
            </tr>
            <tr class="removal">
               <td>2385</td>
               <td colspan="2">Age Group<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2386</td>
               <td colspan="2">Allele_Has_Activity<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2387</td>
               <td colspan="2">Allele_Has_Activity<span class="subclass"> Range </span>Properties_or_Attributes_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2388</td>
               <td colspan="2">Allele_Is_Cancer_Related_Type<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2389</td>
               <td colspan="2">Allele_Is_Cancer_Related_Type<span class="subclass"> Range </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2390</td>
               <td colspan="2">Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2391</td>
               <td colspan="2">Allele_Plays_Role_In_Metabolism_Of_Chemical_Or_Drug<span class="subclass"> Range </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2392</td>
               <td colspan="2">Allylisopropylacetamide<span class="subclass"> SubClassOf </span>Protective Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2393</td>
               <td colspan="2">Aminohippuric Acid<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound.<br></td>
            </tr>
            <tr class="removal">
               <td>2394</td>
               <td colspan="2">Anatomic_Structure_Has_Location<span class="subclass"> Domain </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2395</td>
               <td colspan="2">Anatomic_Structure_Has_Location<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2396</td>
               <td colspan="2">Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2397</td>
               <td colspan="2">Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2398</td>
               <td colspan="2">Angina Pectoris Prompting Medical Attention Event<span class="subclass"> SubClassOf </span>Angina.<br></td>
            </tr>
            <tr class="removal">
               <td>2399</td>
               <td colspan="2">Animal<span class="subclass"> SubClassOf </span>Eukaryota.<br></td>
            </tr>
            <tr class="removal">
               <td>2400</td>
               <td colspan="2">Antigen Processing Cell<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Immune System.<br></td>
            </tr>
            <tr class="removal">
               <td>2401</td>
               <td colspan="2">Antigen Processing Cell<span class="subclass"> SubClassOf </span>Cell.<br></td>
            </tr>
            <tr class="removal">
               <td>2402</td>
               <td colspan="2">Atrial Flutter<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2403</td>
               <td colspan="2">Atrial Premature Complex<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2404</td>
               <td colspan="2">Atrioventricular Nodal Reentry Tachycardia<span class="subclass"> SubClassOf </span>Nodal Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2405</td>
               <td colspan="2">Atrioventricular Nodal Reentry Tachycardia<span class="subclass"> SubClassOf </span>Paroxysmal Supraventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2406</td>
               <td colspan="2">Atrioventricular Reentrant Tachycardia<span class="subclass"> SubClassOf </span>Paroxysmal Supraventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2407</td>
               <td colspan="2">Average Fluorescence Units<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2408</td>
               <td colspan="2">Bacitracin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2409</td>
               <td colspan="2">Bacitracin Zinc<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2410</td>
               <td colspan="2">Bigeminy<span class="subclass"> SubClassOf </span>Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2411</td>
               <td colspan="2">Bioassay<span class="subclass"> SubClassOf </span>Immunology Test.<br></td>
            </tr>
            <tr class="removal">
               <td>2412</td>
               <td colspan="2">Biological_Process_Has_Associated_Location<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2413</td>
               <td colspan="2">Biological_Process_Has_Associated_Location<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2414</td>
               <td colspan="2">Biological_Process_Has_Initiator_Chemical_Or_Drug<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2415</td>
               <td colspan="2">Biological_Process_Has_Initiator_Chemical_Or_Drug<span class="subclass"> Range </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2416</td>
               <td colspan="2">Biological_Process_Has_Initiator_Process<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2417</td>
               <td colspan="2">Biological_Process_Has_Initiator_Process<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2418</td>
               <td colspan="2">Biological_Process_Has_Result_Anatomy<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2419</td>
               <td colspan="2">Biological_Process_Has_Result_Anatomy<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2420</td>
               <td colspan="2">Biological_Process_Has_Result_Biological_Process<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2421</td>
               <td colspan="2">Biological_Process_Has_Result_Biological_Process<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2422</td>
               <td colspan="2">Biological_Process_Has_Result_Chemical_Or_Drug<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2423</td>
               <td colspan="2">Biological_Process_Has_Result_Chemical_Or_Drug<span class="subclass"> Range </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2424</td>
               <td colspan="2">Biological_Process_Is_Part_Of_Process<span class="subclass"> Domain </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2425</td>
               <td colspan="2">Biological_Process_Is_Part_Of_Process<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2426</td>
               <td colspan="2">Birth Cohort<span class="subclass"> SubClassOf </span>Type of Statistical Sample.<br></td>
            </tr>
            <tr class="removal">
               <td>2427</td>
               <td colspan="2">Brodimoprim<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2429</td>
               <td colspan="2">CDISC SDTM Package 2 Terminology<span class="subclass"> SubClassOf </span>Clinical Data Interchange Standards Consortium Terminology.<br></td>
            </tr>
            <tr class="removal">
               <td>2430</td>
               <td colspan="2">Capsule per Animal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2431</td>
               <td colspan="2">Cardiac Arrest<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2432</td>
               <td colspan="2">Cells per Femur<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2434</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Abnormal_Cell<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2435</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Abnormal_Cell<span class="subclass"> Range </span>Abnormal_Cell_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2436</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2437</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2438</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Gene_Product<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2439</td>
               <td colspan="2">Chemical_Or_Drug_Affects_Gene_Product<span class="subclass"> Range </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2440</td>
               <td colspan="2">Chemical_Or_Drug_FDA_Approved_For_Disease<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2441</td>
               <td colspan="2">Chemical_Or_Drug_FDA_Approved_For_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2442</td>
               <td colspan="2">Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2443</td>
               <td colspan="2">Chemical_Or_Drug_Has_Accepted_Therapeutic_Use_For<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2444</td>
               <td colspan="2">Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2445</td>
               <td colspan="2">Chemical_Or_Drug_Has_Mechanism_Of_Action<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2446</td>
               <td colspan="2">Chemical_Or_Drug_Has_Physiologic_Effect<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2447</td>
               <td colspan="2">Chemical_Or_Drug_Has_Physiologic_Effect<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2448</td>
               <td colspan="2">Chemical_Or_Drug_Has_Study_Therapeutic_Use_For<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2449</td>
               <td colspan="2">Chemical_Or_Drug_Has_Study_Therapeutic_Use_For<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2450</td>
               <td colspan="2">Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2451</td>
               <td colspan="2">Chemical_Or_Drug_Is_Metabolized_By_Enzyme<span class="subclass"> Range </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2452</td>
               <td colspan="2">Chemical_Or_Drug_Plays_Role_In_Biological_Process<span class="subclass"> Domain </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2453</td>
               <td colspan="2">Chemical_Or_Drug_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2454</td>
               <td colspan="2">Chemotherapy_Regimen_Has_Component<span class="subclass"> Domain </span>Chemotherapy_Regimen_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2455</td>
               <td colspan="2">Chemotherapy_Regimen_Has_Component<span class="subclass"> Range </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2456</td>
               <td colspan="2">Cinacalcet<span class="subclass"> SubClassOf </span>Adjuvant.<br></td>
            </tr>
            <tr class="removal">
               <td>2458</td>
               <td colspan="2">Clindamycin Hydrochloride<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2459</td>
               <td colspan="2">Clindamycin Phosphate<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2457</td>
               <td colspan="2">Clindamycin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2460</td>
               <td colspan="2">Clinical Chemistry Finding<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2428</td>
               <td colspan="2">Clinical Data Interchange Standards Consortium Proposed Terminology<span class="subclass"> SubClassOf </span>Clinical Data Interchange Standards Consortium Terminology.<br></td>
            </tr>
            <tr class="removal">
               <td>2461</td>
               <td colspan="2">Clofazimine<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2463</td>
               <td colspan="2">Cloxyquin<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2462</td>
               <td colspan="2">Cloxyquin<span class="subclass"> SubClassOf </span>Antifungal Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2464</td>
               <td colspan="2">Colistin Sulfate<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2465</td>
               <td colspan="2">Diagnosis Group<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2466</td>
               <td colspan="2">Diagnostic Accuracy<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2468</td>
               <td colspan="2">Dihydroergotamine Mesylate<span class="subclass"> SubClassOf </span>Serotonin Agonist.<br></td>
            </tr>
            <tr class="removal">
               <td>2467</td>
               <td colspan="2">Dihydroergotamine<span class="subclass"> SubClassOf </span>Serotonin Agonist.<br></td>
            </tr>
            <tr class="removal">
               <td>2523</td>
               <td colspan="2">Disease Vector<span class="subclass"> SubClassOf </span>Invertebrate.<br></td>
            </tr>
            <tr class="removal">
               <td>2469</td>
               <td colspan="2">Disease_Excludes_Abnormal_Cell<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2470</td>
               <td colspan="2">Disease_Excludes_Abnormal_Cell<span class="subclass"> Range </span>Abnormal_Cell_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2471</td>
               <td colspan="2">Disease_Excludes_Cytogenetic_Abnormality<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2472</td>
               <td colspan="2">Disease_Excludes_Cytogenetic_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2473</td>
               <td colspan="2">Disease_Excludes_Finding<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2474</td>
               <td colspan="2">Disease_Excludes_Finding<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2475</td>
               <td colspan="2">Disease_Excludes_Metastatic_Anatomic_Site<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2476</td>
               <td colspan="2">Disease_Excludes_Metastatic_Anatomic_Site<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2477</td>
               <td colspan="2">Disease_Excludes_Molecular_Abnormality<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2478</td>
               <td colspan="2">Disease_Excludes_Molecular_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2479</td>
               <td colspan="2">Disease_Excludes_Normal_Cell_Origin<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2480</td>
               <td colspan="2">Disease_Excludes_Normal_Cell_Origin<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2481</td>
               <td colspan="2">Disease_Excludes_Normal_Tissue_Origin<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2482</td>
               <td colspan="2">Disease_Excludes_Normal_Tissue_Origin<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2483</td>
               <td colspan="2">Disease_Excludes_Primary_Anatomic_Site<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2484</td>
               <td colspan="2">Disease_Excludes_Primary_Anatomic_Site<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2485</td>
               <td colspan="2">Disease_Has_Abnormal_Cell<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2486</td>
               <td colspan="2">Disease_Has_Abnormal_Cell<span class="subclass"> Range </span>Abnormal_Cell_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2487</td>
               <td colspan="2">Disease_Has_Associated_Anatomic_Site<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2488</td>
               <td colspan="2">Disease_Has_Associated_Anatomic_Site<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2489</td>
               <td colspan="2">Disease_Has_Associated_Disease<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2490</td>
               <td colspan="2">Disease_Has_Associated_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2491</td>
               <td colspan="2">Disease_Has_Cytogenetic_Abnormality<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2492</td>
               <td colspan="2">Disease_Has_Cytogenetic_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2493</td>
               <td colspan="2">Disease_Has_Finding<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2494</td>
               <td colspan="2">Disease_Has_Finding<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2495</td>
               <td colspan="2">Disease_Has_Metastatic_Anatomic_Site<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2496</td>
               <td colspan="2">Disease_Has_Metastatic_Anatomic_Site<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2497</td>
               <td colspan="2">Disease_Has_Molecular_Abnormality<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2498</td>
               <td colspan="2">Disease_Has_Molecular_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2499</td>
               <td colspan="2">Disease_Has_Normal_Cell_Origin<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2500</td>
               <td colspan="2">Disease_Has_Normal_Cell_Origin<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2501</td>
               <td colspan="2">Disease_Has_Normal_Tissue_Origin<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2502</td>
               <td colspan="2">Disease_Has_Normal_Tissue_Origin<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2503</td>
               <td colspan="2">Disease_Has_Primary_Anatomic_Site<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2504</td>
               <td colspan="2">Disease_Has_Primary_Anatomic_Site<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2505</td>
               <td colspan="2">Disease_Is_Grade<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2506</td>
               <td colspan="2">Disease_Is_Grade<span class="subclass"> Range </span>Properties_or_Attributes_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2507</td>
               <td colspan="2">Disease_Is_Stage<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2508</td>
               <td colspan="2">Disease_Is_Stage<span class="subclass"> Range </span>Properties_or_Attributes_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2509</td>
               <td colspan="2">Disease_May_Have_Abnormal_Cell<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2510</td>
               <td colspan="2">Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>Abnormal_Cell_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2511</td>
               <td colspan="2">Disease_May_Have_Associated_Disease<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2512</td>
               <td colspan="2">Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2513</td>
               <td colspan="2">Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2514</td>
               <td colspan="2">Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2515</td>
               <td colspan="2">Disease_May_Have_Finding<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2516</td>
               <td colspan="2">Disease_May_Have_Finding<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2517</td>
               <td colspan="2">Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2518</td>
               <td colspan="2">Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2519</td>
               <td colspan="2">Disease_May_Have_Normal_Cell_Origin<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2520</td>
               <td colspan="2">Disease_May_Have_Normal_Cell_Origin<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2521</td>
               <td colspan="2">Disease_May_Have_Normal_Tissue_Origin<span class="subclass"> Domain </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2522</td>
               <td colspan="2">Disease_May_Have_Normal_Tissue_Origin<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2524</td>
               <td colspan="2">Disintegration per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2525</td>
               <td colspan="2">Drug Level Test Result<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2526</td>
               <td colspan="2">EO_Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>EO_Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2527</td>
               <td colspan="2">EO_Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>EO_Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2528</td>
               <td colspan="2">EO_Derived_By_Technique<span class="subclass"> Domain </span>Organism_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2529</td>
               <td colspan="2">EO_Derived_By_Technique<span class="subclass"> Range </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2530</td>
               <td colspan="2">EO_Develops_Disease<span class="subclass"> Domain </span>Organism_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2531</td>
               <td colspan="2">EO_Develops_Disease<span class="subclass"> Range </span>EO_Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2532</td>
               <td colspan="2">EO_Disease_Has_Associated_Cell_Type<span class="subclass"> Domain </span>EO_Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2533</td>
               <td colspan="2">EO_Disease_Has_Associated_Cell_Type<span class="subclass"> Range </span>EO_Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2534</td>
               <td colspan="2">EO_Disease_Has_Associated_EO_Anatomy<span class="subclass"> Domain </span>EO_Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2535</td>
               <td colspan="2">EO_Disease_Has_Associated_EO_Anatomy<span class="subclass"> Range </span>EO_Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2536</td>
               <td colspan="2">EO_Disease_Has_Property_Or_Attribute<span class="subclass"> Domain </span>EO_Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2537</td>
               <td colspan="2">EO_Disease_Has_Property_Or_Attribute<span class="subclass"> Range </span>Properties_or_Attributes_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2538</td>
               <td colspan="2">EO_Disease_Maps_To_Human_Disease<span class="subclass"> Domain </span>EO_Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2539</td>
               <td colspan="2">EO_Disease_Maps_To_Human_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2540</td>
               <td colspan="2">EO_Disease_Metastatic_To_EO_Anatomy<span class="subclass"> Domain </span>EO_Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2541</td>
               <td colspan="2">EO_Disease_Metastatic_To_EO_Anatomy<span class="subclass"> Range </span>EO_Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2542</td>
               <td colspan="2">EO_Models_Human_Disease<span class="subclass"> Domain </span>Organism_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2543</td>
               <td colspan="2">EO_Models_Human_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2544</td>
               <td colspan="2">Ectopic Atrial Rhythm<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2545</td>
               <td colspan="2">Ectopic Supraventricular Rhythm<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2546</td>
               <td colspan="2">Ectopic Ventricular Rhythm<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2548</td>
               <td colspan="2">Erythromycin Gluceptate<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2549</td>
               <td colspan="2">External Ear Infection<span class="subclass"> SubClassOf </span>Otitis.<br></td>
            </tr>
            <tr class="removal">
               <td>2550</td>
               <td colspan="2">False Positive<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2551</td>
               <td colspan="2">Femtomole per Gram<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2552</td>
               <td colspan="2">First Ever Onset of Angina Pectoris Event<span class="subclass"> SubClassOf </span>Angina.<br></td>
            </tr>
            <tr class="removal">
               <td>2553</td>
               <td colspan="2">First Ever Onset of Heart Failure Event<span class="subclass"> SubClassOf </span>Heart Failure.<br></td>
            </tr>
            <tr class="removal">
               <td>2554</td>
               <td colspan="2">Fluorescein Sodium<span class="subclass"> SubClassOf </span>Diagnostic Reagent.<br></td>
            </tr>
            <tr class="removal">
               <td>2555</td>
               <td colspan="2">Fluorescence Units<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2556</td>
               <td colspan="2">Fungus<span class="subclass"> SubClassOf </span>Eukaryota.<br></td>
            </tr>
            <tr class="removal">
               <td>2557</td>
               <td colspan="2">Fuzlocillin<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2558</td>
               <td colspan="2">Gene_Associated_With_Disease<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2559</td>
               <td colspan="2">Gene_Associated_With_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2560</td>
               <td colspan="2">Gene_Found_In_Organism<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2561</td>
               <td colspan="2">Gene_Found_In_Organism<span class="subclass"> Range </span>Organism_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2562</td>
               <td colspan="2">Gene_Has_Abnormality<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2563</td>
               <td colspan="2">Gene_Has_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2564</td>
               <td colspan="2">Gene_Has_Physical_Location<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2565</td>
               <td colspan="2">Gene_Has_Physical_Location<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2566</td>
               <td colspan="2">Gene_In_Chromosomal_Location<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2567</td>
               <td colspan="2">Gene_In_Chromosomal_Location<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2568</td>
               <td colspan="2">Gene_Is_Biomarker_Of<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2569</td>
               <td colspan="2">Gene_Is_Biomarker_Of<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2570</td>
               <td colspan="2">Gene_Is_Biomarker_Type<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2571</td>
               <td colspan="2">Gene_Is_Biomarker_Type<span class="subclass"> Range </span>Diagnostic_and_Prognostic_Factors_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2572</td>
               <td colspan="2">Gene_Is_Element_In_Pathway<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2573</td>
               <td colspan="2">Gene_Is_Element_In_Pathway<span class="subclass"> Range </span>Pathway_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2574</td>
               <td colspan="2">Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2575</td>
               <td colspan="2">Gene_Plays_Role_In_Process<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2576</td>
               <td colspan="2">Gene_Product_Encoded_By_Gene<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2577</td>
               <td colspan="2">Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>Gene_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2578</td>
               <td colspan="2">Gene_Product_Expressed_In_Tissue<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2579</td>
               <td colspan="2">Gene_Product_Expressed_In_Tissue<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2580</td>
               <td colspan="2">Gene_Product_Has_Abnormality<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2581</td>
               <td colspan="2">Gene_Product_Has_Abnormality<span class="subclass"> Range </span>Molecular_Abnormality_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2582</td>
               <td colspan="2">Gene_Product_Has_Associated_Anatomy<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2583</td>
               <td colspan="2">Gene_Product_Has_Associated_Anatomy<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2584</td>
               <td colspan="2">Gene_Product_Has_Biochemical_Function<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2585</td>
               <td colspan="2">Gene_Product_Has_Biochemical_Function<span class="subclass"> Range </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2586</td>
               <td colspan="2">Gene_Product_Has_Chemical_Classification<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2587</td>
               <td colspan="2">Gene_Product_Has_Chemical_Classification<span class="subclass"> Range </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2588</td>
               <td colspan="2">Gene_Product_Has_Malfunction_Type<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2589</td>
               <td colspan="2">Gene_Product_Has_Malfunction_Type<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2590</td>
               <td colspan="2">Gene_Product_Has_Organism_Source<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2591</td>
               <td colspan="2">Gene_Product_Has_Organism_Source<span class="subclass"> Range </span>Organism_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2592</td>
               <td colspan="2">Gene_Product_Has_Structural_Domain_Or_Motif<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2593</td>
               <td colspan="2">Gene_Product_Has_Structural_Domain_Or_Motif<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2594</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Of<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2595</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Of<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2596</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Type<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2597</td>
               <td colspan="2">Gene_Product_Is_Biomarker_Type<span class="subclass"> Range </span>Diagnostic_and_Prognostic_Factors_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2598</td>
               <td colspan="2">Gene_Product_Is_Element_In_Pathway<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2599</td>
               <td colspan="2">Gene_Product_Is_Element_In_Pathway<span class="subclass"> Range </span>Pathway_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2600</td>
               <td colspan="2">Gene_Product_Is_Physical_Part_Of<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2601</td>
               <td colspan="2">Gene_Product_Is_Physical_Part_Of<span class="subclass"> Range </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2602</td>
               <td colspan="2">Gene_Product_Malfunction_Associated_With_Disease<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2603</td>
               <td colspan="2">Gene_Product_Malfunction_Associated_With_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2604</td>
               <td colspan="2">Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Domain </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2605</td>
               <td colspan="2">Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>Biological_Process_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2606</td>
               <td colspan="2">Gentamicin Sulfate<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2607</td>
               <td colspan="2">Geriatric<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2608</td>
               <td colspan="2">Gram per Animal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2609</td>
               <td colspan="2">Gram per Animal per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2610</td>
               <td colspan="2">Gram per Animal per Week<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2611</td>
               <td colspan="2">Gram per Cage<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2612</td>
               <td colspan="2">Gram per Cage per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2613</td>
               <td colspan="2">Gram per Cage per Week<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2614</td>
               <td colspan="2">Gram per Capsule<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2615</td>
               <td colspan="2">Gram per Gram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2616</td>
               <td colspan="2">Gram per Mole<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2617</td>
               <td colspan="2">Gram per Square Meter per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2618</td>
               <td colspan="2">Gram per Tablet<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2619</td>
               <td colspan="2">Gram per Vial<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2620</td>
               <td colspan="2">Granisetron<span class="subclass"> SubClassOf </span>Antiemetic Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2621</td>
               <td colspan="2">Gravity<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2622</td>
               <td colspan="2">Healthy Subject<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2623</td>
               <td colspan="2">Heart Block<span class="subclass"> SubClassOf </span>Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2624</td>
               <td colspan="2">Heart Failure Prompting Medical Attention Event<span class="subclass"> SubClassOf </span>Heart Failure.<br></td>
            </tr>
            <tr class="removal">
               <td>2625</td>
               <td colspan="2">Hereditary<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2626</td>
               <td colspan="2">Immunocompromised<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2627</td>
               <td colspan="2">Infective Otitis Externa<span class="subclass"> SubClassOf </span>External Ear Infection.<br></td>
            </tr>
            <tr class="removal">
               <td>2628</td>
               <td colspan="2">Inherited<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2629</td>
               <td colspan="2">Internal Ear Infection<span class="subclass"> SubClassOf </span>Otitis.<br></td>
            </tr>
            <tr class="removal">
               <td>2630</td>
               <td colspan="2">Intimal Dissection Of Blood Vessel<span class="subclass"> SubClassOf </span>Arterial Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2631</td>
               <td colspan="2">Ionomycin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2632</td>
               <td colspan="2">Isorhythmic Atrioventricular Dissociation<span class="subclass"> SubClassOf </span>Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2633</td>
               <td colspan="2">Junctional Rhythm<span class="subclass"> SubClassOf </span>Supraventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2634</td>
               <td colspan="2">Knuckle Pads<span class="subclass"> SubClassOf </span>Non-Neoplastic Soft Tissue Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2636</td>
               <td colspan="2">Laboratory Animal<span class="subclass"> SubClassOf </span>Animal.<br></td>
            </tr>
            <tr class="removal">
               <td>2635</td>
               <td colspan="2">Laboratory Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2637</td>
               <td colspan="2">Lethargic<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2638</td>
               <td colspan="2">Licostinel<span class="subclass"> SubClassOf </span>Anticonvulsant Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2639</td>
               <td colspan="2">Linezolid<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2640</td>
               <td colspan="2">Liter per Kilogram<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2641</td>
               <td colspan="2">Mean Arterial Pressure<span class="subclass"> SubClassOf </span>Blood Pressure Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2547</td>
               <td colspan="2">Measurement of Left Ventricular Ejection Fraction<span class="subclass"> SubClassOf </span>Cardiovascular System Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2642</td>
               <td colspan="2">Medical Device Difficult to Flush<span class="subclass"> SubClassOf </span>Medical Device Maintenance Issue.<br></td>
            </tr>
            <tr class="removal">
               <td>2643</td>
               <td colspan="2">Microequivalent<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2644</td>
               <td colspan="2">Microgram per Animal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2645</td>
               <td colspan="2">Microgram per Gram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2646</td>
               <td colspan="2">Microgram per Gram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2647</td>
               <td colspan="2">Microgram per Kilogram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2648</td>
               <td colspan="2">Microgram per Kilogram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2649</td>
               <td colspan="2">Microgram per Milligram Protein<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2650</td>
               <td colspan="2">Microgram per Square Meter per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2651</td>
               <td colspan="2">Microgram per Square Meter per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2652</td>
               <td colspan="2">Microgram per Square Meter per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2653</td>
               <td colspan="2">Microliter per Nostril<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2654</td>
               <td colspan="2">Micromole per Milligram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2655</td>
               <td colspan="2">Microosmole<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2656</td>
               <td colspan="2">Milliequivalent per Milliliter<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2657</td>
               <td colspan="2">Milligram per Animal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2658</td>
               <td colspan="2">Milligram per Capsule<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2659</td>
               <td colspan="2">Milligram per Gram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2660</td>
               <td colspan="2">Milligram per Gram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2661</td>
               <td colspan="2">Milligram per Gram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2662</td>
               <td colspan="2">Milligram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2663</td>
               <td colspan="2">Milligram per Square Meter per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2664</td>
               <td colspan="2">Milligram per Square Meter per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2665</td>
               <td colspan="2">Milligram per Vial<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2666</td>
               <td colspan="2">Milliliter per Animal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2667</td>
               <td colspan="2">Milliliter per Animal per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2668</td>
               <td colspan="2">Milliliter per Animal per Week<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2669</td>
               <td colspan="2">Milliliter per Breath<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2670</td>
               <td colspan="2">Milliliter per Cage<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2671</td>
               <td colspan="2">Milliliter per Cage per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2672</td>
               <td colspan="2">Milliliter per Cage per Week<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2673</td>
               <td colspan="2">Milliliter per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2674</td>
               <td colspan="2">Milliliter per Gram<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2675</td>
               <td colspan="2">Milliliter per Gram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2676</td>
               <td colspan="2">Milliliter per Gram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2677</td>
               <td colspan="2">Milliliter per Gram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2678</td>
               <td colspan="2">Milliliter per Kilogram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2679</td>
               <td colspan="2">Milliliter per Kilogram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2680</td>
               <td colspan="2">Milliliter per Kilogram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2681</td>
               <td colspan="2">Milliliter per Square Meter<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2682</td>
               <td colspan="2">Milliliter per Square Meter per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2683</td>
               <td colspan="2">Milliliter per Square Meter per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2684</td>
               <td colspan="2">Millimeter of Mercury per Second<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2685</td>
               <td colspan="2">Millipascal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2686</td>
               <td colspan="2">Mixed Lymphocyte Reaction Test<span class="subclass"> SubClassOf </span>Bioassay.<br></td>
            </tr>
            <tr class="removal">
               <td>2687</td>
               <td colspan="2">Mold<span class="subclass"> SubClassOf </span>Other Organism Groupings.<br></td>
            </tr>
            <tr class="removal">
               <td>2688</td>
               <td colspan="2">Most Recent Angina Pectoris Event<span class="subclass"> SubClassOf </span>Angina.<br></td>
            </tr>
            <tr class="removal">
               <td>2689</td>
               <td colspan="2">Most Recent Heart Failure Event<span class="subclass"> SubClassOf </span>Heart Failure.<br></td>
            </tr>
            <tr class="removal">
               <td>2690</td>
               <td colspan="2">Multifocal Atrial Tachycardia<span class="subclass"> SubClassOf </span>Supraventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2691</td>
               <td colspan="2">Nanogram per Well<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2692</td>
               <td colspan="2">Nanosecond<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2693</td>
               <td colspan="2">Negative Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2694</td>
               <td colspan="2">Nimesulide<span class="subclass"> SubClassOf </span>Phenol Compound.<br></td>
            </tr>
            <tr class="removal">
               <td>2695</td>
               <td colspan="2">Non-Sustained Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2696</td>
               <td colspan="2">Normal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2697</td>
               <td colspan="2">Novobiocin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2698</td>
               <td colspan="2">Onset of Angina Pectoris Event<span class="subclass"> SubClassOf </span>Angina.<br></td>
            </tr>
            <tr class="removal">
               <td>2699</td>
               <td colspan="2">Osteolysis<span class="subclass"> SubClassOf </span>Non-Neoplastic Bone Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2700</td>
               <td colspan="2">Osteopenia<span class="subclass"> SubClassOf </span>Non-Neoplastic Bone Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2701</td>
               <td colspan="2">Otitis Media<span class="subclass"> SubClassOf </span>Otitis.<br></td>
            </tr>
            <tr class="removal">
               <td>2702</td>
               <td colspan="2">Patient Characteristics Qualifier<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>2703</td>
               <td colspan="2">Patient Death<span class="subclass"> SubClassOf </span>Vital Status.<br></td>
            </tr>
            <tr class="removal">
               <td>2704</td>
               <td colspan="2">Pediatric<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2705</td>
               <td colspan="2">Percentile<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2706</td>
               <td colspan="2">Peripheral Vascular Disease<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2707</td>
               <td colspan="2">Perzinfotel<span class="subclass"> SubClassOf </span>Analgesic Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2708</td>
               <td colspan="2">Picosecond<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2709</td>
               <td colspan="2">Pirlimycin Hydrochloride<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2710</td>
               <td colspan="2">Plant<span class="subclass"> SubClassOf </span>Eukaryota.<br></td>
            </tr>
            <tr class="removal">
               <td>2711</td>
               <td colspan="2">Poikilotherms<span class="subclass"> SubClassOf </span>Animal.<br></td>
            </tr>
            <tr class="removal">
               <td>2712</td>
               <td colspan="2">Polycystic Ovarian Disease<span class="subclass"> SubClassOf </span>Ovarian Non-Neoplastic Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2713</td>
               <td colspan="2">Poor Vascular Access<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2714</td>
               <td colspan="2">Population Based Sampling<span class="subclass"> SubClassOf </span>Type of Statistical Sample.<br></td>
            </tr>
            <tr class="removal">
               <td>2715</td>
               <td colspan="2">Positive Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2717</td>
               <td colspan="2">Povidone-Iodine Solution<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2716</td>
               <td colspan="2">Povidone-Iodine<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2433</td>
               <td colspan="2">Precise Histogenesis Unknown<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2718</td>
               <td colspan="2">Primary Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Addison's Disease.<br></td>
            </tr>
            <tr class="removal">
               <td>2719</td>
               <td colspan="2">Procedure_May_Have_Target_Anatomy<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2720</td>
               <td colspan="2">Procedure_May_Have_Target_Anatomy<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2721</td>
               <td colspan="2">Pulmonary Vascular Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Lung Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2722</td>
               <td colspan="2">Pyogenic Arthritis<span class="subclass"> SubClassOf </span>Infective Arthritis.<br></td>
            </tr>
            <tr class="removal">
               <td>2723</td>
               <td colspan="2">Quantile<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2724</td>
               <td colspan="2">R-R Interval<span class="subclass"> SubClassOf </span>Electrocardiographic Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2725</td>
               <td colspan="2">Radiation Colitis<span class="subclass"> SubClassOf </span>Radiation Enteritis.<br></td>
            </tr>
            <tr class="removal">
               <td>2726</td>
               <td colspan="2">Radiologic Finding<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2727</td>
               <td colspan="2">Range of Motion<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2728</td>
               <td colspan="2">Raynaud's Syndrome<span class="subclass"> SubClassOf </span>Peripheral Vascular Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2729</td>
               <td colspan="2">Regimen_Has_Accepted_Use_For_Disease<span class="subclass"> Domain </span>Chemotherapy_Regimen_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2730</td>
               <td colspan="2">Regimen_Has_Accepted_Use_For_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2731</td>
               <td colspan="2">Risk Estimate<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2732</td>
               <td colspan="2">S3 Gallop<span class="subclass"> SubClassOf </span>Cardiovascular System Signs<br><span class="keyword"> and </span>Symptoms.<br></td>
            </tr>
            <tr class="removal">
               <td>2733</td>
               <td colspan="2">Salmonella Enterica Serovar Typhi Antigen<span class="subclass"> SubClassOf </span>Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>2734</td>
               <td colspan="2">Salmonella Enterica Serovar Typhi Antigen, A<span class="subclass"> SubClassOf </span>Salmonella Enterica Serovar Typhi Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>2735</td>
               <td colspan="2">Schirmer Test Wetting<span class="subclass"> SubClassOf </span>Laboratory Test Result.<br></td>
            </tr>
            <tr class="removal">
               <td>2736</td>
               <td colspan="2">Se-Methyl-seleno-L-cysteine<span class="subclass"> SubClassOf </span>Amino Acid Derivative.<br></td>
            </tr>
            <tr class="removal">
               <td>2737</td>
               <td colspan="2">Secondary Adrenal Insufficiency<span class="subclass"> SubClassOf </span>Addison's Disease.<br></td>
            </tr>
            <tr class="removal">
               <td>2738</td>
               <td colspan="2">Septic Arthritis<span class="subclass"> SubClassOf </span>Bacterial Arthritis.<br></td>
            </tr>
            <tr class="removal">
               <td>2739</td>
               <td colspan="2">Serositis<span class="subclass"> SubClassOf </span>Inflammation.<br></td>
            </tr>
            <tr class="removal">
               <td>2740</td>
               <td colspan="2">Sevelamer Hydrochloride<span class="subclass"> SubClassOf </span>Adjuvant.<br></td>
            </tr>
            <tr class="removal">
               <td>2741</td>
               <td colspan="2">Sick Sinus Syndrome<span class="subclass"> SubClassOf </span>Sinus Node Dysfunction.<br></td>
            </tr>
            <tr class="removal">
               <td>2742</td>
               <td colspan="2">Sinus Node Dysfunction<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2743</td>
               <td colspan="2">Socioeconomic Indicator<span class="subclass"> SubClassOf </span>Statistical Technique.<br></td>
            </tr>
            <tr class="removal">
               <td>2744</td>
               <td colspan="2">Sore Throat<span class="subclass"> SubClassOf </span>Non-Neoplastic Neck Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2745</td>
               <td colspan="2">Sprays per Nostril<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2746</td>
               <td colspan="2">Square Micrometer<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2747</td>
               <td colspan="2">Staphylococcal Septic Arthritis<span class="subclass"> SubClassOf </span>Septic Arthritis.<br></td>
            </tr>
            <tr class="removal">
               <td>2748</td>
               <td colspan="2">Statistical Confidence<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2749</td>
               <td colspan="2">Statistical Significance<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2750</td>
               <td colspan="2">Statistically Significant<span class="subclass"> SubClassOf </span>Property<br><span class="keyword"> or </span>Attribute.<br></td>
            </tr>
            <tr class="removal">
               <td>2751</td>
               <td colspan="2">Stein-Leventhal Syndrome<span class="subclass"> SubClassOf </span>Polycystic Ovarian Disease.<br></td>
            </tr>
            <tr class="removal">
               <td>2752</td>
               <td colspan="2">Sustained Ventricular Tachycardia<span class="subclass"> SubClassOf </span>Ventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2753</td>
               <td colspan="2">Synovitis<span class="subclass"> SubClassOf </span>Connective<br><span class="keyword"> and </span>Soft Tissue Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2754</td>
               <td colspan="2">Synovitis<span class="subclass"> SubClassOf </span>Inflammation.<br></td>
            </tr>
            <tr class="removal">
               <td>2755</td>
               <td colspan="2">Taurolidine<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2756</td>
               <td colspan="2">Technique_Has_Associated_Condition<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2757</td>
               <td colspan="2">Technique_Has_Associated_Condition<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2758</td>
               <td colspan="2">Technique_Has_Purpose<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2759</td>
               <td colspan="2">Technique_Has_Purpose<span class="subclass"> Range </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2760</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Anatomy<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2761</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Anatomy<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2762</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2763</td>
               <td colspan="2">Technique_Has_Sample_Or_Specimen_Chemical_Or_Drug<span class="subclass"> Range </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2764</td>
               <td colspan="2">Technique_Has_Target_Anatomy<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2765</td>
               <td colspan="2">Technique_Has_Target_Anatomy<span class="subclass"> Range </span>Anatomy_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2766</td>
               <td colspan="2">Technique_Has_Target_Chemical_Or_Drug<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2767</td>
               <td colspan="2">Technique_Has_Target_Chemical_Or_Drug<span class="subclass"> Range </span>Chemicals_and_Drugs_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2768</td>
               <td colspan="2">Technique_Has_Target_Disease<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2769</td>
               <td colspan="2">Technique_Has_Target_Disease<span class="subclass"> Range </span>Findings_and_Disorders_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2770</td>
               <td colspan="2">Technique_Has_Target_Organism<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2771</td>
               <td colspan="2">Technique_Has_Target_Organism<span class="subclass"> Range </span>Organism_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2772</td>
               <td colspan="2">Technique_Has_Target_Protein<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2773</td>
               <td colspan="2">Technique_Has_Target_Protein<span class="subclass"> Range </span>Gene_Product_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2774</td>
               <td colspan="2">Technique_Is_Used_In_Technique<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2775</td>
               <td colspan="2">Technique_Is_Used_In_Technique<span class="subclass"> Range </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2776</td>
               <td colspan="2">Technique_Uses_Equipment<span class="subclass"> Domain </span>Activity_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2777</td>
               <td colspan="2">Technique_Uses_Equipment<span class="subclass"> Range </span>Equipment_Kind.<br></td>
            </tr>
            <tr class="removal">
               <td>2778</td>
               <td colspan="2">Thousand per Deciliter<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2779</td>
               <td colspan="2">Thrombohemorrhagic Event<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2780</td>
               <td colspan="2">Ticarcillin Disodium<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2781</td>
               <td colspan="2">Tissue Differentiation Uncertain<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2782</td>
               <td colspan="2">Titanium Dioxide<span class="subclass"> SubClassOf </span>Pigment.<br></td>
            </tr>
            <tr class="removal">
               <td>2783</td>
               <td colspan="2">Torsades De Pointes<span class="subclass"> SubClassOf </span>Ventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2784</td>
               <td colspan="2">Toxicology Finding<span class="subclass"> SubClassOf </span>Laboratory Finding.<br></td>
            </tr>
            <tr class="removal">
               <td>2785</td>
               <td colspan="2">Toxoplasma<span class="subclass"> SubClassOf </span>Eukaryota.<br></td>
            </tr>
            <tr class="removal">
               <td>2786</td>
               <td colspan="2">Tracheal Calcification<span class="subclass"> SubClassOf </span>Non-Neoplastic Tracheal Disorder.<br></td>
            </tr>
            <tr class="removal">
               <td>2787</td>
               <td colspan="2">Triclosan<span class="subclass"> SubClassOf </span>Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2788</td>
               <td colspan="2">Triclosan<span class="subclass"> SubClassOf </span>Antifungal Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2789</td>
               <td colspan="2">Trigeminy<span class="subclass"> SubClassOf </span>Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2790</td>
               <td colspan="2">Type of Statistical Sample<span class="subclass"> SubClassOf </span>Statistical Technique.<br></td>
            </tr>
            <tr class="removal">
               <td>2791</td>
               <td colspan="2">UBD Gene<span class="subclass"> SubClassOf </span>Ubiquitin Ligase Gene.<br></td>
            </tr>
            <tr class="removal">
               <td>2792</td>
               <td colspan="2">Under No Medication<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2793</td>
               <td colspan="2">Under No Sedation<span class="subclass"> SubClassOf </span>Patient Characteristics Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2794</td>
               <td colspan="2">Unit of Gravity<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2795</td>
               <td colspan="2">Unit per Animal<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2796</td>
               <td colspan="2">Unit per Gram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2797</td>
               <td colspan="2">Unit per Gram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2798</td>
               <td colspan="2">Unit per Gram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2799</td>
               <td colspan="2">Unit per Kilogram per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2800</td>
               <td colspan="2">Unit per Kilogram per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2801</td>
               <td colspan="2">Unit per Kilogram per Minute<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2802</td>
               <td colspan="2">Unit per Milligram<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2803</td>
               <td colspan="2">Unit per Milligram of Creatinine<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2804</td>
               <td colspan="2">Unit per Milligram of Protein<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2805</td>
               <td colspan="2">Unit per Square Meter per Day<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2806</td>
               <td colspan="2">Unit per Square Meter per Hour<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2808</td>
               <td colspan="2">Vancomycin Hydrochloride<span class="subclass"> SubClassOf </span>Antibacterial Agent.<br></td>
            </tr>
            <tr class="removal">
               <td>2807</td>
               <td colspan="2">Vancomycin<span class="subclass"> SubClassOf </span>Miscellaneous Antibiotic.<br></td>
            </tr>
            <tr class="removal">
               <td>2809</td>
               <td colspan="2">Variance<span class="subclass"> SubClassOf </span>Statistics.<br></td>
            </tr>
            <tr class="removal">
               <td>2810</td>
               <td colspan="2">Ventricular Couplet<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2811</td>
               <td colspan="2">Ventricular Flutter<span class="subclass"> SubClassOf </span>Ventricular Tachycardia.<br></td>
            </tr>
            <tr class="removal">
               <td>2812</td>
               <td colspan="2">Ventricular Premature Complex<span class="subclass"> SubClassOf </span>Ventricular Arrhythmia.<br></td>
            </tr>
            <tr class="removal">
               <td>2813</td>
               <td colspan="2">Vertical<span class="subclass"> SubClassOf </span>General Qualifier.<br></td>
            </tr>
            <tr class="removal">
               <td>2814</td>
               <td colspan="2">Viable Cell per Femur<span class="subclass"> SubClassOf </span>Animal Dosing Unit.<br></td>
            </tr>
            <tr class="removal">
               <td>2815</td>
               <td colspan="2">Yeast<span class="subclass"> SubClassOf </span>Other Organism Groupings.<br></td>
            </tr>
            <tr class="removal">
               <td>2816</td>
               <td colspan="2">Z-Average<span class="subclass"> SubClassOf </span>Population Parameter.<br></td>
            </tr>
            <tr class="removal">
               <td>2822</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Agent Combination Not Indexed in Open Clinical Trials.<br></td>
            </tr>
            <tr class="removal">
               <td>2817</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Chemotherapy_Regimen_Has_Component<span class="some"> some </span>Incomplete Freund's Adjuvant.<br></td>
            </tr>
            <tr class="removal">
               <td>2818</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Chemotherapy_Regimen_Has_Component<span class="some"> some </span>MART-1 Antigen.<br></td>
            </tr>
            <tr class="removal">
               <td>2819</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Chemotherapy_Regimen_Has_Component<span class="some"> some </span>Recombinant Interleukin-12.<br></td>
            </tr>
            <tr class="removal">
               <td>2820</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Chemotherapy_Regimen_Has_Component<span class="some"> some </span>Tyrosinase Peptide.<br></td>
            </tr>
            <tr class="removal">
               <td>2821</td>
               <td colspan="2">gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase
                  Peptide<span class="subclass"> SubClassOf </span>Chemotherapy_Regimen_Has_Component<span class="some"> some </span>gp100 Antigen.<br></td>
            </tr>
         </tbody>
         <tbody id="wkequiv" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3"><a name="redef"></a><h4 style="display: inline-block;">Modified Definitions with Shared Terms (3)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Target Definition in Ontology 1</th>
               <th class="normalrem">Source Definition in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td>2823</td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Cell with Primitive Myoblastic Differentiation). 
                  			
               </td>
               <td>Alveolar Rhabdomyosarcoma<span class="subclass"> EquivalentTo </span>Rhabdomyosarcoma<br><span class="keyword"> and </span>Sarcoma Differentiation Score 3<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;13)(q36;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-FKHR Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;13)(q35;q14))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX7-FKHR Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;2)(q35;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-NCOA1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q13;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PAX3-AFX Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Round Cell with Primitive Myoblastic Differentiation).<br></td>
            </tr>
            <tr class="removal">
               <td>2824</td>
               <td>Monoblastic Sarcoma<span class="subclass"> EquivalentTo </span>Myeloid Sarcoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic Granulocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast). 
                  			
               </td>
               <td>Monoblastic Sarcoma<span class="subclass"> EquivalentTo </span>Myeloid Sarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic Granulocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast).<br></td>
            </tr>
            <tr class="removal">
               <td>2825</td>
               <td>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation<span class="subclass"> EquivalentTo </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lobulated Growth Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Slow Growing Mass). 
                  			
               </td>
               <td>Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation<span class="subclass"> EquivalentTo </span>Thyroid Gland Carcinoma<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Epithelial Spindle Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monophasic Pattern))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Biphasic Pattern)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Adenocarcinoma Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Epithelial Spindle Cell)))<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Calcitonin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Thyroglobulin Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lobulated Growth Pattern)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Slow Growing Mass).<br></td>
            </tr>
         </tbody>
         <tbody id="rst" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Prospective Novel Redundant (74)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="1">2826</td>
               <td rowspan="1">Abnormal Hard Tissue Formation in Pulp<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Finding. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Abnormal Hard Tissue Formation in Pulp<span class="subclass"> SubClassOf </span>Oral Cavity Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Oral Cavity Finding<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2827</td>
               <td rowspan="2">Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Morphologic Finding<span class="subclass"> SubClassOf </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Auer Rods Present<span class="subclass"> SubClassOf </span>Morphologic Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clinical Course of Disease<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Favorable Clinical Outcome<span class="subclass"> SubClassOf </span>Clinical Course of Disease. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2828</td>
               <td rowspan="2">Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Oncogene Deregulation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; MDM2 Gene Mutation<span class="subclass"> SubClassOf </span>Oncogene Deregulation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; MDM2 Gene Amplification<span class="subclass"> SubClassOf </span>MDM2 Gene Mutation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; TP53 Gene Inactivation<span class="subclass"> SubClassOf </span>Tumor-Suppressor Gene Inactivation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Tumor-Suppressor Gene Inactivation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2829</td>
               <td rowspan="1">Algeldrate<span class="subclass"> SubClassOf </span>Adjuvant. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Combination Medication<span class="subclass"> SubClassOf </span>Adjuvant. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Antacid Preparation<span class="subclass"> SubClassOf </span>Combination Medication. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Algeldrate<span class="subclass"> SubClassOf </span>Antacid Preparation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2830</td>
               <td rowspan="1">Antitubercular Agent<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Antibacterial Agent<span class="subclass"> SubClassOf </span>Anti-Infective Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Antitubercular Agent<span class="subclass"> SubClassOf </span>Antibacterial Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2831</td>
               <td rowspan="1">Arbaclofen Placarbil<span class="subclass"> SubClassOf </span>Pharmacologic Substance. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Arbaclofen Placarbil<span class="subclass"> SubClassOf </span>Adjuvant Analgesic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Adjuvant Analgesic<span class="subclass"> SubClassOf </span>Analgesic Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Analgesic Agent<span class="subclass"> SubClassOf </span>Pharmacologic Substance. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2832</td>
               <td rowspan="1">Bacillus Calmette-Guerin Antigen, A<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bacillus Calmette-Guerin Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bacillus Calmette-Guerin Antigen, A<span class="subclass"> SubClassOf </span>Bacillus Calmette-Guerin Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2833</td>
               <td rowspan="1">Bacillus Calmette-Guerin Antigen, B<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bacillus Calmette-Guerin Antigen, B<span class="subclass"> SubClassOf </span>Bacillus Calmette-Guerin Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bacillus Calmette-Guerin Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2834</td>
               <td rowspan="1">Bordetella Pertussis Antigen, B<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen, B<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2835</td>
               <td rowspan="1">Bordetella Pertussis Antigen, C<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen, C<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2836</td>
               <td rowspan="1">Bordetella Pertussis Antigen, D<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen, D<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2837</td>
               <td rowspan="1">Bordetella Pertussis Antigen, E<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen, E<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2838</td>
               <td rowspan="1">Bordetella Pertussis Antigen, F<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen, F<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2839</td>
               <td rowspan="1">Bordetella Pertussis Antigen, G<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen, G<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2840</td>
               <td rowspan="1">Bordetella Pertussis Antigen, H<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen, H<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2841</td>
               <td rowspan="1">Bordetella Pertussis Antigen, I<span class="subclass"> SubClassOf </span>Antigen. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bordetella Pertussis Antigen, I<span class="subclass"> SubClassOf </span>Bordetella Pertussis Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Bordetella Pertussis Antigen<span class="subclass"> SubClassOf </span>Antigen. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2842</td>
               <td rowspan="1">Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; TP53 Gene Inactivation<span class="subclass"> SubClassOf </span>Tumor-Suppressor Gene Inactivation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Tumor-Suppressor Gene Inactivation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2843</td>
               <td rowspan="5">Buccal Mucosa<span class="subclass"> SubClassOf </span>Mucosa. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Oral Cavity<span class="subclass"> SubClassOf </span>Body Cavity. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Body Cavity<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Anatomic_Structure_Has_Location<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Buccal Mucosa<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Oral Cavity. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Oral Cavity<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Head. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomic_Structure_Has_Location<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Buccal Mucosa<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Oral Cavity. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Head<span class="subclass"> SubClassOf </span>Body Region. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Oral Cavity<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Head. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Body Region<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Buccal Mucosa<span class="subclass"> SubClassOf </span>Oral Mucosa. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Oral Mucosa<span class="subclass"> SubClassOf </span>Mucosa. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck<span class="subclass"> SubClassOf </span>Body Region. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Head<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Head<br><span class="keyword"> and </span>Neck. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Buccal Mucosa<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Oral Cavity. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Oral Cavity<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Head. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Body Region<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomic_Structure_Has_Location<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Oral Cavity<span class="subclass"> SubClassOf </span>Body Cavity. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Body Cavity<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Buccal Mucosa<span class="subclass"> SubClassOf </span>Anatomic_Structure_Has_Location<span class="some"> some </span>Oral Cavity. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2845</td>
               <td rowspan="1">Chenodiol<span class="subclass"> SubClassOf </span>Adjuvant. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cholagogues<br><span class="keyword"> or </span>Choleretic Agents<span class="subclass"> SubClassOf </span>Adjuvant. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Chenodiol<span class="subclass"> SubClassOf </span>Cholagogues<br><span class="keyword"> or </span>Choleretic Agents. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2846</td>
               <td rowspan="2">Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Oncogene Deregulation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; MDM2 Gene Mutation<span class="subclass"> SubClassOf </span>Oncogene Deregulation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; MDM2 Gene Amplification<span class="subclass"> SubClassOf </span>MDM2 Gene Mutation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; TP53 Gene Inactivation<span class="subclass"> SubClassOf </span>Tumor-Suppressor Gene Inactivation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Tumor-Suppressor Gene Inactivation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2847</td>
               <td rowspan="1">Congestive Heart Failure<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Heart Failure<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Congestive Heart Failure<span class="subclass"> SubClassOf </span>Heart Failure. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2848</td>
               <td rowspan="1">Cryptococcus neoformans<span class="subclass"> SubClassOf </span>Fungus. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cryptococcus<span class="subclass"> SubClassOf </span>Basidiomycota. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Basidiomycota<span class="subclass"> SubClassOf </span>Fungus. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Cryptococcus neoformans<span class="subclass"> SubClassOf </span>Cryptococcus. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2849</td>
               <td rowspan="1">Cyanocobalamin, Co-60<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Radioconjugate<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cyanocobalamin, Co-60<span class="subclass"> SubClassOf </span>Radioconjugate. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2850</td>
               <td rowspan="1">Donor Lymphocyte Infusion<span class="subclass"> SubClassOf </span>Infusion Procedure. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Donor Cellular Infusion<span class="subclass"> SubClassOf </span>Infusion Procedure. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Donor Lymphocyte Infusion<span class="subclass"> SubClassOf </span>Donor Cellular Infusion. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2851</td>
               <td rowspan="1">Escherichia coli<span class="subclass"> SubClassOf </span>Proteobacteria. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Escherichia coli<span class="subclass"> SubClassOf </span>Escherichia. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Escherichia<span class="subclass"> SubClassOf </span>Proteobacteria. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2852</td>
               <td rowspan="1">Eukaryota<span class="subclass"> SubClassOf </span>Organism. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Other Organism Groupings<span class="subclass"> SubClassOf </span>Organism. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Eukaryota<span class="subclass"> SubClassOf </span>Other Organism Groupings. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2853</td>
               <td rowspan="1">Faropenem Medoxomil<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Faropenem Medoxomil<span class="subclass"> SubClassOf </span>Beta-Lactam Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Beta-Lactam Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2854</td>
               <td rowspan="1">Fenbenicillin<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Penicillin Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Fenbenicillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2855</td>
               <td rowspan="1">Fibracillin<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Fibracillin<span class="subclass"> SubClassOf </span>Penicillin Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Penicillin Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2856</td>
               <td rowspan="1">Flomoxef<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Flomoxef<span class="subclass"> SubClassOf </span>Cephalosporin Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cephalosporin Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2857</td>
               <td rowspan="1">Friday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Friday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2859</td>
               <td rowspan="1">Garenoxacin Mesylate<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Quinolone Compound<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Garenoxacin Mesylate<span class="subclass"> SubClassOf </span>Quinolone Compound. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2858</td>
               <td rowspan="1">Garenoxacin<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Quinolone Compound<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Garenoxacin<span class="subclass"> SubClassOf </span>Quinolone Compound. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2860</td>
               <td rowspan="5">Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Antiemetic Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Receptor Gene<span class="subclass"> SubClassOf </span>Ligand Binding Protein Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Serotonin 5-HT-3 Receptor<span class="subclass"> EquivalentTo </span>Cell Surface Receptor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>HTR3A Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Receptor)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Neuronal Transmission)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; HTR3A Gene<span class="subclass"> SubClassOf </span>Receptor Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; HTR3A Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Receptor Signaling. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Serotonin 5-HT-3 Receptor. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neurologic Process<span class="subclass"> SubClassOf </span>Organismal Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Serotonin 5-HT-3 Receptor<span class="subclass"> EquivalentTo </span>Cell Surface Receptor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>HTR3A Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Receptor)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Neuronal Transmission)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neuronal Transmission<span class="subclass"> SubClassOf </span>Biological_Process_Is_Part_Of_Process<span class="some"> some </span>Neurologic Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Organismal Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Serotonin 5-HT-3 Receptor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Biological_Process_Is_Part_Of_Process<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Pharmacologic Substance<span class="subclass"> SubClassOf </span>Drug, Food, Chemical<br><span class="keyword"> or </span>Biomedical Material. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Drug, Food, Chemical<br><span class="keyword"> or </span>Biomedical Material<span class="subclass"> SubClassOf </span>Chemicals_and_Drugs_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Serotonin Antagonist<span class="subclass"> SubClassOf </span>Adjuvant. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Adjuvant<span class="subclass"> SubClassOf </span>Pharmacologic Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Chemical_Or_Drug_Affects_Gene_Product<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Chemicals_and_Drugs_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Serotonin Antagonist. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Serotonin 5-HT-3 Receptor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Receptor Gene<span class="subclass"> SubClassOf </span>Ligand Binding Protein Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Serotonin 5-HT-3 Receptor<span class="subclass"> EquivalentTo </span>Cell Surface Receptor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>HTR3A Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Receptor)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Neuronal Transmission)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Receptor<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Receptor Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Serotonin 5-HT-3 Receptor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Drug, Food, Chemical<br><span class="keyword"> or </span>Biomedical Material<span class="subclass"> SubClassOf </span>Chemicals_and_Drugs_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Serotonin 5-HT-3 Receptor<span class="subclass"> EquivalentTo </span>Cell Surface Receptor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>HTR3A Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Receptor)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Neuronal Transmission)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Biological_Process_Has_Initiator_Chemical_Or_Drug<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Physiology-Regulatory Factor<span class="subclass"> SubClassOf </span>Drug, Food, Chemical<br><span class="keyword"> or </span>Biomedical Material. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Chemicals_and_Drugs_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neurotransmitter<span class="subclass"> SubClassOf </span>Physiology-Regulatory Factor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neuronal Transmission<span class="subclass"> SubClassOf </span>Biological_Process_Has_Initiator_Chemical_Or_Drug<span class="some"> some </span>Neurotransmitter. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Granisetron Hydrochloride<span class="subclass"> SubClassOf </span>Chemical_Or_Drug_Affects_Gene_Product<span class="some"> some </span>Serotonin 5-HT-3 Receptor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2861</td>
               <td rowspan="1">Guaiacol Carbonate<span class="subclass"> SubClassOf </span>Pharmacologic Substance. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Guaiacol Carbonate<span class="subclass"> SubClassOf </span>Expectorant. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Adjuvant<span class="subclass"> SubClassOf </span>Pharmacologic Substance. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Expectorant<span class="subclass"> SubClassOf </span>Adjuvant. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2862</td>
               <td rowspan="1">Household Income<span class="subclass"> SubClassOf </span>Socioeconomic Factors. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Income<span class="subclass"> SubClassOf </span>Socioeconomic Factors. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Household Income<span class="subclass"> SubClassOf </span>Income. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2863</td>
               <td rowspan="1">Human Parainfluenza Virus 1<span class="subclass"> SubClassOf </span>Paramyxovirus. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Human Parainfluenza Virus 1<span class="subclass"> SubClassOf </span>Parainfluenza Virus. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Parainfluenza Virus<span class="subclass"> SubClassOf </span>Paramyxovirus. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2864</td>
               <td rowspan="5">Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Epstein-Barr Virus Infection<span class="subclass"> SubClassOf </span>Viral Infection. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Viral Infection<span class="subclass"> SubClassOf </span>Infectious Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Splenic Rupture)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Atypical Lymphocytes Present in Peripheral Blood)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Immunoblastic Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Polymorphic Cellular Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Infectious Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Special Category. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Non-Neoplastic Disorder by Special Category<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_Has_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Splenic Rupture)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Atypical Lymphocytes Present in Peripheral Blood)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Immunoblastic Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Polymorphic Cellular Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Morphologic Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Non-Malignant Cellular Infiltrate<span class="subclass"> SubClassOf </span>Cellular Infiltrate. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Cellular Infiltrate<span class="subclass"> SubClassOf </span>Morphologic Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Benign Lymphoproliferative Disorder<span class="subclass"> EquivalentTo </span>Lymphoproliferative Disorder<br><span class="keyword"> and </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Malignant Cellular Infiltrate). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_Has_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Splenic Rupture)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Atypical Lymphocytes Present in Peripheral Blood)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Immunoblastic Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Polymorphic Cellular Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Lymphadenopathy<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Lymphoproliferative Disorder<span class="subclass"> EquivalentTo </span>Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Myeloid Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lymphatic System). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disorder by Site<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Splenic Rupture)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Atypical Lymphocytes Present in Peripheral Blood)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Immunoblastic Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Polymorphic Cellular Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder<span class="subclass"> SubClassOf </span>Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Benign Lymphoproliferative Disorder<span class="subclass"> EquivalentTo </span>Lymphoproliferative Disorder<br><span class="keyword"> and </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Malignant Cellular Infiltrate). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Infectious Mononucleosis<span class="subclass"> EquivalentTo </span>Benign Lymphoproliferative Disorder<br><span class="keyword"> and </span>Epstein-Barr Virus Infection<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Splenic Rupture)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Atypical Lymphocytes Present in Peripheral Blood)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Immunoblastic Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Polymorphic Cellular Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Acute Hepatitis)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Reactive Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Fever)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>EBV-Specific Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Benign Lymphoproliferative Disorder<span class="subclass"> EquivalentTo </span>Lymphoproliferative Disorder<br><span class="keyword"> and </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Clonal Antigen Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Non-Malignant Cellular Infiltrate). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2865</td>
               <td rowspan="1">Insect<span class="subclass"> SubClassOf </span>Invertebrate. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Insect<span class="subclass"> SubClassOf </span>Arthropoda. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Arthropoda<span class="subclass"> SubClassOf </span>Invertebrate. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2866</td>
               <td rowspan="5">Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Cell Adhesion Molecule Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Cell Adhesion Molecule Gene<span class="subclass"> SubClassOf </span>Ligand Binding Protein Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Ligand Binding Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Ligand Binding Protein Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Ligand Binding Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Biochemical Reaction<span class="subclass"> SubClassOf </span>Subcellular Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; ITGA5 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Protein-Protein Interaction. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Protein-Protein Interaction<span class="subclass"> SubClassOf </span>Biological_Process_Is_Part_Of_Process<span class="some"> some </span>Biochemical Reaction. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Subcellular Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Biological_Process_Is_Part_Of_Process<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Ligand Binding Protein<span class="subclass"> SubClassOf </span>Protein, Organized by Function. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Gene Product<span class="subclass"> SubClassOf </span>Gene_Product_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Protein, Organized by Function<span class="subclass"> SubClassOf </span>Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene_Product_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Protein<span class="subclass"> SubClassOf </span>Gene Product. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Ligand Binding Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Integrin Alpha 5<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGA5 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Chemical_Classification<span class="some"> some </span>Glycoprotein)<br><span class="keyword"> and </span>(Gene_Product_Is_Physical_Part_Of<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Gene_Product_Is_Biomarker_Type<span class="some"> some </span>Differentiation Antigen. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Differentiation Antigen<span class="subclass"> SubClassOf </span>Biomarker. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene_Product_Is_Biomarker_Type<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Diagnostic<br><span class="keyword"> or </span>Prognostic Factor<span class="subclass"> SubClassOf </span>Diagnostic_and_Prognostic_Factors_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Biomarker<span class="subclass"> SubClassOf </span>Diagnostic<br><span class="keyword"> or </span>Prognostic Factor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Diagnostic_and_Prognostic_Factors_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2867</td>
               <td rowspan="5">Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Cell Adhesion Molecule Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Ligand Binding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Cell Adhesion Molecule Gene<span class="subclass"> SubClassOf </span>Ligand Binding Protein Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Ligand Binding<span class="subclass"> SubClassOf </span>Molecular Interaction. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Ligand Binding Protein<span class="subclass"> SubClassOf </span>Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Ligand Binding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Interaction<span class="subclass"> SubClassOf </span>Biophysical Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Biophysical Process<span class="subclass"> SubClassOf </span>Subcellular Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Subcellular Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Ligand Binding Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Ligand Binding Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Ligand Binding Protein Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Ligand Binding Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Platelet Aggregation<span class="subclass"> SubClassOf </span>Biological_Process_Is_Part_Of_Process<span class="some"> some </span>Coagulation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Multicellular Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Biological_Process_Is_Part_Of_Process<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Platelet Aggregation<span class="subclass"> SubClassOf </span>Multicellular Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; ITGB3 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Platelet Aggregation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Integrin Beta-3<span class="subclass"> EquivalentTo </span>Cell Adhesion Molecule<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>ITGB3 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Integrin)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Adhesion)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Protein-Protein Interaction)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Receptor Signaling)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Wound Repair). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Ligand Binding Protein Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Ligand Binding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Ligand Binding Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Ligand Binding Protein Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Cell Adhesion Molecule<span class="subclass"> SubClassOf </span>Ligand Binding Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2868</td>
               <td rowspan="1">Iodohippurate Sodium, I-123<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Radioconjugate<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Iodohippurate Sodium, I-123<span class="subclass"> SubClassOf </span>Radioconjugate. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2869</td>
               <td rowspan="1">Iodohippurate Sodium, I-131<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Radioconjugate<span class="subclass"> SubClassOf </span>Radiopharmaceutical Compound. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Iodohippurate Sodium, I-131<span class="subclass"> SubClassOf </span>Radioconjugate. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2870</td>
               <td rowspan="1">LY573636<span class="subclass"> SubClassOf </span>Antineoplastic Agent. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Diarylsulfonylurea Compound<span class="subclass"> SubClassOf </span>Antineoplastic Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; LY573636<span class="subclass"> SubClassOf </span>Diarylsulfonylurea Compound. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2894</td>
               <td rowspan="1">Laboratory Test Result<span class="subclass"> SubClassOf </span>Finding. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Laboratory Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Clinical Test Result<span class="subclass"> SubClassOf </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2871</td>
               <td rowspan="1">Lactic Acid, L-<span class="subclass"> SubClassOf </span>Industrial Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Industrial Aid<span class="subclass"> SubClassOf </span>Industrial Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Lactic Acid, L-<span class="subclass"> SubClassOf </span>Industrial Aid. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2872</td>
               <td rowspan="5">Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cutaneous Precancerous Condition<span class="subclass"> SubClassOf </span>Skin Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disorder by Site<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Mycosis Fungoides))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Skin Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Complete Spontaneous Regression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Skin Disorder<span class="subclass"> SubClassOf </span>Disorder by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal T-Cell Receptor Gamma Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal T-Cell Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; T-Cell Proliferation of Uncertain Malignant Potential<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Neoplasm of Uncertain Malignant Potential<br><span class="keyword"> and </span>Premalignant Hematologic Condition<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Clonal T-Cell Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Mycosis Fungoides))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Skin Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Complete Spontaneous Regression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; T-Cell Proliferation of Uncertain Malignant Potential<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Neoplasm of Uncertain Malignant Potential<br><span class="keyword"> and </span>Premalignant Hematologic Condition<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal T-Cell Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Clonal T-Cell Receptor Beta Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal T-Cell Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Mycosis Fungoides))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Skin Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Complete Spontaneous Regression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Precancerous Condition<span class="subclass"> SubClassOf </span>Cancer-Related Condition. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; T-Cell Proliferation of Uncertain Malignant Potential<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Neoplasm of Uncertain Malignant Potential<br><span class="keyword"> and </span>Premalignant Hematologic Condition<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Cancer-Related Condition<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Precancerous Condition by Site<span class="subclass"> SubClassOf </span>Precancerous Condition. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Mycosis Fungoides))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Skin Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Complete Spontaneous Regression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Cutaneous Precancerous Condition<span class="subclass"> SubClassOf </span>Precancerous Condition by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Indolent Clinical Course<span class="subclass"> SubClassOf </span>Clinical Course of Disease. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clinical Course of Disease<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Lymphomatoid Papulosis<span class="subclass"> EquivalentTo </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Precancerous Condition<br><span class="keyword"> and </span>T-Cell Proliferation of Uncertain Malignant Potential<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Anaplastic Large Cell Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Hodgkin Lymphoma)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Mycosis Fungoides))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Skin Nodule)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Papular Lesion)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Complete Spontaneous Regression)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Skin-Homing T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2844</td>
               <td rowspan="1">MDR Modulator CBT-1<span class="subclass"> SubClassOf </span>Adjuvant. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Multidrug Resistance Modulator<span class="subclass"> SubClassOf </span>Adjuvant. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; MDR Modulator CBT-1<span class="subclass"> SubClassOf </span>Multidrug Resistance Modulator. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2873</td>
               <td rowspan="1">Magnesium Stearate<span class="subclass"> SubClassOf </span>Industrial Product. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Magnesium Stearate<span class="subclass"> SubClassOf </span>Industrial Aid. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Industrial Aid<span class="subclass"> SubClassOf </span>Industrial Product. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2874</td>
               <td rowspan="5">Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Deep Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lesion with Diameter Greater than 2cm))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Marked Nuclear Atypia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplasm by Morphology<span class="subclass"> SubClassOf </span>Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Malignant Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm<br><span class="keyword"> and </span>Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Connective<br><span class="keyword"> and </span>Soft Tissue Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Mesenchymal Cell Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<br><span class="keyword"> and </span>Neoplasm by Morphology<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Neuron, Neuroepithelial Cell,<br><span class="keyword"> and </span>Supporting Cell of the Nervous System)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Mesenchymal Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Perivascular Arrangement of Tumor Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Pericyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Glomus Tumor<span class="subclass"> EquivalentTo </span>Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Glomus Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Deep Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lesion with Diameter Greater than 2cm))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Marked Nuclear Atypia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplasm by Morphology<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Mesenchymal Cell Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<br><span class="keyword"> and </span>Neoplasm by Morphology<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Neuron, Neuroepithelial Cell,<br><span class="keyword"> and </span>Supporting Cell of the Nervous System)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Mesenchymal Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Perivascular Arrangement of Tumor Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Pericyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Deep Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lesion with Diameter Greater than 2cm))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Marked Nuclear Atypia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Malignant Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm<br><span class="keyword"> and </span>Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Connective<br><span class="keyword"> and </span>Soft Tissue Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Soft Tissue Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<br><span class="keyword"> and </span>Soft Tissue Disorder<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Soft Tissue). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Disorder<br><span class="keyword"> and </span>Neoplasm by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Malignant Soft Tissue Neoplasm<span class="subclass"> EquivalentTo </span>Soft Tissue Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Indolent Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplasm by Site<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Deep Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lesion with Diameter Greater than 2cm))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Marked Nuclear Atypia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Malignant Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Malignant Soft Tissue Neoplasm<br><span class="keyword"> and </span>Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Connective<br><span class="keyword"> and </span>Soft Tissue Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Disorder<br><span class="keyword"> and </span>Neoplasm by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Mesenchymal Cell Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<br><span class="keyword"> and </span>Neoplasm by Morphology<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Neuron, Neuroepithelial Cell,<br><span class="keyword"> and </span>Supporting Cell of the Nervous System)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplasm by Site<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Mesenchymal Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Perivascular Arrangement of Tumor Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Pericyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Glomus Tumor<span class="subclass"> EquivalentTo </span>Pericytic Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Glomus Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Malignant Glomus Tumor<span class="subclass"> EquivalentTo </span>Glomus Tumor<br><span class="keyword"> and </span>Malignant Pericytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Deep Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lesion with Diameter Greater than 2cm))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Marked Nuclear Atypia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Mitotic Activity)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Atypical Mitotic Figures)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Glomus Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Disorder<br><span class="keyword"> and </span>Neoplasm by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Mesenchymal Cell Neoplasm<span class="subclass"> EquivalentTo </span>Connective<br><span class="keyword"> and </span>Soft Tissue Neoplasm<br><span class="keyword"> and </span>Neoplasm by Morphology<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Neuron, Neuroepithelial Cell,<br><span class="keyword"> and </span>Supporting Cell of the Nervous System)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Connective<br><span class="keyword"> and </span>Soft Tissue). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplasm by Site<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Pericytic Neoplasm<span class="subclass"> EquivalentTo </span>Mesenchymal Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Perivascular Arrangement of Tumor Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Pericyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2875</td>
               <td rowspan="1">Monday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Monday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2876</td>
               <td rowspan="5">Mucosa of the Lip<span class="subclass"> SubClassOf </span>Mucosa. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Body Part<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Lip<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Head. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Mucosa of the Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Lip. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Part<span class="subclass"> SubClassOf </span>Body Part. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Head. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mucosa of the Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Lip. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Head<span class="subclass"> SubClassOf </span>Body Region. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Body Region<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Head. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mucosa of the Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Lip. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Head<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Head<br><span class="keyword"> and </span>Neck. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Head<span class="subclass"> SubClassOf </span>Body Region. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Body Region<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Body Part<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Lip<span class="subclass"> SubClassOf </span>Head<br><span class="keyword"> and </span>Neck Part. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Mucosa of the Lip<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Lip. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Head<br><span class="keyword"> and </span>Neck Part<span class="subclass"> SubClassOf </span>Body Part. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Mucosa of the Lip<span class="subclass"> SubClassOf </span>Oral Mucosa. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Oral Mucosa<span class="subclass"> SubClassOf </span>Mucosa. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2877</td>
               <td rowspan="1">Myxoid/Round Cell Liposarcoma<span class="subclass"> EquivalentTo </span>Liposarcoma<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Mesenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Painless Mass<span class="subclass"> SubClassOf </span>Mass. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Mass<span class="subclass"> SubClassOf </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Myxoid/Round Cell Liposarcoma<span class="subclass"> EquivalentTo </span>Liposarcoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;16)(q13;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-DDIT3 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(12;22)(q13;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-DDIT3 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Mesenchymal Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Well-Circumscribed Lesion). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Liposarcoma<span class="subclass"> EquivalentTo </span>Malignant Lipomatous Neoplasm<br><span class="keyword"> and </span>Sarcoma<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Painless Mass). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2878</td>
               <td rowspan="5">NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Biochemical Reaction<span class="subclass"> SubClassOf </span>Subcellular Process. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Oxidation<span class="subclass"> SubClassOf </span>Biochemical Reaction. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Subcellular Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Enzyme Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; NDUFV1 Gene<span class="subclass"> SubClassOf </span>Oxidoreductase Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Oxidoreductase Gene<span class="subclass"> SubClassOf </span>Enzyme Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; NDUFV1 Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Oxidation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gene Product<span class="subclass"> SubClassOf </span>Gene_Product_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Protein, Organized by Function<span class="subclass"> SubClassOf </span>Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene_Product_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Enzyme<span class="subclass"> SubClassOf </span>Protein, Organized by Function. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Protein<span class="subclass"> SubClassOf </span>Gene Product. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Oxidoreductase<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Enzyme. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Gene_Product_Has_Biochemical_Function<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Mitochondrion<span class="subclass"> SubClassOf </span>Membranous Cytoplasmic Organelle. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Cytoplasmic Organelle<span class="subclass"> SubClassOf </span>Cell Part. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Cell Part<span class="subclass"> SubClassOf </span>Body Part. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Body Part<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Membranous Cytoplasmic Organelle<span class="subclass"> SubClassOf </span>Cytoplasmic Organelle. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Biological_Process_Has_Associated_Location<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Cell Respiration<span class="subclass"> SubClassOf </span>Biological_Process_Has_Associated_Location<span class="some"> some </span>Mitochondrion. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Enzyme Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; NDUFV1 Gene<span class="subclass"> SubClassOf </span>Oxidoreductase Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Oxidoreductase Gene<span class="subclass"> SubClassOf </span>Enzyme Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; NADH Dehydrogenase [Ubiquinone] Flavoprotein 1, Mitochondrial<span class="subclass"> EquivalentTo </span>Oxidoreductase<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>NDUFV1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Associated_Anatomy<span class="some"> some </span>Mitochondrion)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Oxidoreductase)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Respiration)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Oxidation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2879</td>
               <td rowspan="1">Pancreatic Injury<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Pancreatic Injury<span class="subclass"> SubClassOf </span>Gastrointestinal Injury. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Gastrointestinal Injury<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2880</td>
               <td rowspan="2">Phagocytic Cell<span class="subclass"> SubClassOf </span>Antigen Processing Cell. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Organ System<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Antigen Presenting Cell<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Immune System. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Immune System<span class="subclass"> SubClassOf </span>Organ System. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Phagocytic Cell<span class="subclass"> SubClassOf </span>Antigen Presenting Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Microanatomic Structure<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Anatomic_Structure_Is_Physical_Part_Of<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Antigen Presenting Cell<span class="subclass"> SubClassOf </span>Anatomic_Structure_Is_Physical_Part_Of<span class="some"> some </span>Immune System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Antigen Presenting Cell<span class="subclass"> SubClassOf </span>Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Cell<span class="subclass"> SubClassOf </span>Microanatomic Structure. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Phagocytic Cell<span class="subclass"> SubClassOf </span>Antigen Presenting Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2881</td>
               <td rowspan="2">Phlebitis<span class="subclass"> SubClassOf </span>Vascular Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Vein Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Non-Neoplastic Vascular Disorder<span class="subclass"> SubClassOf </span>Vascular Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Phlebitis<span class="subclass"> SubClassOf </span>Vein Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_Has_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cardiovascular System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Varicose Vein<span class="subclass"> SubClassOf </span>Cardiovascular System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Phlebitis<span class="subclass"> SubClassOf </span>Vein Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Vein Disorder<span class="subclass"> SubClassOf </span>Disease_Has_Finding<span class="some"> some </span>Varicose Vein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2882</td>
               <td rowspan="1">Photosensitive Dermatitis<span class="subclass"> SubClassOf </span>Dermatitis. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Photodermatitis<span class="subclass"> SubClassOf </span>Dermatitis. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Photosensitive Dermatitis<span class="subclass"> SubClassOf </span>Photodermatitis. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2883</td>
               <td rowspan="1">Postencephalitic Parkinsonism<span class="subclass"> SubClassOf </span>Non-Neoplastic Central Nervous System Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Secondary Parkinsonism<span class="subclass"> SubClassOf </span>Non-Neoplastic Central Nervous System Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Postencephalitic Parkinsonism<span class="subclass"> SubClassOf </span>Secondary Parkinsonism. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2884</td>
               <td rowspan="1">Proctosigmoiditis<span class="subclass"> SubClassOf </span>Non-Neoplastic Gastrointestinal Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Proctocolitis<span class="subclass"> SubClassOf </span>Non-Neoplastic Gastrointestinal Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Proctosigmoiditis<span class="subclass"> SubClassOf </span>Proctocolitis. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2885</td>
               <td rowspan="1">Prone Position<span class="subclass"> SubClassOf </span>Body Position. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Prone Position<span class="subclass"> SubClassOf </span>Recumbent Position. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Recumbent Position<span class="subclass"> SubClassOf </span>Body Position. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2886</td>
               <td rowspan="1">Raynaud's Disease<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Peripheral Vascular Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Vascular Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Raynaud's Disease<span class="subclass"> SubClassOf </span>Peripheral Vascular Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2887</td>
               <td rowspan="1">Recombinant Thymosin<span class="subclass"> SubClassOf </span>Therapeutic Hormone. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Miscellaneous Hormone Agent<span class="subclass"> SubClassOf </span>Therapeutic Hormone. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Recombinant Thymosin<span class="subclass"> SubClassOf </span>Miscellaneous Hormone Agent. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2888</td>
               <td rowspan="1">Saccharomyces cerevisiae<span class="subclass"> SubClassOf </span>Fungus. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Saccharomyces cerevisiae<span class="subclass"> SubClassOf </span>Ascomycota. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Ascomycota<span class="subclass"> SubClassOf </span>Fungus. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2889</td>
               <td rowspan="1">Saturday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Saturday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2890</td>
               <td rowspan="1">Sedecamycin<span class="subclass"> SubClassOf </span>Antibiotic. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sedecamycin<span class="subclass"> SubClassOf </span>Macrolide Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Macrolide Antibiotic<span class="subclass"> SubClassOf </span>Antibiotic. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2891</td>
               <td rowspan="1">Sunday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Sunday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2892</td>
               <td rowspan="1">Supine Position<span class="subclass"> SubClassOf </span>Body Position. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Supine Position<span class="subclass"> SubClassOf </span>Recumbent Position. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Recumbent Position<span class="subclass"> SubClassOf </span>Body Position. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2893</td>
               <td rowspan="5">T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Transcription Factor Gene<span class="subclass"> SubClassOf </span>Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>TBX1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Transcription Factor<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Transcription Factor Gene. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Transcription Factor<span class="subclass"> SubClassOf </span>Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Transcription Regulatory Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Transcription Regulatory Protein<span class="subclass"> SubClassOf </span>Regulatory Protein. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>TBX1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Regulatory Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Regulatory Protein<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Regulatory Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Gene_Product_Encoded_By_Gene<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Tissue Growth<span class="subclass"> SubClassOf </span>Multicellular Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Multicellular Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Cell Proliferation<span class="subclass"> SubClassOf </span>Biological_Process_Is_Part_Of_Process<span class="some"> some </span>Tissue Growth. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>TBX1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Biological_Process_Is_Part_Of_Process<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gene_Plays_Role_In_Process<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Transcription Factor Gene<span class="subclass"> SubClassOf </span>Gene_Plays_Role_In_Process<span class="some"> some </span>Transcriptional Regulation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Transcription Factor Gene<span class="subclass"> SubClassOf </span>Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene<span class="subclass"> SubClassOf </span>Gene_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>TBX1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Transcription Factor<span class="subclass"> SubClassOf </span>Gene_Product_Encoded_By_Gene<span class="some"> some </span>Transcription Factor Gene. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Biological_Process_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Multicellular Process<span class="subclass"> SubClassOf </span>Biological Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Cell Proliferation<span class="subclass"> SubClassOf </span>Multicellular Process. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; T-Box Transcription Factor TBX1<span class="subclass"> EquivalentTo </span>Transcription Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>TBX1 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Organism_Source<span class="some"> some </span>Human)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Cell Proliferation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Transcription). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Biological Process<span class="subclass"> SubClassOf </span>Biological_Process_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene_Product_Plays_Role_In_Biological_Process<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2895</td>
               <td rowspan="1">Thursday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Thursday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2896</td>
               <td rowspan="1">Tuesday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Tuesday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2897</td>
               <td rowspan="5">Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Light Chain Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal Immunoglobulin Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Aggressive Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Non-Hodgkin Lymphoma by Clinical Course<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Aggressive Clinical Course). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clinical Course of Disease<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Aggressive Clinical Course<span class="subclass"> SubClassOf </span>Clinical Course of Disease. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Lymphadenopathy<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Immunoglobulin Heavy Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Lymphoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Reed-Sternberg Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; B-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Non-Hodgkin Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplasm by Special Category<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Mature B-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mature B-Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Type 3 Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(11)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Common Neoplasm<span class="subclass"> SubClassOf </span>Neoplasm by Special Category. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Common Hematopoietic Neoplasm<span class="subclass"> SubClassOf </span>Common Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(14)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2898</td>
               <td rowspan="1">Unit of Luminous Flux<span class="subclass"> SubClassOf </span>Unit by Category. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Unit of Illuminance<span class="subclass"> SubClassOf </span>Unit by Category. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Unit of Luminous Flux<span class="subclass"> SubClassOf </span>Unit of Illuminance. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2899</td>
               <td rowspan="1">Wednesday<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Wednesday<span class="subclass"> SubClassOf </span>Day of the Week. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Day of the Week<span class="subclass"> SubClassOf </span>Temporal Qualifier. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
         </tbody>
         <tbody id="rpsnovred" style="display:none">
            <tr class="withoutstyle">
               <td colspan="3">
                  <h4 style="display: inline-block;">Prospective Pseudo Novel Redundant (26)</h4> [<a href="#">back to top</a>]
               </td>
            </tr>
            <tr>
               <th class="removal">ID</th>
               <th class="removal">Axiom in Ontology 1</th>
               <th class="normalrem">Justifications in Ontology 2</th>
            </tr>
            <tr class="removal">
               <td rowspan="5">2900</td>
               <td rowspan="5">ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Anaplastic Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature T-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal T-Cell Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Clonal T-Cell Receptor Beta Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal T-Cell Receptor Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Lymphadenopathy<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Extranodal Disease<span class="subclass"> SubClassOf </span>Clinical Course of Disease. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Clinical Course of Disease<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic Large Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Hodgkin-Like Cell<span class="subclass"> SubClassOf </span>Neoplastic Large Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Large Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Large Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; ALK-Positive Anaplastic Large Cell Lymphoma<span class="subclass"> EquivalentTo </span>Anaplastic Large Cell Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(2)(p23q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ATIC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>ALO17-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(p23;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MYH9-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;3)(p23;q21))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TFG-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;5)(p23;q35))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NPM-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(X;2)(q11-12;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MSN-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Doughnut Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Hodgkin-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Reed-Sternberg-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Extranodal Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hallmark Cell)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Rearrangement of 2p23)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated Mature Cytotoxic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Large Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Hodgkin-Like Cell<span class="subclass"> SubClassOf </span>Neoplastic Large Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2901</td>
               <td rowspan="5">Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Gastrointestinal System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hepatomegaly<span class="subclass"> SubClassOf </span>Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Immature Myeloid Cells Increased in Bone Marrow<span class="subclass"> SubClassOf </span>Abnormal Bone Marrow Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Bone Marrow Test Result<span class="subclass"> SubClassOf </span>Abnormal Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Hematology Test Result<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(11)</i>&nbsp; Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells<span class="subclass"> SubClassOf </span>Immature Myeloid Cells Increased in Bone Marrow. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Thrombocytosis<span class="subclass"> SubClassOf </span>Abnormal Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Hematology Test Result<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Mental<br><span class="keyword"> and </span>Behavioral Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Fatigue<span class="subclass"> SubClassOf </span>Mental<br><span class="keyword"> and </span>Behavioral Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Other Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Symptom<span class="subclass"> SubClassOf </span>Other Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Hepatomegaly<span class="subclass"> SubClassOf </span>Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Accelerated Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Basophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myeloblasts 10-19 Percent of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Accelerated Phase of Disease)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Splenomegaly). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Other Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Symptom<span class="subclass"> SubClassOf </span>Other Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2912</td>
               <td rowspan="2">Activated B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene mRNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD44 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Increased NFkappaB Pathway Activation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>PKCbeta1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated B-Lymphocyte). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Activated B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene mRNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD44 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Increased NFkappaB Pathway Activation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>PKCbeta1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated B-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Heavy Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Activated B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene mRNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD44 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Cyclin D2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>IRF4/MUM1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Increased NFkappaB Pathway Activation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>PKCbeta1 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Activated B-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Light Chain Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Clonal Immunoglobulin Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2902</td>
               <td rowspan="5">Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Neoplastic Medium-Sized T-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Medium-Sized Lymphocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Opportunistic Infection)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>T-Cell Immunodeficiency))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osteoclastic Activity Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pautrier-Like Microabscess Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Bone Marrow Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Medium-Sized Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic Medium-Sized T-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Medium-Sized Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Opportunistic Infection)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>T-Cell Immunodeficiency))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osteoclastic Activity Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pautrier-Like Microabscess Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Bone Marrow Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Medium-Sized Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Pleomorphic T-Lymphocyte<span class="subclass"> SubClassOf </span>Pleomorphic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Pleomorphic Lymphocyte<span class="subclass"> SubClassOf </span>Pleomorphic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Pleomorphic Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Polylobated T-Lymphocyte<span class="subclass"> SubClassOf </span>Pleomorphic T-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Opportunistic Infection)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>T-Cell Immunodeficiency))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osteoclastic Activity Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pautrier-Like Microabscess Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Bone Marrow Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Abnormal Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Medium-Sized T-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Medium-Sized Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Opportunistic Infection)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>T-Cell Immunodeficiency))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osteoclastic Activity Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pautrier-Like Microabscess Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Bone Marrow Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Medium-Sized Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Acute Adult T-Cell Leukemia/Lymphoma<span class="subclass"> EquivalentTo </span>Adult T-Cell Leukemia/Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Associated_Disease<span class="some"> some </span>Opportunistic Infection)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>T-Cell Immunodeficiency))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Osteoclastic Activity Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Pautrier-Like Microabscess Present))<br><span class="keyword"> or </span>((Disease_Has_Finding<span class="some"> only </span>Bone Marrow Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Medium-Sized T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Medium-Sized to Large T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Small T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Polylobated T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lactate Dehydrogenase Increased)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Small T-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Small Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Pleomorphic Small T-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Small T-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Small Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2903</td>
               <td rowspan="5">Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Bone Marrow Neoplasm<span class="subclass"> EquivalentTo </span>Bone Marrow Disorder<br><span class="keyword"> and </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Leukemia<br><span class="keyword"> and </span>Myeloid Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Myeloid Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Malignant Bone Marrow Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloid Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Hematopoietic Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bone Marrow). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder<br><span class="keyword"> and </span>Neoplasm by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Acute Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Acute Leukemia<br><span class="keyword"> and </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic Lymphoblast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;V)(p11;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MOZ-V Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Malignant Bone Marrow Neoplasm<span class="subclass"> EquivalentTo </span>Bone Marrow Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Malignant Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Neoplasm by Site<span class="subclass"> SubClassOf </span>Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(14)</i>&nbsp; Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present in 50 Percent<br><span class="keyword"> or </span>More of the Cells of Two Cell Lines). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;V)(p11;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MOZ-V Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Chromosomal Translocation<span class="subclass"> SubClassOf </span>Chromosomal Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Chromosomal Rearrangement<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; t(7;11)(p15;p15)<span class="subclass"> SubClassOf </span>Chromosomal Translocation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; t(8;22)(p11;q13)<span class="subclass"> SubClassOf </span>Chromosomal Translocation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;V)(p11;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MOZ-V Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Chromosomal Translocation<span class="subclass"> SubClassOf </span>Chromosomal Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Chromosomal Rearrangement<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;V)(p11;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MOZ-V Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Unfavorable Clinical Outcome<span class="subclass"> SubClassOf </span>Clinical Course of Disease. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clinical Course of Disease<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Acute Monoblastic Leukemia<br><span class="keyword"> and </span>Acute Monocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;V)(p11;v))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MOZ-V Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(V;11)(v;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>V-MLL Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;22)(p11;q13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Some Commitment to Monocytic Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal Bone Marrow Test Result<span class="subclass"> SubClassOf </span>Abnormal Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Hematology Test Result<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Hypercellular Bone Marrow<span class="subclass"> SubClassOf </span>Abnormal Bone Marrow Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2904</td>
               <td rowspan="5">Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Abnormal Granulocyte<span class="subclass"> SubClassOf </span>Abnormal Myeloid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Abnormal Granulocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Abnormal Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Neutrophilic Precursor<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Leukemic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Leukemic Cell<span class="subclass"> SubClassOf </span>Malignant Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Neutrophilic Precursor<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Malignant Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Leukemic Cell<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Leukemic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Neutrophilic Precursor<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Leukemic Cell<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Leukemic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Neutrophilic Precursor<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Abnormal Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Acute Myeloid Leukemia with 11q23 (MLL) Abnormalities<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia with Recurrent Genetic Abnormalities<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(10;11)(p11;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF10 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;19)(q23;p13.1))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-EEN Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ELL Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-ENL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF9 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Cells of Monocytic Lineage 80 Percent<br><span class="keyword"> or </span>More of Bone Marrow Leukemic Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Disseminated Intravascular Coagulation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Therapy-Related Toxicity)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Myeloid Cells Increased in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Multipotent Bone Marrow Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Neutrophilic Precursor<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2905</td>
               <td rowspan="5">Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Leukemic Cell<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Leukemic Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(12p11p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Basophilia))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>DEK-CAN Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Myeloblast<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplastic Myeloblast without Azurophilic Granules<span class="subclass"> SubClassOf </span>Neoplastic Myeloblast. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(12p11p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Basophilia))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>DEK-CAN Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Morphologic Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Auer Rods Present<span class="subclass"> SubClassOf </span>Morphologic Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Abnormal Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(12p11p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Basophilia))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>DEK-CAN Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Myeloblast<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Myeloblast without Azurophilic Granules<span class="subclass"> SubClassOf </span>Neoplastic Myeloblast. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Leukemic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(12p11p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Basophilia))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>DEK-CAN Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Granulocyte<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Myeloblast<span class="subclass"> SubClassOf </span>Neoplastic Granulocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Leukemic Cell<span class="subclass"> SubClassOf </span>Malignant Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Malignant Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplastic Myeloblast without Azurophilic Granules<span class="subclass"> SubClassOf </span>Neoplastic Myeloblast. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic Myeloid Blast<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Abnormal Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Acute Myeloid Leukemia with Maturation<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(12p11p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Basophilia))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;9)(p23;q34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>DEK-CAN Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;16)(p11;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemophagocytosis))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;21)(q22;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>AML1-ETO Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast with Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Myeloblast without Azurophilic Granules)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Cytoplasmic Hypogranularity)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neutrophil with Pseudo Pelger-Huet Nucleus)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;11)(p15;p15))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CEBPA Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Myeloblasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Promyelocytes, Myelocytes,<br><span class="keyword"> and </span>Mature Neutrophils 10 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell at the Earliest Stage of Myeloid Differentiation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Myeloblast<span class="subclass"> SubClassOf </span>Neoplastic Myeloid Blast. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Myeloblast without Azurophilic Granules<span class="subclass"> SubClassOf </span>Neoplastic Myeloblast. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="3">2827</td>
               <td rowspan="3">Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Leukemia<br><span class="keyword"> and </span>Myeloid Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<span class="subclass"> EquivalentTo </span>Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Neoplasm<br><span class="keyword"> and </span>Neoplasm by Morphology<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Myeloid Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Malignant Bone Marrow Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Myeloid Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Hematopoietic Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Bone Marrow). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Acute Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Acute Leukemia<br><span class="keyword"> and </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic Lymphoblast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Acute Myelomonocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplasm by Morphology<span class="subclass"> SubClassOf </span>Neoplasm. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present in 50 Percent<br><span class="keyword"> or </span>More of the Cells of Two Cell Lines). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Acute Myelomonocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Anemia<span class="subclass"> SubClassOf </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Acute Myelomonocytic Leukemia<span class="subclass"> EquivalentTo </span>Acute Myeloid Leukemia <span class="keyword">not </span>Otherwise Categorized<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monoblast)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Monocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Neutrophilic Precursor)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Promonocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Granulocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Monocytes<br><span class="keyword"> and </span>Precursors 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Cells)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Stem Cell with Potential to Differentiate to Granulocytic<br><span class="keyword"> and </span>Monocytic Lineages). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disorder by Site<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Acute Myelomonocytic Leukemia with Abnormal Eosinophils<span class="subclass"> EquivalentTo </span>Acute Myelomonocytic Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;16)(p13;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CBFbeta-MYH11 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Auer Rods Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Eosinophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Abnormal Eosinophilic Granules Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Eosinophilia). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Anemia<span class="subclass"> SubClassOf </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder<span class="subclass"> SubClassOf </span>Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(11)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="3">2828</td>
               <td rowspan="3">Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Tumor-Suppressor Gene Inactivation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; PTEN Gene Inactivation<span class="subclass"> SubClassOf </span>Tumor-Suppressor Gene Inactivation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Chromosomal Deletion<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; del(10q23)<span class="subclass"> SubClassOf </span>Chromosomal Deletion. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Loss of Chromosome 9p<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Adult Glioblastoma<span class="subclass"> EquivalentTo </span>Adult Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2906</td>
               <td rowspan="5">Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anemia<span class="subclass"> SubClassOf </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; NRAS Gene Mutation<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Myelodysplastic/Myeloproliferative Disease<span class="subclass"> EquivalentTo </span>Myeloid Neoplasm<br><span class="keyword"> and </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Ineffective Hematopoiesis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>NRAS Gene Mutation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Peripheral Blood White Cells). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Cytopenia<span class="subclass"> SubClassOf </span>Abnormal Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Hematology Test Result<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Thrombocytopenia<span class="subclass"> SubClassOf </span>Cytopenia. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Abnormal Erythroid Precursor<span class="subclass"> SubClassOf </span>Abnormal Myeloid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Abnormal Myeloid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Dysplastic Erythroid Precursor<span class="subclass"> SubClassOf </span>Abnormal Erythroid Precursor. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Atypical Chronic Myeloid Leukemia<span class="subclass"> EquivalentTo </span>Myelodysplastic/Myeloproliferative Disease<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(p24;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-JAK2 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;12)(q34;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TEL-ABL Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(p24;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>BCR-JAK2 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Dysplastic Erythroid Precursor)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Thrombocytopenia)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Megakaryocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Dysplastic Neutrophil)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Bone Marrow Dysplasia Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Immature Granulocytes in Peripheral Blood Increased)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neutrophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow Myeloid Stem Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Loss of Chromosome 12p<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2907</td>
               <td rowspan="5">Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Loss of Chromosome Y<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; i(17q)<span class="subclass"> SubClassOf </span>Isochromosome. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Isochromosome<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; White Blood Cell Count Increased<span class="subclass"> SubClassOf </span>Abnormal Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Hematology Test Result<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Mental<br><span class="keyword"> and </span>Behavioral Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Fatigue<span class="subclass"> SubClassOf </span>Mental<br><span class="keyword"> and </span>Behavioral Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Other Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Symptom<span class="subclass"> SubClassOf </span>Other Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Blast Phase Chronic Myelogenous Leukemia<span class="subclass"> EquivalentTo </span>Chronic Myelogenous Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p230 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(3;21)(q26;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EVI1-AML1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome Y)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Trisomy 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(17q))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>i(19))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Blasts 20 Percent<br><span class="keyword"> or </span>More of Peripheral Blood White Cells)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fatigue)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>White Blood Cell Count Increased)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Blast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Anemia<span class="subclass"> SubClassOf </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="4">2842</td>
               <td rowspan="4">Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Headache<span class="subclass"> SubClassOf </span>Neurological Signs<br><span class="keyword"> and </span>Symptoms. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Other Finding<span class="subclass"> SubClassOf </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Symptom<span class="subclass"> SubClassOf </span>Other Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neurological Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Glial Cell<span class="subclass"> SubClassOf </span>Neoplastic Neuroepithelial Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Astrocyte<span class="subclass"> SubClassOf </span>Neoplastic Glial Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Neuroepithelial Cell<br><span class="keyword"> and </span>Neoplastic Perineural Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Gemistocytic Neoplastic Astrocyte<span class="subclass"> SubClassOf </span>Neoplastic Astrocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplastic Neuroepithelial Cell<span class="subclass"> SubClassOf </span>Neoplastic Neuroepithelial Cell<br><span class="keyword"> and </span>Neoplastic Perineural Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Nervous System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Seizure<span class="subclass"> SubClassOf </span>Neurological Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neurological Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Nervous System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Brain Glioblastoma<span class="subclass"> EquivalentTo </span>Glioblastoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Brain). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Chromosomal Deletion<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; del(10q23)<span class="subclass"> SubClassOf </span>Chromosomal Deletion. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="3">2846</td>
               <td rowspan="3">Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Loss of Chromosome 9p<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Chromosomal Deletion<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; del(10q23)<span class="subclass"> SubClassOf </span>Chromosomal Deletion. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Childhood Glioblastoma<span class="subclass"> EquivalentTo </span>Childhood Astrocytic Tumor<br><span class="keyword"> and </span>Glioblastoma<br><span class="keyword"> and </span>Malignant Childhood Central Nervous System Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EGFR Protein Overexpression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Gene Mutation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PDGFRalpha Protein Overexpression)))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MDM2 Gene Amplification)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TP53 Gene Inactivation). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Nervous System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Seizure<span class="subclass"> SubClassOf </span>Neurological Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Glioblastoma<span class="subclass"> EquivalentTo </span>Anaplastic Malignant Neoplasm<br><span class="keyword"> and </span>Astrocytic Tumor<br><span class="keyword"> and </span>Malignant Glioma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Fibrillary Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Gemistocytic Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 10p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q23))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(10q25-26))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Headache)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Seizure)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Poorly Differentiated Neoplastic Astrocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Infiltrative Growth)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Microvascular Proliferation)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Mitotic Activity)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Nuclear Atypia)<br><span class="keyword"> and </span>(Disease_Is_Grade<span class="some"> only </span>Grade 4). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neurological Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Nervous System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2908</td>
               <td rowspan="5">Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Non-Neoplastic Heart Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Cardiovascular Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Non-Neoplastic Cardiovascular Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Endomyocardial Fibrosis<span class="subclass"> SubClassOf </span>Non-Neoplastic Heart Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;4)(q44;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;13)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell))<br><span class="keyword"> or </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Loss of Chromosome 13q<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;4)(q44;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;13)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell))<br><span class="keyword"> or </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Chromosomal Translocation<span class="subclass"> SubClassOf </span>Chromosomal Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Chromosomal Rearrangement<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; t(8;9)(p11;q32-34)<span class="subclass"> SubClassOf </span>Chromosomal Translocation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;4)(q44;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;13)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell))<br><span class="keyword"> or </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disorder by Site<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Thoracic Disorder<span class="subclass"> SubClassOf </span>Respiratory<br><span class="keyword"> and </span>Thoracic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Eosinophilic Endomyocardial Disease<span class="subclass"> SubClassOf </span>Heart Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Respiratory<br><span class="keyword"> and </span>Thoracic Disorder<span class="subclass"> SubClassOf </span>Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;4)(q44;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;13)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell))<br><span class="keyword"> or </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Heart Disorder<span class="subclass"> SubClassOf </span>Thoracic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Anatomic Structure, System,<br><span class="keyword"> or </span>Substance<span class="subclass"> SubClassOf </span>Anatomy_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Multipotent Stem Cell<span class="subclass"> SubClassOf </span>Stem Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Microanatomic Structure<span class="subclass"> SubClassOf </span>Anatomic Structure, System,<br><span class="keyword"> or </span>Substance. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Anatomy_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Multipotent Bone Marrow Stem Cell<span class="subclass"> SubClassOf </span>Multipotent Stem Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Stem Cell<span class="subclass"> SubClassOf </span>Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Normal_Cell_Origin<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Cell<span class="subclass"> SubClassOf </span>Microanatomic Structure. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Chronic Eosinophilic Leukemia<span class="subclass"> EquivalentTo </span>Chronic Leukemia<br><span class="keyword"> and </span>Chronic Myeloproliferative Disorder<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;4)(q44;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FIP1L1-PDGFRalpha Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;13)(p11;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Pluripotent Bone Marrow Stem Cell))<br><span class="keyword"> or </span>((Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_Excludes_Cytogenetic_Abnormality<span class="some"> only </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_Excludes_Molecular_Abnormality<span class="some"> only </span>BCR-ABL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Endomyocardial Fibrosis)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Eosinophilic Endomyocardial Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Neuropathy)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 13q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 20q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(4)(q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(6;8)(q27;p11))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(8;9)(p11;q32-34))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Charcot-Leyden Crystals Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Splenomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Multipotent Bone Marrow Stem Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Blasts Under 20 Percent of Bone Marrow Nucleated Cells)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Monoclonal Eosinophils Present)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilia)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Hypercellular Bone Marrow). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2909</td>
               <td rowspan="5">Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Molecular Pathway Deregulation<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Apoptotic Pathway Deregulation<span class="subclass"> SubClassOf </span>Molecular Pathway Deregulation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Mature B-Lymphocyte at the Germinal Center Stage of Differentiation))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Peripheral (Post-Thymic) T-Lymphocyte)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Reed-Sternberg Cell<span class="subclass"> SubClassOf </span>Neoplastic Large Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mummified Cell<span class="subclass"> SubClassOf </span>Reed-Sternberg Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Large Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Mature B-Lymphocyte at the Germinal Center Stage of Differentiation))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Peripheral (Post-Thymic) T-Lymphocyte)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Reed-Sternberg Cell<span class="subclass"> SubClassOf </span>Neoplastic Large Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mummified Cell<span class="subclass"> SubClassOf </span>Reed-Sternberg Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Large Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Mature B-Lymphocyte at the Germinal Center Stage of Differentiation))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Peripheral (Post-Thymic) T-Lymphocyte)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Reed-Sternberg Cell<span class="subclass"> SubClassOf </span>Neoplastic Large Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Large Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mummified Cell<span class="subclass"> SubClassOf </span>Reed-Sternberg Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Large Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Large Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Mature B-Lymphocyte at the Germinal Center Stage of Differentiation))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Peripheral (Post-Thymic) T-Lymphocyte)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Reed-Sternberg Cell<span class="subclass"> SubClassOf </span>Neoplastic Large Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Abnormal Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Mummified Cell<span class="subclass"> SubClassOf </span>Reed-Sternberg Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Neoplastic Large Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Classical Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Hodgkin Lymphoma<br><span class="keyword"> and </span>(((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Mature B-Lymphocyte at the Germinal Center Stage of Differentiation))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Normal_Cell_Origin<span class="some"> some </span>Peripheral (Post-Thymic) T-Lymphocyte)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mummified Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 12q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 2p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9p)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD15-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>CD30-Positive Neoplastic Cells Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Colony-Stimulating Factor Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-10 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-13 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-2 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-5 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-6 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-7 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Interleukin-9 Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphotoxin-Alpha Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Night Sweats)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Transforming Growth Factor-Beta Overexpression)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Weight Loss)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Apoptotic Pathway Deregulation)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Classical Reed-Sternberg Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Hodgkin Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="1">2910</td>
               <td rowspan="1">Coagulation Factor X<span class="subclass"> SubClassOf </span>Coagulation Factor. 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Coagulation Factor X<span class="subclass"> EquivalentTo </span>Coagulation Factor<br><span class="keyword"> and </span>(Gene_Product_Encoded_By_Gene<span class="some"> some </span>F10 Gene)<br><span class="keyword"> and </span>(Gene_Product_Has_Biochemical_Function<span class="some"> some </span>Coagulation Factor)<br><span class="keyword"> and </span>(Gene_Product_Is_Element_In_Pathway<span class="some"> some </span>Intrinsic Prothrombin Activation Pathway)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Coagulation)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Homeostasis)<br><span class="keyword"> and </span>(Gene_Product_Plays_Role_In_Biological_Process<span class="some"> some </span>Proteolytic Processing). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div>
               </td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2921</td>
               <td rowspan="5">DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Solitary Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cyclin D1 Protein Overexpression<span class="subclass"> SubClassOf </span>Protein Deregulation. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Protein Deregulation<span class="subclass"> SubClassOf </span>Deregulation of Protein<br><span class="keyword"> and </span>Messenger RNA Expression. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Deregulation of Protein<br><span class="keyword"> and </span>Messenger RNA Expression<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Chromosomal Translocation<span class="subclass"> SubClassOf </span>Chromosomal Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Solitary Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; t(11;14)(q13;q32)<span class="subclass"> SubClassOf </span>Chromosomal Translocation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Chromosomal Rearrangement<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Laboratory Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Monoclonal Paraproteinemia<span class="subclass"> SubClassOf </span>Paraproteinemia. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Paraproteinemia<span class="subclass"> SubClassOf </span>Abnormal Blood Chemistry<br><span class="keyword"> and </span>Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Solitary Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Blood Chemistry<br><span class="keyword"> and </span>Hematology Test Result<span class="subclass"> SubClassOf </span>Abnormal Laboratory Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Clinical Test Result<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br><i>(10)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Solitary Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Loss of Chromosome 8<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; DS Stage I Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Solitary Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage I). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Common Neoplasm<span class="subclass"> SubClassOf </span>Neoplasm by Special Category. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Plasma Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Finding<span class="some"> only </span>Localized Lesion)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Neoplastic Plasma Cells Present in Bone Marrow)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>Clonal Immunoglobulin Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Bone Marrow-Homing Plasma Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Common Hematopoietic Neoplasm<span class="subclass"> SubClassOf </span>Common Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplasm by Special Category<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2920</td>
               <td rowspan="5">DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Pleomorphic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Loss of Chromosome X<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Laboratory Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Monoclonal Paraproteinemia<span class="subclass"> SubClassOf </span>Paraproteinemia. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Paraproteinemia<span class="subclass"> SubClassOf </span>Abnormal Blood Chemistry<br><span class="keyword"> and </span>Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal Blood Chemistry<br><span class="keyword"> and </span>Hematology Test Result<span class="subclass"> SubClassOf </span>Abnormal Laboratory Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Clinical Test Result<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br><i>(9)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Chromosomal Translocation<span class="subclass"> SubClassOf </span>Chromosomal Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; t(11;14)(q13;q32)<span class="subclass"> SubClassOf </span>Chromosomal Translocation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Chromosomal Rearrangement<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Cyclin D1 Protein Overexpression<span class="subclass"> SubClassOf </span>Protein Deregulation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Protein Deregulation<span class="subclass"> SubClassOf </span>Deregulation of Protein<br><span class="keyword"> and </span>Messenger RNA Expression. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Deregulation of Protein<br><span class="keyword"> and </span>Messenger RNA Expression<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; DS Stage III Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression)<br><span class="keyword"> and </span>(Disease_Is_Stage<span class="some"> only </span>Stage III). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2913</td>
               <td rowspan="5">Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Neoplastic Round Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Malignant Small Round Cell<span class="subclass"> SubClassOf </span>Neoplastic Small Round Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Small Round Cell<span class="subclass"> SubClassOf </span>Neoplastic Round Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ZSG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-E1AF Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ETV1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anemia<span class="subclass"> SubClassOf </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ZSG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-E1AF Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ETV1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Hemorrhagic Change<span class="subclass"> SubClassOf </span>Morphologic Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Morphologic Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ZSG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-E1AF Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ETV1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Chromosomal Translocation<span class="subclass"> SubClassOf </span>Chromosomal Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Chromosomal Rearrangement<span class="subclass"> SubClassOf </span>Structural Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; t(11;22)(q24;q12)<span class="subclass"> SubClassOf </span>Chromosomal Translocation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ZSG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-E1AF Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ETV1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Structural Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Malignant Small Round Cell<span class="subclass"> SubClassOf </span>Malignant Small Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Malignant Small Cell<span class="subclass"> SubClassOf </span>Malignant Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Malignant Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor<span class="subclass"> EquivalentTo </span>Embryonal Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>inv(22q12))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;22)(p36.1;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ZSG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(16;21)(p11;q22))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>FUS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(17;22)(q21;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-E1AF Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(21;22)(q22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ERG Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;22)(q33;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FEV Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(7;22)(p22;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-ETV1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>EWS-FL1 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Malignant Small Round Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;22)(q24;q12))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hemorrhagic Change)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Homer Wright Rosette Formation)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Necrotic Change)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Primitive Round to Oval Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Neural Crest). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="2">2911</td>
               <td rowspan="2">Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>A-myb Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL-6 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD10 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>LMO2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Germinal Center B-Lymphocyte). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>A-myb Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL-6 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD10 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>LMO2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Germinal Center B-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Light Chain Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Clonal Immunoglobulin Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Diffuse Large B-Cell Lymphoma by Gene Expression Profile<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic B-Immunoblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Immunoblastic Lymphoma))<br><span class="keyword"> or </span>((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Centroblast)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Centroblastic Lymphoma)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Favorable Clinical Outcome)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>A-myb Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL2 Gene Translocation)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>BCL-6 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>CD10 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>LMO2 Messenger RNA Overexpression)<br><span class="keyword"> and </span>(Disease_Has_Molecular_Abnormality<span class="some"> only </span>REL Gene Amplification)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Germinal Center B-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Heavy Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Diffuse Large B-Cell Lymphoma<span class="subclass"> EquivalentTo </span>Mature B-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Large B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Diffuse Pattern)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Diffuse Large B-Cell Lymphoma by Gene Expression Profile<span class="subclass"> SubClassOf </span>Diffuse Large B-Cell Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="4">2914</td>
               <td rowspan="4">Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell<span class="subclass"> SubClassOf </span>Abnormal Connective<br><span class="keyword"> and </span>Soft Tissue Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Abnormal Connective<br><span class="keyword"> and </span>Soft Tissue Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Stellate Cell<span class="subclass"> SubClassOf </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Stellate Cell<span class="subclass"> SubClassOf </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell<span class="subclass"> SubClassOf </span>Abnormal Connective<br><span class="keyword"> and </span>Soft Tissue Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Abnormal Connective<br><span class="keyword"> and </span>Soft Tissue Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Ganglion-Like Cell<span class="subclass"> SubClassOf </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Inflammatory Myofibroblastic Tumor<span class="subclass"> EquivalentTo </span>Intermediate Fibrocytic Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;2)(q25;p23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM3-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;17)(p23;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CLTC-ALK Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(2;19)(p23;p13))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>TPM4-ALK Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Ganglion-Like Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Neoplastic Stellate Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Well-Circumscribed Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fascicular Pattern)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Fever)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Multinodular Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Myxoid Background)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pain)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Spindle-Shaped Myofibroblast)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Eosinophilic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphocytic Infiltrate)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Plasmacytic Infiltrate). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Ganglion-Like Cell<span class="subclass"> SubClassOf </span>Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Connective<br><span class="keyword"> and </span>Soft Tissue Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2915</td>
               <td rowspan="5">Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Indolent Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Non-Hodgkin Lymphoma by Clinical Course<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Indolent Clinical Course). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Lymphoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Reed-Sternberg Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Non-Hodgkin Lymphoma by Clinical Course<span class="subclass"> SubClassOf </span>Non-Hodgkin Lymphoma. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Lymphoma<span class="subclass"> EquivalentTo </span>Lymphocytic Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Plasma Cell). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Progressive Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Lymphocytic Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Lymphoproliferative Disorder<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Lymphoproliferative Disorder<span class="subclass"> EquivalentTo </span>Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Myeloid Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lymphatic System). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disorder by Site<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(13)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder<span class="subclass"> SubClassOf </span>Disorder by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(14)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>T-Cell Non-Hodgkin Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Common Hematopoietic Neoplasm<br><span class="keyword"> and </span>Lymphoma<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Reed-Sternberg Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; T-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte<br><span class="keyword"> and </span>Neoplastic Natural Killer Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>T-Lymphocyte<br><span class="keyword"> and </span>Natural Killer Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Progressive Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Neoplasm by Special Category<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(11)</i>&nbsp; Common Neoplasm<span class="subclass"> SubClassOf </span>Neoplasm by Special Category. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Common Hematopoietic Neoplasm<span class="subclass"> SubClassOf </span>Common Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(13)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<span class="subclass"> EquivalentTo </span>Lymphocytic Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte<br><span class="keyword"> and </span>Neoplastic Natural Killer Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>T-Lymphocyte<br><span class="keyword"> and </span>Natural Killer Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>T-Cell Non-Hodgkin Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; T-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic T-Lymphocyte<br><span class="keyword"> and </span>Neoplastic Natural Killer Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>T-Lymphocyte<br><span class="keyword"> and </span>Natural Killer Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<span class="subclass"> EquivalentTo </span>Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Neoplasm<br><span class="keyword"> and </span>Neoplasm by Morphology<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Progressive Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Lymphocytic Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Lymphoproliferative Disorder<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplasm by Morphology<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(13)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Cutaneous T-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Cutaneous Lymphoma<br><span class="keyword"> and </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Progressive Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<span class="subclass"> EquivalentTo </span>Cutaneous Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Lymphoproliferative Disorder<br><span class="keyword"> and </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplasm<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Skin Neoplasm<span class="subclass"> EquivalentTo </span>Neoplasm by Site<br><span class="keyword"> and </span>Skin Disorder<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(10)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Neoplasm by Site<span class="subclass"> SubClassOf </span>Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Cutaneous Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Skin Neoplasm. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Cutaneous T-Cell Non-Hodgkin Lymphoma<span class="subclass"> EquivalentTo </span>Cutaneous Lymphoma<br><span class="keyword"> and </span>Cutaneous Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Neoplasm<br><span class="keyword"> and </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Lymphoma<span class="subclass"> EquivalentTo </span>Lymphocytic Neoplasm<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Plasma Cell). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Mycosis Fungoides<span class="subclass"> EquivalentTo </span>Cutaneous T-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Indolent Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Progressive Disease)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>CDKN2A Gene Inactivation)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>PTEN Gene Inactivation)))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Chronic Clinical Course)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Dermatopathic Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Scaly Skin Eruption)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Patch)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Skin Plaque)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Lymphoma by Site<span class="subclass"> SubClassOf </span>Lymphoma. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Lymphocytic Neoplasm<span class="subclass"> EquivalentTo </span>Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Lymphoproliferative Disorder<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Lymphoproliferative Disorder<span class="subclass"> EquivalentTo </span>Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Myeloid Cell)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Abnormal Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Normal_Tissue_Origin<span class="some"> only </span>Lymphoid Tissue)<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Lymphatic System). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Disorder by Site<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Cutaneous Lymphoma<span class="subclass"> EquivalentTo </span>Cutaneous Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell Neoplasm<br><span class="keyword"> and </span>Cutaneous Lymphoproliferative Disorder<br><span class="keyword"> and </span>Lymphoma by Site<br><span class="keyword"> and </span>Malignant Skin Neoplasm<br><span class="keyword"> and </span>(Disease_Has_Primary_Anatomic_Site<span class="some"> only </span>Skin). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(12)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Domain </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(13)</i>&nbsp; Hematopoietic<br><span class="keyword"> and </span>Lymphoid System Disorder<span class="subclass"> SubClassOf </span>Disorder by Site. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(14)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2916</td>
               <td rowspan="5">Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal Immunoglobulin Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Clonal Immunoglobulin Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coarse Azurophilic Granules Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>E2A-PBX1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Immunoglobulin Light Chain Gene Rearrangement. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Hematopoietic System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Lymphadenopathy<span class="subclass"> SubClassOf </span>Hematopoietic System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coarse Azurophilic Granules Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>E2A-PBX1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Hepatomegaly<span class="subclass"> SubClassOf </span>Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Other Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coarse Azurophilic Granules Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>E2A-PBX1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Symptom<span class="subclass"> SubClassOf </span>Other Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Loss of Chromosome 12p<span class="subclass"> SubClassOf </span>Chromosomal Loss. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coarse Azurophilic Granules Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>E2A-PBX1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Chromosomal Loss<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Gastrointestinal System Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Gastrointestinal System Finding<span class="subclass"> SubClassOf </span>Finding by Site<br><span class="keyword"> or </span>System. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Hepatomegaly<span class="subclass"> SubClassOf </span>Gastrointestinal System Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Finding by Site<br><span class="keyword"> or </span>System<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Precursor B-Lymphoblastic Lymphoma/Leukemia<span class="subclass"> EquivalentTo </span>B-Cell Neoplasm<br><span class="keyword"> and </span>Precursor Lymphoblastic Lymphoma/Leukemia<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Philadelphia Chromosome)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(9;22)(q34;q11))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Coarse Azurophilic Granules Present)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p190 Fusion Protein Expression)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>p210 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(1;19)(q23;p13.3))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>E2A-PBX1 Fusion Protein Expression))<br><span class="keyword"> or </span>((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(4;11)(q21;q23))<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>MLL-AF4 Fusion Protein Expression)))<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 12p)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 6q)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;v)(q23;v))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hepatomegaly)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Heavy Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal Immunoglobulin Kappa Light Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Excludes_Normal_Cell_Origin<span class="some"> only </span>Mature B-Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Neoplastic B-Lymphoblast)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Precursor B-Lymphoblast). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2917</td>
               <td rowspan="5">Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Anemia<span class="subclass"> SubClassOf </span>Non-Neoplastic Hematologic<br><span class="keyword"> and </span>Lymphocytic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Abnormal Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Pleomorphic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Laboratory Test Result<span class="subclass"> SubClassOf </span>Clinical Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Monoclonal Paraproteinemia<span class="subclass"> SubClassOf </span>Paraproteinemia. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Paraproteinemia<span class="subclass"> SubClassOf </span>Abnormal Blood Chemistry<br><span class="keyword"> and </span>Hematology Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Abnormal Blood Chemistry<br><span class="keyword"> and </span>Hematology Test Result<span class="subclass"> SubClassOf </span>Abnormal Laboratory Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Clinical Test Result<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Laboratory Test Result<span class="subclass"> SubClassOf </span>Laboratory Test Result. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Ineffectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[i]</sup></div><br><i>(10)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(11)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Cyclin D1 Protein Overexpression<span class="subclass"> SubClassOf </span>Protein Deregulation. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Protein Deregulation<span class="subclass"> SubClassOf </span>Deregulation of Protein<br><span class="keyword"> and </span>Messenger RNA Expression. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Deregulation of Protein<br><span class="keyword"> and </span>Messenger RNA Expression<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Recurrent Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Recurrent Hematologic Malignancy<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(2)</i>&nbsp; Chromosomal Gain<span class="subclass"> SubClassOf </span>Numerical Chromosomal Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Cytogenetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Gain of Chromosome 5<span class="subclass"> SubClassOf </span>Chromosomal Gain. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Numerical Chromosomal Abnormality<span class="subclass"> SubClassOf </span>Cytogenetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Cytogenetic_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(8)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2918</td>
               <td rowspan="5">Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Anaplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Pleomorphic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Neoplastic Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Abnormal Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(4)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Pleomorphic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(3)</i>&nbsp; Neoplastic Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Pleomorphic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Malignant Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Malignant Cell<span class="subclass"> SubClassOf </span>Neoplastic Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Neoplastic B-Lymphocyte<span class="subclass"> SubClassOf </span>Neoplastic Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Abnormal Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Anaplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic Plasma Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease_May_Have_Abnormal_Cell<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(5)</i>&nbsp; Neoplastic Lymphocyte<span class="subclass"> SubClassOf </span>Abnormal Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Refractory Plasma Cell Myeloma<span class="subclass"> EquivalentTo </span>Plasma Cell Myeloma<br><span class="keyword"> and </span>Refractory Plasma Cell Neoplasm<br><span class="keyword"> and </span>(((Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>del(13q14))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Unfavorable Clinical Outcome))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Bone Pain)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hypercalcemia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Lytic Metastatic Bone Lesion)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pathologic Fracture)))<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Anaplastic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Flame Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Mott Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Plasmablast)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Pleomorphic Plasma Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Anemia)<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Renal Failure)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 11)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 15)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 19)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 3)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 5)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 7)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Gain of Chromosome 9)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 14)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome 8)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Loss of Chromosome X)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>Monosomy 13)<br><span class="keyword"> and </span>(Disease_May_Have_Cytogenetic_Abnormality<span class="some"> some </span>t(11;14)(q13;q32))<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Monoclonal Paraproteinemia)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Cyclin D1 Protein Overexpression). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Abnormal_Cell_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Abnormal Cell<span class="subclass"> SubClassOf </span>Abnormal_Cell_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Abnormal Hematopoietic<br><span class="keyword"> and </span>Lymphoid Cell<span class="subclass"> SubClassOf </span>Abnormal Cell. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Neoplastic Plasma Cell<span class="subclass"> SubClassOf </span>Neoplastic B-Lymphocyte. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td rowspan="5">2919</td>
               <td rowspan="5">Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  			
               </td>
               <td><i>(1)</i>&nbsp; Disease<br><span class="keyword"> or </span>Disorder<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Erythroderma<span class="subclass"> SubClassOf </span>Non-Neoplastic Skin Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Non-Neoplastic Disorder by Site<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Non-Neoplastic Disorder<span class="subclass"> SubClassOf </span>Disease<br><span class="keyword"> or </span>Disorder. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Disease_May_Have_Associated_Disease<span class="subclass"> Range </span>NCI_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Lutzner Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Non-Neoplastic Skin Disorder<span class="subclass"> SubClassOf </span>Non-Neoplastic Disorder by Site. 
                  						
                  <div style="display:inline;color:#323232" class="hotspot" onmouseout="tooltip.hide();" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');"><sup>[s]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal T-Cell Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Clonal T-Cell Receptor Beta Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal T-Cell Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Lutzner Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Clonal T-Cell Receptor Gamma Chain Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal T-Cell Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Clonal Gene Rearrangement<span class="subclass"> SubClassOf </span>Gene Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Clonal Antigen Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Clonal T-Cell Receptor Gene Rearrangement<span class="subclass"> SubClassOf </span>Clonal Antigen Receptor Gene Rearrangement. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<span class="subclass"> EquivalentTo </span>Mature T-Cell<br><span class="keyword"> and </span>NK-Cell Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Beta Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_May_Have_Molecular_Abnormality<span class="some"> some </span>Clonal T-Cell Receptor Gamma Chain Gene Rearrangement)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Cerebriform Lymphocyte)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Cutaneous Involvement)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Gene Abnormality<span class="subclass"> SubClassOf </span>Molecular Genetic Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Molecular Genetic Abnormality<span class="subclass"> SubClassOf </span>Molecular Abnormality. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Lutzner Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(9)</i>&nbsp; Molecular Abnormality<span class="subclass"> SubClassOf </span>Molecular_Abnormality_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(10)</i>&nbsp; Molecular_Abnormality_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(11)</i>&nbsp; Disease_May_Have_Molecular_Abnormality<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Hyperkeratosis<span class="subclass"> SubClassOf </span>Morphologic Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Morphologic Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Lutzner Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(6)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(7)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
            <tr class="removal">
               <td><i>(1)</i>&nbsp; Findings_and_Disorders_Kind<span class="subclass"> DisjointWith </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(2)</i>&nbsp; Pruritus<span class="subclass"> SubClassOf </span>Integumentary System Signs<br><span class="keyword"> and </span>Symptoms. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(3)</i>&nbsp; Other Finding<span class="subclass"> SubClassOf </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(4)</i>&nbsp; Integumentary System Signs<br><span class="keyword"> and </span>Symptoms<span class="subclass"> SubClassOf </span>Symptom. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(5)</i>&nbsp; Disease, Disorder<br><span class="keyword"> or </span>Finding<span class="subclass"> SubClassOf </span>Findings_and_Disorders_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(6)</i>&nbsp; Sezary Syndrome<span class="subclass"> EquivalentTo </span>Aggressive Non-Hodgkin Lymphoma<br><span class="keyword"> and </span>Leukemic Phase of Lymphoma<br><span class="keyword"> and </span>Mycosis Fungoides<br><span class="keyword"> and </span>Sezary Syndrome<br><span class="keyword"> and </span>(((Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Lutzner Cell)<br><span class="keyword"> and </span>(Disease_May_Have_Abnormal_Cell<span class="some"> some </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Peripheral Blood Involvement))<br><span class="keyword"> or </span>((Disease_May_Have_Finding<span class="some"> some </span>Pautrier Microabscess Present)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Single Cell Exocytosis)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Epidermotropic Lymphocytic Infiltrate)))<br><span class="keyword"> and </span>(Disease_May_Have_Associated_Disease<span class="some"> some </span>Erythroderma)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Alopecia)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Hyperkeratosis)<br><span class="keyword"> and </span>(Disease_May_Have_Finding<span class="some"> some </span>Pruritus)<br><span class="keyword"> and </span>(Disease_Has_Abnormal_Cell<span class="some"> only </span>Sezary Cell)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Hematopoietic System)<br><span class="keyword"> and </span>(Disease_Has_Associated_Anatomic_Site<span class="some"> only </span>Skin)<br><span class="keyword"> and </span>(Disease_Has_Finding<span class="some"> only </span>Lymphadenopathy)<br><span class="keyword"> and </span>(Disease_Has_Normal_Cell_Origin<span class="some"> only </span>Peripheral Epidermotropic T-Lymphocyte). 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br><i>(7)</i>&nbsp; Symptom<span class="subclass"> SubClassOf </span>Other Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(8)</i>&nbsp; Finding<span class="subclass"> SubClassOf </span>Disease, Disorder<br><span class="keyword"> or </span>Finding. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Shared axiom between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[s]</sup></div><br><i>(9)</i>&nbsp; Disease_May_Have_Finding<span class="subclass"> Range </span>NCI_Kind. 
                  							
                  <div style="display:inline;color:#323232" class="hotspot" onmouseover="tooltip.show('Effectual change between Ontology 1 and 2');" onmouseout="tooltip.hide();"><sup>[e]</sup></div><br></td>
            </tr>
         </tbody>
         <tr class="withoutstyle">
            <td>&nbsp;</td>
         </tr>
      </table>
      <div id="shared" style="display:none" class="footnote">Shared axiom between Ontology 1 and 2.</div>
   </body>
</html>